AMENDING  EXECUTIVE  ORDER  12866:
GOOD  GOVERNANCE  OR  REGULATORY

USURPATION?  PART  I  AND  PART  II

HEARINGS

BEFORE THE

SUBCOMMITTEE ON INVESTIGATIONS AND

OVERSIGHT

COMMITTEE ON SCIENCE AND

TECHNOLOGY

ONE  HUNDRED  TENTH  CONGRESS

FIRST  SESSION

FEBRUARY  13,  2007

and

APRIL  26,  2007

Serial No. 110–4

and

Serial No. 110–21

Printed  for  the  use  of  the  Committee  on  Science  and  Technology

(

Available  via  the  World  Wide  Web:  http://www.house.gov/science

33–105PS

WASHINGTON  : 

2007

U.S.  GOVERNMENT  PRINTING  OFFICE

For sale by the Superintendent of Documents, U.S. Government Printing Office

Internet: bookstore.gpo.gov Phone: toll free (866) 512–1800; DC area (202) 512–1800

Fax: (202) 512–2104 Mail: Stop IDCC, Washington, DC 20402–0001

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00001 Fmt 5011 Sfmt 5011 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

COMMITTEE  ON  SCIENCE  AND  TECHNOLOGY

HON.  BART  GORDON,  Tennessee,  Chairman

JERRY  F.  COSTELLO,  Illinois
EDDIE  BERNICE  JOHNSON,  Texas
LYNN  C.  WOOLSEY,  California
MARK  UDALL,  Colorado
DAVID  WU,  Oregon
BRIAN  BAIRD,  Washington
BRAD  MILLER,  North  Carolina
DANIEL  LIPINSKI,  Illinois
NICK  LAMPSON,  Texas
GABRIELLE  GIFFORDS,  Arizona
JERRY  MCNERNEY,  California
PAUL  KANJORSKI,  Pennsylvania
DARLENE  HOOLEY,  Oregon
STEVEN  R.  ROTHMAN,  New  Jersey
MICHAEL  M.  HONDA,  California
JIM  MATHESON,  Utah
MIKE  ROSS,  Arkansas
BEN  CHANDLER,  Kentucky
RUSS  CARNAHAN,  Missouri
CHARLIE  MELANCON,  Louisiana
BARON  P.  HILL,  Indiana
HARRY  E.  MITCHELL,  Arizona
CHARLES  A.  WILSON,  Ohio

RALPH  M.  HALL,  Texas
F.  JAMES  SENSENBRENNER  JR.,

Wisconsin

LAMAR  S.  SMITH,  Texas
DANA  ROHRABACHER,  California
KEN  CALVERT,  California
ROSCOE  G.  BARTLETT,  Maryland
VERNON  J.  EHLERS,  Michigan
FRANK  D.  LUCAS,  Oklahoma
JUDY  BIGGERT,  Illinois
W.  TODD  AKIN,  Missouri
JO  BONNER,  Alabama
TOM  FEENEY,  Florida
RANDY  NEUGEBAUER,  Texas
BOB  INGLIS,  South  Carolina
DAVID  G.  REICHERT,  Washington
MICHAEL  T.  MCCAUL,  Texas
MARIO  DIAZ-BALART,  Florida
PHIL  GINGREY,  Georgia
BRIAN  P.  BILBRAY,  California
ADRIAN  SMITH,  Nebraska

SUBCOMMITTEE ON INVESTIGATION AND OVERSIGHT

HON.  BRAD  MILLER,  North  Carolina,  Chairman

JERRY  F.  COSTELLO,  Illinois
EDDIE  BERNICE  JOHNSON,  Texas
DARLENE  HOOLEY,  Oregon
STEVEN  R.  ROTHMAN,  New  Jersey
BRIAN  BAIRD,  Washington
BART  GORDON,  Tennessee

F.  JAMES  SENSENBRENNER  JR.,

Wisconsin

DANA  ROHRABACHER,  California
TOM  FEENEY,  Florida
MICHAEL  T.  MCCAUL,  Texas

RALPH  M.  HALL,  Texas

DAN  PEARSON  Subcommittee  Staff  Director

JAMES  PAUL  Democratic  Professional  Staff  Member

DOUG  PASTERNAK  Democratic  Professional  Staff  Member

TOM  HAMMOND  Republican  Professional  Staff  Member

STACEY  STEEP  Research  Assistant

(II)

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00002 Fmt 5904 Sfmt 5904 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

C O N T E N T S
February  13,  2007

Witness List .............................................................................................................
Hearing Charter ......................................................................................................

Page
2
3

Opening  Statements

Statement by Representative Brad Miller, Chairman, Subcommittee on Inves-
tigations and Oversight, Committee on Science and Technology, U.S. House
of Representatives ................................................................................................
Written Statement ............................................................................................
Statement by Representative F. James Sensenbrenner, Jr., Ranking Minority
Member,  Subcommittee  on  Investigations  and  Oversight,  Committee  on
Science and Technology, U.S. House of Representatives ..................................
Written Statement ............................................................................................
Prepared  Statement  by  Representative  Jerry  F.  Costello,  Member,  Sub-
committee  on  Investigations  and  Oversight,  Committee  on  Science  and
Technology, U.S. House of Representatives .......................................................
Prepared Statement by Representative Eddie Bernice Johnson, Member, Sub-
committee  on  Investigations  and  Oversight,  Committee  on  Science  and
Technology, U.S. House of Representatives .......................................................

Witnesses:

Ms.  Sally  Katzen,  Adjunct  Professor  and  Public  Interest/Public  Service  Fel-

low, University of Michigan Law School

Oral Statement .................................................................................................
Written Statement ............................................................................................
Biography ..........................................................................................................
Mr. David C. Vladeck, Director, Institute for Public Representation; Associate

Professor of Law, Georgetown University Law Center

Oral Statement .................................................................................................
Written Statement ............................................................................................
Biography ..........................................................................................................
Mr.  William  L.  Kovacs,  Vice  President,  Environment,  Technology,  and  Regu-

latory Affairs, U.S. Chamber of Commerce

Oral Statement .................................................................................................
Written Statement ............................................................................................
Biography ..........................................................................................................
Financial Disclosure .........................................................................................

Mr. Rick Melberth, Director of Regulatory Policy, OMB Watch

Oral Statement .................................................................................................
Written Statement ............................................................................................
Biography ..........................................................................................................

Discussion

Role of OIRA .........................................................................................................
Transparency Provisions .....................................................................................
Outside Comment on E.O. 12866 ........................................................................
Cost-Benefit Analyses ..........................................................................................
Market Failure Provisions ...................................................................................
More on Transparency Provisions ......................................................................
More on Market Failure Provisions ....................................................................
Regulation and the Public Interest .....................................................................

(III)

10
11

12
13

14

15

16
17
22

23
25
33

33
35
39
40

41
42
56

56
57
58
59
60
62
63
64

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00003 Fmt 5904 Sfmt 5904 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

IV

More on Transparency Provisions ......................................................................
Transparency Costs ..............................................................................................

Appendix  1:  Answers  to  Post-Hearing  Questions

Ms.  Sally  Katzen,  Adjunct  Professor  and  Public  Interest/Public  Service  Fel-
low, University of Michigan Law School ............................................................
Mr. David C. Vladeck, Director, Institute for Public Representation; Associate
Professor of Law, Georgetown University Law Center .....................................
Mr.  William  L.  Kovacs,  Vice  President,  Environment,  Technology,  and  Regu-
latory Affairs, U.S. Chamber of Commerce ........................................................
Mr. Rick Melberth, Director of Regulatory Policy, OMB Watch ..........................

Appendix  2:  Additional  Material  for  the  Record

Memorandum  for  Heads  of  Executive  Departments  and  Agencies,  and  Inde-
pendent  Regulatory  Agencies,  from  Rob  Portman,  Director,  Office  of  Man-
agement and Budget, April 25, 2007 ..................................................................
Analysis of E.O. 12866 with edits made by E.O. 13422 .......................................
While  on  the  Home  Front,  Unpublished  OP–ED  by  Dr.  Peter  Strauss,  Betts
Professor of Law, Columbia Law School ............................................................
Bush Order Limits Agencies’ ‘Guidance,’ by Cindy Skrzycki, Bloomberg News,
January 30, 2007 ..................................................................................................
Bush  order  on  government  regulation  stirs  debate,  by  Tabassum  Zakaria,
Reuters, January 30, 2007 ..................................................................................
Comments  submitted  by  the  Union  of  Concerned  Scientists,  February  12,
2007 .......................................................................................................................
Public  Citizen  position  on  the  January  2007  Executive  Order  and  Bulletin
on Guidance, January 2007 .................................................................................

C O N T E N T S

April  26,  2007

Witness List .............................................................................................................
Hearing Charter ......................................................................................................

Page
67
69

74

76

80
85

90
108

122

123

125

126

129

Page
134
135

Opening  Statements

Statement by Representative Brad Miller, Chairman, Subcommittee on Inves-
tigations and Oversight, Committee on Science and Technology, U.S. House
of Representatives ................................................................................................

142
Written Statement ............................................................................................ 1143

Statement  by  Representative  Dana  Rohrabacher,  Acting  Ranking  Minority
Member,  Subcommittee  on  Investigations  and  Oversight,  Committee  on
Science and Technology, U.S. House of Representatives ..................................
Written Statement ............................................................................................
Prepared  Statement  by  Representative  Jerry  F.  Costello,  Member,  Sub-
committee  on  Investigations  and  Oversight,  Committee  on  Science  and
Technology, U.S. House of Representatives .......................................................

Panel  1:

Mr.  Steven  D.  Aitken,  General  Counsel  for  the  Office  of  Information  and

Regulatory Affairs, Office of Management and Budget

Oral Statement .................................................................................................
Written Statement ............................................................................................
Biography ..........................................................................................................

Discussion

Executive Order Consultation Process ...............................................................

144
145

146

147
148
158

159

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00004 Fmt 5904 Sfmt 5904 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

V

Market Failure Provisions ...................................................................................
Transparency Provisions .....................................................................................
Confidentiality Concerns .....................................................................................
Regulatory Policy Officers ...................................................................................
Division of Power in the Federal Government ..................................................

Panel  2:

Mr. Peter L. Strauss, Betts Professor of Law, Columbia Law School

Oral Statement .................................................................................................
Written Statement ............................................................................................
Biography ..........................................................................................................
Dr.  Robert  W.  Hahn,  Executive  Director,  AEI–Brookings  Joint  Center  for

Regulatory Studies

Oral Statement .................................................................................................
Written Statement ............................................................................................
Biography ..........................................................................................................

Dr. Gary D. Bass, Executive Director, OMB Watch

Oral Statement .................................................................................................
Written Statement ............................................................................................
Biography ..........................................................................................................
Mr.  Richard  W.  Parker,  Professor,  University  of  Connecticut  Law  School
Oral Statement .................................................................................................
Written Statement ............................................................................................
Biography ..........................................................................................................

Discussion

More on Regulatory Policy Officers ....................................................................
More on Separation of Powers and Market Failure Provisions .......................
More on Transparency Provisions ......................................................................

Page
166
169
171
172
173

178
180
185

185
186
190

191
193
202

203
205
210

210
211
214

Appendix:  Additional  Material  for  the  Record

Changes  to  the  OMB  Regulatory  Review  Process  by  Executive  Order  13422,
CRS Report for Congress, Updated February 21, 2007 ....................................

218

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00005 Fmt 5904 Sfmt 5904 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00006 Fmt 5904 Sfmt 5904 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

AMENDING  EXECUTIVE  ORDER  12866:  GOOD
GOVERNANCE  OR  REGULATORY  USURPA-
TION?  PART  I

TUESDAY,  FEBRUARY  13,  2007

HOUSE OF REPRESENTATIVES,

SUBCOMMITTEE ON INVESTIGATIONS AND OVERSIGHT,

COMMITTEE ON SCIENCE AND TECHNOLOGY,

Washington, DC.

The  Subcommittee  met,  pursuant  to  call,  at  11:35  a.m.,  in  Room
2141  of  the  Rayburn  House  Office  Building,  Hon.  Brad  Miller
[Chairman of the Subcommittee] presiding.

(1)

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00007 Fmt 6633 Sfmt 6633 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

2

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00008 Fmt 6633 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

3

HEARING CHARTER

SUBCOMMITTEE ON INVESTIGATIONS AND OVERSIGHT

COMMITTEE ON SCIENCE AND TECHNOLOGY

U.S. HOUSE OF REPRESENTATIVES

Amending Executive Order 12866:

Good Governance or

Regulatory Usurpation? Part I

TUESDAY, FEBRUARY 13, 2007

12:00 P.M.–1:30 P.M.

2141 RAYBURN HOUSE OFFICE BUILDING

Purpose

On  Tuesday,  February  13,  2007  the  Subcommittee  on  Investigations  and  Over-
sight of the Committee on Science and Technology will hold a hearing to receive tes-
timony regarding the President’s recent amendment to Executive Order 12866. That
order  provides  guidance  to  agencies  for  submitting  proposed  regulations  to  the  Of-
fice of Management and Budget (OMB) for pre-approval.

The amendment (Executive Order 13422) expands this process by requiring agen-
cies to submit proposed significant guidance documents for pre-approval. The Order
also  requires  for  the  first  time  that  agencies  identify  in  writing  the  specific  market
failure or problem that warrants the proposed regulation or guidance; that a Presi-
dential appointee in each agency be designated as regulatory policy officer and that
officer must approve each regulatory undertaking by the agency.

The  hearing  will  explore  the  consequences  of  Executive  Order  12866,  as  it  has
been  used  by  the  Bush  Administration,  as  well  as  the  impact  of  this  amendment
to the order. Among the issues the Subcommittee will seek information on are:

1. What  has  been  the  record  of  OMB’s  use  of  Executive  Order  12866  to  date,

with particular attention to its use under the Bush Administration?

2. How will the expansion of OMB’s role impact the ability of agencies to follow

the laws passed by Congress to protect public safety and health?

3. What  are  the  practical  implications  of  having  a  Presidential  appointee  at
each  agency  act  as  a  minder  on  what  rule-making  work  can  be  started  at
an agency and what can leave the agency to go to OMB?

Witnesses
Sally  Katzen:  Adjunct  Professor  and  Public  Service  Fellow  at  University  of  Michi-
gan Law School: Former Director of OIRA during the Clinton Administration.
David Vladick: Professor of Law, Georgetown University Law Center.
Rick Melberth, Ph.D.: Director, Federal Regulatory Policy, OMB Watch
Bill  Kovacs:  Vice  President  for  Environment,  Technology,  and  Regulatory  Affairs,
U.S. Chamber of Commerce (minority witness).

Key Issues

Regulatory  authority  is  the  main  tool  Congress  has  used  to  charge  Executive
agencies  with  responsibilities  to  protect  the  environment,  public  health,  the  safety
of the workplace, the use of public lands and a myriad of other good purposes. Con-
gress  obviously  cannot  pass  a  law,  or  amend  statute,  every  time  a  new  threat  to
air or health arises. Instead, Congress puts into place general purposes, general au-
thority and a set of values that the agency should use in carrying out the law.

When the Office of Information and Regulatory Analysis (OIRA) injects itself into
the  regulatory  process  there  can  be  a  fine  line  between  guaranteeing  that  a  pro-
posed regulation is convincingly demonstrated and efficient in its likely outcome and
substituting the President’s values and preferences for the goals and purposes Con-
gress enacted in statute. This line can be crossed either in the guidance to agencies
from OIRA or by the way OIRA conducts itself.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00009 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

4

OIRA has quietly grown into the most powerful regulatory agency in Washington.
The  Reagan  Administration  used  OIRA  push  further  and  further  into  the  process
of vetting regulations. A string of Executive Orders in the 1980s, many issued dur-
ing  David  Stockman’s  tenure  at  OMB,  forced  agencies  to  let  OIRA  be  a  full  part-
ner—some  thought  dominant  partner—in  moving  regulations  forward.  Several
House  Chairs  fought  a  very  bitter  struggle  to  push  OIRA  back  out  of  the  business
of  interfering  with  the  conduct  of  agencies  as  they  carried  out  the  law.  That  fight
met only mixed success.

As discussed below, E.O. 12866 was a Clinton-era effort to retain Reagan-initiated
White  House  oversight  of  agency  regulatory  processes  that  had  been  the  product  of
Reagan  initiatives,  balanced  against  the  recognition  that  agencies  should  have  pri-
macy in the regulatory process. The thrust of E.O. 12866 was to pare back the array
of  regulatory  actions  that  would  be  swept  up  into  OIRA’s  review  (the  estimate  was
that the annual number of regulations for review declined from 2000 to a mere 500
or so). Clinton’s OIRA, while still assertive, was cognizant that it was ultimately the
agencies  that  were  charged  by  Congress  with  carrying  out  public  purposes  and
OIRA’s assertions of authority had to be tempered by that legal reality.

The  Bush  Administration  has  moved  very  aggressively  to  supplant  the  agencies’
authority  with  a  centralized  command-and-control  system  whereby  OIRA  acts  as  a
very  stingy  gatekeeper  on  what  proposed  regulations  can  see  the  light  of  day.  In
tone, OIRA has returned to the Reagan-era where OIRA uses its privileged position
as ‘‘the President’s voice’’ in regulatory matters, to push agencies into rethinking ev-
erything they are doing on regulation.

Critics of OIRA’s role since 2001 describe a process whereby the values and judg-
ments of OIRA’s small staff (dominated by economists) trump the judgments of tech-
nical  experts  in  the  agencies  and  supplant  the  values  in  statute  designed  to  guide
agency  regulatory  activities.  The  cumulative  effect  of  OIRA’s  behavior  since  2001
has  been  to  intimidate  agencies  into  running  away  from  pursuing  their  statutory
responsibilities  rather  than  get  caught  up  in  the  political  struggles  associated  with
moving regulation forward. Supporters of this approach are happy to see some office
moving  to  slow  agency  actions  and  argue  that  the  net  result  of  OIRA’s  actions  is
a more defensible regulation at the end of the day.

How does all this matter for science and the agencies under the Science Commit-

tee’s jurisdiction?

Every  year  the  Federal  Government  funds  billions  of  dollars  of  research  at  the
Environmental  Protection  Administration,  the  Department  of  Labor,  the  Depart-
ment of Transportation, the Department of Agriculture, the Department of the Inte-
rior, the Department of Energy and the National Oceanic and Atmospheric Adminis-
tration  that  contribute  directly  or  indirectly  to  regulatory  considerations.  Even  the
National Institutes of Health and the National Science Foundation fund science that
finds  its  way  into  regulatory  proposals.  Experts  at  agencies—often  federal  sci-
entists—charged  with  regulatory  responsibilities  survey  the  relevant  scientific  lit-
erature  to  determine  where  there  may  be  dangers  to  the  public  or  the  public  inter-
est.  In  determining  the  need  for  a  regulation,  the  agency  uses  science  funded  with
public  dollars,  as  well  as  that  from  private  sources,  to  make  reasoned  assessments
of  risks  and  propose  responses.  This  is  all  to  be  done  consistent  with  statutory  re-
sponsibilities as established by Congress.

OIRA  has  been  using  its  circulars  to  force  agencies  to  analyze  and  reanalyze  the
information underlying and supporting proposed regulations. Now, with the amend-
ed Executive Order, OIRA is putting in place very clear economic criteria for regula-
tion and guidance that may have nothing to do with the values established in stat-
ute.  This  effort  is  coming  with  no  consultation  or  input  from  Congress.  Further,  by
making the regulatory policy officer a more empowered gatekeeper, with political al-
legiance  to  the  President,  it  raises  the  chances  that  the  agencies  themselves  will
find it hard during the Bush years to get regulatory proposals started or completed
simply  to  submit  them  to  OIRA  for  review.  Congress  did  not  empower  agencies  to
protect  public  health  and  safety  simply  to  then  sit  on  its  hands  to  see  all  Congress
appropriates  for  regulatory-relevant  science  and  the  legal  authority  seated  in  agen-
cies be trumped through a sweeping Executive Order.
Background
Brief  History  of  OMB:  What  is  now  known  as  the  Office  of  Management  and
Budget  (‘‘OMB’’)  was  originally  created  in  the  Budget  and  Accounting  Act  of  1921.1
The  Act  created  the  Bureau  of  Budget  (‘‘BOB’’)  in  the  Treasury  Department.  Con-
gress  created  the  BOB  to  unify  the  budget  process  and  have  the  executive  branch

1 42 Stat. 22, Ch. 18, Sec. 207. OMB currently resides at U.S.C. Title 31, Chapter 5 (31 U.S.C.

Sec. 501).

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00010 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

5

send  a  single  budget  to  Congress.  Previously,  the  executive  branch  transmitted
budgets  to  Congressional  committees  independently  of  one  another,  and  the  budget
process  was  consequently  highly  fragmented.  Created  at  the  same  time  was  the
Congress’s General Accounting Office (now the Government Accountability Office) to
give Congress an ability to independently check the budgetary information from the
Executive as well as to examine the way programs were being funded and managed.
In  1939,  Congress  moved  the  BOB  from  the  Treasury  Department  to  the  Execu-
tive Office of the President.2 FDR, largely through executive order, expanded BOB’s
functions to include broad management oversight of federal operations.

In  1970,  BOB  went  through  another  major  reorganization  which  saw  it  trans-
formed  into  OMB.3 At  this  time,  the  federal  management  oversight  functions  of
OMB were expanded, and have continued to be expanded until the present day.

The next major change to OMB occurred with the 1980 Paperwork Reduction Act.4
This  act  created  the  Office  of  Information  and  Regulatory  Affairs  (‘‘OIRA’’)  within
OMB.5 OIRA’s  original  charge  was  primarily  to  reduce  the  Government  paperwork
burden on the public and to develop policies and standards with regard to informa-
tion management. One focus of this was to eliminate duplicitous or unnecessary pa-
perwork and information collections.

Other  major  laws  affecting  OMB  are  the  Congressional  Budget  Act  of  1974,  and
the  Budget  Enforcement  Act  of  1990.  The  Budget  Enforcement  Act  expired  in  2002.
OIRA and Executive Order 12866: The  Office  of  Information  and  Regulatory  Af-
fairs (‘‘OIRA’’) was created with the 1980 Paperwork Reduction Act.6 Under the ena-
bling  act,  OIRA  was  charged  with  reducing  the  Government  paperwork  burden  on
the  public  and  developing  policies  and  standards  with  regard  to  information  man-
agement. Throughout the years, OIRA’s functions have been expanded through leg-
islation  and  executive  action.  The  major  surviving  changes  include  the  Paperwork
Reduction  Act  of  19957 and  Executive  Order  #12866  (1993).  In  addition,  during
the  current  Bush  Administration,  OIRA  has  come  to  oversee  implementa-
tion of the Data Access Law8 and the Data Quality Law,9 including the peer
review practices of agencies. The effect of these, and other changes to OIRA, has
guaranteed that OIRA is the central player in the promulgation of virtually all fed-
eral regulations.

Executive Order 12866 requires the following from all agencies:

1. Assess the economic costs and benefits of all regulatory proposals;
2. Complete  a  Regulatory  Impact  Analysis  (RIA)  for  all  major  rules  (any  rule
that  will  have  an  impact  of  $100  million  or  more,  or  that  OMB  designates
as major). The RIA must describe the costs and benefits of the proposed rule
and alternative approaches, and then justify the chosen approach;

3. Submit all major proposed and final rules to OMB for review;
4. Wait  until  OMB  reviews  and  approves  the  rule  before  publishing  proposed

and final rules;

5. Submit  an  annual  plan  to  OMB  to  establish  regulatory  priorities  and  im-
prove  coordination  of  the  Administration’s  regulatory  program  (this  require-
ment also applies to independent agencies);

6. Periodically review existing rules.

Most of these requirements actually originated in earlier administrations (particu-
larly  the  Reagan  Administration).  The  initiatives  of  the  Reagan  years  had  turned
OIRA into a kind of ‘‘gatekeeper’’ that stood between the agencies and putting regu-
lations  out  for  comment  (or  finalizing  them).  However,  the  Clinton  Administration
intended  to  set  a  different  tone  and,  drawing  on  what  they  felt  to  be  the  best  of
the ideas of the Reagan years, drafted a new Executive Order to organize and guide
the work of OIRA.

Sally  Katzen,  an  attorney  by  training  with  experience  in  the  Carter  Administra-
tion’s  management  system,  took  the  lead  in  drafting  E.O.  12866.  That  process  in-
volved  comment  and  review  from  all  the  agencies,  as  well  as  participation  by  OMB
General  Counsel,  White  House  Counsel  and  Domestic  Policy  Staff  and  even  the
President himself. What Katzen attempted to do has been described as the ‘‘hot tub

2 53 Stat. 1423, Sec. 1.
3 84 Stat. 2085, Sec. 102(a), restated 88 Stat. 11, Sec. 1.
4 44 U.S.C. Chapter 35, P.L. 96–511, restated P.L. 104–13, 109 Stat. 163.
5 44 U.S.C. Sec. 3503.
6 44 U.S.C. Chapter 35, P.L. 96–511, restated P.L. 104–13, 109 Stat. 163.
7 44 U.S.C. Chapter 35, P.L. 104–13, 109 Stat. 163.
8 P.L. 105–277, 112 Stat 2681.
9 P.L. 106–554, Sec. 515, 114 Stat. 2763.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00011 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

6

theory’’ of managing regulation. Rather than being a gatekeeper, OIRA would work
with  agencies  to  put  out  the  best  regulations  possible.  The  economics  of  a  proposal
were important, but not to the exclusion of other values. Indeed, there was recogni-
tion  that  not  everything  valued  by  society  could  have  a  dollar  value  assigned  to  it.
In addition, some statutes require agencies to consider economic costs only
in choosing among alternatives for achieving the goal of the regulation, not
whether to issue the regulation or not.

Clinton’s  approach  changed  regulatory  oversight.  First,  it  set  up  a  90-day  period
for  OMB  review  of  proposed  rules,  and  created  a  mechanism  for  the  timely  resolu-
tion  of  disputes  between  OMB  and  agency  heads.  There  would  be  no  ‘‘paralysis  by
analysis’’  if  these  commitments  were  kept.  Second,  it  created  new  public  disclosure
requirements which mandated that all documents exchanged between OMB and the
agency  during  regulatory  review  be  made  available  to  the  public  at  the  conclusion
of  the  rule-making.  Lastly,  the  Order  created  a  process  for  meetings  between  OMB
officials  and  people  outside  the  executive  branch  regarding  pending  reviews  which
attempted to shine a more public light on these types of meetings.

These aspects of E.O. 12866 made the OMB regulatory review process much more
transparent and limited OMB’s ability to ‘‘kill’’ agency rule-making by endless OMB
review.  The  E.O.  also  focused  OMB  review  to  only  include  major  rule-making  in-
stead  of  all  rule-making,  reducing  the  number  of  regulations  reviewed  each  year
from 2,200 under Reagan, to about 500 under Clinton.
Bush  Amendments  to  E.O.  12866:  The  Bush  Administration  has  amended  this
Executive  Order  two  times.  The  first  amendment  in  2002  simply  removed  the  Vice
President from the process, replacing that office with that of the White House chief
of  staff.  This  second  occasion  for  amendment  has  come  with  limited  warning,  little
discussion  and  with  much  broader  implications.  The  attached  CRS  report  goes  into
detailed  discussion  of  the  major  changes,  and  some  of  their  implications.  Below  is
a summary of the key observations.
1. Elevating ‘‘Market Failure’’:

First,  the  amendment  establishes  a  new  standard  that  must  be  met  by  any  pro-
posed  guidance  or  regulation.  Originally,  the  first  principle  guiding  submissions  to
OIRA seeking approval of a proposed regulation was that ‘‘[e]ach agency shall iden-
tify the problem that it intends to address (including, where applicable, the failures
of  private  markets  or  public  institutions  that  warrant  new  agency  action)  as  well
as assess the significance of that problem.’’

Under  the  amended  language,  ‘‘Each  agency  shall  identify  in  writing  the  specific
market  failure  (such  as  externalities,  market  power,  lack  of  information)  or  other
specific problem that it intends to address (including, where applicable, the failures
of public institutions) that warrant new agency action, as well as assess the signifi-
cance  of  the  problem,  to  enable  assessment  of  whether  any  new  regulation  is  war-
ranted.’’

Critics  of  OIRA  allege  that  this  new  standard  of  ‘‘market  failure’’  supplants  the
values  that  exist  in  statute  for  regulatory  action.  They  also  worry  that  OIRA  will
use this standard to summarily dispense with proposals that they deem to be uncon-
vincing  in  their  articulation  of  a  market  failure.  However,  there  is  permissive  lan-
guage allowing for other kinds of analysis. The core question will rest on how OIRA
applies this language in practice.
2. Presidential Appointees as Regulatory Policy Officers

The  amendment  directs  that  each  agency  shall  name  a  regulatory  policy  officer
who  shall  be  a  Presidential  appointee.  While  regulatory  policy  officers  had  been  re-
quired in the Executive Order as originally propounded in 1993, the notion that the
officer must be a Presidential appointee takes the expert staff of agencies out of the
picture.  The  language  of  the  amendment  charges  this  officer  with  being  ‘‘involved
at each stage of the regulatory process to foster the development of effective, innova-
tive, and least burdensome regulations and to further the principles set forth in this
Executive order.’’

This political appointee appears to serve as a kind of gatekeeper’s gatekeeper. The
officer will compose an annual plan and ‘‘no rule-making shall commence nor be in-
cluded  on  the  Plan  without  the  approval  of  the  agency’s  Regulatory  Policy  Office.’’
Previously  such  officers  were  to  be  involved  in  the  rule-making  process  and  now
they have total discretion over the initiation of work that could lead to a regulation.
(CRS  states  that  these  Regulatory  officers  are  largely  drawn  from  political  ap-
pointees  already  so  this  may  not  be  a  notable  change;  however,  the  source  on  that
is  OIRA  and  they  do  not  keep  a  master  list  of  these  officers  so  it  is  hard  to  know
how to evaluate this assertion.)

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00012 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

3. Aggregate Regulatory Costs and Benefits

7

The  original  of  12866  required  a  ‘‘summary  of  planned  significant  regulatory  ac-
tion including, to the extent possible, alternatives to be considered and preliminary
estimates  of  anticipated  costs  and  benefits.’’  The  amendment  expands  this  require-
ment  to  direct  that  each  agency  provide  the  ‘‘best  estimate  of  the  combined  aggre-
gate costs and benefits of all its regulations planned for that calendar year to assist
with the identification of priorities.’’

Critics allege that this will elevate cost-benefit analysis in the regulatory process.
Cost-benefit analysis is a very controversial analytical tool in guiding regulatory be-
havior. While the call to make sure that the benefits of a regulation exceed its costs
has  a  simple  appeal,  the  reality  is  that  many  of  the  benefits  regulations  are  de-
signed  to  capture  (the  survival  of  a  species,  to  protect  the  lives  and  health  of  citi-
zens,  the  quality  of  the  air  or  water)  are  impossible  to  accurately  value.  However,
the  costs  of  steps  to  implement  a  regulation  are  usually  easy  to  specify  with  preci-
sion.  The  result  is  a  process  that  tends  to  be  very  complete  in  its  enumeration  of
costs  and  incomplete  in  its  ability  to  set  values  on  the  benefits.  Retrospective  stud-
ies  have  found  that  costs  used  in  estimating  the  costs  of  a  regulation  turn  out  to
be  overstated.  And  of  course  because  you  are  using  ‘‘dollars’’  to  estimate  costs,  it
provides the illusion of a precision that does not—perhaps cannot—exist.

Critics  also  view  this  as  a  potential  first  step  towards  a  regulatory  ‘‘budget’’  that
could  be  used  to  stop  future  regulations  based  on  some  ‘‘capping’’  of  that  budget.
4. Review of Significant Guidance Documents

Under the amendment each agency is to provide OIRA with advance notice of all
proposed  significant  guidance  documents.  OIRA  may  then  decide  which  guidance  it
deems to be ‘‘significant’’ from its perspective and ask for the proposed guidance and
a  brief  explanation  of  need.  ‘‘The  OIRA  administrator  shall  notify  the  agency  when
additional  consultation  will  be  required  before  issuance  of  the  significant  guidance
document.’’

There  is  no  time  limit  on  how  long  OIRA  may  take  in  moving  on  these  guidance

proposals.

The impact on agency conduct may be very, very significant and could potentially
sweep up thousands of such proposals each year. Guidance is issued to communicate
to  an  effected  public  how  an  agency  intends  to  interpret  or  enforce  statutory  direc-
tions.  The  business  community  relies  on  guidance  to  ensure  that  conduct  will  com-
ply with agency intentions for application of law.
Conclusion

While  the  language  of  the  Amendment  to  Executive  Order  12866  is  alarming  to
many,  the  fundamental  issue  is  how  does  OIRA  intend  to  implement  it?  The  re-
emergence  of  the  ‘‘gatekeeper’’  approach  to  OIRA  under  President  Bush—an  event
that has not so far received the kind of institutional push-back from Congress which
that  role  drew  in  the  1980s—suggests  that  the  rule  as  amended  will  be  used  very
aggressively  to  stall  agency  action.  But  how  OIRA  intends  to  apply  this  language
in practice is a subject worth some study.

Two other issues loom large from the Committee on Science and Technology’s per-
spective. First, what will these changes imply for the science-based regulatory agen-
cies?  Will  we  increasingly  find  that  the  ‘‘science’’  that  matters  is  no  longer  that  of
climate,  biological  or  medical  researchers,  but  narrow  applications  of  cost-benefit
analysis and market failure theory drawn from economics? Should the science com-
mittee, uniquely positioned to examine and evaluate research, undertake a more rig-
orous  review  of  the  validity  and  utility  of  these  economic  approaches  to  regulation?
Second,  what  does  this  new  amendment  imply  for  the  institutional  prerogatives
of  the  legislative  branch?  Agencies  exist  in  statute  and  are  given  mandates  under
the  law.  Should  Congress  passively  accept  an  Executive  Order  that,  just  as  an  ex-
ample, places Presidential appointees in a position where they can arbitrarily block
career  agency  officials  from  carrying  out  the  purposes  of  the  law  Congress  charged
them with?

The growth of power at the Office of Information and Regulatory Affairs has gone
largely  unexamined  in  recent  years.  This  amendment  invites  Congress  as  a  body,
and  many,  many  Committees  that  are  affected,  to  undertake  a  vigorous  and  thor-
ough review of the changes in that office since 2001.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00013 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

Appendix:

8

Other Regulatory Tools that OMB has used to expand its Powers:

Data Quality: There were two recent acts of legislation that affected OMB’s over-
sight  of  data.  They  are  the  Data  Access  Law  and  the  Data  Quality  Law.  Both  of
these  laws  were  inserted  into  omnibus  appropriations  bills,  and  neither  was  fully
debated in Congress.

The entire Data Access Law consists of the following short passage:
‘‘Office of Management and Budget Salaries and Expenses

. . .Provided  further,  That  the  Director  of  OMB  amends  Section———.36
of OMB Circular A–110 to require federal awarding agencies to ensure that
all  data  produced  under  an  award  will  be  made  available  to  the  public
through  the  procedures  established  under  the  Freedom  of  Information  Act:
Provided  further,  That  if  the  agency  obtaining  the  data  does  so  solely  at
the  request  of  a  private  party,  the  agency  may  authorize  a  reasonable  use
fee equaling the incremental cost of obtaining the data. . .’’ 10

The purpose of the law was to increase public access to data conducted with fund-
ing  from  federal  grants.  Another  purpose  of  the  law  was  to  overturn  Forsham  v.
Harris,11 which stood for the principle that data generated by a privately controlled
organization  which  received  grant  funds  from  a  federal  agency  were  not  ’agency
records’ accessible under the Freedom of Information Act.

The Data Quality Act (‘‘DQA’’), was inserted into the FY 2001 Consolidated Appro-
priations Act.12 The Data Quality Act instructed OMB to establish guidelines to fed-
eral  agencies  for  ‘‘ensuring  and  maximizing  the  quality,  objectivity,  utility,  and  in-
tegrity  of  information  (including  statistical  information)  disseminated  by  federal
agencies.’’ Through its guidelines,13 OMB directed agencies to establish ‘‘administra-
tive mechanisms allowing affected persons to seek and obtain correction of informa-
tion  maintained  and  disseminated  by  the  agency.’’  To  date,  there  appears  to  have
been  over  100  DQA  petitions  filed  with  numerous  federal  agencies.  OMB  does  not
compile  a  list  of  DQA  petitions,  so  ascertaining  the  exact  number  of  petitions  filed
is cumbersome. OMB Watch (www.ombwatch.org) keeps track of the individual peti-
tions filed at each agency, and maintains a comprehensive list of DQA petitions.

Two major questions concerning the DQA remain unresolved. The first is whether
the  DQA  applies  to  agency  rule-making.  It  is  clear  that  the  DQA  applies  to  agency
action  outside  the  rule-making  process  (for  instance,  agency  dissemination  of  infor-
mation  through  websites).  However,  there  is  no  guidance  in  the  actual  legislation
as to the applicability of the DQA to rule-making. There appears to be a consensus
position  across  the  federal  agencies  that  the  DQA  doesn’t  apply  to  rule-making,  as
the  rule-making  process  already  allows  for  public  comment.  Furthermore,  the  DQA
contains  no  reference  to  the  Administrative  Procedure  Act.  Nevertheless,  industry
petitioners have successfully used the DQA petition process to influence agency rule-
making. One instance involves the chemical atrizine. As a result of a DQA petition,
the EPA included a sentence in a scientific assessment of the risks of atrazine that
stated  hormone  disruption  cannot  be  considered  a  ‘‘legitimate  regulatory  endpoint
at this time.’’ 14 Atrazine is banned in Europe precisely because of the evidence that
it is an endocrine disruptor. By attacking the science underlying potential rule-mak-
ing, the petitioners were able to avoid agency rule-making altogether.

Another  major  question  concerning  the  DQA  is  whether  DQA  petitions  are  judi-
cially reviewable. Thus far, the major case on the issue held that DQA petitions are
not  judicially  reviewable.15 However,  further  challenges  in  different  circuits  are
planned,  and  the  issue  may  not  be  fully  settled.  Judicial  review  of  DQA  petitions
would cause massive delays to the petition process.

DQA Based Regulations: OIRA developed two important new regulations based on
the  Data  Quality  Act:  OMB  Peer  Review  Guidelines16 and  OMB  Risk  Assessment
Bulletin  (Proposed).  OMB’s  Peer  Review  Guidelines  dictate  that  ‘‘important  sci-
entific  information  shall  be  peer  reviewed  by  qualified  specialists  before  it  is  dis-
seminated by the Federal Government.’’ The guidelines apply to all ‘‘scientific infor-

10 P.L. 105–277, 112 Stat. 2681.
11 445 U.S. 169 (1980).
12 P.L. 106–554, 114 Stat. 2763(A).
13 67 FR 8452 (2002).
14 Data Quality Law is Nemesis of Regulation, Washington Post, August 16, 2004.
15 Salt Institute v. Michael O. Leavitt, 440 F.3d 156 (2006).
16 70 FR 2664 (2005).

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00014 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

9

mation  disseminations  that  contain  findings  or  conclusions  that  represent  the  offi-
cial position of one or more agencies of the Federal Government.’’ OMB’s guidelines
establish  minimum  peer  review  standards  for  federal  agencies.  Varying  require-
ments  for  peer  review  are  established  based  on  the  potential  influence  of  the  sci-
entific  information,  with  ‘‘highly  influential  scientific  assessments’’  receiving  the
strictest  peer  review  requirements.  OMB  asserts  its  legal  authority  to  impose  the
Peer Review Guidelines flows from the Data Quality Act’s direction to OMB to pro-
vide  guidance  for  federal  agencies  for  ‘‘ensuring  and  maximizing  the  quality,  objec-
tivity, utility and integrity of information’’ which is disseminated.

OIRA recently proposed a Risk Assessment Bulletin.17 This has not yet been pub-
lished in its final form. The Risk Assessment Bulletin establishes ‘‘quality standards
for  risk  assessment  disseminated  by  federal  agencies.’’  Much  like  the  Peer  Review
Bulletin,  the  Risk  Assessment  guidelines  have  varying  levels  of  quality  standards.
There is one set of standards for general risk assessments and another set of strict-
er standards for influential risk assessments. Influential risk assessment is defined
as  ‘‘a  risk  assessment  the  agency  reasonably  can  determine  will  have  or  does  have
a  clear  and  substantial  impact  on  important  public  policies  or  private  sector  deci-
sions.’’ OMB again asserts legal authority to issue the bulletin arises from the Data
Quality  Act.  This  Risk  Assessment  proposal  was  soundly  rejected  by  the  National
Academy  of  Sciences  in  their  January  review.  That  step  seems  to  have  killed  the
proposal.
Analysis

The  effect  of  the  Data  Quality  Act,  Peer  Review  Bulletin  and  Risk  Assessment
Bulletin  is  to  impose  an  additional  layer  of  regulatory  administration  on  agencies
that,  for  the  most  part,  already  have  strong  internal  guidelines  (at  least  for  peer
review and risk assessment). The result of this will likely be greater delay in agency
dissemination  of  information,  and  a  chilling  effect  that  might  discourage  agencies
from  attempting  to  disseminate  information  in  the  first  place.  The  bulletins  also
represent another step in OMB’s continuing effort to insert itself into agency affairs.
In  addition,  the  possibility  remains  that  OMB  will  attempt  to  use  its  authority
under the Data Quality Act to insert itself into the agency rule-making process. This
could  potentially  reek  havoc  on  the  rule-making  process,  and  create  years  of  new
legal  challenges  related  to  the  rule-making  process.  Needless  to  say,  that  would
cause significant slowdown of an already slow rule-making process.

17 Notice of proposal at: 71 FR 2600. Text of the proposed bulletin is not published in the Fed-

eral Register.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00015 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

10

Chairman  MILLER.  The  Committee  hearing  will  come  to  order.
And  good  afternoon  to  all  of  you.  I  want  to  welcome  all  of  you  to
this first hearing of the Investigations and Oversight Subcommittee
of  the  Committee  of  Science  and  Technology  for  purposes  of  this
hearing on the growing role of the Office of Information and Regu-
latory Affairs, OIRA.

Mr.  Costello,  who  is  not  here,  will  serve  as  the  Vice  Chairman.
There has not been an Investigations and Oversight Subcommittee
of the Committee on Science and Technology for a dozen years, and
I look forward to working with all of you, the Members who are not
here,  plus  anyone  out  there  as  well,  and  working  with  all  of  you
on a very active, very engaged subcommittee.

We  will  work  to  expose  abuse  of  power,  corruption,  and  waste.
A  great  American  political  scientist,  Woodrow  Wilson,  called  that
the  informing  power  of  Congress,  and  said  that  it  was  probably
more  important  than  Congress’  legislative  powers.  The  light  we
shine  will  often  be  unwelcome  by  those  whose  conduct  we  illu-
minate,  but  unflattering  scrutiny  from  Congress  should  be  a
healthy deterrent to the abuse of power.

Today’s hearing is part of our oversight duties, to consider broad-
er  public  policy  questions  that  need  the  attention  of  Congress.  I
have heard the phrase ‘‘it takes an act of Congress’’ my entire life,
but  it  has  taken  on  new  meaning  for  me  in  these  last  four  years
that  I  have  served  in  Congress.  When  Congress  enacts  legislation
to  protect  public  health,  the  environment,  safety,  civil  rights,  pri-
vacy, and on and on, Congress cannot possibly anticipate every cir-
cumstance  that  will  arise,  and  Congress  cannot  possibly  address
every  new  circumstance  by  new  legislation.  So  Congress  has  long
delegated  to  federal  agencies  the  power  to  enforce  the  laws  that
Congress  passes,  and  to  adopt  regulations  that  address  cir-
cumstances  within  the  intended  protection  of  the  legislation,  but
not specifically addressed.

Federal  agencies  frequently  rely  on  scientific  research,  whether
applied or basic, to inform their decisions. Scientific research with-
in the jurisdiction of the Committee on Science and Technology, re-
search  by  NOAA,  EPA,  NIH,  the  Departments  of  Labor  and  Agri-
culture,  is  all  properly  part  of  rule-making  decisions,  as  are  the
standards  and  guidelines  work  at  NIST  and  the  Department  of
Transportation. We spend billions on that research. We should cer-
tainly examine how it is used in rule-making.

Rule-making decisions should properly be based on expertise, but
that  does  not  mean  that  they  are  beyond  challenge.  The  authority
of  federal  agencies  should  not  amount  to  government  by  Platonic
guardians,  experts  better  informed  and  wiser  than  we  are,  and
untroubled  by  tawdry  concerns  of  politics.  Congress  and  the  Presi-
dent should pay close attention when agencies act, and should pay
close  attention  when  agencies  fail  to  act.  And  we  should  pay  close
attention  to  the  reasons  for  agency  action  or  inaction,  to  what  ex-
tent  is  agency  action  or  inaction  based  on  considerations  of  sci-
entific  expertise  such  as  environmental  or  public  health  con-
sequences,  and  to  what  extent  is  agency  action  or  inaction  based
on economic or political considerations.

When  agencies  act,  they  must  explain  their  decisions  and  allow
public  participation  in  that  decision,  but  are  decisions  not  to  act

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00016 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

11

being  made  in  back  rooms,  based  upon  considerations  that  never
would  withstand  public  scrutiny?  Does  Executive  Order  13422  cre-
ate an almost insuperable bias in favor of agency inaction, even in
the  face  of  clear  need  for  action  and  a  clear  statutory  directive  to
act?  Does  the  order  shield  decisions  at  agencies  from  the  scrutiny
that they should receive? Does the order shift to the President pow-
ers  that  the  Framers  of  our  Constitution  intended  be  exercised  by
Congress?

I  welcome  the  testimony  of  our  distinguished  panelists  on  those
issues. I also look forward to working with our distinguished Rank-
ing  Member,  James  Sensenbrenner.  Mr.  Sensenbrenner  is  by  far
my  senior  in  Congress.  He  has  served  for  four  years  as  Chairman
of  the  Judiciary  Committee—excuse  me,  of  this  committee,  the
Committee  on  Science,  six  years  as  Chairman  of  the  Judiciary
Committee, and I hope he does not feel that after having been star
player in the big leagues, he has now been sent back to the minors.

[The prepared statement of Chairman Miller follows:]

PREPARED STATEMENT OF CHAIRMAN BRAD MILLER

I  want  to  welcome  all  of  you  to  this  first  hearing  of  the  Investigations  and  Over-
sight  Subcommittee  of  the  Committee  on  Science  and  Technology.  For  purposes  of
this hearing on the growing role of the Office of Information and Regulatory Affairs
(OIRA), Mr. Costello will serve as the Vice Chairman.

There has not been an Investigations and Oversight Subcommittee of the Science
and  Technology  Committee  for  a  dozen  years,  and  I  look  forward  to  working  with
all of you on a very active, very engaged subcommittee.

We  will  work  to  expose  abuse  of  power,  corruption  and  waste.  A  great  American
political  scientist,  Woodrow  Wilson,  called  that  the  ‘‘informing  power’’  of  Congress,
and said that it was probably more important than Congress’ legislative powers. The
light  we  shine  will  often  be  unwelcome  by  those  whose  conduct  we  illuminate,  but
unflattering  scrutiny  from  Congress  should  be  a  healthy  deterrent  to  the  abuse  of
power.

Today’s  hearing  is  part  of  our  oversight  duties,  to  consider  broader  public  policy

questions that need the attention of Congress.

I’ve heard the phrase ‘‘it takes an act of Congress’’ all of my life, but it has taken
on new meaning for me in first four years of my service in Congress. When Congress
enacts legislation—to protect public health, the environment, safety, civil rights, pri-
vacy,  and  on  and  on—Congress  cannot  possibly  anticipate  every  circumstance  that
will  arise,  and  Congress  cannot  possibly  address  every  new  circumstance  by  new
legislation.

So Congress has long delegated to federal agencies the power to enforce the laws
that  Congress  passes,  and  to  adopt  regulations  that  address  circumstances  within
the intended protection of the legislation, but not specifically addressed.

Federal  agencies  frequently  rely  on  scientific  research,  whether  applied  or  basic,
to  inform  their  decisions.  Scientific  research  within  the  jurisdiction  of  the  Com-
mittee on Science and Technology, research by NOAA, EPA, NIH, the Departments
of  Labor  and  Agriculture,  is  properly  part  of  rule-making  decisions,  as  are  the
standards and guidelines work at NIST and the Department of Transportation. We
spend  billions  on  that  research;  we  should  certainly  examine  how  it’s  used  in  rule-
making.

Rule-making  decisions  should  properly  be  based  on  expertise,  but  that  does  not
mean those decisions are beyond challenge. The authority of federal agencies should
not amount to government by Platonic guardians, experts better informed and wiser
than  we  are  and  untroubled  by  tawdry  political  concerns.  Congress  and  the  Presi-
dent  should  pay  close  attention  to  when  agencies  act,  and  to  when  agencies  fail  to
act,  and  we  should  pay  close  attention  to  the  reasons  for  agency  action  or  inaction.
To  what  extent  is  agency  action  or  inaction  based  on  considerations  of  scientific
expertise, such as environmental or public health consequences, and to what extent
is  agency  action  or  inaction  based  on  economic  or  political  considerations?  When
agencies act, they must explain their decisions and allow public participation in the
decision. But are decisions not to act being made in back rooms, based upon consid-
erations that would never withstand public scrutiny?

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00017 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

12

Does Executive Order 13422 create an almost insuperable bias in favor of agency
inaction,  even  in  the  face  of  a  clear  need  for  action  and  a  clear  statutory  directive
to  act?  Does  the  Order  shield  decisions  at  agencies  from  the  scrutiny  they  should
receive?  And  does  the  Order  shift  to  the  President  powers  that  the  framers  of  our
Constitution intended be exercised by Congress?

I welcome the testimony of our distinguished panelists on these issues.
I  also  look  forward  to  working  with  our  very  distinguished  Ranking  Member,
James Sensenbrenner. Mr. Sensenbrenner served for four years as Chairman of the
Committee on Science, and for six years on the Judiciary Committee. I hope he does
not feel that after being a star player in the big leagues, he has now been sent back
to the minors.

We very much welcome his experience and his expertise.
And I now recognize Mr. Sensenbrenner for his opening remarks.
Mr.  SENSENBRENNER.  I  thank  the  gentleman  from  North  Caro-
lina for his comments. I am not in the minor leagues. I have a little
bit  different  role,  and  not  only  is  this  role  to  keep  the  agencies  on
their  toes,  but  also,  to  keep  the  Chairman  and  the  Majority  on
their toes as well.

So,  I  would  like  to  welcome  him  to  the  Chair  of  the  Sub-
committee, and say that I am looking forward to working with him
and looking forward to making him a better Chair during the next
two years.

Chairman MILLER. Something for me to look forward to.
And  I  also  want  to  announce  the  one  baseball  analogy  is  out  of
deference and respect to our immediate past Chairman, Mr. Sherry
Boehlert,  but  it  will  be  the  policy  of  this  committee  going  forward
that  the  preferred  sports  analogy  are  analogies  to  college  basket-
ball.

Elections have consequences.
Mr.  SENSENBRENNER.  That  is  fine,  because  Wisconsin  is  ranked

third in the country, sir.

May I have an opening statement now?
Chairman  MILLER.  Actually,  that  is  in  my  remarks,  and  I  now

recognize Mr. Sensenbrenner for his opening remarks.

Mr.  SENSENBRENNER.  Although  this  is  the  first  Investigations
and  Oversight  Subcommittee  hearing  since  1995,  the  record  of
oversight under my chairmanship speaks for itself, from monitoring
the  status  of  the  Spallation  Neutron  Source  of  the  Department  of
Energy  to  evaluating  the  proposal  to  bring  Russia  into  the  Inter-
national Space Station Program, the Science and Technology Com-
mittee’s  vigilant  oversight  produced  better  programs  and  policies,
and  I  look  forward  to  returning  to  this  committee  and  continuing
the same rigorous oversight.

Having  been  the  Chair  of  two  committees,  I  am  uniquely  aware
of  the  topic  before  us,  and  I  am  glad  to  see  that  my  colleagues  on
the  Judiciary  Committee  have  taken  an  interest  as  well,  and  their
expertise is appreciated.

As for the Executive Order and the OMB Bulletin, I am inclined
to think that the issues that will be brought up today have less to
do  with  their  implications  and  more  to  do  with  who  issued  them.
While  I  do  get  concerned  when  any  Administration,  be  it  Repub-
lican  or  Democratic,  asserts  too  much  control  over  the  regulatory
process,  it  is  important  to  note  that  organizing  that  process  is  not
and should not be a partisan endeavor, and it certainly didn’t start
with the current President.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00018 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

13

President  Clinton,  just  like  several  Presidents  before  him,  used
the  regulatory  process  to  advance  his  own  agenda  in  the  waning
years of his Presidency. Ultimately, these policies last only as long
as the current Administration allows them to, and the best way to
ensure that longevity is to include the legislative branch. To quote
a recent article on the topic in CQ Weekly: ‘‘While executive power
is mighty, it is also ephemeral.’’ Most of the issues that the Execu-
tive  Order  and  the  OMB  Bulletin  address  are  simple  clarifications
of organizational changes that President Clinton’s Executive Order
12866,  and  will  ultimately  help  OMB  better  coordinate  the  regu-
latory process. None of the amendments call for additional hurdles
to be overcome. They simply require the reporting of work that has
already been done.

Additionally, none of the issues or changes are anything new. All
of  them  have  either  been  released  for  public  comment,  like  the
OMB Bulletin on guidance documents, or are clarifications to Presi-
dent  Clinton’s  original  Executive  Order.  For  example,  the  OMB
Bulletin  was  issued  in  draft  form  over  a  year  ago.  While  31  com-
ments were received, only three or four were negative. It is also in-
teresting  to  note  that  none  of  our  witnesses  here  today  chose  to
issue  comments  on  that  Bulletin,  save  Mr.  Kovacs.  But  OMB  will
have  an  opportunity  to  defend  their  document  at  the  next  hearing
before  the  Judiciary  Committee,  and  I  am  told  we  will  be  inviting
them back before us at a later time as well.

Right now, I am more concerned with the impact that these guid-
ance  documents  and  regulations  have  on  the  American  economy,
particularly small businesses that can’t afford high priced counsels
and lobbyists to monitor the thousands of guidance documents and
rules agencies issue each year. The increased use of guidance docu-
ments  by  agencies  to  circumvent  the  regulatory  process  has  been
diligently documented. They often conflict with each other, and are
not subject to public notice and comment, and rarely receive agency
approval, not to mention OMB review.

While  I  am  concerned  about  the  impact  that  Presidential  ap-
pointees  may  have  on  the  regulatory  process,  just  as  in  the  issue
of  market  failure,  these  issues  have  all  been  addressed  previously
by  other  Administrations  as  well.  In  reality,  the  EO  and  the  OMB
Bulletin simply formalize many of the principles derived under the
previous Administrations.

That  being  said,  as  a  part  of  this  committee’s  day-to-day  over-
sight, I will certainly follow how these changes are implemented to
ensure  that  public  health  and  safety  is  preserved,  and  that  there
is transparency and accountability in our regulatory process.

Thank you.
[The prepared statement of Mr. Sensenbrenner follows:]

PREPARED STATEMENT OF REPRESENTATIVE F. JAMES SENSENBRENNER, JR.

Although this is the first Investigation & Oversight hearing since 1995, the record
of  oversight  under  my  Chairmanship  speaks  for  itself.  From  monitoring  the  status
of  the  Spallation  Neutron  Source  at  the  Department  of  Energy  to  evaluating  the
proposal  to  bring  Russia  into  the  International  Space  Station  Program,  the  Science
and  Technology  Committee’s  vigilant  oversight  produced  better  programs  and  poli-
cies, and I look forward to returning to this committee and continuing the same rig-
orous oversight.

Having  been  Chairman  of  both  the  Science  and  Technology  Committee  and  the
Judiciary  Committee,  I  am  uniquely  aware  of  the  topic  before  us.  I  am  glad  to  see

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00019 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

14

my  colleagues  on  the  Judiciary  Committee  have  taken  an  interest  as  well,  as  their
expertise is certainly appreciated.

As  for  the  Executive  Order  and  the  OMB  Bulletin,  I  am  inclined  to  think  that
the  issues  that  will  be  brought  up  today  have  less  to  do  with  their  policy  implica-
tions,  and  more  to  do  with  who  issued  them.  While  I  do  get  concerned  when  any
Administration  (be  it  Republican  or  Democratic)  asserts  too  much  control  over  the
Regulatory Process, it is important to note that organizing that process is not a par-
tisan endeavor, and it certainly didn’t start with the current President.

President  Clinton,  just  like  several  Presidents  before  him,  used  the  regulatory
process  to  advance  his  own  agenda  in  the  waning  years  of  his  Presidency.  Ulti-
mately,  these  policies  last  only  as  long  as  the  current  Administration  allows  them
to,  and  the  best  way  to  ensure  their  longevity  is  to  include  the  Legislative  Branch.
To  quote  a  recent  article  on  the  topic  in  CQ  Weekly,  ‘‘while  Executive  power  is
mighty, it is also ephemeral.’’

Most  of  the  issues  that  the  E.O.  and  the  OMB  Bulletin  address  are  simple  clari-
fications and organizational changes to President Clinton’s E.O. (12866) and will ul-
timately  help  OMB  better  coordinate  the  regulatory  process.  None  of  the  amend-
ments  call  for  additional  hurdles  to  be  overcome;  they  simply  require  the  reporting
of  work  that  has  already  been  done.  Additionally,  none  of  these  issues  or  changes
are  anything  new—all  of  them  have  either  been  released  for  public  comment  (like
the  OMB  Bulletin  on  Guidance  Documents)  or  are  clarifications  to  President  Clin-
ton’s Executive Order.

For  example,  the  OMB  Bulletin  was  issued  in  draft  form  over  a  year  ago.  While
31  comments  were  received,  only  three  or  four  were  negative.  But  OMB  will  have
an  opportunity  to  defend  their  document  at  the  next  hearing  before  the  Judiciary
Committee,  and  I  am  told  we  will  be  inviting  them  back  before  us  at  a  later  time
as well.

Right  now  I  am  more  concerned  with  the  impact  that  these  guidance  documents
and  regulations  have  on  the  American  economy,  particularly  small  businesses  that
can’t  afford  high-priced  counsels  to  monitor  the  thousands  of  guidance  documents
and rules agencies issue a year.

The  increased  use  of  guidance  documents  by  agencies  to  circumvent  the  regu-
latory  process  has  been  diligently  documented.  They  often  conflict  with  each  other,
are  not  subject  to  public  notice  and  comment,  and  rarely  receive  agency  approval
(not to mention OMB review).

While  I  am  concerned  about  the  impact  that  Presidential  Appointees  may  have
on  the  regulatory  process,  just  as  in  the  issue  of  Market  Failure,  these  issues  have
all  been  addressed  previously  under  other  Administrations  as  well.  In  reality,  the
E.O.  and  the  OMB  Bulletin  simply  formalize  many  of  the  principles  derived  under
those previous Administrations. That being said, as part of the Committee’s day-to-
day  oversight,  I  will  certainly  follow  how  these  changes  are  implemented  to  ensure
that  public  health  and  safety  is  preserved,  and  that  there  is  transparency  and  ac-
countability in our regulatory process.

I look forward to our witnesses’ testimony today.
Chairman MILLER. Thank you, Mr. Sensenbrenner.
[The prepared statement of Mr. Costello follows:]

PREPARED STATEMENT OF REPRESENTATIVE JERRY F. COSTELLO

Good afternoon. Thank you, Mr. Chairman, for calling this hearing to examine the
consequences  of  President  Bush’s  recent  amendment  to  Executive  Order  12866,
which requires Federal Government agencies to submit any proposed regulations to
the Office of Management and Budget (OMB) for pre-approval.

The  Science  and  Technology  Committee  has  the  authority  to  examine  and  evalu-
ate  the  validity  and  utility  of  economic  approaches  to  regulation.  Further,  agencies
exist  in  statute  and  are  given  mandates  under  the  law  issued  by  Congress.  The
amendment put in place by the Bush Administration goes one step further than the
current process by requiring agencies to identify in writing the specific market fail-
ure or problem that warrants the proposed regulation or guidance. Therefore, I look
forward  to  hearing  the  perspective  of  the  witnesses  as  to  how  they  perceive  the
Bush  Administration  will  implement  its  new  amendment  to  Executive  Order  12866
and their assessment on how this will impact science-based regulatory agencies and
public safety.

I welcome today’s witnesses and look forward to their testimony.
[The prepared statement of Ms. Johnson follows:]

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00020 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

PREPARED STATEMENT OF REPRESENTATIVE EDDIE BERNICE JOHNSON

15

Thank you, Mr. Chairman. The President amended a key executive order to tight-
en  the  president’s  grip  on  federal  agencies  that  enforce  health,  safety  and  environ-
mental protections.

This  order  gives  the  White  House’s  Office  of  Information  and  Regulatory  Affairs
(OIRA)  enhanced  tools  to  oversee  and  interfere  with  federal  regulations  on  every-
thing  from  warning  labels  on  medicines  to  safety  standards  for  construction  work
sites.

Executive  Order  12866  built  on  a  Clinton-era  executive  order  which  authorized
OIRA  to  use  cost-benefit  analysis  and  other  market-based  calculations  to  evaluate
rules and regulations proposed by federal agencies.

The  Executive  Order  now  enables  the  Bush  Administration  to  oversee  not  only
regulations,  but  also  guidance  documents  that  agencies  issue  to  inform  the  public
about  how  rules  will  be  enforced.  OIRA  can  now  examine  all  significant  guidance.
The  amended  executive  order  also  now  lists  the  economic  concept  of  market  fail-

ure as a standard for reviewing a proposed rule.

The notion of the free market having the ability to eventually resolve public needs
could  become  an  expansive  pretext  for  OIRA  to  dismiss  crucial  regulatory  protec-
tions.

I  welcome  the  witnesses  who  are  here  today,  especially  Sally  Katzen,  the  creator

and Former Director of OIRA under the Clinton Administration.

Thank you, Mr. Chairman. I yield back.
Chairman  MILLER.  I  would  now  like  to  welcome  our  witnesses.
Today,  we  are  honored  to  have  a  very  distinguished  and  knowl-
edgeable panel of witnesses.

Ms.  Sally  Katzen,  the  former  head  of  the  Office  of  Information
and Regulatory Affairs, again OIRA, in the Clinton Administration,
and  currently  a  professor  at  the  University  of  Michigan  Law
School.  She  is  a  recognized  expert  in  federal  regulatory  matters,
and we are very pleased to have her here today.

Mr.  David  Vladeck  is  a  Director  of  the  Institute  for  Public  Rep-
resentation, and a professor at Georgetown University Law Center.
He  is  also  an  expert  in  administrative  and  regulatory  law,  topics
on which he writes and testifies frequently before Congress.

Dr. Rick Melberth is the Director of Federal Regulatory Policy for
OMB Watch, which works to protect and improve the government’s
ability  to  develop  and  enforce  safeguards  for  public  health,  safety,
the environment, and civil rights.

And  finally,  Mr.  Bill  Kovacs  is  the  Vice  President  for  Environ-
ment,  Technology,  and  Regulatory  Affairs,  the  Regulatory  Affairs
Division  for  the  United  States  Chamber  of  Commerce.  That  divi-
sion is responsible for such significant issues, including the system-
atic  application  of  sound  science  to  the  federal  regulatory  process.
Now,  it  is  the  custom  of  the  Investigations  and  Oversight  Sub-
committee,  well,  going  back  a  dozen  years,  when  we  last  had  one,
it is the custom of the Investigations and Oversight Subcommittee,
and it will be our custom going forward, we are establishing it now,
to swear in our witnesses.

Do any of you have any objection to being sworn in? Okay. If not,

then if you would please stand and raise your right hand.

[Witnesses sworn.]
Chairman MILLER. We will now hear the statements of the entire
panel,  beginning  with  Ms.  Katzen.  To  the  panel,  please  limit  your
remarks to five minutes. We do have written testimony from all of
you.

After all the statements have been received, the oral statements,

all Members will have five minutes to ask questions.

Ms. Katzen, I think we begin with you.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00021 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

16

STATEMENT  OF  MS.  SALLY  KATZEN,  ADJUNCT  PROFESSOR
AND  PUBLIC  INTEREST/PUBLIC  SERVICE  FELLOW,  UNIVER-
SITY OF MICHIGAN LAW SCHOOL
Ms.  KATZEN.  Thank  you  very  much,  and  thank  you  for  inviting

me to testify today.

During  the  last  six  years,  there  has  been  a  slow  but  steady
change in the process by which federal regulatory agencies develop
and  issue  regulations,  specifically  in  the  balance  of  authority  be-
tween  those  agencies  and  the  Office  of  Management  and  Budget.
With  its  most  recent  actions,  the  Bush  Administration  has  taken
yet  another  step  restricting  agency  discretion  and  making  it  more
difficult for the agencies to do the job that Congress has delegated
to them.

As you mentioned in your introduction, I served as the Adminis-
trator  of  OIRA  for  over  five  years  during  the  Clinton  Administra-
tion, and was involved in the drafting and implementation of Exec-
utive  Order  12866.  I  am  a  strong  proponent  of  centralized  review
of  agency  rule-making,  and  have  often  spoken  and  written  in  sup-
port  or  defense  of  OIRA.  I  am  also  a  strong  proponent  of  regula-
tions, believing that if carefully crafted, they can improve the qual-
ity  of  our  lives,  the  performance  of  our  economy,  and  our  nation’s
well-being.

Why,  then,  am  I  so  critical  of  the  new  Executive  Order?  I  have
prepared  written  testimony  that  provides  extensive  background
and  explanatory  information.  I  would  like  to  use  my  five  minutes
to emphasize several important points. First, the Bush Administra-
tion  has  taken  many  discrete  steps  to  tighten,  incrementally  to  be
sure,  but  tighten  nonetheless  OMB  control  over  the  agencies.  The
information  or  data  quality  guidelines,  the  peer  review  guidelines,
Circular  A–4  for  regulatory  analyses,  the  Risk  Assessment  Bul-
letin,  and  now,  the  Bulletin  on  Good  Guidance  Practices,  all  of
which are described in my written testimony.

Now, each step, standing on its own, can be justified or defended,
and  none,  standing  on  its  own,  warrants  the  outrage  that  was  di-
rected  at  them  by  the  critics  of  the  Administration.  At  the  same
time, the cumulative effect has been overwhelming on the agencies,
and there is a dramatically different dynamic between the agencies
and the White House than there was at the end of the Clinton Ad-
ministration.

In Executive Order 12866, President Clinton continued the prac-
tice of centralized review of rule-makings by OIRA, but at the same
time,  he  reaffirmed  the  primacy  of  the  agencies,  which  are  the  re-
positories  of  significant  expertise  and  experience,  and  the  entities
to  which  Congress  has  delegated  the  authority  to  issue  rules  that
have  the  force  and  effect  of  law.  Today,  those  same  agencies  have
at least one arm tied behind their backs, two ten pound bricks tied
to  their  ankles,  and  they  are  set  on  an  obstacle  course  to  navigate
before they can issue any regulations. Forgive me for mangling my
metaphors,  but  the  combination  of  all  the  multiple  mandates  that
OMB has imposed on the agencies makes it so much more difficult
for  them  to  do  their  job.  Oversight  is  one  thing—I  am  talking  of
Presidential  oversight—but  burdening  the  agencies  to  slow  them
down, or destroy their morale, is something else.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00022 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

17

Now,  I  have  heard  that  there  is  nothing  new  in  the  Executive
Order. It is all business as usual. It is simply what the Clinton Ad-
ministration had done. That is not the case. This is a dramatically
different  environment,  and  a  dramatically  different  thrust.  And  I
can go into detail, if you would like, during questions.

It  is  also—the  one  explanation  that  was  given  when  the  Execu-
tive Order was issued, had to do with increasing transparency and
producing better decisions. That simply is not credible. Look at the
way  it  was  done.  There  was  no  consultation  or  explanation.  Look
at  the  effect  it  has  on  the  agencies,  coming  on  the  heels  of  the
many  mandates  that  OMB  has  imposed  on  them,  and  look  at  the
message it sends. Regulations to protect the environment or to pro-
mote  the  health  and  safety  of  American  people  are  disfavored.  Let
the market, not the government, do it.

Executive  Order  12866,  as  originally  drafted,  was  neutral  as  to
process,  even  though  President  Clinton  was  highly  supportive  of
regulations as part of the solution to serious problems plaguing our
society. The Executive Order was not skewed to achieve a pro-regu-
latory  result.  It  was  not  a  codification  of  a  pro-regulatory  philos-
ophy  or  ideology.  It  was,  on  its  face  and  by  intent,  a  charter  for
good  government,  without  any  predetermination  of  outcomes.  Sim-
ply  stated,  the  agencies’  regulations  would  be  debated  on  the  mer-
its, not preordained by the process through which they were devel-
oped and issued.

In  light  of  the  actions  taken  over  the  last  six  years  by  the  Bush
Administration,  that  is  no  longer  the  case.  With  Executive  Order
12866,  as  amended,  each  step  in  the  process  of  extending  Presi-
dential  control  over  the  agencies  has  placed  a  thumb  on  the  scale.
By now, we have a whole fist influencing the outcome.

Thank  you  so  much  for  holding  this  hearing.  It  is  important  for
Congress to let the executive know that it takes these matters seri-
ously and is deeply concerned about the implications of their recent
actions on the integrity of the administrative process.

[The prepared statement of Ms. Katzen follows:]
PREPARED STATEMENT OF SALLY KATZEN

Chairman  Miller  and  Members  of  the  Subcommittee.  Thank  you  for  inviting  me
to testify today on a subject that is vitally important to the American people. During
the last six years, there has been a slow but steady change in the process by which
regulations  are  developed  and  issued—specifically,  in  the  balance  of  authority  be-
tween  the  federal  regulatory  agencies  and  the  Office  of  Management  and  Budget.
With  its  most  recent  actions,  the  Bush  Administration  has  again  restricted  agency
discretion and made it more difficult for them to do the job that Congress has dele-
gated  to  the  federal  agencies.  It  is  therefore  important  that  this  subcommittee  con-
sider the reasons for these changes and the implications of these changes for admin-
istrative law and regulatory practice.

I served as the Administrator of the Office of Information and Regulatory Affairs
(OIRA)  at  the  Office  of  Management  and  Budget  (OMB)  for  the  first  five  years  of
the  Clinton  Administration,  then  as  the  Deputy  Assistant  to  the  President  for  Eco-
nomic  Policy  and  Deputy  Director  of  the  National  Economic  Council,  and  then  as
the  Deputy  Director  for  Management  of  OMB.  I  am  a  proponent  of  centralized  re-
view  of  agency  rule-making,  and  I  was  personally  involved  in  the  drafting  and  im-
plementation  of  Executive  Order  12866.  I  have  remained  active  in  the  area  of  ad-
ministrative law generally and rule-making in particular. Since leaving government
service  in  January  2001,  I  have  taught  Administrative  Law  and  related  subjects  at
the  University  of  Michigan  Law  School,  George  Mason  University  Law  School,  and
the  University  of  Pennsylvania  Law  School,  and  I  have  also  taught  American  Gov-
ernment  seminars  to  undergraduates  at  Smith  College,  Johns  Hopkins  University,

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00023 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

18

and  the  University  of  Michigan  in  Washington  Program.  I  frequently  speak  and
have written articles for scholarly publications on these issues.

On January 18, 2007, the Bush Administration released two documents. One was
expected;  the  other  was  not.  I  can  understand  why  OMB  issued  a  ‘‘Final  Bulletin
for  Good  Guidance  Practices.’’  While  I  disagree  with  several  of  the  choices  made,  I
recognize  that  a  case  can  be  made  that  there  is  a  need  for  such  a  Bulletin.  On  the
other hand, there is no apparent need for Executive Order 13422, further amending
Executive  Order  12866.  Regrettably,  none  of  the  plausible  explanations  for  its
issuance is at all convincing. As I will discuss below, there are at least three aspects
of the new Executive Order that warrant attention: 1) the way it was done—without
any consultation or explanation; 2) the context in which it was done—coming on the
heels  of  OMB’s  imposing  multiple  mandates/requirements  on  the  agencies  when
they  are  developing  regulations;  and  3)  the  effect  it  will  have  and  the  message  it
sends to the agencies—it will be even more difficult for agencies to do their jobs be-
cause regulations are disfavored in this Administration.

To  put  the  most  recent  Executive  Order  in  perspective,  a  little  history  may  be
helpful. The first steps towards centralized review of rule-making were taken in the
1970’s  by  Presidents  Nixon,  Ford  and  Carter,  each  of  whom  had  an  ad  hoc  process
for  selectively  reviewing  agency  rule-makings:  President  Nixon’s  was  called  the
Quality  of  Life  Review;  President  Ford’s  was  focused  on  the  agency’s  Inflationary
Impact  Analysis  that  accompanied  the  proposed  regulation;  and  President  Carter’s
was  through  the  Regulatory  Analysis  Review  Group.  Those  rule-makings  that  were
considered  significant  were  reviewed  by  an  inter-agency  group,  which  then  contrib-
uted  their  critiques  (often  strongly  influenced  by  economists)  to  the  rule-making
record.

In  1981,  President  Reagan  took  a  significant  additional  step  in  issuing  Executive
Order 12291. That Order formalized a process that called for the review of all Exec-
utive Branch agency rule-makings—at the initial and the final stages—under speci-
fied  standards  for  approval.  The  Office  that  President  Reagan  chose  to  conduct  the
review was the Office of Information and Regulatory Affairs (OIRA), established by
the Congress for other purposes under the Paperwork Reduction Act of 1980. Unless
OIRA  approved  the  draft  notice  of  proposed  rule-making  and  the  draft  final  rule,
the agency could not issue its regulation.

Executive  Order  12291  was  highly  controversial,  provoking  three  principal  com-
plaints. One was that the Executive Order was unabashedly intended to bring about
regulatory  relief—not  reform—relief  for  the  business  community  from  the  burdens
of  regulation.  Second,  the  Order  placed  enormous  reliance  on  (and  reflected  un-
equivocal  faith  in)  cost/benefit  analysis,  with  an  emphasis  on  the  cost  side  of  the
equation.  Third,  the  process  was,  by  design,  not  transparent;  indeed,  the  mantra
was  ‘‘leave  no  fingerprints,’’  with  the  result  that  disfavored  regulations  were  sent
to OMB and disappeared into a big black hole. The critics of Executive Order 12291,
including Members of Congress, expressed serious and deep concerns about the Ex-
ecutive  Order,  raising  separation  of  powers  arguments,  the  perceived  bias  against
regulations, and the lack of openness and accountability of the process.

When President Clinton took office and I was confirmed by the Senate as the Ad-
ministrator  of  OIRA,  my  first  assignment  was  to  evaluate  Executive  Order  12291
in  light  of  the  12  years  of  experience  under  Presidents  Reagan  and  Bush,  and  help
draft a new Executive Order that would preserve the strengths of the previous Exec-
utive Order but correct the flaws that had made the process so controversial. Presi-
dent Clinton would retain centralized review of Executive Branch agency rule-mak-
ings, but the development and the tone of the Executive Order he would sign (Execu-
tive order 12866) was to be very different.

I  was  told  that  Executive  Order  12291  was  drafted  in  the  White  House  (Boyden
Gray  and  Jim  Miller  take  credit  for  the  document)  and  presented,  after  President
Reagan  had  signed  it,  as  a  fait  accomplis  to  the  agencies.  The  protests  from  the
agencies  were  declared  moot.  We  took  a  different  route,  consulting  and  sharing
drafts  with  the  agencies,  public  interest  groups,  industry  groups,  Congressional
staffers,  and  State  and  local  government  representatives.  When  all  their  comments
were  considered  and  changes  made  to  the  working  draft,  we  again  consulted  and
shared our new drafts with all the groups, and again took comments. More changes
were made, and where comments were not accepted, we explained the basis for our
decisions.

The tenor of Executive Order 12866 was also quite different from Executive Order
12291.  As  noted  above,  Executive  Order  12866  retained  centralized  review  of  rule-
makings, but also reaffirmed the primacy of the agencies to which Congress had del-
egated  the  authority  to  regulate.  (Preamble)  Among  other  things,  Executive  Order
12866 limited OIRA review to ‘‘significant regulations’’—those with a likely substan-
tial  effect  on  the  economy,  on  the  environment,  on  public  health  or  safety,  etc.,  or

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00024 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

19

those  raising  novel  policy  issues  (Section  6(b)(1) )—leaving  to  the  agencies  the  re-
sponsibility for carrying out the principles of the Executive Order on the vast major-
ity (roughly 85 percent) of their regulations.

Executive  Order  12866  continued  to  require  agencies  to  assess  the  consequences
of  their  proposals  and  to  quantify  and  monetize  both  the  costs  and  the  benefits  to
the  extent  feasible.  (Section  1(a) )  But  it  explicitly  recognized  that  some  costs  and
some  benefits  cannot  be  quantified  or  monetized  but  are  ‘‘nevertheless  essential  to
consider.’’  (Section  1(a) )  I  believe  it  was  Einstein  who  had  a  sign  in  his  office  at
Princeton to the effect that ‘‘not everything that can be counted counts, and not ev-
erything that counts can be counted.’’

While  Executive  Order  12291  required  agencies  to  set  their  regulatory  priorities
‘‘taking into account the conditions of the particular industries affected by the regu-
lations [and] the condition of the national economy’’ (Section 2 (e) ), Executive Order
12866  instructed  agencies  to  consider  ‘‘the  degree  and  nature  of  the  risks  posed  by
various  substances  and  activities  within  its  jurisdiction’’  (Section  1(b)(4) ),  and  it
added to the list of relevant considerations for determining if a proposed regulation
qualified  as  ‘‘significant’’  not  only  an  adverse  effect  on  the  economy  or  a  sector  of
the  economy,  but  also  ‘‘productivity,  competition,  jobs,  the  environment,  public
health or safety or State, local, or tribal governments or communities.’’ (Section 3(f) )
There  were  other  significant  differences  between  Executive  Order  12291  and  Ex-
ecutive  Order  12866,  including  those  relating  to  the  timeliness  of  review  and  the
transparency of the process, but for present purposes, the key to the difference was
that  President  Clinton  was  focused  on  a  process  for  better  decision-making  and
hence  better  decisions  and  not  a  codification  of  a  regulatory  philosophy  or  ideology.
Centralized review was seen as a valid exercise of presidential authority, facilitating
political  accountability  (the  President  takes  the  credit  and  gets  the  blame  for  what
his  agencies  decide)  and  to  enhance  regulatory  efficacy  (that  is,  decisions  that  take
into account the multitude of disciplines and the multitude of perspectives that can
and  should  be  brought  to  bear  in  solving  problems  in  our  complex  and  inter-
dependent  society).  But  whatever  one’s  view  of  centralized  review  of  agency  rule-
makings, Executive Order 12866 was—on its face and by intent—a charter for good
government, without any predetermination of outcomes.

The  neutrality  of  the  process  was  essential.  President  Clinton  viewed  regulations
as  perhaps  the  ‘‘single  most  critical. . .vehicle  to  achieve  his  domestic  policy  goals’’
(Kagan,  114  Harv.  L.  Rev.  2245,  2281–82  ((2001) ),  and  he  spoke  often  of  the  salu-
tary  effects  of  regulations  on  the  Nation’s  quality  of  life  and  how  regulations  were
part of the solution to perceived problems. But the Executive Order was not skewed
to achieve a pro-regulatory result. The regulations would be debated on their merits,
not preordained by the process through which they were developed and issued.

When George W. Bush became President in January 2001, his philosophy was de-
cidedly anti-regulatory. I know that his advisors considered whether to change Exec-
utive Order 12866 and they concluded that it was not necessary to accomplish their
agenda.  Indeed,  President  Bush’s  OMB  Director  instructed  the  agencies  to  scru-
pulously  adhere  to  the  principles  and  procedures  of  Executive  Order  12866  and  its
implementing  guidelines.  (OMB  M–01–23,  June  19,  2001)  The  only  changes  to  the
Executive  Order  came  two  years  into  President  Bush’s  first  term,  and  the  changes
were  limited  to  transferring  the  roles  assigned  to  the  Vice  President  to  the  Chief
of Staff or the OMB Director. (Executive Order 13258)

Almost  five  years  later,  President  Bush  signed  Executive  Order  13422,  further
amending  Executive  Order  12866.  So  far  as  I  am  aware,  there  was  no  consultation
and no explanation of the problems under the existing Executive Order that prompt-
ed these amendments, or whether the amendments would have a salutary effect on
whatever  problems  existed,  or  whether  the  amendments  would  have  unintended
consequences  that  should  be  considered.  Press  statements  issued  after  the  fact  do
not make for good government.

Second, the new Executive Order comes in the course of a steady and unwavering
effort  to  consolidate  authority  in  OMB  and  further  restrict  agency  autonomy  and
discretion.  On  February  22,  2002,  OMB  issued  its  Information  Quality  Act  (IQA)
Guidelines.  (67  Fed.  Reg.  8452).  The  IQA  itself  was  three  paragraphs  attached  to
a  more  than  700-page  Treasury  and  General  Government  Appropriations  Act  for
Fiscal  Year  2001,  with  no  hearings,  no  Floor  debate  and  no  committee  reports.  Its
objective  was  ‘‘to  ensure  the  quality,  objectivity,  utility  and  integrity  of  information
disseminated  to  the  public.’’  OMB  took  up  the  assignment  with  a  vigor  and  deter-
mination  that  was  remarkable.  OMB’s  government-wide  guidelines  created  a  new
construct:  now,  there  would  be  ‘‘information’’  and  ‘‘influential  information’’  and  dif-
ferent  (more  stringent  standards)  would  apply  to  the  higher  tiers.  OMB  also  re-
quired the agencies to issues their own guidelines (subject to OMB approval); estab-
lish administrative mechanisms allowing people or entities to seek the correction of

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00025 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

20

information  they  believe  does  not  comply  with  these  guidelines;  and  report  periodi-
cally  to  OMB  on  the  number  and  nature  of  these  complaints.  The  U.S.  Chamber  of
Commerce thought this ‘‘would have a revolutionary impact on the regulatory proc-
ess’’—keeping the agencies from relying on data that industry thought was question-
able.

Then  came  OMB’s  Proposed  Draft  Peer  Review  Standards  for  Regulatory  Science
(August. 29, 2003), in which OMB attempted to establish uniform government-wide
standards  for  peer  review  of  scientific  information  used  in  the  regulatory  process.
Peer review is generally considered the gold standard for scientists. Yet leading sci-
entific  organizations  were  highly  critical  of  what  OMB  was  trying  to  do  and  how
it was doing it, and they were joined by citizen advocacy groups and former govern-
ment  officials.  They  argued  that  the  proposed  standards  were  unduly  prescriptive,
unbalanced (in favor of industry), and introduced a new layer of OMB review of sci-
entific  or  technical  studies  used  in  developing  regulations.  The  reaction  was  so
strong  and  so  adverse  that  OMB  substantially  revised  its  draft  Bulletin  to  make  it
appreciably less prescriptive and restrictive, and in fact OMB resubmitted it in draft
form for further comments before finalizing the revised Bulletin.

On March 2, 2004, OMB replaced a 1996 ‘‘best practices’’ memorandum with Cir-
cular  A–4,  setting  forth  instructions  for  the  federal  agencies  to  follow  in  developing
the  regulatory  analyses  that  accompany  significant  draft  notices  of  proposed  rule-
making  and  draft  final  rules.  The  Circular,  almost  50-pages  single  spaced,  includes
a  detailed  discussion  of  the  dos  and  don’ts  of  virtually  every  aspect  of  the  docu-
mentation that is needed to justify a regulatory proposal. While the term ‘‘guidance’’
is  used,  agencies  that  depart  from  the  terms  of  the  Circular  do  so  at  their  peril  (or
more precisely, at the peril of their regulatory proposal).

Then  came  the  OMB  Proposed  Risk  Assessment  Bulletin  (January  9,  2006),  pro-
viding  technical  guidance  for  risk  assessments  produced  by  the  Federal  Govern-
ment.  There  were  six  standards  specified  for  all  risk  assessments  and  a  seventh
standard,  consisting  of  five  parts,  for  risk  assessments  related  to  regulatory  anal-
ysis. In addition, using the terminology from the IQA Guidance, OMB laid out spe-
cial  standards  for  ‘‘Influential  Risk  Assessments’’  relating  to  reproducibility,  com-
parisons with other results, presentation of numerical estimates, characterizing un-
certainty,  characterizing  results,  characterizing  variability,  characterizing  human
health  effects,  discussing  scientific  literature  and  addressing  significant  comments.
Agency  comments  raised  a  number  of  very  specific  problems  and  such  general  con-
cerns as that OMB was inappropriately intervening into the scientific underpinnings
of  regulatory  proposals.  OMB  asked  the  National  Academies  of  Scientists  (NAS)  to
comment  on  the  draft  Bulletin.  The  NAS  panel  (on  which  I  served)  found  the  Bul-
letin ‘‘fundamentally flawed’’ and recommended that it be withdrawn.

Then, on January 18, 2007, OMB issued its final Bulletin on ‘‘Agency Good Guid-
ance  Practices.’’  Agencies  are  increasingly  using  guidance  documents  to  inform  the
public and to provide direction to their staff regarding agency policy on the interpre-
tation  or  enforcement  of  their  regulations.  While  guidance  documents—by  defini-
tion—do not have the force and effect of law, this trend has sparked concern by com-
mentators, including scholars and the courts. In response, the Bulletin sets forth the
policies  and  procedures  agencies  must  follow  for  the  ‘‘development,  issuance,  and
use’’ of such documents. It calls for internal agency review and increased public par-
ticipation—all to the good. In addition, however, the Bulletin also imposes specified
‘‘standard  elements’’  for  significant  guidance  documents;  provides  instructions  as  to
the  organization  of  agency  websites  containing  significant  guidance  documents;  re-
quires  agencies  to  develop  procedures  (and  designate  an  agency  official/office)  so
that  the  public  can  complain  about  significant  guidance  documents  and  seek  their
modification or rescission; and extends OIRA review to include significant guidance
documents. I do not believe it is an overstatement to say that the effect of the Bul-
letin  is  to  convert  significant  guidance  documents  into  legislative  rules,  subject  to
all  the  requirements  of  Section  553  of  the  Administrative  Procedure  Act,  even
though  the  terms  of  that  Section  explicitly  exempt  guidance  documents  from  its
scope.  To  the  extent  that  the  Bulletin  makes  the  issuance  of  guidance  documents
much  more  burdensome  and  time  consuming  for  the  agencies,  it  will  undoubtedly
result  in  a  decrease  of  their  use.  That  may  well  have  unintended  unfortunate  con-
sequences,  because  regulated  entities  often  ask  for  and  appreciate  receiving  clari-
fication of their responsibilities under the law, as well as protection from haphazard
enforcement of the law, by agency staff.

This is quite a record. While each step can be justified as helping to produce bet-
ter  regulatory  decisions,  the  cumulative  effect  is  overwhelming.  Requirements  are
piled on requirements, which are piled on requirements that the agencies must sat-
isfy  before  they  can  issue  regulations  (and  now,  significant  guidance  documents)
that Congress authorized (indeed, often instructed) them to issue. And OMB has not

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00026 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

21

requested,  nor  has  the  Congress  in  recent  years  appropriated,  additional  resources
for  the  agencies  to  carry  out  OMB’s  ever  increasing  demands.  As  agencies  must  do
more with less, the result is that fewer regulations can be issued—which is exactly
what the business community has been calling on this Administration to do.

It  is  in  this  context  that  Executive  Order  13422,  further  amending  Executive
Order 12866, is released. Until the Bulletin on guidance documents, OIRA extended
its  influence  throughout  the  Executive  Branch  without  any  amendments  to  Execu-
tive Order 12866. As discussed above, OMB issued Circulars and Bulletins covering
a  wide  variety  of  subjects,  virtually  all  of  which  were  quite  prescriptive  (and  often
quite  burdensome)  in  nature.  OMB  Circulars  and  Bulletins  do  not  have  the  same
status  as  an  Executive  Order,  but  they  are  treated  as  if  they  did  by  the  federal
agencies.  Why  then  did  OMB  draft  and  the  President  sign  Executive  Order  13422?
One indication of a possible answer is that while Executive Order 13422 in effect
codifies the Bulletin on guidance documents, it does not pick up and codify the ear-
lier  pronouncements  on  data  quality,  peer  review,  regulatory  impact  analyses,  or
even  risk  assessment  principles.  It  may  be  that  it  was  thought  necessary  to  amend
Executive Order 12866 for guidance documents because Executive Order 12866 was
written to apply only where the agencies undertook regulatory actions that had the
force and effect of law. But it is unlikely that the agencies would balk at submitting
significant guidance documents to OIRA if there were an OMB Bulletin instructing
them  to  do  so,  and  since  neither  Executive  Orders  nor  Circulars  or  Bulletins  are
judicially  reviewable,  it  is  also  unlikely  that  anyone  could  successfully  challenge  in
court an agency’s decision to submit a significant guidance document to OIRA.

Perhaps  more  revealing  of  the  reason(s)  for  Executive  Order  13422  is  that  it  is
not limited to guidance documents. Consider the other amendments included in the
new  Executive  Order.  First,  Executive  Order  12866  had  established  as  the  first
principle of regulation that:

Each  agency  shall  identify  the  problem  that  it  intends  to  address  (including,
where applicable, the failure of private markets or public institutions that war-
rant new agency action) as well as assess the significance of that problem’’

Executive Order 13422 amends Executive Order 12866 to state instead:

Each  agency  shall  identify  in  writing  the  specific  market  failure  (such  as
externalities,  market  power,  lack  of  information)  or  other  specific  problem  that
it intends to address (including, where applicable, the failures of public institu-
tions) that warrant new agency action, as well as assess the significance of that
problem, to enable assessment of whether any new regulation is warranted.

By  giving  special  emphasis  to  market  failures  as  the  source  of  a  problem  war-
ranting  a  new  regulation,  the  Administration  is  saying  that  not  all  problems  are
equally  deserving  of  attention;  those  caused  by  market  failures  are  in  a  favored
class and possibly the only class warranting new regulations. This could be read as
a  throw  back  to  the  ‘‘market-can-cure-almost-anything’’  approach,  which  is  the  lit-
any  of  opponents  of  regulation;  in  fact,  history  has  proven  them  wrong—there  are
many areas of our society where there are serious social or economic problems—e.g.,
civil rights—that are not caused by market failures and that can be ameliorated by
regulation.

Second,  the  new  Executive  Order  amends  Section  4  of  Executive  Order  12866,
which relates to the regulatory planning process and specifically references the Uni-
fied  Regulatory  Agenda  prepared  annually  to  inform  the  public  about  the  various
proposals  under  consideration  at  the  agencies.  The  original  Executive  Order  in-
structed each agency to also prepare a Regulatory Plan that identifies the most im-
portant  regulatory  actions  that  the  agency  reasonably  expects  to  issue  in  proposed
or  final  form  in  that  fiscal  year.  Section  4,  unlike  the  rest  of  the  Executive  Order,
applies  not  only  to  Executive  Branch  agencies,  but  also  to  independent  regulatory
commissions,  such  as  the  Securities  and  Exchange  Commission,  the  Federal  Com-
munications  Commission,  the  Federal  Trade  Commission,  and  the  Federal  Reserve
Board.  It  is  not  without  significance  that  the  new  Executive  Order  uses  Section  4
to impose an additional restraint on the agencies:

Unless  specifically  authorized  by  the  head  of  the  agency,  no  rule-making  shall
commence  nor  be  included  on  the  Plan  without  the  approval  of  the  agency’s
Regulatory Policy Office. . .

This language should be read in conjunction with an amendment to Section 6(a)(2)
that  specifies  that  the  agency’s  Regulatory  Policy  Officer  must  be  ‘‘one  of  the  agen-
cy’s  Presidential  Appointees.’’  Executive  Order  12866  had  provided  that  the  agency
head  was  to  designate  the  agency’s  Regulatory  Policy  Officer,  with  the  only  condi-
tion  that  the  designee  was  to  report  to  the  agency  head.  The  original  Executive

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00027 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

22

Order  further  provided  that  the  Regulatory  Policy  Officer  was  to  ‘‘be  involved  at
every  stage  of  the  regulatory  process. . .’’—in  other  words,  a  hands-on  job.  Now,
there  is  an  explicit  politicalization  of  the  process;  a  ‘‘sign-off,’’  not  a  hands-on,  as-
signment;  and,  most  significantly,  no  accountability.  The  newly  appointed  officer  is
not  required  to  be  subject  to  Senate  confirmation,  nor  is  the  person  required  to  re-
port to a Senate-confirmed appointee.

The other changes to Section 4 are also troubling. As amended, the agencies must

now include with the Regulatory Plan the:

agency’s  best  estimate  of  the  combined  aggregate  costs  and  benefits  of  all  its
regulations planned for that calendar year. . .

Very few would dispute that the Regulatory Plan has been notoriously unreliable
as  an  indicator  of  what  an  agency  is  likely  to  accomplish  in  any  given  timeframe;
it  is  not  unusual  for  regulations  that  are  not  included  in  the  Plan  to  be  issued
should circumstances warrant, nor is it unusual for regulations included in the Plan
with specific dates for various milestones to languish year after year without getting
any closer to final form.

In any event, the requirement to aggregate the costs and benefits of all the regu-
lations  included  in  the  Plan  for  that  year  is  very  curious.  We  know  that  costs  and
benefits  can  be  estimated  (at  least  within  a  range)  at  the  notice  stage  because  the
agency  will  have  settled  on  one  or  more  options  for  its  proposal.  But  to  try  to  esti-
mate either costs or benefits at the notice of inquiry stage or before the agency has
made  even  tentative  decisions  is  like  trying  to  price  a  new  house  before  there  is
even an option on the land and before there are any architect’s plans. The numbers
may be interesting, but hardly realistic, and to aggregate such numbers would likely
do little to inform the public but could do much to inflame the opponents of regula-
tion. This would not be the first time that large numbers that have virtually no re-
lation to reality have driven the debate on regulation—e.g., the $1.1 trillion estimate
of the annual costs of regulations that is frequently cited by opponents of regulation,
even  though  every  objective  critique  of  the  study  that  produced  that  number  con-
cludes  that  it  not  only  overstates,  but  in  fact  grossly  distorts,  the  truth  about  the
costs of regulation. The only other plausible explanation for this amendment to the
Executive Order it that it is the first step toward implementing a regulatory budget.
In  my  view,  the  concept  of  a  regulatory  budget  is  deeply  flawed,  but  it  should  be
debated on the merits and not come in through the back door of an Executive Order
designed for other purposes.

There is also a gratuitous poke at the agencies in the amendment to Section 4(C).
The  original  Executive  Order  instructed  the  agencies  to  provide  a  ‘‘summary  of  the
legal  basis’’  for  each  action  in  the  Regulatory  Plan,  ‘‘including  whether  any  aspect
of  the  action  is  required  by  statute  or  court  order.’’  The  new  amendment  adds  to
the  previous  language  the  clause,  ‘‘and  specific  citation  to  such  statute,  order  or
other  legal  authority.’’  It  may  appear  to  be  trivial  to  add  this  requirement,  but  by
the same token, why is it necessary to impose such a requirement?

As noted above, I am not aware of any consultation about either the merits of any
of  the  amendments  or  the  perception  that  may  attach  to  the  cumulative  effect  of
those  amendments.  Therefore,  I  do  not  know  whether  the  agencies  have,  for  exam-
ple,  been  proposing  regulations  based  on  problems  caused  by  something  other  than
market  failure  which  OMB  does  not  consider  an  appropriate  basis  for  a  regulation;
whether  senior  civil  servants  at  the  agencies  have  been  sending  proposed  regula-
tions  to  OMB  that  run  contrary  to  the  wishes  of  the  political  appointees  at  those
agencies;  or  whether  agencies  have  been  misrepresenting  what  applicable  statutes
or court orders require.

If not, then there is little, if any, need for these amendments, other than to send
a  signal  that  the  bar  is  being  raised;  that  OMB  is  deciding  the  rules  of  the  road;
and  that  those  rules  are  cast  so  as  to  increase  the  I’s  that  must  be  dotted  and  the
T’s  that  must  be  crossed.  In  other  words,  the  message  is  that  agencies  should  not
be doing the job that Congress has delegated to them. This is not a neutral process.
If  the  Bush  Administration  does  not  like  some  or  all  agency  proposed  regulations,
they  can  debate  them  on  the  merits.  But  the  Executive  Order  should  not  become
a codification of an anti-regulatory manifesto. This is not good government.

BIOGRAPHY FOR SALLY KATZEN

Since  leaving  government  service  in  January  2001,  she  has  been  teaching  both
graduate  students  (University  of  Pennsylvania  Law  School  in  Spring  ’03;  Johns
Hopkins University in Fall ’03, 04, University of Michigan Law School in Spring ’04,
Fall ’05, Spring ’06); George Mason University Law School, Spring and Fall ’06) and
undergraduates  (at  Smith  College  in  Fall  ’01–’04;  Johns  Hopkins  University  in

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00028 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

23

Spring ’02, ’06; University of Michigan in Washington Program ’05–’07). She served
almost  eight  years  in  the  Clinton  Administration,  first  as  Administrator  of  the  Of-
fice of Information and Regulatory Affairs in the Office of Management and Budget
(OMB), then Deputy Assistant to the President for Economic Policy and Deputy Di-
rector  of  the  National  Economic  Council  in  the  White  House,  and  then  as  the  Dep-
uty  Director  for  Management  at  OMB.  Before  joining  the  Clinton  Administration,
Ms.  Katzen  was  a  partner  in  the  Washington,  DC  law  firm  of  Wilmer,  Cutler  &
Pickering,  specializing  in  regulatory  and  legislative  matters.  While  in  private  prac-
tice,  Ms.  Katzen  was  an  adjunct  Professor  at  the  Georgetown  Law  Center  and
served in various leadership roles in the American Bar Association (including Chair
of the Section on Administrative Law and Regulatory Practice and two terms as DC
Delegate to the House of Delegates of the ABA), as well as President of the Federal
Communications  Bar  Association  and  President  of  the  Women’s  Legal  Defense
Fund.  She  graduated  magna  cum  laude  from  Smith  College  and  magna  cum  laude
from the University of Michigan Law School, where she was the first woman Editor
in  Chief  of  the  Law  Review.  Following  graduation  from  law  school,  she  clerked  for
Judge J. Skelly Wright of the United States Court of Appeals for the District of Co-
lumbia  Circuit.  She  also  served  in  the  Carter  Administration  for  two  years  as  the
General Counsel of the Council on Wage and Price Stability in the Executive Office
of the President.

Chairman MILLER. Thank you, Ms. Katzen. Mr. Vladeck.

STATEMENT  OF  MR.  DAVID  C.  VLADECK,  DIRECTOR,  INSTI-
TUTE  FOR  PUBLIC  REPRESENTATION;  ASSOCIATE  PRO-
FESSOR OF LAW, GEORGETOWN UNIVERSITY LAW CENTER
Mr.  VLADECK.  Mr.  Chairman,  Mr.  Sensenbrenner,  thank  you
very  much  for  inviting  me  here  to  testify  before  you  today.  I  have
submitted  a  detailed  testimony  outlining  my  major  concerns  with
the  new  Executive  Order,  so  I  would  like  to  use  my  five  minutes
to outline some of my most pressing concerns.

Let me begin with the bad news. The bad news is this: our regu-
latory  process,  and  particularly,  our  health  and  science  agencies,
have  been  stretched  to  the  breaking  point.  Agency  budgets  have
been  slashed,  agency  staffing  levels  have  been  cut  to  the  bone,
agency  scientists  have  been  demoralized  by 
the  blatant
politicization of science, and not surprisingly, our agencies are fray-
ing  at  the  seams.  It  now  takes  OSHA  a  decade,  a  decade  to  issue
standards  to  protect  workers  from  occupational  safety  and  health
threats.  The  FDA,  long  the  gold  standard  of  our  health  and  safety
agencies,  has  experienced  substantial  regulatory  failure.  Defective
medical  devices,  unsafe  drugs,  slip  by  the  FDA  and  onto  our  mar-
kets.

We are now reaping what we have sown: under-resourced, under-
funded, over-politicized agencies that can’t do their job of protecting
us,  but  these  are  the  very  agencies  on  which  we  depend  to  ensure
that the food we eat is pure, the drugs we take are safe and effec-
tive,  that  the  air  we  breathe  is  clean,  and  that  our  workplaces  are
not unreasonably dangerous.

Now,  this  is  an  Executive  Order,  and  that  means  something.  It
is  not  simply  a  trivial  statement  of  business  as  usual.  Presidents
use  Executive  Orders  to  mark  important  and  dramatic  steps,  in
terms of the way they organize the executive branch, and Executive
Order  13422  is  no  different.  It  takes  a  number  of  steps  that  are
problematic,  and  which  Congress  ought  to  take  a  very  careful  look
at.

The  first  problem  with  the  Executive  Order  that  I  see  is  that  it
usurps Congressional authority by directing agencies to justify reg-
ulatory  action  on  the  basis  of  market  failure.  And  make  no  mis-

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00029 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

24

take,  an  agency,  particularly  if  it  is  developing  a  regulation  or
guidance that OIRA deems significant, is going to have to do busi-
ness  with  market  failure.  To  be  sure,  there  is  an  escape  valve  left
in  the  Executive  Order,  but  that  escape  valve  is  operative  at
OIRA’s  insistence,  not  the  agency’s,  and  so  agencies,  if  they  want
to get their rules approved, if they want to go ahead with guidance,
they are going to have to at least do business with OIRA on market
failure bases.

The  problem  with  this,  of  course  is  that,  as  Sally  has  just  said,
agencies  have  been  given  just  an  enormous  number  of  analytic  re-
quirements  that  they  have  to  navigate  through  in  order  to  take
regulatory  action.  Now,  not  simply  binding  regulatory  action,  but
non-binding regulatory action. The executive branch seems to think
that there is no limit to the number of analytical requirements that
they can impose on the process. This process is already broken, and
putting  another  straw  on  the  camel’s  back  is  going  to  further  un-
dermine  the  ability  of  agencies  to  deliver  the  protection  that  Con-
gress has decreed they deliver to us.

But  the  second  problem—the  expansion  of  OIRA’s  authority  to
guidance  documents—makes  no  sense.  Guidance  documents,  by
their  nature,  are  non-binding.  The  courts  have  been  very  clear  in
holding  that  a  guidance  document  does  not  impose  a  binding  re-
quirement  on  a  regulated  industry.  There  is—there  are  arguments
to be made about whether centralized review is a good idea or not.
I  disagree  with  my  colleague  Sally.  I  have  always  thought  central-
ized  review  was  bad,  whether  practiced  by  Republicans  or  Demo-
crats,  Mr.  Sensenbrenner,  but  this  is  a  completely  unwarranted
step, and oddly, a step that is going to hurt regulated business.

Mr. Sensenbrenner, you talked about small business. Small busi-
nesses need guidance from agencies about how to comply with fed-
eral  mandates.  Now,  if  they  pick  up  a  phone  and  call  a  regulatory
officer at the FDA, for example, they are going to have to say, wait,
I’ve got to do a market failure analysis before I can give you guid-
ance?  That  kind  of  interaction  is  covered  by  this  Executive  Order.
You are handcuffing the ability of our agencies to interact with the
people  they  regulate,  and  interposing  OIRA  between  them  is  not
sound government policy.

The last point I want to make is this. I am very troubled by, and
I  would  urge  Congress  to  take  a  hard  look  at  this,  the  Executive
Order  requiring  a  Presidential  appointee  to  run  the  regulatory  of-
fices  at  the  agencies.  If  you  look  and  here—I  hate  to  do  this,  be-
cause  I  have  such  respect  for  Mr.  Copeland,  but  if  you—and  I  dis-
agree  with  him  on  this  point—if  you  look  at  the  way  the  agencies
structure  their  regulatory  compliance.  In  many  agencies,  particu-
larly  at  the  sub-cabinet  level,  the  regulatory  officers  are  political,
but not Presidential appointees, but they are experts in regulation.
They know the details, the arcane aspects of our regulatory process
that now is all-enveloping.

To  force  the  agency  to  find  another  employee,  a  Presidentially-
appointed  person,  who  may  or  may  not  be  subject  to  Senate  con-
firmation,  is  bad  policy,  and  it  is  a  threat  to  Congress,  because
when  you  give  an  agency  authority  to  exercise  regulatory  power,
you  delegate  that  authority  not  to  the  agency,  the  statute  doesn’t
read: ‘‘We ask the Department of Transportation to do something.’’

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00030 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

25

You  tell  the  Secretary  of  Transportation  to  do  it.  Why?  Because
that person is accountable to you as well as the President.

I am fearful that this Executive Order seeks to end-run that kind

of accountability that Congress has always demanded.

I see my time is up. Thank you very much.
[The prepared statement of Mr. Vladeck follows:]
PREPARED STATEMENT OF DAVID C. VLADECK

Mr. Chairman and Members of the Science and Technology Committee, thank you
for inviting me to be here today to share with you my views about the January 18,
2007  revisions  to  Executive  Order  12866,  which  are  set  forth  in  Executive  Order
13422,  72  Fed.  Reg.  2763  (January  23,  2007).  I  am  the  Director  of  the  Institute  for
Public Representation and an Associate Professor of Law at Georgetown University
Law  Center.  Prior  to  joining  Georgetown’s  law  faculty,  I  spent  nearly  thirty  years
at  Public  Citizen  Litigation  Group,  serving  as  its  director  from  1992  through  2002.
I  have  practiced  extensively  in  the  area  of  administrative  law,  served  as  a  Public
Member  of  the  Administrative  Conference  of  the  United  States,  the  Chair  of  the
D.C.  Bar  Association’s  Section  on  Administrative  Law,  on  the  Council  of  the  Amer-
ican Bar Association’s Section on Administrative Law and Agency Practice, testified
on  many  occasions  before  congressional  committees  on  administrative  law  issues—
including  issues  concerning  the  constitutionality  and  wisdom  of  centralized  regu-
latory review—and I write in the field of administrative law. I also serve as a Schol-
ar with the Center for Progressive Reform.

My testimony today will explain why Executive Order 13422 represents an impor-
tant chapter in the Executive Branch’s longstanding effort to wrest control over ad-
ministrative  agencies  from  Congress,  and  certainly  the  most  important  measure
taken  by  President  Bush.  To  put  the  new  Order  in  context,  I  will  begin  by  briefly
describing  the  problems  brought  about  by  Executive  Order  12866  and  its  prede-
cessor,  Executive  Order  12291,  and  explain  why  centralized  regulatory  review  has
seriously impaired the ability of federal agencies to provide needed safeguards to the
American people.

I  will  then  turn  to  Executive  Order  13422  and  address  why  it  marks  a  further
and  substantial  erosion  of  Congress’  role  in  the  administrative  process  and  deals  a
body  blow  to  the  ability  of  our  agencies  to  do  their  jobs.  Here  I  make  a  number  of
points about Executive Order 13422:
• The Executive Order Usurps Congressional Authority By Directing Agen-
cies  to  Justify  Regulatory  Actions  on  the  Basis  of  Market  Failure.  Under
our  system  of  separated  powers,  it  is  Congress,  not  the  Executive,  that  sets  the
substantive  standards  that  guide  agencies  in  the  performance  of  their  delegated
tasks. Executive Order 13422 disrespects this structural limit in the Constitution.
It  requires  agencies,  as  a  precondition  to  taking  any  regulatory  action  at  all,  to
justify  their  proposed  action  on  the  basis  of  ‘‘market  failure.’’  And  ‘‘significant’’
agency  guidance  may  not  be  issued  until  the  agency  obtains  clearance  from  the
Office  or  Regulatory  Affairs  (OIRA)  of  the  Office  of  Management  and  Budget
(OMB). The ‘‘market failure’’ super-mandate appears nowhere in statute. It is not
in  keeping  with  the  decisional  criteria  that  Congress  has  established,  and  it  can-
not  be  reconciled  with  the  dominant  thrust  of  the  health  and  safety  statutes,
which  are  designed  to  prevent  deaths  and  injuries  by  avoiding  market  failure,
rather than waiting until it is too late and market failure is evident.

• The  Executive  Order  Unwisely  Expands  OIRA’s  Authority  to  Guidance
Documents. Whatever the wisdom of centralized OIRA review of binding agency
rules,  the  same  arguments  do  not  extend  to  centralized  review  of  non-binding
agency  guidance.  Hundreds  of  guidance  documents  are  issued  each  year,  often  in
response to emergencies or other time-sensitive developments. Requiring agencies
to stop dead in their tracks to justify the provision of guidance on ‘‘market failure’’
grounds cannot be defended on policy grounds; nor can giving OIRA the authority
to meddle in the substance of significant agency guidance.

• The Executive Order Resurrects the Discredited Concept of a Regulatory
Budget. Amended section 4(c)(1)(B) forbids any agency—even the so-called ‘‘inde-
pendent’’  agencies—from  commencing  any  rule-making  unless  the  agency’s  regu-
latory plan sets forth, among other things, ‘‘the agency’s best estimate of the com-
bined aggregated costs and benefits of all its regulations planned for that calendar
year.’’ These estimates give OIRA the ability to effectively cap the amount of com-
pliance  costs  an  agency  may  impose  in  a  calendar  year,  a  power  OIRA  has  long

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00031 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

26

coveted. Nothing in the statutes Congress has enacted give OIRA the right to ra-
tion the protection to be provided to the American people through regulation.

• The  Executive  Order  Further  Politicizes  the  Regulatory  Process.  Execu-
tive  Order  13422  requires  each  agency  ‘‘to  designate  one  of  the  agency’s  Presi-
dential Appointees’’ to serve as the agency’s regulatory policy officer. At the same
time,  the  Order  greatly  expands  the  duties  of  the  policy  officer,  providing  that,
‘‘[u]nless  specifically  authorized  by  the  head  of  the  agency,  no  rule-making  shall
commence  nor  be  included  on  the  [agency’s  annual  regulatory]  Plan  without  the
approval’’ of the policy officer. Nothing in the Order suggests that the political ap-
pointee  must  also  be  subject  to  Senate  confirmation.  This  is  a  troubling,  and  no
doubt  deliberate,  omission.  The  statutes  Congress  enacts  to  delegate  power  to
agencies  designate  the  agency  head—and  not  a  subordinate—as  the  decision-
maker.  Congress  does  this  to  ensure  that  decisions  are  made  by  an  official  ac-
countable to Congress as well as the President. The amended Executive Order un-
dermines  Congress’  designation  of  the  agency  head  as  the  decision-maker  by  re-
quiring  that  a  political  employee—accountable  to  the  President  but  not  nec-
essarily  to  Congress—be  given  control  over  an  agency’s  regulatory  output.  That,
to me, is quite a disturbing development and one that should not be accomplished
by Executive fiat, but, if at all, by legislation.

BACKGROUND

To  understand  the  significance  of  Executive  Order  13422,  it  is  useful  to  quickly
sketch the development of the Executive Order on regulatory review and what it re-
quires.1 Although  all  Presidents  since  President  Ford  have  employed  some  form  of
centralized review of agency regulations, systematic, wholesale review of regulations
did not begin until the Reagan Administration. Just a month after his inauguration,
President Reagan issued Executive Order 12291, which required agencies to prepare
detailed  Regulatory  Impact  Analyses  specifying  the  costs  and  benefits  of  all  pro-
posed  ‘‘major’’  rules.  The  Order  provided  that,  unless  otherwise  forbidden  by  law,
an  agency  could  not  undertake  rule-making  unless  ‘‘the  potential  benefits  to  soci-
ety. . .outweigh the costs,’’ and the agency selected the regulatory option ‘‘involving
the least net cost to society.’’ 2 The Order further required agencies to submit drafts
of  all  proposed  and  final  rules  to  OIRA  before  publication  in  the  Federal  Register,
and publication could not proceed without OIRA’s approval.

From the outset, Congress was troubled by the dominant and often obstructionist
role OIRA played in rule-makings. OIRA delayed and weakened rules, met in secret
with  industry  representatives,  overrode  agency  determinations  on  complex  matters
of science, and otherwise thwarted the ability of the regulatory agencies to do their
jobs.3 During  1982–83,  the  House  held  no  fewer  than  seven  hearings  to  examine
health and safety rules seriously delayed or weakened by OIRA.4 And when the first
challenge  to  the  constitutionality  of  OIRA’s  meddling  in  agency  rule-making  came
before an appellate court, the Chairmen of the five House Committees having juris-
diction  over  regulatory  agencies  filed  a  brief  setting  forth  a  blistering  critique  of
OIRA review. Here is just a brief sampling of what the five Chairmen said:

The amici Congressmen object to the systematic usurpation of legislative power
by OMB pursuant to Executive Order 12291 *
* * Executive Order 12291 is the cornerstone of a steadily growing Presidential
apparatus,  the  effect  of  which  is  to  contravene  explicit  Congressional  delega-
tions of authority, to subvert meaningful public participation in and judicial re-
view  of  federal  regulations,  and  to  impose  substantive  standards  on  decision-
makers  foreign  to  the  statutes  they  administer.  Unless  it  is  checked,  the  pro-
gram  embodied  in  Executive  Order  12291  will  fundamentally  damage  the  ad-
ministrative process by which our laws are implemented, the legislative system

1 See generally Curtis W. Copeland, CRS Report for Congress: Changes to the OMB Regulatory

Review Process by Executive Order 13422, at 2–3 (Feb. 5, 2007) (hereinafter ‘‘CRS Report’’).

(1982).

2 Exec.  Order  12291,  §§ 1(b),  7(g)(2);  3  C.F.R.  127  (1981),  reprinted  in  5  U.S.C.  § 601,  at  431

3 See generally Morton Rosenberg, Beyond the Limits of Executive Power: Presidential Control
of  Agency  Rule-making  Under  Executive  Order  12291,  80  Mich.  L.  Rev.  193  (1981);  David  C.
Vladeck,  Unreasonable  Delay,  Unreasonable  Intervention:  The  Battle  to  Force  Regulation  of
Ethylene  Oxide,  in  Peter  L.  Strauss,  Ed.,  Administrative  Law  Stories  (Foundation  Press  2006).
4 See, e.g., OMB Control of OSHA Rule-making, Hearings before the Subcomm. on Manpower
of  the  House  Comm.  on  Gov’t.  Operations,  97th  Cong.,  2d  Sess.  (1982);  Infant  Formula:  The
Present  Danger,  Hearings  before  the  Subcomm.  on  Oversight  and  Investigations  of  the  House
Comm. on Energy and Commerce, 97th Cong., 2d Sess. (1982); EPA: Investigations of Superfund
and  Agency  Abuses  (Part  3),  Hearings  before  the  Subcomm.  on  Oversight  and  Investigations  of
the House Comm. on Energy and Commerce, 97th Cong., 1st Sess. (1981).

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00032 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

27

by  which  our  laws  are  enacted  and  monitored,  and  the  separation  of  powers
upon which our system of government rests.5

In  1993,  shortly  after  taking  office,  President  Clinton  issued  Executive  Order
12866 to make a number of significant modifications to the Reagan Executive Order.
In  my  view,  the  most  important  was  to  inject  transparency  into  the  OIRA  review
process.6 The  Clinton  Order  cut  back  on  the  number  of  ‘‘significant’’  agency  rules
reviewed  by  OIRA.  It  also  required  OIRA,  as  a  general  rule,  to  complete  its  review
of  proposed  and  final  rules  within  ninety  calendar  days.  And  it  required  all  agen-
cies, including the so-called independents, to prepare an annual regulatory plan out-
lining  all  important  regulatory  actions  the  agency  intended  to  take  during  that  fis-
cal year. The plans had to be personally approved by agency heads.7

Even  with  the  adjustments  made  by  President  Clinton,  centralized  review  of  the
regulatory output of administrative agencies has never accomplished its objective of
making  our  regulatory  agencies  better  serve  the  public.  Indeed,  the  ultimate  irony
is that if OIRA’s review process was subjected to cost-benefit analysis, OIRA review
would flunk. The amount of time, energy, money and, at times, political capital that
goes  into  satisfying  OIRA  that  a  rule  is  worthy  of  publication  dwarfs  any  conceiv-
able benefits that flow from the process. We have now had a twenty-five year experi-
ment  with  centralized  review.  Judged  by  any  legitimate  measure,  it  is  time  to  de-
clare  the  experiment  a  failure  and  move  on.  There  are  several  reasons  for  my  con-
clusion.

To  begin  with,  centralized  review  is  a  one-way  ratchet.  OIRA  presses  agencies  to
do  less  to  protect  the  public  health,  not  more.  Agencies  do  not  complain  that  OIRA
is forcing them to do more; they complain that OIRA is forcing them to weaken re-
quired protections.

OIRA’s  insistence  that  agencies  do  less,  not  more,  stems  from  its  singular  focus
on  ‘‘least  net  cost  options’’—or,  in  other  words,  minimizing  regulatory  compliance
costs. The Executive Order requires agencies to perform cost-benefit analysis, which
many  experts  claim  is  inherently  anti-regulatory.8 My  own  litigation  experience
bears  this  out.  I  have  represented  workers  and  labor  unions  in  litigation  to  force
OSHA  to  protect  workers  from  exposure  to  many  highly  toxic  and  carcinogenic
chemicals,  including  ethylene  oxide,  cadmium,  hexavalent  chromium,  formaldehyde
and  benzene.9 In  each  case,  OIRA  was  an  obstacle  to  the  agency’s  action.  Part  of
OIRA’s objection was its unwillingness to place any value on important health bene-
fits  of  regulation—including  avoided  cancers,  miscarriages,  genetic  damage  that
might cause infertility or birth defects, and kidney failure that might require dialy-
sis or transplant—because they were too difficult to quantify. While the anticipated
costs  of  regulation  are  generally  easier  to  estimate  (and  overestimate),  the  benefits
of  regulation  are  notoriously  difficult  to  quantify  and  are  often  downplayed  or  ig-
nored  by  OIRA.  And  when  OIRA  does  place  a  value  on  a  benefit  or  regulation,  it
discounts those values heavily. Indeed, lives that are going to be lost twenty or thir-
ty years down the road are devalued to the point of insignificance.

There  is  also  the  problem  of  competence.  The  next  car  you  buy  is  almost  certain
to  have  a  gauge  on  the  dashboard  to  warn  you  when  the  car’s  tires  are  under-in-
flated. Congress required this safety feature after a spate of deadly roll-over crashes
caused,  in  part,  by  under-inflated  tires.  The  National  Highway  Traffic  Safety  Ad-
ministration  (NHTSA)  proposed  to  require  automobile  manufacturers  to  install  de-
vices that would detect under-inflated tires in virtually all cases. OIRA insisted that
NHTSA  permit  the  installation  not  only  of  the  device  NHTSA’s  engineers  deter-
mined  was  best,  but  also  a  far  less  effective  (and  less  expensive)  device  favored  by

5 Brief of John Dingell, Chair, House Energy and Commerce Committee, Peter Rodino, Chair,
House Judiciary Committee, Jack Brooks, House Government Operations Committee, Augustus
Hawkins,  Chair,  House  Education  and  Labor  Committee,  and  William  D.  Ford,  Chair,  House
Post Office and Civil Service Committee, in Public Citizen Health Research Group v. Tyson, 796
F.2d 1479 (D.C. Cir. 1986).

6 See Executive Order 12866, §§ 6(b) & (c); 58 Fed. Reg. 51,735 (1993).
7 Harvard Law School Dean Elena Kagan has traced the development of the Clinton Executive

Order in Presidential Administration, 114 Harv. L. Rev. 2245 (2001).

8 See  generally  Frank  Ackerman  &  Lisa  Heinzerling,  PRICELESS:  ON KNOWING THE PRICE OF
EVERYTHING AND THE VALUE OF NOTHING (New Press 2004); Lisa Heinzerling, Regulatory Costs
of Mythic Proportion, 107 Yale L. J. 1981 (1998).

9 See,  e.g.,  Public  Citizen  Health  Research  Group  v.  Auchter,  702  F.2d  1150  (D.C.  Cir.  1983);
796 F.2d 1479 (D.C. Cir. 1986); 823 F.2d 626 (D.C. Cir. 1987) (decisions requiring OSHA to regu-
late  ethylene  oxide,  a  potent  carcinogen  and  teratogen);  International  Chemical  Workers  Union
v. Pendergrass, 958 F.2d 1144 (D.C. Cir. 1992); 830 F.2d 369 (D.C. Cir. 1987) (decisions compel-
ling  OSHA  to  regulate  cadmium,  a  potent  lung  carcinogen);  Public  Citizen  Health  Research
Group v. Chao, 314 F.3d 143 (3d Cir. 2002); 145 F.3d 120 (3d Cir. 1998) (decisions forcing OSHA
to regulate hexavalent chromium, a potent lung and liver carcinogen); UAW v. Pendergrass, 878
F.2d 389 (D.C. Cir. 1989) (decision requiring OSHA to regulate formaldehyde).

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00033 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

28

the  auto  industry.  Not  surprisingly,  NHTSA  did  what  it  was  told.  Empowering
OIRA  economists  to  second-guess  highly  technical  judgments  made  by  expert  agen-
cies is not good government. Ultimately, Public Citizen succeeded in getting a court
to overturn the OIRA-dictated decision and direct NHTSA to require the installation
of  the  more  effective  devices.  But  the  introduction  of  this  important,  life-saving  de-
vice  was  delayed  because  of  OIRA’s  interference.  This  is  hardly  an  isolated  case.10
There  is  also  enormous  delay  built  into  OIRA  review  which  has  resulted  in  the
ossification of the regulatory process. The regulatory process is so overlain with pro-
cedural  and  regulatory  requirements  that  agencies  cannot  get  their  work  done  in
a reasonable time. It now takes OSHA a decade to promulgate a standard to protect
workers  from  exposure  to  toxic  substances.11 While  the  rule-making  process  grinds
glacially ahead, workers are exposed to unreasonable risks to their health and well-
being. Other agencies face comparable delays. And much of the delay can be traced
back to all of the requirements imposed by the Executive Order.

These problems are all well-known, and in fairness to the Clinton Administration,
and  my  friend  and  co-panelist  Sally  Katzen,  some  efforts  were  undertaken  to  ad-
dress  them.  But  Executive  Order  13422  makes  a  bad  situation  worse.  Let  me  now
address how Executive Order 13422 is a significant step backwards, and an affront
to the power of Congress.
PRINCIPAL DEFECTS IN EXECUTIVE ORDER 13422

As noted above, although packaged as an innocuous and minor amendment to Ex-
ecutive Order 12866, the new Executive Order takes a number of dramatic and im-
portant steps in the wrong direction. The principal ones are these:
1. The  Amendments  Impose  a  ‘‘Super-Mandate’’  That  Supersedes  Legisla-

tion and Needlessly Burdens Already Overburdened Agencies.
The  amendments  to  the  Executive  Order  give  OIRA  a  powerful  new  tool  to  block
agency  action.  Before  moving  forward  with  any  regulatory  action,  an  agency  must
determine in writing that the action the agency wants to take or guidance the agen-
cy  wants  to  provide  is  warranted  by  ‘‘market  failure.’’  There  are  several  problems
with the imposition of this mandate.

First, it serves to undermine the criteria that Congress has established for agency
action.  Under  our  system  of  separated  powers,  it  is  Congress,  not  the  Executive,
that sets the substantive standards that guide agencies in the performance of their
delegated  tasks.  Executive  Order  13422  is  at  odds  with  this  rule.  No  statute  re-
quires an agency to consider ‘‘market failure’’ as a precondition to taking action. Nor
is  the  consideration  of  market  failure  in  keeping  with  the  decisional  criteria  that
Congress  has  established—which  generally  focus  on  health,  safety,  and  the  protec-
tion of our environment and natural resources. Indeed, the elevation of ‘‘market fail-
ure’’  as  a  key  determinant  for  agency  action  cannot  be  reconciled  with  the  funda-
mental  goal  of  the  health  and  safety  statutes,  which  is  to  prevent  deaths  and  inju-
ries  by  avoiding  market  failure,  rather  than  waiting  until  it  is  too  late  and  market
failure is evident.12

Second,  the  mandate  adds  a  burden  that  will  sap  the  resources  of  already  over-
burdened  agencies.  To  take  any  regulatory  action  at  all,  agencies  will  have  to  con-
sider ‘‘market failure’’ and write a justification of the action it seeks to take on that

10 OIRA’s meddling in the tire pressure rule is recounted in Public Citizen v. Mineta, 340 F.3d
39  (2d  Cir.  2003).  For  a  more  recent,  but  equally  troubling,  example  of  OIRA’s  improper  med-
dling,  see  Public  Citizen  v.  FMCSA,  374  F.3d  1209  (D.C.  Cir.  2004)  (setting  aside  on  safety
grounds  a  rule  extending  the  hours  truck  drivers  may  drive  after  OIRA  intervened  on  behalf
of trucking companies to reverse the agency’s proposed rule reducing the hours).

11 See  Public  Citizen  Health  Research  Group  v.  Chao,  314  F.3d  143  (3d  Cir.  2002);  145  F.3d

120 (3d Cir. 1998) (describing pace of hexavalent chromium rule-making).

12 I recognize that the Executive Order does not completely foreclose the possibility that OIRA
will permit an agency to proceed with rule-making even if the agency cannot show that its pro-
posed action is warranted by market failure. Executive Order 13422, § 1(b), does allow an agency
to  make  the  case  to  OIRA  that  a  showing  of  market  failure  is  not  ‘‘applicable’’  to  the  proposed
regulatory  action.  But  there  are  reasons  to  doubt  that  an  agency  intent  on  skirting  the  market
failure analysis will succeed with OIRA. For one thing, the change in the language of § 1(b) from
Executive  Order  12866  to  Executive  Order  13422  is  profound;  the  former  Order  required  the
agency to ‘‘identify the problem that it intends to address. . .as well as the significance of that
problem.’’  The  new  Order  deletes  that  language  and  says  that  ‘‘[e]ach  agency  shall  identify  in
writing  the  specific  market  failure. . .or  other  specific  problem  that  it  intends  to  address. . ..’’
That  substitution  plainly  signals  that,  from  now  on,  OIRA  will  expect  to  see  an  economic  anal-
ysis  of  market  failure  as  a  precondition  to  regulation  absent  a  convincing  economic  argument
from the agency that market failure is not at the root of the ‘‘other specific problem’’ the agency
intends  to  address.  Moreover,  the  use  of  the  word  ‘‘shall’’  underscores  that  agencies  have  no
choice  but  to  engage  in  this  analysis,  even  if  the  agency  ultimately  decides  not  to  rest  its  case
on market failure grounds.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00034 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

29

basis. And for ‘‘significant’’ agency action—including ‘‘significant’’ non-binding agen-
cy  guidance  documents—agencies  will  have  to  demonstrate  to  OIRA’s  satisfaction
that the failure of market forces warrants the action the agency seeks to undertake.
Giving OIRA another tool to block agency initiatives is unwise; permitting OIRA to
meddle in the substance of agency guidance is doubly unwise.

There is a related problem as well. Where agencies propose to take regulatory ac-
tion,  the  Executive  Order  already  requires  agencies  to  conduct  a  rigorous  cost/ben-
efit  analysis  as  part  of  the  Regulatory  Impact  Analysis  it  must  provide  to  OIRA.
Now  the  amended  Executive  Order  requires  a  market  failure  analysis  as  well.  The
Executive  Branch  apparently  takes  the  view  that  it  can  continue  to  pile  on  analyt-
ical  requirements  on  overtaxed  regulatory  agencies  without  limit  and  without  Con-
gress’  approval.  Make  no  mistake;  each  of  these  analytical  requirements  consumes
scarce resources that agencies could use to carry out the instructions given to them
by  Congress.  At  some  point—if  indeed  that  point  has  not  already  been  reached—
the requirements imposed by Executive Order will crowd out those imposed by stat-
ute.

Third, and perhaps most problematic, while there is a modest effort in the Execu-
tive  Order  to  define  ‘‘market  failure’’  (e.g.,  ‘‘externalities,  market  power,  lack  of  in-
formation’’),  market  failure  is  in  the  eye  of  the  beholder.  There  is  no  commonly-ac-
cepted definition of the term, and, as a result, much will then depend on the defini-
tion OIRA’s staff gives to the term market failure.

This concern takes on special force when one considers the views of Susan E. Dud-
ley, President Bush’s nominee to head OIRA. Ms. Dudley’s writings suggest that she
believes  markets  almost  never  fail,  and  that  government  intervention  is  therefore
rarely  if  ever  appropriate.13 For  instance,  Ms.  Dudley  was  virtually  alone  in  oppos-
ing  NHTSA’s  recent  advanced  air-bag  rule.  She  did  so  on  the  ground  that,  in  her
view,  there  was  no  evidence  of  market  failure,  and  therefore  NHTSA’s  ‘‘attempt[]
to make all vehicles equally safe for occupants’’ was unwarranted.14 Ms. Dudley sees
little  room  for  government  intervention  in  the  market,  even  for  protective  health
and  safety  regulation.  Ms.  Dudley’s  restrictive  understanding  of  market  failure
raises  serious  questions.  If  Ms.  Dudley  saw  no  evidence  of  market  failure  with  air
bags—where  the  evidence  of  continual  market  failure  is  overwhelming—would  she
have insisted on clearer evidence of market failure before she let the EPA order the
phase-out of lead in gasoline, the Consumer Product Safety Commission ban the use
of flammable material for children’s sleep-wear, or the FDA require that iron pills—
the single largest cause of poisoning children in the United States—be sold in child-
proof  containers?  We  ought  not  wait  for  ‘‘market  failure’’  to  exact  a  toll  on  human
health and safety before we permit our agencies to act. In the health and safety con-
text, the only way market failure becomes apparent is when the body count gets too
high.  The  point  of  regulation  is  to  prevent  market  failure,  not  to  try  to  remedy  it
once the damage is done. The Executive Order subverts that fundamental principle.
2. The  Amendments  Inappropriately  Expand  OMB’s  Authority  and  En-

trench Gridlock.
Whatever  the  wisdom  of  centralized  OIRA  review  of  binding  agency  rules,  the
same arguments do not extend to centralized review of non-binding guidance. Agen-
cies provide guidance constantly, in literally hundreds of guidance documents or in-
terpretative  missives  each  year.  Consider  just  one  agency.  The  most  recent  listing
of the titles of guidance documents used by the Food and Drug Administration was
published  in  January  2005.  It  runs  nearly  ninety  pages  in  the  Federal  Register.15
Agencies  often  use  guidance  documents  to  help  industry  meet  regulatory  obliga-
tions  in  time-sensitive  or  emergency  situations.  For  example,  OSHA’s  most  recent
guidance  document  provides  employers  with  advice  about  how  to  address  an  influ-

(available 

at 

13 Ms.  Dudley’s  writings  are  explored  in  depth  in  a  report  by  Public  Citizen  and  OMB  Watch
entitled  The  Cost  Is  Too  High:  How  Susan  Dudley  Threatens  Public  Health  Protections  (Sept.
2006) 
http://www.citizen.org/publications/release.cfm?ID=7448&secID=
2565&catID=126).

14 Susan  E.  Dudley,  Regulatory  Studies  Program  Comments:  Advanced  Air  Bags  7  (Dec.  17,
1998)  (available  at  http://mercatus.org.repository/docLib/MC¥RSP¥PIC1998-04¥NHTSA-Air-
Bags¥981130.pdf).

15 70 Fed. Reg. 824–913 (Jan. 5, 2005); see also FDA Center for Drug Evaluation and Research
List  of  Guidance  Documents  (Feb.  1,  2007)  (33-page  document  setting  forth  currently  in  force
guidance  documents)  (available  at  http://www.fda.gov/cder/guidance/CompList02¥2007.pdf).
The CRS Report cited above, supra n.1, notes that the Occupational Safety and Health Adminis-
tration  reported  in  2000  that  it  had  issued  3,374  guidance  documents  since  March  1996,  thus
averaging around 1,000 guidance documents a year. CRS Report at 10, n.22.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00035 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

30

enza pandemic,16 one of the FDA’s most recent guidance documents advises clinical
laboratories on how to address public health problems that resulted from the failure
of  certain  laboratories  to  properly  conduct  tests  on  human  donors,17 and  one  of  the
EPA’s  most  recent  guidance  documents  provides  advice  to  manufacturers  of  anti-
microbial agents on how to properly test and register their products with the EPA.18
Congress  has  long  understood  that,  when  it  comes  to  the  provision  on  guidance
and  advice,  it  is  unwise  to  erect  barriers  between  agencies  and  regulated  entities
and  the  public.  Government  must  be  accessible  to  those  it  regulates  and  to  those
who  benefit  from  regulation.  For  that  reason,  when  Congress  enacted  the  Adminis-
trative  Procedure  Act,  it  exempted  guidance  documents  and  interpretative  pro-
nouncements  from  all  of  the  informal  and  formal  rule-making  requirements  of  the
Act.

Executive Order 13422 upsets Congress’ judgment on that balance. Before issuing
any guidance document, an agency must address in writing the question of ‘‘market
failure’’—an analytic requirement that will delay the issuance of sorely needed guid-
ance. The Executive Order is also highly prescriptive about the contents of guidance
documents. Rather than permit agencies to retain flexibility and tailor guidance doc-
uments  to  their  audiences,  the  Executive  Order  instructs  agencies  that  every  guid-
ance document must (a) be based ‘‘on the best reasonably obtainable scientific, tech-
nical,  economic,  and  other  information;’’  (b)  be  compatible  and  not  duplicative  of
guidance  given  by  other  agency;  (c)  be  ‘‘simple  and  easy  to  understand;’’  and  (e)  be
tailored  ‘‘to  impose  the  least  burden  on  society,  including  individuals,  businesses  of
different  sizes,  and  other  entities. . .taking  into  account,  among  other  things,  the
costs of cumulative regulations.’’ 19

Not only do ‘‘significant’’ guidance documents have to survive that gauntlet,20 but
also subjecting them to full-bore OIRA review invites additional, substantial delays.
There  is  a  conspicuous  and  undoubtedly  deliberate  omission  in  the  new  Executive
Order.  Although  the  amended  Order  retains  the  long-standing  time  constraints  on
OIRA to act on agency regulatory proposals, there is no similar time limit on OIRA’s
review  of  guidance  documents.21 If  OIRA  takes  months  or  longer  to  review  a  guid-
ance document OIRA deems significant, the agency has no recourse under the Exec-
utive Order. If the past is prologue, OIRA review process will certainly delay, often
substantially, the issuance of needed significant guidance.22

16 OSHA,  Guidance  Document  for  Preparing  Workplaces  for  an  Influenza  Pandemic  (2007)

(available at http://www.osha.gov/Publications/influenza¥pandemic.html).

17 FDA, Center for Biologics Evaluation and Research, Certain Human Cells, Tissues, and Cel-
lular  and  Tissue-Based  Products  (HCT/Ps)  Recovered  From  Donors  Who  Were  Tested  For  Com-
municable  Diseases  Using  Pooled  Specimens  or  Diagnostic  Tests  (Jan.  23,  2007)  (available  at
http://www.fda.gov/cber/gdlns/hctppool.htm).

18 EPA, Regulating Antimicrobial Pesticides (Jan. 25, 2007) (available at http://www.epa.gov/

oppad001).

19 Executive Order 13422, §§ 1(b)(1), 1(b)(7), 1(b)(10), 1(b)(11) & 1(b)(12).
20 There  is  a  definitional  ambiguity  embedded  in  the  Executive  Order  that  gives  OIRA  broad
authority  to  designate  virtually  any  guidance  document  ‘‘significant,’’  triggering  mandatory
OIRA review. In section 3(h)(1)(A), the Order defines the term ‘‘[s]ignificant guidance document’’
as  one  that  ‘‘may  reasonably  be  anticipated  to. . .[l]ead  to  an  annual  effect  of  $100  million  or
more  or  adversely  affect  in  a  material  way  the  economy,  a  sector  of  the  economy,  productivity,
competition, jobs, the environment, public health or safety, or State, local or tribal governments
or communities.’’ Because guidance documents are by definition non-binding, it is difficult to see
how one could ‘‘lead to an annual effect of $100 million or more,’’ although the phrase ‘‘lead to’’
permits OIRA to claim that even the most indirect action by the agency could have a substantial
effect on the economy. OIRA has already suggested that it will take this view. See OMB, Final
Bulletin for Agency Good Guidance Practices, 72 Fed. Reg. 3432 (Jan. 25, 2007). But aside from
the  indirect  effects  point,  the  definition  is  written  in  the  disjunctive  and  it  is  easy  to  see  how
one could argue that virtually any guidance document that addresses broad public health ques-
tions,  such  as  OSHA’s  guidance  on  pandemic  influenza  or  the  EPA’s  guidance  on  antimicrobial
agents,  might  be  said  to  ‘‘adversely  affect  in  a  material  way  the  economy,  a  sector  of  the  econ-
omy,  productivity,  competition,  jobs,  the  environment,  public  health  or  safety.’’  Thus,  it  is  dif-
ficult to tell what guidance documents might be deemed ‘‘significant.’’ It could be that hundreds
or  thousands  of  guidance  documents  each  year  would  qualify  under  this  potentially  sweeping
definition—a concern heightened because OIRA, not the agency, will have the final say on what
constitutes a ‘‘significant’’ guidance document.

21 Compare  Executive  Order  13422,  § 9  (requiring  agency  consultation  with  OIRA  on  signifi-
cant  guidance  documents  but  not  setting  any  time  limit  for  such  consultation)  with  id.  §§ 6  &
8 (setting strict time limits for OIRA/agency consultation on regulations).

22 The  CRS  Report,  supra  n.1,  raises  another  question  of  omission:  Executive  Order  13422
does  not  clearly  extend  the  transparency  requirements  applicable  to  rule-makings  to  OIRA  re-
view  of  guidance  documents.  CRS  Report  at  11–12.  As  I  read  the  new  Order,  CRS’s  concerns
are  well-founded.  There  is  nothing  in  the  Order  that  makes  explicit  that  the  transparency  and
accountability  provisions  relating  to  OIRA  clearance  of  rule-makings  apply  to  OIRA  review  of
guidance documents, and one may reasonably conclude that omissions of this sort are not inad-

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00036 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

31

3. Rationing of Health and Safety Protection.

Executive  Order  13422  also  sets  the  stage  for  the  resurrection  of  the  discredited
concept  of  a  ‘‘regulatory  budget.’’  Under  the  new  Order,  ‘‘no  rule-making  may  be
commenced’’ unless it appears on the agency’s Regulatory Plan and the agency sets
forth  ‘‘the  agency’s  best  estimate  of  the  combined  aggregated  costs  and  benefits  of
all its regulations planned for that calendar year.’’ 23 These estimates give OIRA the
ability  effectively  to  cap  the  amount  of  compliance  costs  an  agency  may  impose  in
a calendar year—or set a ‘‘regulatory budget’’—a power OIRA has long coveted.

The  goal  of  this  amendment  is  quite  clearly  to  limit  industries’  exposure  to  regu-
latory  costs.  OIRA  could  wield  this  tool  regardless  of  whether  the  compliance  costs
will  be  absorbed  by  different  industries,  regardless  of  the  benefits  that  flow  from
regulation,  and  regardless  of  the  mandates  Congress  has  set  for  the  agencies.  If
Congress believes it is appropriate to experiment with regulatory budgeting, that is
one  thing.  It  is  quite  another  for  the  Executive  Branch  to  arrogate  that  power  to
itself.
4. Further Politicization of the Regulatory Process.

Executive Order 13422 breaks from past practice in another important respect: It
requires each agency to designate a political appointee to head its regulatory policy
office.  In  many  agencies,  the  regulatory  policy  office  has  traditionally  been  headed
by a career civil servant who is an expert in the arcane details of regulation.24 But
in  all  agencies,  regulatory  action  is  reviewed  and  approved  by  the  agency  head,  or
his designee, to ensure that there is political accountability for agency actions.

The amendments to the Executive Order, however, undermine the authority Con-
gress  has  conferred  on  the  agency  head.  This  is  a  troubling  development  that  Con-
gress  ought  to  care  deeply  about.  The  statutes  Congress  enacts  to  delegate
decisional power to agencies explicitly designate the agency head—and not a subor-
dinate—as  the  decision-maker.  Congress  is  careful  to  designate  the  agency  head  to
ensure that decisions are made by an official accountable to Congress as well as the
President. To be sure, the President retains the power of appointment and removal,
but Cabinet Secretaries and agency heads are presumed to have the power to decide
questions  independently,  even  at  the  risk  of  removal.  Disputes  between  the  White
House  and  Cabinet  officers  and  agency  heads  have  emerged  and,  at  times,  the
White House has relented.

The  amended  Executive  Order  strips  Congress’  designation  of  much  of  its  force
by  giving  a  different  political  appointee—accountable  to  the  President  but  not  nec-
essarily  to  Congress—substantial  control  over  the  agency’s  regulatory  output.  This
is not hyperbole. The Order expands the duties of the policy officer, providing that,
‘‘[u]nless  specifically  authorized  by  the  head  of  the  agency,  no  rule-making  shall
commence  nor  be  included  on  the  [agency’s  annual  regulatory]  Plan  without  the  ap-
proval’’ of the policy officer.25 Under the new Order, the policy officer—who has ties
with  and  owes  his  allegiance  to  the  White  House—will  be  the  gatekeeper  of  the
agency’s  regulatory  output.  As  The  New  York  Times  put  it,  ‘‘[t]he  White  House  will
thus have a gatekeeper in each agency to analyze the costs and benefits of new rules
and to make sure the agency carries out the president’s priorities,’’ 26 which are not
necessarily Congress’ priorities.27

vertent. Congress, of course, has at times been critical of OIRA’s penchant for behind-close-door
dealings  in  the  past,  and  the  apparent  decision  to  shield  agency-OIRA  interactions  over  guid-
ance documents from public view appears to be an unwarranted return to the past.

23 Executive Order 13422, § 4(c)(1)(B).
24 On  this  issue  in  particular,  I  want  to  endorse  the  views  of  Columbia  University  Law  Pro-
fessor Peter L. Strauss, who is testifying on Executive Order 13422 today before the House Judi-
ciary  Committee’s  Subcommittee  on  Commercial  and  Administrative  Law.  Professor  Strauss
suggests  that  Congress,  not  an  agency  head  or  the  White  House,  ought  to  select  the  regulatory
officer,  a  suggestion  I  endorse.  The  CRS  Report,  supra  n.1,  also  suggests  that  this  portion  of
the  Executive  Order  might  run  afoul  of  the  Appointments  Clause  on  the  ground  that  with  the
enhanced powers provided by the Executive Order, the policy officer must be seen as a principal
officer  of  the  United  States,  requiring  Senate  confirmation  under  Buckley  v.  Valeo,  424  U.S.  1,
126  (1976).  Although  the  courts  have  been  wary  about  Appointments  Clause  claims,  the  CRS
Report raises serious constitutional questions that should be explored fully by Congress.

25 Executive Order 13422, § 4(c)(1) (emphasis added).
26 Robert Pear, Bush Directive Increases Sway on Regulation, N.Y. Times, A1 (Jan. 30, 2007).
27 The  CRS  Report,  supra  n.1  at  7  &  n.16,  suggests  that  the  problems  I  see  in  this  provision
of  the  Order  may  be  more  theoretical  than  real,  because  many  of  the  presidential  appointees
in  the  major  agencies  are  subject  to  Senate  confirmation.  I  am  skeptical  of  this  assertion.  For
years, the White House has used non-career SES slots to place presidential appointees in high-
level,  non-confirmation  positions  at  many  agencies,  such  as  the  non-career  deputy  commis-
Continued

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00037 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

32

5. The Push to Formal Rule-making.

Executive Order 13422 amends section 6 of Executive Order 12866 by adding the
following: ‘‘In consultation with OIRA, each agency should also consider whether to
utilize formal rule-making procedures under 5 U.S.C. 556 and 557 for the resolution
of complex determinations.’’ To administrative law scholars, the suggestion that the
White  House  is  pushing  agencies  to  undertake  formal  rule-making  under  sections
556  and  557  of  the  Administrative  Procedure  Act  is  both  stunning  and  stunningly
ill-advised.  To  begin  with,  it  betrays  a  misunderstanding  of  administrative  law  to
call sections 556 and 557 ‘‘rule-making’’ provisions; they are not, they are ‘‘hearing’’
provisions. Rule-making under the APA is generally governed by section 553, which
calls for notice and comment rule-making, not rule-making based on a formal hear-
ing. Sections 556 and 557 establish procedures for formal agency adjudicatory hear-
ings  (a)  where  adjudications  are  required  under  section  554  of  the  APA  or  (b)  in
those  rare  instances  in  which  Congress  has  specified  that  an  agency  must  hold  a
hearing  as  part  of  its  rule-making  process.  But  agencies  do  not  voluntarily  hold
hearings in rule-making proceedings. Formal hearings are notoriously cumbersome,
labor-intensive,  and  time-consuming  and  agencies  have  long  sought  to  avoid  them
by any means possible—a stratagem largely endorsed by the Courts.28 Moreover, in
the  rare  instances  in  which  agencies  engage  in  formal  hearings  under  sections  556
and  557,  the  hearing  is  used  to  resolve  matters  of  dispute  between  two  parties,  or
among a small number of discrete parties—such as a proceeding to confer a license
on  one  of  two  or  more  competing  parties.  Unless  mandated  by  Congress,  formal
hearings have not been used to establish regulatory policy or rules of general appli-
cability for decades, and no one has advocated otherwise, until the issuance of Exec-
utive Order 13422.29

The inclusion of this provision in the Executive Order heightens concern about the
purpose  of  the  Order.  As  I  have  explained,  one  inevitable  consequence  of  Executive
Order  13422  is  that  it  will  lead  to  the  further  ossification  of  an  already  overbur-
dened  administrative  process.  As  an  instrument  of  delay,  formal  rule-making  has
no  peer;  it  is  the  American  version  of  Dickens’  nightmarish  Jardynce  v.  Jardynce.
Empowering OIRA to push agencies to employ formal rule-making to make complex
determinations  sends  a  disturbing  signal,  namely  that  delay  and  not  resolution  is
the real goal.
CONCLUSION

Executive  Order  13422  constitutes  an  unprecedented  consolidation  of  power  over
our  regulatory  agencies  in  the  White  House.  It  also  constitutes  an  unprecedented
assault on the ability of Congress to set the substantive standards that guide agen-
cies  in  the  performance  of  their  delegated  tasks.  The  consequences  of  this  shift  are
far-reaching  and  tragic.  Effective  regulation  is  essential  to  our  nation’s  well-being.
For  that  reason,  administrative  agencies  were  created  to  bring  expertise,  independ-
ence, and transparency to the regulatory process. This Executive Order undermines
those  values.  It  gives  a  small  group  of  generalists  at  OIRA  the  power  to  second-
guess  and  undermine  the  expert  and  impartial  judgments  of  the  scientists,  physi-
cians,  epidemiologists,  engineers,  and  toxicologists  who  staff  our  health  and  safety
agencies.  It  holds  health  and  safety  regulation  hostage  to  economic  considerations
of market failure and cost/benefit analysis. It puts partisan politics at the center of
our  regulatory  process  by  giving  the  White  House  substantial  control  over  the  day-
to-day work of our agencies. And it undermines transparency by establishing an off-
the-record process for OIRA review of significant guidance documents.

sioners  at  the  Food  and  Drug  Administration.  The  CRS  Report  recognizes  the  possibility  that
these  appointees  will  qualify  under  the  Executive  Order  and  concedes  that  if  these  appointees
qualify  ‘‘then  the  agency  heads  would  have  a  wider  range  of  ’presidential  appointee’  positions
from  which  to  designate  regulatory  policy  officers.’’  Id.  Because  the  White  House  alone  will  de-
cide  which  appointees  qualify  as  ‘‘presidential  appointees’’  under  the  Executive  Order,  I  do  not
believe  that  the  narrow  view  of  what  constitutes  a  ‘‘presidential  appointee’’  expressed  in  the
CRS  Report  will  be  the  one  chosen  by  the  White  House,  which  has  strong  incentives  to  ensure
that its operatives are appointed agency regulatory officers.

28 See  generally  United  States  v.  Florida  East  Coast  R.R.  Co.,  410  U.S.  224  (1973);  Chemical
Waste Management, Inc. v. EPA, 873 F.2d 1477 (D.C. Cir. 1989) (rejecting claim for formal hear-
ing in part on efficiency grounds).

29 See  generally  ACUS  Recommendations  72–5,  Procedures  for  the  Adoption  of  Rules  of  Gen-
eral  Applicability,  38  Fed.  Reg.  19782  (1972)  (arguing  that  proceedings  under  section  556  and
557 should be sharply circumscribed).

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00038 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

33

Congress has acquiesced in this accretion of power to the President. I would urge
that  the  time  has  come  for  Congress  to  consider  reclaiming  its  authority.  Thank
you.30

BIOGRAPHY FOR DAVID C. VLADECK

David  C.  Vladeck  is  the  Director  of  the  Institute  for  Public  Representation  and
Associate  Professor  of  Law  at  Georgetown  University  Law  Center.  He  teaches
courses in federal courts, civil procedure, and first amendment litigation, and co-di-
rects the Institute for Public Representation, a clinical law program at the Law Cen-
ter  where  he  handles  a  broad  array  of  civil  rights,  civil  liberties,  first  amendment,
open government, and regulatory litigation.

Prior  to  joining  the  Georgetown  faculty  in  2002,  Professor  Vladeck  spent  nearly
30  years  with  Public  Citizen  Litigation  Group,  serving  as  its  Director  from  1992  to
2002. He has handled a wide range of complex litigation, including first amendment,
health and safety, civil rights, class actions, preemption and open government cases.
He  has  argued  a  number  of  First  Amendment  and  civil  rights  cases  before  the
United  States  Supreme  Court,  and  more  than  60  cases  before  the  federal  courts  of
appeal and state courts of last resort.

Professor  Vladeck  also  testifies  before  Congress,  advises  Members  of  Congress  on
legal  matters,  and  writes  on  administrative  law,  first  amendment,  legal  ethics,  and
access  to  justice  issues.  He  serves  as  a  Scholar  with  the  Center  for  Progressive  Re-
form  and  on  the  boards  of  various  non-profit  organizations.  He  has  also  served  on
the Council of the Administrative Law and Regulatory Practice Section of the Amer-
ican  Bar  Association,  as  a  Public  Member  of  the  Administrative  Conference  of  the
United  States,  and  as  the  Chair  of  the  Administrative  Law  Section  of  the  District
of  Columbia  Bar.  Professor  Vladeck  received  his  undergraduate  degree  from  New
York  University,  his  law  degree  from  Columbia  University  School  of  Law,  and  an
LL.M. degree from Georgetown University Law Center.

Chairman MILLER. Thank you, Mr. Vladeck. Mr. Kovacs. I wasn’t

paying attention.
STATEMENT  OF  MR.  WILLIAM  L.  KOVACS,  VICE  PRESIDENT,
ENVIRONMENT,  TECHNOLOGY,  AND  REGULATORY  AFFAIRS,
U.S. CHAMBER OF COMMERCE
Mr.  KOVACS.  Thank  you,  Mr.  Chairman,  and  Ranking  Member

Sensenbrenner.

It  is  really  a  privilege  to  be  here  today,  and  to  discuss  oversight
issues  with  federal  agencies.  The  Chamber  cares  about  this  issue
probably  more  than  any  other  issue.  The  regulatory  mill,  contrary
to what has been stated, has not stopped. There are about 110,000
regulations  out  there  right  now.  There  are  4,000  new  regulations
a  year.  The  cost  to  the  American  economy  is  about  $1.1  trillion,
and  to  put  it  in  perspective,  there  are  only  $857  billion  in  indi-
vidual  income  taxes,  and  another  $226  billion  in  corporate  taxes,
so  it  is  one  significant  mandate.  It  costs  small  business  about  45
percent more than it costs a large business to comply with it.

So,  the  regulatory  mill,  and  the  regulation  mill,  hasn’t  stopped.
Executive  Order  13422,  you  know,  there  is  a  lot  of  hyperbole  and
a  lot  of  rancor  about  this,  but  this  Executive  Order  contains  noth-
ing  that  hasn’t  been  contained  in  an  Executive  Order  since  the
Presidency  of  Richard  Nixon,  and  through  Nixon,  with  his  quality
of  life,  and  Jimmy  Carter,  with  his  regulatory  reform,  right
through  Reagan  and  Bush  and  Clinton,  have  all  issued  something
like  this.  And  it  is  an  attempt  by  the  Administrations  to  get  some
management  structure  in  the  agencies,  because  what  does  it  ask
them  to  do?  It  asks  them  to—asks  to  state  a  purpose  for  the  rule.

30 I  would  like  to  acknowledge  the  assistance  of  Sandra  C.  George,  a  third-year  student  at

Georgetown University Law Center, in the preparation of this testimony.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00039 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

34

It asks that they have a cumulative cost benefit, which some people
would say is new, but it actually came in Carter’s time, and to have
a regulatory appointment. That also came in Carter’s time.

And  during  this  same  30  year  time  period,  it  hasn’t  been  as  if
the  agencies  were  just  off,  or  the  executive  was  off  trying  to  man-
age the agencies. Congress has gone through the Regulatory Flexi-
bility Act, where you have asked the agencies every seven years to
come  back  and  talk  about  the  regulations  that  should  be  elimi-
nated,  or  Small  Business  Regulatory  Fairness  Act  (SBREFA)  with
Congressional review, or negative—or reg negs. You can go through
a  whole  list.  This  has  been  a  bipartisan  effort  for  30  years,  and  it
is an attempt to manage.

The  Good  Guidance  Practices,  yeah,  we  did  comment  on  it,  and
most of the comments were very positive. But what does it ask the
public  to  do?  It  asks  the  public  and  the  agencies  that  if  you  have
a significant guidance document, and some of these guidance docu-
ments  are  very  significant,  because  on  top  of  the  110,000  regula-
tions,  you  have  several—tens  of  thousands  of  guidance  documents.
What  does  it  ask  them  to  do?  It  says  if  it  has  got  significant  guid-
ance,  of  general  applicability  to  the  entire  regulated  community,
what  should  you  do?  You  should  put  it  on  your  website?  That  is
corrupting  government?  You  should  put  it  on  your  website,  and
allow  the  public  to  comment?  You  should  give  them  a  list  of  docu-
ments,  and  put  it  on  your  website,  so  that  the  public  knows  what
the  guidance  is?  Everyone  feels  sorry—oh,  the  poor  small  business
can’t speak to a regulatory officer. That is foolish. They—it has got
to  be  of  general  applicability,  and  it  requires  notice  and  comment
on the website.

The  second  part  of  it  is  if  it  is  an  economically  significant  rule,
which imposes costs of $100 million or more, then they have to put
a notice in the Federal Register, and they have to accept comments
from  the  public.  I  don’t  know  that  these  are  huge  burdens,  but
what  it  does  do  is  it  opens  up  the  transparency.  Think  about  it.
You  are  a  small  business  in  North  Carolina,  and  you  have  got  a
set  of  regulations  that  are  four  feet  long  and  six  feet  high,  going
up to the ceiling, and you have to deal with health issues, pensions,
environmental  issues,  OSHA  issues,  and  everything  else,  and  you
have got to deal with it every day, and you have ten employees.

And so, what this is doing is it is making the process more trans-
parent, and it is putting, yes, a political figure, someone who works
for  the  President  of  the  United  States,  who  is  the  executive  officer
of  the  United  States,  and  is  trying  to  manage  a  government  that
he  really  has  a  very  difficult  time  controlling.  There  are  all  these
buildings that you look at, with all these regulations coming out of
these  buildings,  and  what  is  he  asking  the  political  officer  to  do?
He  is  saying:  ‘‘Look,  I  have  got  a  policy  here,  I  want  regulations
that  have  some  compliance  with  my  Executive  Orders.  Would  you
tell  me  if  the  agency  is  not  going  to  comply  with  my  Executive
Order?’’ I don’t think that that is an unreasonable request.

And then, finally, over the years, the courts have been very clear
on Executive Orders and guidance documents. I mean, on the guid-
ance  documents,  Appalachia  Power,  the  D.C.  Court  of  Appeals
made  it  very  clear,  if  it  has  got  the  force  and  effect  of  law,  it  is  a
regulation,  whether  you  call  it  guidance  or  regulation.  All  this  Ex-

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00040 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

35

ecutive  Order  is  trying  to  do  is  say  it  doesn’t  matter  whether  it  is
guidance  or  regulation,  let  us  have  the  public  have  the  right  to
comment.

And  then,  finally,  even  on  the  scope  of  the  Executive  Order,  the
courts have dealt with these for years, since Harry Truman and the
Steel  Seizure  case,  if  the  President  is  legislating,  then  it  is  uncon-
stitutional.  If  the  President  is  managing  government,  then  it  is
within his prerogative, and I think that this is—I really thank you
for  having  this  hearing,  because  I  think  that  having  a  discussion
over  the  role  of  agencies  and  government  is  really  crucial,  and  I
think you are doing a great service to everyone.

Thank you.
[The prepared statement of Mr. Kovacs follows:]

PREPARED STATEMENT OF WILLIAM L. KOVACS

Chairman  Miller,  Ranking  Member  Sensenbrenner,  and  Members  of  the  Sub-
committee, thank you for inviting me here today to testify concerning the Adminis-
tration’s amendment to Executive Order 12866 (which is in the form of E.O. 13422)
and  the  Office  of  Management  and  Budget’s  (OMB)  Final  Bulletin  for  Agency  Good
Guidance  Practices.  I  am  William  Kovacs,  Vice  President  of  Environment,  Tech-
nology,  and  Regulatory  Affairs  at  the  U.S.  Chamber  of  Commerce.  The  U.S.  Cham-
ber  is  the  world’s  largest  business  federation,  representing  more  than  three  million
businesses and organizations of every size, sector, and region. More than 96 percent
of the U.S. Chamber’s members qualify as small businesses.
WHY WE CARE

As  a  business  federation,  the  U.S.  Chamber  is  all  too  familiar  with  the  over-
whelming  regulatory  burdens  our  members  face  at  the  hands  of  government  regu-
lators. Each year approximately 4,000 new regulations are issued by federal agen-
cies, and the Federal Register exceeds 73,000 pages annually.1 Currently, there are
more than 110,000 regulations in existence,2 not including the thousands of guid-
ance  documents  that  implement  them!  Since  1995,  more  than  44,000  new  final
rules have  been  issued.  The  annual  cost  to  implement  the  Nation’s  regulatory  sys-
tem exceeds the amounts collected from individual income taxes.3

Moreover,  the  cost  of  federal  regulations  to  the  public  is  estimated  to  be  as  high
as $1.13 trillion4—a cost which equals almost half the amount of last year’s entire
federal budget! 5 And the impact of federal regulations is especially severe on small
businesses.  For  example,  the  annual  cost  of  all  federal  regulations  is,  on  a  per  em-
ployee  basis,  $7,647  for  firms  with  fewer  than  20  employees—nearly  45  percent
higher than the $5,282 for companies with 500 or more employees.6

In  addition,  the  number  of  paperwork  burden  hours—hours  spent  by  businesses
in preparing paperwork imposed by federal regulations—has skyrocketed. Last year
alone,  the  number  of  paperwork  burden  hours  imposed  on  the  public  exceeded  an
extraordinary  10.5  billion  hours—the  highest  in  history—and  2.5  billion  hours
more than just two years ago.7

With  the  regulatory  process  so  increasingly  complex  and  expensive,  it  is  easy  to
understand  why  Presidents  and  Congress—both  Democrat  and  Republican—have

1 Ten  Thousand  Commandments:  An  Annual  Snapshot  of  the  Federal  Regulatory  State,  by
Clyde  Wayne  Crews,  Vice  President  for  Policy  and  Director  of  Technology  Studies  at  the  Com-
petitive Enterprise Institute (June 28, 2006).

2 John  D.  Graham,  Administrator  of  the  Office  of  Information  and  Regulatory  Affairs,  Testi-
mony  before  the  Subcommittee  on  Energy  Policy,  Natural  Resources,  and  Regulatory  Affairs,
U.S. House of Representatives (Nov. 17, 2004).

3 Ten Thousand Commandments: An Annual Snapshot of the Federal Regulatory State, supra,
pg. 6. The amount of individual income taxes collected in 2005 was $894 billion, and the amount
of corporate income taxes collected was $226 billion.

4 The  Impact  of  Regulatory  Costs  on  Small  Firms,  Report  RFP  No.  SBHQ–03–M–0522,  by  W.
Mark Crain, Lafayette College, for The Office of Advocacy, U.S. Small Business Administration
(Sept. 2005).

5 Budget of the United States Government, Fiscal Year 2005, Office of Management and Budg-

et. Accessible at: http://www.whitehouse.gov/omb/budget/fy2005/.

6 Ibid, footnote 2, page 5.
7 Paperwork  Reduction  Act:  New  Approaches  Can  Strengthen  Information  Collection  and  Re-
duce Burden, U.S. Government Accountability Office Report, GAO–06–477T, pg. 7, Washington,
DC (Mar. 8, 2006).

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00041 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

36

tried,  albeit  unsuccessfully,  to  exercise  some  management  responsibility  over  the
system.  And,  similarly,  it  is  hard  to  understand  the  current  fervor  over  Executive
Order 13422 and OMB’s Final Bulletin for Agency Good Guidance Practices (GGP).
The  E.O.  and  GGP  are  merely  the  latest  efforts  in  a  long-term,  bipartisan  attempt
to  exercise  oversight  of  the  regulatory  process.  Congress  certainly  would  not  want
guidance documents masquerading as regulations, adding cost and complexity to the
regulatory process and without appropriate public review and comment as required
by the Administrative Procedure Act (APA).

In my testimony today, I want to make three key points:

1. Regulatory  reform  is  not  new—rather  it  has  been  an  ongoing  bipartisan  ef-

fort for more than 30 years;

2. E.O.  13422  and  GGP  are  essential  tools  for  the  executive  branch  to  exercise

oversight over the regulatory process; and

3. E.O.  13422  and  GGP  are  part  of  a  larger  government  effort  to  ensure  and
maximize  the  quality,  utility,  integrity,  and  objectivity  of  information  dis-
seminated by the Federal Government.

BACKGROUND

One  of  the  fundamental  cornerstones  of  good  government  is  ensuring  that  the
public has the opportunity to participate in the policy-making process. This partici-
pation  allows  the  public  to  have  a  voice  in  the  making  of  the  laws  that  regulate
them. Public participation protects citizens from arbitrary decisions by federal agen-
cies by enabling citizens to effectively engage in the rule-making process.

Citizens  cannot  participate  effectively,  however,  without  knowing  all  the  facts.
Why  do  we  need  this  rule?  How  much  will  it  cost  to  implement?  How  does  it  fit
in  with  other  regulations?  Without  such  basic  information,  citizens  are  precluded
from  intelligently  voicing  their  concerns.  Rules  do  not  operate  in  a  vacuum.  As
such, their cost and impact must be considered in conjunction with other rules.

Likewise,  federal  agencies  exclude  the  public  by  issuing  documents  that  are  not
legally binding, yet effectively regulate people’s behavior. By calling such documents
‘‘guidance,’’  they  circumvent  the  public  participation  requirements  guaranteed  by
the APA. By law, agency advisory opinions and guidance documents have no legally
binding  effect.  They  are  merely  an  agency’s  interpretation  of  how  the  public  can
comply with a particular rule or regulation. Unfortunately, however, the use of guid-
ance documents to regulate the public has become a common practice. That is, even
though  guidance  documents  do  not  have  legally  binding  effect,  they  have  practical
binding effect when the agencies use them to establish criteria that affect the rights
and obligations of private persons.

It  is  far  easier  to  issue  a  guidance  document  than  to  undergo  the  rigors  of  rule-
making.  Consider  that  rule-makings  require  internal  agency  review,  public  partici-
pation  (including  notice  and  comment  under  the  APA),  compliance  with  the  analyt-
ical  requirements  of  Executive  Order  12866,  the  Regulatory  Flexibility  Act,  and  the
Unfunded Mandates Reform Act, OMB review, Congressional review, and potentially
judicial review. Because of these stringent requirements, agencies have a strong in-
centive to issue rules as less procedurally onerous guidance documents that—inten-
tionally or not—cut the public and the regulated community out of the process.

The problem with regulations and guidance documents is symptomatic of a larger
problem  concerning  the  entire  regulatory  system.  But,  over  the  years,  efforts  have
been made to address it.
I. REGULATORY REFORM HAS BEEN A BIPARTISAN EFFORT

For  years,  the  Executive  and  Legislative  branches  of  government—regardless  of
party or politics—have tried hard to exercise oversight over a cumbersome, complex,
and  often  times  inequitable  regulatory  system.8 Through  a  vast  array  of  executive
orders  and  statutes,  efforts  to  inject  sanity  into  the  regulatory  process  have  made
slow, but noticeable, progress.9 As guidance document abuse became more and more

8 For  example,  Executive  Order  12044,  Improving  Government  Regulations,  signed  by  Presi-
dent  Carter  in  1978,  established  requirements  for  centralized  review  of  regulations  and  the
preparation  of  regulatory  analyses,  and  mandated  that  agencies  ‘‘periodically’’  review  existing
regulations.  Executive  Order  12866,  Regulatory  Planning  and  Review,  was  signed  by  President
Clinton  in  1993  and  required  agencies  to  review  existing  regulations  to  identify  which  could  be
modified  or  eliminated.  Section  610  of  the  Regulatory  Flexibility  Act  requires  federal  agencies
to review regulations every 10 years to determine whether they are meeting their objectives and
if they should be rescinded.

9 See Appendix A.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00042 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

37

prevalent,10 however,  Congress  again  intervened  to  try  to  correct  the  inequity.  In
2000,  the  House  Committee  on  Government  Reform  adopted  a  report  titled  ‘‘Non-
Binding  Legal  Effect  of  Agency  Guidance  Documents,’’  which  highlighted  agency
abuse of guidance documents and severely criticized the use of such so-called ‘‘back-
door regulation.’’ 11 Still, agencies continued to issue guidance to effectively regulate
the public. The judicial branch eventually weighed in, with courts alerting congress
to the problem, and encouraging legislation to correct it:

The  phenomenon  we  see  in  this  case  is  familiar.  Congress  passes  a  broadly
worded statute. The agency follows with regulations containing broad language,
open-ended phrases, ambiguous standards and the like. Then as years pass, the
agency issues circulars or guidance or memoranda, explaining, interpreting, de-
fining  and  often  expanding  the  commands  in  regulations.  One  guidance  docu-
ment may yield another and then another and so on. Several words in a regula-
tion  may  spawn  hundreds  of  pages  of  text  as  the  agency  offers  more  and  more
detail  regarding  what  its  regulations  demand  of  regulated  entities.  Law  is
made,  without  notice  and  comment,  without  public  participation,  and  without
publication in the Federal Register or the Code of Federal Regulations.12

While  presidential  and  Congressional  efforts  at  regulatory  reform  have  improved

the system, much work remains to be done.
II. THE  E.O.  AND  GGP  ARE  ESSENTIAL  TO  EXERCISING  OVERSIGHT

OVER THE REGULATORY PROCESS

a. E.O. 13422
When President Bush signed Executive Order 13422, he was expanding the scope
of  E.O.  12866,  issued  under  President  Clinton,  to  include  not  just  rules,  but  also,
for  the  first  time,  guidance  documents.  This  would  serve  to  correct  the  abuse  of
guidance documents by federal agencies seeking to avoid public participation in the
policy-making  process.  Far  from  being  radical,  E.O.  13422  merely  instructs  federal
agencies to:

1. State the reason for the regulation;
2. State  the  cost  of  the  regulation,  and  an  estimate  of  the  combined  costs  and
benefits of all of its regulations planned for that calendar year (to assist with
the identification of agency priorities); and

3. Have  a  Regulatory  Policy  Officer  ensure  that  these  requirements  have  been

followed by the agency.

Perhaps  the  most  talked  about  requirement  in  E.O.  13422  has  been  the  appoint-
ment  of  a  Regulatory  Policy  Officer  (RPO)  by  the  President.  Critics  have  declared
that  this  provision  is  an  illegal  expansion  of  executive  authority  because  it  allows
the  President  to  control  the  regulatory  agenda.  Yet  what  is  it  the  RPO  is  tasked
to  do?  First,  the  RPO  ensures  that  any  guidance  document  is  not  actually  a  rule—
one that will regulate public behavior. Second, the RPO ensures that the agency has
explained  the  need  for  a  rule,  and  has  looked  at  the  costs  and  benefits  of  the  pro-
posed rule, and the aggregate costs and benefits of all the rules being issued by that
agency for the year. If it hasn’t, then the RPO can notify OMB. Is it really so insid-
ious to require accountability in our rule-making process?

Nevertheless,  critics  continue  to  decry  E.O.  13422  as  an  unwarranted  (and  pos-
sibly  unconstitutional)  expansion  of  executive  power.  Yet,  without  delving  into  a
constitutional  law  treatise  on  the  subject—which  is  beyond  the  scope  of  this  testi-

10 Perhaps  the  most  notorious  example  of  an  agency  guidance  document  regulating  behavior
is  EPA’s  ‘‘Interim  Guidance  for  Investigating  Title  IV  Administrative  Complaints  Challenging
Permits’’  (the  so-called  ‘‘Environmental  Justice’’  guidance),  which  a  GAO  investigation  subse-
quently concluded was a rule disguised as guidance.
11 H. Rep. 106–1009 (106th Cong., 2d Sess. 2000).
12 Appalachian  Power  Co.  v.  EPA,  208  F.3d  1015  (D.C.  Cir.  2000)  (striking  down  emissions
monitoring  guidance  as  legislative  rule  requiring  notice  and  comment).  See  also,  Chamber  of
Commerce  v.  Dept.  of  Labor,  174  F.3d  206  (D.C.  Cir.  1999)  (striking  down  OSHA  Directive  as
legislative rule requiring notice and comment); General Electric Co. v. EPA, 290 F.3d 377 (D.C.
Cir. 2002) (striking down PCB risk assessment guidance as legislative rule requiring notice and
comment).  Even  the  American  Bar  Association,  recognizing  the  problem  with  guidance  docu-
ments,  stated  in  its  Annual  Report  Including  Proceedings  of  the  Fifty-Eighth  Annual  Meeting,
August 10–11, 1993, Vol. 118, No. 2, at 57: ‘‘Before an agency adopts a non-legislative rule that
is likely to have a significant impact on the public, the agency must provide an opportunity for
members  of  the  public  to  comment  on  the  proposed  rule  and  to  recommend  alternative  policies
or  interpretations,  provided  that  it  is  practical  to  do  so;  when  non-legislative  rules  are  adopted
without  prior  public  participation,  immediately  following  adoption,  the  agency  must  afford  the
public an opportunity for post-adoption comment and give notice of this opportunity.’’

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00043 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

38

mony—it is certainly well settled that the President has the power to make political
appointments  of  officers  within  his  own  executive  agencies.13 Hysterical  claims  of
unconstitutional ‘‘power grabs’’ only serve to distract us from the important and siz-
able  problems  with  the  regulatory  process  that  E.O.  13422  is  intended  to  address.

b. GGP
The final version of OMB’s GGP bulletin, released simultaneously with the Presi-
dent’s E.O. 13422, establishes policies and procedures for the development, issuance
and  use  of  significant  guidance  documents  in  order  to  increase  the  quality  and
transparency  of  internal  agency  practices.  The  purpose  of  GGP  is  to  ensure  that
guidance  documents  of  Executive  Branch  departments  and  agencies  are  developed
with  appropriate  review  and  public  participation,  accessible  and  transparent  to  the
public, and not improperly treated as legally binding. The GGP also provides a dis-
tinction between what does and does not constitute a guidance document to provide
greater clarity to the public.

Such  criteria  are  not  new.  In  fact,  there  is  a  strong  foundation  for  establishing
standards  for  the  initiation,  development,  and  issuance  of  guidance  documents  to
improve  their  quality  and  transparency.  The  former  Administrative  Conference  of
the United States (ACUS), for example, developed recommendations for the develop-
ment and use of agency guidance documents.14 In 1997, the Food and Drug Admin-
istration (FDA) created a guidance document distilling its good guidance practices.15
Congress  then  codified  aspects  of  the  FDA  document  into  the  Food  and  Drug  Ad-
ministration  Modernization  Act  of  1997.16 Much  of  GGP  is  modeled  on  the  FDA’s
early efforts.
III. E.O.  13422  AND  GGP  ARE  PART  OF  A  LARGER  GOVERNMENT  EF-
FORT  TO  INCREASE  TRANSPARENCY  AND  MAXIMIZE  THE  QUAL-
ITY,  UTILITY,  INTEGRITY,  AND  OBJECTIVITY  OF  INFORMATION
DISSEMINATED BY THE FEDERAL GOVERNMENT

E.O. 13422 and the GGP are part of a long effort by Congress and several Admin-
istrations  to  improve  the  transparency  and  quality  of  government  data  and  provide
effective  parameters  to  guide  the  regulatory  activities  of  federal  agencies.17 These
efforts finally coalesced in the passage of the Information Quality Act (IQA) in 2001,
which serves as the basis for the issuance of the GGP. Were it not for a unified com-
mitment to quality data by this and former Administrations and Congresses—as ex-
emplified in the passage of the IQA—the GGP would not exist today.

In order to understand the connection between GGP and IQA, it is helpful to un-

derstand what the IQA really is.

More  than  any  law  before  it,  the  IQA  served  to  promote  integrity  in  the  agency
decision  making  process,  and  to  enhance  the  accuracy  of  the  data  underlying  gov-
ernment  regulatory  decisions.  It  does  this  by  creating  a  mechanism  by  which  the
public  can  challenge  poor  data.  In  this  way,  the  IQA  is  a  tool  for  everyone—from
industrialists  to  environmentalists—providing  equal  opportunity  to  correct  faulty
government data.

Data  quality  is  a  matter  of  great  importance  to  all  of  us.  For  me  to  have  con-
fidence  that  my  decisions  are  sound,  I  must  have  good  information.  This  is  just
plain  common  sense.  Similarly,  Members  of  Congress  must  be  able  to  rely  on  their
staff to provide good information. Why shouldn’t we be able to expect United States
government  agencies  to  do  the  same,  that  is,  rely  on  good  information  when  devel-
oping regulations and guidelines?

The  IQA  seeks  to  assure  that  this  expectation  can  in  fact  be  realized.  It  requires
federal  agencies  to  ensure  and  maximize  the  quality,  objectivity,  utility,  and  integ-
rity  of  disseminated  information  and  establishes  a  system  whereby  interested  par-
ties can seek correction of erroneous, disseminated information. Ideally, the Act im-
proves  information  quality,  and  in  so  doing,  provides  a  firmer  basis  for  regulatory
authorities  to  make  sound  policy  decisions.  This  is  why  the  Chamber  has  been  one
of the strongest proponents of the IQA.

At the time of its passage, just like now with the issuance of E.O. 13422 and the
GGP, many critics insisted that the IQA would ‘‘shut down’’ the regulatory process,
result in thousands of regulatory challenges, and ultimately rollback environmental,
health and safety protections in this country. Of course, nothing of the sort occurred.

13 Article II, U.S. Constitution.
14 ACUS, Rec. 92–2, 1 C.F.R. 305.92–2 (1992).
15 Notice,  ‘‘The  Food  and  Drug  Administration’s  Development,  Issuance,  and  Use  of  Guidance

Documents,’’ 62 FR 8961 (Feb. 27, 1997).

16 Public Law No. 105–115.
17 See Appendix A.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00044 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

39

In fact, in FY 2005 only 27 IQA petitions were filed with federal agencies. And only
12  IQA  appeals  were  handled  by  federal  agencies  that  year—two  new  appeals,  and
10 from FY 2003 and FY 2004.18

Nevertheless, even faced with these facts regarding the IQA, there are still people
that claim the law is an underhanded attempt by industry to stymie the regulatory
system. It is difficult to understand why people wouldn’t want regulations based on
the most accurate and objective available data. It is likely they are the same people
that are currently decrying E.O. 13422 and GGP, and, consequently, time will again
prove them wrong. But more importantly, it is essential that federal agencies clearly
explain  to  the  American  public  why  they  are  issuing  rules,  and  the  cost  of  these
rules.  For  after  all,  it  is  the  American  public  that  must  live  under  these  rules,  and
as  a  society  of  laws,  not  of  men,  it  is  not  unreasonable  to  ask  that  our  government
clearly  explain  to  us  what  they  are  asking  us  to  obey,  particularly  when  disobe-
dience results in severe civil and criminal penalties.
CONCLUSION

The  long-standing  debate  over  regulatory  reform  will  not  end  today.  The  U.S.
Chamber strongly believes that the regulatory reform process is critical to ensuring
that  regulations  and  guidance  documents  are  sound,  balanced,  cost-effective,  and
open  to  the  public.  Congress  must  not  abandon  its  oversight  role  in  this  area,  and
the U.S. Chamber applauds this committee for this hearing today.

The  U.S.  Chamber  is  grateful  for  the  opportunity  to  present  its  views  about  this

important topic.

BIOGRAPHY FOR WILLIAM L. KOVACS

Bill Kovacs provides the overall direction, strategy, and management of the Envi-
ronment,  Technology  &  Regulatory  Affairs  division  of  the  U.S.  Chamber  of  Com-
merce, the world’s largest business federation representing more than three million
businesses of every size, sector, and region.

Since  assuming  the  position  of  Vice  President  in  March  1998,  Mr.  Kovacs  has
transformed a small division that has focused on a handful of issues and committee
meetings into one of the most significant in the institution. Presently, the Environ-
ment,  Technology  &  Regulatory  Affairs  division  initiates  and  leads  complex,  multi-
dimensional,  national  issue  campaigns  for  such  significant  issues  as  comprehensive
energy legislation, the permanent storage of spent nuclear fuel, telecommunications
reform,  and  the  systematic  application  of  sound  science  to  the  federal  regulatory
process.

Throughout  his  tenure  at  the  U.S.  Chamber,  Kovacs  has  focused  on  finding  new
leadership opportunities for the institution. He pioneered the use of cybercasting for
Chamber events in 1998, recruited and assembled the first science team to work in
tandem  with  policy  staff  to  ensure  that  federal  regulations  are  based  on  sound
science,  formed  and  chaired  the  Chamber’s  Technology  Coordinating  Group,  and
helped to develop numerous national coalitions in the areas of environment, energy,
regulatory affairs, and technology.

Prior to joining the U.S. Chamber, Kovacs was Director of worldwide legal affairs
for Sunshine Makers, Inc., manufacturer of the Simple Green line of non-toxic clean-
ing products. Additionally, Mr. Kovacs held the position of partner in several Wash-
ington, D.C. law firms where his practice focused on environmental law.

As for government service, Kovacs served as Vice Chairman and Chairman of the
Commonwealth  of  Virginia’s  Hazardous  Waste  Facilities  Siting  Board,  as  Chief
Counsel  and  Staff  Director  for  the  U.S.  House  of  Representatives  Subcommittee  on
Transportation and Commerce, and as Legislative Director and Counsel for a mem-
ber of Congress.

During  his  tenure  as  Chief  Counsel,  Mr.  Kovacs  was  the  primary  counsel  on  two
landmark laws that were enacted in a single session of Congress: the Resource Con-
servation  and  Recovery  Act,  the  primary  federal  law  that  regulates  solid  and  haz-
ardous  waste;  and  the  Rail  Revitalization  and  Regulatory  Reform  Act  that  re-orga-
nized  the  bankrupt  Penn  Central  Railroad  into  Conrail,  the  largest  corporate  reor-
ganization in the United States at the time.

Mr.  Kovacs  is  a  frequent  commentator  on  national  environmental,  energy,  and
regulatory issues that impact the business community. He is regularly quoted in the
Nation’s  leading  newspapers  and  appears  on  talk  radio  and  television  as  a  spokes-

18 2006  Report  to  Congress  on  the  Cost  and  Benefits  of  Federal  Regulations  and  Unfunded
Mandates  on  State,  Local,  and  Tribal  Entities,  OMB’s  Office  of  Information  and  Regulatory  Af-
fairs. January 2007.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00045 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

40

person  for  American  business.  He  is  listed  in  Who’s  Who  in  the  World,  Who’s  Who
in America, Who’s Who in American Law, and Who’s Who in Emerging Leaders.

Mr.  Kovacs  holds  his  law  degree  from  the  Ohio  State  University  College  of  Law
and  his  Bachelor  of  Science  degree  from  the  University  of  Scranton,  magna  cum
laude.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00046 Fmt 6633 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

41

Chairman MILLER. Thank you, Mr. Kovacs. The Chair, on behalf

of the Subcommittee, welcomes that endorsement.

Dr. Melberth.

STATEMENT OF MR. RICK MELBERTH, DIRECTOR OF

REGULATORY POLICY, OMB WATCH

Mr. MELBERTH. Thank you, Mr. Chairman.
You  have  heard  testimony  about  the  Executive  Order  amend-
ment, so I would like to focus my comments on the tools of the reg-
ulatory process that Mr. Vladeck referred to.

A  great  deal  of  attention  has  been  given  to  things  like  cost-ben-
efit  analysis,  risk  assessment,  peer  review  and  federal  advisory
committees  have  been  the  focus  of  more  recent  attention.  The  Ad-
ministration has consistently used regulatory tools like risk assess-
ment, peer reviews, and federal advisory committees to manipulate
science  for  its  own  ends,  attempted  to  impose  a  one  size  fits  all
framework  on  the  agencies’  use  of  these  tools,  and  has  shifted  the
criteria  for  defining  when  regulations  are  necessary  away  from  a
health and safety problem and toward a market-based criteria.

Cost-benefit  analysis  is  often  touted  by  the  Administration  and
conservative think tanks as a neutral tool in policy-making, but re-
cent  studies  by  legal  scholars  show  that  the  CBA  is  inherently  po-
litical. There are several shortcomings in the way CBA is used, and
these  deficiencies  have  been  exacerbated  by  actions  during  the
Bush Administration.

A  second  regulatory  tool  that  OIRA  tried  to  manipulate  was  the
use  of  risk  assessments.  In  January  2006,  John  Graham  issued
OMB’s  proposed  Risk  Assessment  Bulletin,  which  contained  a  set
of  one  size  fits  all  guidelines  to  govern  all  risk  assessments,  and
included  technical  standards  for  all  federal  agencies  to  use  when
conducting risk assessments, as well as other scientific documents.
The National Research Council’s review of the Bulletin called for
its withdrawal. The rebuke by the NRC is one of the strongest com-
mentaries  issued  on  a  trend  over  the  last  six  years  to  centralize
power over the regulatory process. The strongly worded NRC eval-
uation  should  provide  a  Congress  interested  in  executive  oversight
with a strong example of the dangers of this regulatory trend.

OMB again attempts a one size fits all approach that doesn’t con-
sider  different  agency  functions  and  expertise  required  to  imple-
ment  legislation  in  its  use  of  peer  review.  OMB  is  a  political  office
working  directly  for  the  Administration,  not  an  unbiased  scientific
office,  yet  the  agency  places  itself  in  the  role  of  supervisor  for  im-
plementing scientific peer review.

The science community has often argued that by appointing peo-
ple  from  the  regulated  industries  as  members  of  federal  advisory
committees, as the Bush Administration has consistently done, the
advice the committees offer to an agency might create real dangers
to public health and safety. This is one example of the growing in-
fluence of regulated industries in the rule-making process.

Like  the  tools  discussed  above,  federal  advisory  committees  spe-
cifically,  and  the  processes  in  which  they  are  used,  are  being  ma-
nipulated to achieve results desired by political considerations, not
science, health, safety, or environmental protection.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00047 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

42

OMB  Watch  has  several  concerns  about  the  trends  in  the  regu-
latory  process  that  have  occurred  over  the  last  few  decades,  such
as  the  reduced  governmental  role,  devolving  responsibility  to  the
states,  and  privatization.  The  Bush  Administration  has  further  re-
duced the role of the Federal Government’s general welfare protec-
tions by putting special interest concerns above the general public’s
concerns.

There  has  been  a  sustained  attack  upon  scientific  integrity,  on
the  quality  of  scientific  information,  on  the  scientific  expertise  of
agency  professionals,  and  on  the  integrity  of  the  scientific  process.
The tools have been manipulated, and the Executive Order amend-
ments  just  issued,  coupled  with  the  Good  Guidance  Practices  Bul-
letin,  have  further  established  control  over  the  regulatory  process
in  the  executive  branch,  and  OIRA  especially,  at  the  expense  of
both Congressional power and agency discretion.

The real loser, however, is the public. In the end, less regulation
means  less  protection.  Every  year,  more  than  40,000  people  die  on
our nation’s highways; food-borne illnesses kill an estimated 5,000,
and sicken 76 million; nearly 6,000 workers die as a result of injury
on  the  job,  with  an  additional  50,000  to  60,000  killed  by  occupa-
tional  disease;  and  asthma,  linked  to  air  pollution,  is  rising  dra-
matically, afflicting 17 million, including 6 million children.

I  want  to  leave  you  with  just  one  example  of  the  danger  of  this
regulatory  process.  The  Transportation  Recall  Enhancement  Ac-
countability  and  Documentation  Act,  TREAD,  passed  by  Congress
in  November  2000,  required  that  ‘‘The  Secretary  of  Transportation
shall complete a rule-making for a regulation to require a warning
system  in  new  motor  vehicles  to  indicate  to  the  operator  when  a
tire is significantly under-inflated.’’ Yet, the tire pressure alert sys-
tem regulations that were significantly—that were required by law
to  be  in  place  by  the  end  of  2000  have  not  been  adequately  devel-
oped,  although  the  National  Highway  Transportation  Safety  Ad-
ministration  determined  in  its  rule-making  that  a  direct  tire  pres-
sure monitoring system should be installed in new vehicles.

But  OMB  sent  a  letter  to  NHTSA,  after  meeting  with  the  auto
industry,  directing—deciding  that  the  direct  system  was  inappro-
priate, claiming its cost-benefit calculations provided a basis for de-
laying the requirement of the direct systems. The final rule, issued
May 2002, would have allowed lawmakers, I am sorry, would have
allowed  automakers  to  install  ineffective  tire  pressure  monitoring
systems,  and  would  have  left  many  drivers  unaware  of  the  dan-
gerously  under-inflated  tires.  NHTSA  was  sued  because  its  final
rule  would  have  allowed  manufacturers  to  choose  to  install  either
an effective direct system or an inferior indirect system.

In August 2003, the U.S. Court of Appeals for the Second Circuit
ordered  NHTSA  to  rewrite  the  rule,  because  NHTSA  acted  in  an
arbitrary  and  capricious  manner  by  writing  a  standard  that  would
allow installation of a clearly faulty indirect system.

Thank you, Mr. Chairman. I see my time is up.
[The prepared statement of Mr. Melberth follows:]

Mr. Chairman and Members of the Subcommittee:

PREPARED STATEMENT OF RICK MELBERTH

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00048 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

43

Thank  you  for  the  opportunity  to  testify  before  you  today.  I  am  Rick  Melberth,
Director  of  Regulatory  Policy  for  OMB  Watch.  OMB  Watch  is  a  nonprofit,  non-
partisan  research  and  advocacy  center  promoting  an  open,  accountable  government
responsive to the public’s needs. Founded in1983 to remove the veil of secrecy from
the White House Office of Management and Budget, OMB Watch has since then ex-
panded  its  focus  beyond  monitoring  OMB  itself.  We  currently  address  four  issue
areas: right to know and access to government information; advocacy rights of non-
profits;  effective  budget  and  tax  policies;  and  the  use  of  regulatory  policy  to  protect
the public.

My testimony focuses on 1) the amendments to E.O. 12866 and the impacts of the
amendments, 2) the manipulation of the analytical tools used in the regulatory proc-
ess  as  part  of  a  broader  assault  by  this  administration,  and  3)  a  brief  description
of actions Congress might take to minimize the impact of the changes just enacted.
I. Amendments to E.O. 12866: Executive Order 13422

On  January  18,  President  Bush  issued  amendments  to  Executive  Order  (E.O.)
12866,  which  further  centralize  regulatory  power  in  the  Office  of  Information  and
Regulatory Affairs (OIRA) in the Office of Management and Budget (OMB) and shift
it  away  from  the  federal  agencies  given  this  power  by  legislative  enactments.  It  is
another brick in the foundation this administration has been building for a unitary
theory  of  the  presidency,  one  in  which  the  executive  is  superior  to  the  other
branches  in  our  constitutional  system  and  one  in  which  the  White  House  exhibits
significant control.

We  are  particularly  concerned  with  three  aspects  of  the  amendments:  the  identi-
fication  of  ‘‘market  failure’’  as  the  first  principle  in  promulgating  regulations,  the
designation  of  a  presidential  appointee  as  the  Regulatory  Policy  Officer  in  each
agency  covered  by  the  E.O.,  and  the  requirement  that  significant  guidance  docu-
ments undergo nearly the same OIRA review process required of significant regula-
tions.  Attached  to  this  testimony  is  a  copy  of  our  analysis  of  the  amendments.  I
want to focus on these three aspects here.
A. The Market Failure Criterion

Through  amending  the  regulatory  process,  the  President  is  institutionalizing  an
anti-regulatory  approach  by  using  a  market  failure  criterion  in  place  of  actually
identifying  threats  to  public  health  and  safety.  It  diminishes  standards  Congress
may require agencies to use, such as the best control technology, by elevating a new
market failure standard that Congress has never required.

The  market  failure  criterion  is  yet  another  layer  added  to  the  agency  analysis.
The  agency  must  comply  with  statutory  criteria  (such  as  best  available  technology)
as  well  as  perform  an  analysis  demonstrating  market  failures.  If  the  agency  meets
OMB’s standards for assessing ‘‘whether any new regulation is warranted,’’ then the
agency  must  also  comply  with  other  standards  in  the  E.O.,  including  cost-benefit
analysis.  We  believe  this  new  standard  decidedly  favors  the  regulated  community
and  places  another  hurdle  for  agencies  to  promulgate  health,  safety,  and  environ-
mental regulations, and creates more delay.

In addition, the language of the amendments makes clear that this economic test

is front and center in the review process. Compare the language:

Not  only  is  the  market  failure  test  a  primary  consideration,  but  the  agency’s  de-
scription of the problem will be used to ‘‘enable assessment of whether new regula-

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00049 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

44

tion is warranted.’’ This clearly forces the agency to think again about whether the
best course is to do nothing and provides OIRA with another justification, or assess-
ment, for halting or delaying regulations. The regulatory process set out in the exec-
utive  order  applies  after  Congress  has  passed  legislation  having  determined  that  a
problem  existed  and  needed  to  be  addressed.  Under  the  amendments,  agencies  are
directed  to  ask  that  same  question  again:  is  the  problem  worth  addressing?  More-
over,  OIRA’s  assessment  of  whether  any  new  regulation  is  warranted  raises  the
question  of  whether  OMB  intends  to  supersede  legislative  intent  when  the  market
failure  test  does  not  met  OIRA’s  satisfaction.  Although  Congress  may  have  already
legislated,  without  the  implementing  regulation,  the  legislation  may  not  be  able  to
be executed. Thus the executive branch has assumed a legislative function.

Adding the market failure criterion challenges the role of Congress. Theoretically,
employees  could  contract  with  employers  for  a  certain  level  of  risk  in  their  jobs.
Nevertheless,  Congress  has  passed  workplace  safety  regulations  (as  well  as  con-
sumer protections, environmental protections, and economic protections to help mar-
kets function better for businesses) where markets might have resolved problems if
given  time.  As  Georgetown  University  law  professor  Lisa  Heinzerling  wrote:  ‘‘Judg-
ing  regulations  implementing  these  laws  based  on  whether  the  regulations  respond
to  ’market  failure’  misunderstands  the  premises  of  many  of  the  laws  Congress  en-
acts.’’  In  short,  there  are  multiple  contexts  in  which  Congress  might  justify  taking
legislative action, market failure being only one.

The  supporters  of  using  the  market  failure  criterion  believe  the  free  market  will
supply  the  protections  the  American  people  want  without  government  intervention.
Susan  Dudley,  one  of  these  free  market  advocates  and  the  nominee  to  head  OIRA,
would  have  preferred  to  leave  safety  to  the  unsteady  hand  of  the  market,
hypothesizing  that  ‘‘[i]f  air  bags  protect  lives,  and  consumers  demand  them,  it  is
reasonable  to  assume  that  automobile  manufacturers  would  have  installed  air  bags
in  the  absence  of  federal  requirements  to  do  so.’’ 1 According  to  Dudley,  federal  ac-
tion requiring air bags in cars was unnecessary because the market would have pro-
vided air bags to the public absent regulation.

OMB Watch believes that the market failure criterion is a furtherance of the eco-
nomic criteria which OIRA has increasingly required as justification for taking regu-
latory  action.  OIRA  has  substituted  economics  for  all  other  values  the  American
public has consistently said to be important to them.
B. The Regulatory Policy Officer (RPO)

The  amendments  require  each  agency  to  have  a  Regulatory  Policy  Office  run  by
a political appointee and that ‘‘no rule-making shall commence nor be included’’ for
consideration  in  the  agency’s  regulatory  plan  without  the  political  appointee’s  ap-
proval. This will further politicize the rule-making process and provide more White
House control over the agency rule-making process.

Section  4(c)  The  Regulatory  Plan,  is  amended  to  place  this  regulatory  planning

authority directly in the RPO’s hands. The language is changed from

The Plan shall be approved personally by the agency head and shall contain at
a minimum:

to

Unless  specifically  authorized  by  the  head  of  the  agency,  no  rule-making  shall
commence  nor  be  included  on  the  Plan  without  the  approval  of  the  agency’s
Regulatory Policy Office, and shall contain at a minimum:. . .

(B)  A  summary  of  each  planned  significant  regulatory  action  including,  to
the extent possible, alternatives to be considered and preliminary estimates
of the anticipated costs and benefits of each rule as well as the agency’s
best estimate of the combined aggregate costs and benefits of all its
regulations planned for that calendar year to assist with the identi-
fication of priorities; [emphasis added].

The  amendments  add  the  highlighted  language  which  requires  not  only  signifi-
cantly  more  analysis  by  the  agencies  because  of  the  ‘‘best  estimates’’  requirement,
but also provides a basis to allow the RPO to establish priorities.

A  similar  approach  was  attempted  by  President  Reagan  through  his  E.O.  12498,
the  Regulatory  Planning  Process,  which  was  issued  January  4,  1985.  Under  E.O.
12498,  agencies  were  to  get  approval  from  OMB  prior  to  starting  a  rule-making—

1 Susan  E.  Dudley,  Regulatory  Studies  Program  Comments:  Advanced  Air  Bags  7  (Dec.  17,
http://mercatus.org/repository/docLib/MC¥RSP¥PIC1998-

available 

1998), 
04¥NHTSAAirBags¥981130.pdf.

at 

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00050 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

45

a  pre-rule-making  review.  Many  in  the  business  community  thought  this  would  be
a wonderful approach for choking off agency ideas before they ever really got going.
That  approach,  however,  proved  too  cumbersome  and  difficult  to  administer.  In
short order it failed.

The new Bush E.O. amendments have the same objective, but put the choke-hold
in  the  agencies,  instead  of  at  OMB.  To  ensure  that  the  process  works,  the  amend-
ments  grant  authority  to  these  new  political  appointees  to  be  the  eyes  and  ears  for
OMB.  And  it  again  mounts  a  challenge  to  congressional  authority.  In  writing  legis-
lation, Congress often directs agencies to initiate a rule-making. The presence in the
agencies  of  these  appointees  by  whom  rule-making  must  now  be  initiated  creates
a  process  that  is  as  if  Congress  had  not  directed  the  agencies  to  act,  or  as  if  that
direction is irrelevant if the White House appointees disagree with it.

A  civil  servant  reacting  to  the  new  amendments  provided  an  agency  perspective

(http://fromthearchives.blogspot.com/2007/01/long-and-esoteric-twice-in-one-day-
just.html).

From  the  perspective  of  a  low  level  bureaucrat  looking  up  the  line,  there  are
two big problems with this, independent of ideology.
The first is simple. I just don’t want to add a single step that adds time to man-
agement review. Honestly, you’d be shocked how long it takes for us to get any-
thing through management review. Anything we release to the public, including
our  non-controversial,  small  scale  documents,  must  go  through  six  (6)  levels  of
review.  We  schedule  three  to  four  weeks  for  management  review.  Yeah.  Three
days on each desk, if we give them advance notice that our stuff will be coming.
If  we  were  doing  controversial  stuff,  it  would  be  longer.  If  we  had  to  route
through  one  additional  back-logged  office?  If  they  were  far  away,  and  my  boss
man  couldn’t  chat  with  them  to  prep  them  for  the  document,  and  we  were  just
another insignificant office on the west coast? I can’t even guess.
But  the  more  important  reason  is  that  a  distant  political  appointee,  even  as-
suming  that  she  is  not  a  partisan  hack  and  that  she  is  interested  in  the  topic
and  not  using  the  office  as  a  stepping  stone,  would  know  exactly  the  wrong
amount.  Anyone  at  a  distance  from  the  process  can  only  know  enough  to  be
dangerous.  When  we  go  to  write  anything  that  tells  people  what  they  have  to
do,  there  is  an  intricate  multi-year  negotiation  between  everyone  involved.
There are drafts, and comments, and drafts, and workshops, and drafts, and in-
ternal meetings, and drafts, and formal written comment, and more drafts. Usu-
ally,  in  the  end,  you  will  come  down  to  very  awkwardly  written  compromises
that no one will sue you for.
Every word in there was hard fought. People snorted and sat back at the table
with their arms crossed. We changed it until no one threatened to call their con-
gress  person  any  more.  We  explained  to  them  why  we  have  to  implement  the
law  that  way,  and  caved  when  we  couldn’t  get  more,  or  when  we  were  wrong.
We brought in someone’s good idea. I know how people laugh at ridiculous regu-
lations,  but  I  swear  they  didn’t  get  to  be  ridiculous  because  no  one  was  think-
ing.  They’re  ridiculous  because  the  topics  are  complicated,  and  we  have  to  ac-
commodate widely divergent views, and because there were so many iterations.
Anyway, a political appointee who wasn’t there for the painful years of writing
regulations  can  only  disrupt  a  very  precarious  balance. . ..  Unless  she  was
there, she can only make things worse. I don’t want her in the loop.

Even  worse,  if  the  political  appointee  is  a  ‘‘partisan  hack,’’  then  the  integrity  of
the  science  may  be  compromised.  The  regulatory  process  is  a  complex  one  that  in-
volves agency experts of all types. Imagine if a political appointee were to shape the
regulatory options from the start: invariably the outcomes would be skewed.

There  are  two  concerns  with  the  Regulatory  Policy  Officer  approach.  First,  OIRA
may  be  creating  political  outposts  in  each  agency  thereby  magnifying  its  impact.
The amendments to the E.O. allow OIRA to play an active role during the pre-rule-
making stage when agencies are formulating annual plans for regulatory activities.
OIRA  will  be  able  to  quash  any  contemplated  regulatory  or  guidance  issues  before
agencies propose them for the Regulatory Plan. Under the amended E.O., OIRA can
now  engage  the  agency,  along  with  other  government  personnel  (as  provided  for  in
one amendment), in reaching a ‘‘common understanding’’ on regulatory efforts.

Second, the content to be collected raises questions about priorities. Collecting cu-
mulative costs and benefits leads to little more than comparing apples and oranges.
And  what  value  does  this  information  provide  to  policy-makers?  We  believe  this  is
leading to the creation of regulatory budgets which would be used to determine the
regulatory  agenda  without  congressional  approval.  Using  these  budgets,  regulation

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00051 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

46

proceeds  on  a  cost  effectiveness  basis  only,  with  agencies’  budgets  ranked  by  total
costs  and  benefits.  It  completely  divorces  policy-making  from  the  need  for  health,
safety and environmental protections.
C. Guidance Document Review

The  amendments  issued  to  E.O.  12866  require  review  by  OIRA  of  agencies’  guid-
ance  documents  for  the  first  time.  These  documents  are  issued  to  clarify  how  regu-
lated  parties  are  expected  to  implement  legally  binding  regulations.  By  subsuming
guidance  documents  into  a  review  process  almost  identical  to  the  review  process
OIRA uses to review and approve regulations, the extent of OIRA’s reach into agen-
cies’ responsibilities will be at an all-time high.

By requiring agency guidance documents to come under OIRA review, and to treat
‘‘significant’’ guidance in the same way as ‘‘significant’’ regulations, the E.O. amend-
ments will lead to further delay in providing information to the public about compli-
ance with regulations, as well as with general guidance on agency policies.

If it is true that more and more agencies are using guidance as a means of avoid-
ing the regulatory process, then that should be a signal to Congress and the public
that  the  rule-making  process  is  seriously  flawed.  If  agencies  are  looking  for  faster
ways  of  doing  their  job  and  have  turned  to  guidance,  the  solution  is  certainly  not
to  require  guidance  to  go  through  the  same  regulatory  process  that  agencies  were
trying to avoid in the first place.

The  Final  Bulletin  for  Agency  Good  Guidance  Practices,  issued  the  same  day  as
the  E.O.,  defines  guidance  documents  to  include  ‘‘interpretive  memoranda,  policy
statements,  guidances  (sic),  manuals,  circulars,  memoranda,  bulletins,  advisories,
and  the  like.’’  Federal  agencies  issue  thousands  and  thousands  of  guidance  docu-
ments each year relating to hundreds of different types of activities. All of these doc-
uments deemed significant will now come under review by OIRA’s staff of 55 people.
The  fourth  part  of  the  ‘‘significant  guidance  document’’  definition,  whether  the
issue  raises  ‘‘novel  legal  or  policy  issues  arising  out  of  legal  mandates,  the  Presi-
dent’s  priorities,  or  principles  set  forth  in  this  Executive  order,’’  is  nearly  broad
enough  to  permit  OIRA  to  sweep  into  its  review  any  guidance  it  wishes  to  review.
Section I.5 of the Bulletin adds a further category of guidance document, the ‘‘eco-

nomically significant guidance document’’ which is:

‘‘a significant guidance document that may reasonably be anticipated to lead to
an  annual  effect  on  the  economy  of  $100  million  or  more  or  adversely  affect  in
a  material  way  the  economy  or  a  sector  of  the  economy,  except  that  economi-
cally significant guidance documents do not include guidance documents on fed-
eral expenditures and receipts.’’

The  definitions  of  both  significant  and  economically  significant  guidance  docu-
ments  include  documents  that  ‘‘may  reasonably  be  anticipated  to  lead  to’’  certain
conditions.  The  Bulletin  ‘‘makes  clear  that  the  impacts  of  guidance  often  will  be
more indirect and attenuated than binding legislative rules.’’ In other words, it will
be even easier to reasonably anticipate that a guidance document will have a signifi-
cant  effect  on  the  economy  than  will  a  regulation.  The  reasonable  people  doing  the
anticipating no doubt work for OIRA.

Furthermore,  according  to  the  Bulletin,  the  ‘‘relevant  economic  impacts  include
those that may be [emphasis added] imposed by federal agencies, State, or local gov-
ernments,  or  foreign  governments  that  affect  the  U.S.  economy,  as  well  as  impacts
that  could  arise  from  private  sector  conduct.’’  This  creates  a  largely  speculative
analysis  to  be  conducted  by  the  agencies  even  assuming  reasonably  anticipated  ef-
fects by a third parties. The Bulletin does not, however, require a formal regulatory
impact analysis, so it is unclear just how this determination is to be conducted.

The  example  cited  in  the  Bulletin  of  an  economically  significant  guidance  docu-
ment is an agency pronouncement that a particular product or substance is unsafe.
In  this  instance,  ‘‘Unless  the  guidance  document  is  exempted  due  to  an  emergency
or  other  appropriate  consideration,  the  agency  should  observe  the  notice-and-com-
ment procedures.’’ The determination that a substance or product is unsafe involves
some scientific assessment. This provides an example of OIRA reviewing a scientific
conclusion  and  having  the  opportunity  to  substitute  an  economic  analysis  for  a  sci-
entific one. This substitution, or even second-guessing the scientific judgment, could
lead to substantial delays in protecting the public.

In the end, the review of guidance documents by OIRA will simply result in more
delay  and  more  White  House  control  over  the  substantive  work  of  the  agencies.  It
will inevitably lead to a usurpation of agencies’ powers.
II. Manipulation of Regulatory Tools

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00052 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

47

A  great  deal  of  attention  has  been  given  to  the  tools  of  the  regulatory  process,
especially cost-benefit analysis (CBA). More recently, risk assessment (RA), peer re-
view,  and  federal  advisory  committees  (FAC)  have  also  been  the  focus  of  attention
from a regulatory standpoint. I want to address each of these briefly and to convey
to  the  members  that  these  tools  have  been  manipulated  by  OIRA  and  Administra-
tion appointees to achieve results-oriented processes and biased decisions that have
delayed, dismantled or diminished public protections.
A. Cost-benefit Analysis

CBA  is  a  policy-making  tool  by  which  the  costs  of  imposing  a  regulation  are
weighed  against  the  potential  benefits  of  reducing  the  harm.  For  example,  in  the
case of pollution regulation, cost is generally construed as the cost of implementing
technology to comply with regulation. These costs are more easily quantifiable than
other factors, although some evidence exists that costs are often inflated.

The  benefits  of  a  regulation  require  two  separate  analyses:  an  assessment  of  the
risk posed by the harm in question as well as a monetization of the potential bene-
fits. Both factors prove to be difficult to calculate; many benefits resist monetization,
and risk assessments can be hindered either through incomplete data sets or a large
degree of indeterminable factors. In order to estimate the health effects of a regula-
tion,  for  example,  agencies  generally  must  rely  on  laboratory  data  on  other  species
or  on  human  experience  with  much  higher  levels  of  exposure.  To  extrapolate  from
this data the potential benefits of a regulation requires a large degree of guesswork,
and agencies often come up with wide ranging numbers on the potential health ben-
efits.

CBA is often touted by the Administration and conservative think tanks as a neu-
tral tool in policy-making, but recent studies by legal scholars show that CBA is in-
herently  political  and  may  even  advise  against  what  we  consider  our  most  immu-
table public protections.2

I  would  argue  that  there  are  several  shortcomings  in  the  way  that  CBA  is  used,
and  these  deficiencies  have  been  exacerbated  by  actions  during  the  Bush  Adminis-
tration:

• The overriding criterion of CBA is efficiency, but efficiency doesn’t mean fair-
ness.  The  net  benefit  calculation  that  results  from  using  CBA  is  without  re-
gard for who wins and who loses, and without regard for any public participa-
tion.  This  focus  on  efficiency  is  critical  to  business  but  doesn’t  work  for  gov-
ernment because there is no single, public sector measurement comparable to
profit maximization in the private sector.

• CBA  tends  to  overestimate  costs  for  a  variety  of  reasons.  Agencies  generally
rely on the regulated industries to provide them with costs of compliance over
a  certain  number  of  years.  Studies  show  compliance  costs  drop  after  regula-
tion  due  to  the  decline  in  the  costs  of  technology  (like  pollution  controls),
management  efficiencies,  and  business  innovations.  These  cost  savings,  how-
ever,  are  not  calculated  into  the  analysis  generally;  and  CBA  takes  a  snap-
shot of one point in time resulting in a static analysis.

• The  major  objection  I  have  to  relying  on  CBA  as  the  determinative  factor  in
rule-making  is  that  it  does  such  poor  job  of  calculating  benefits.  How  do  you
monetize  benefits  like  clean  drinking  water,  good  health,  being  alive?  There
are certain values we hold dear that cannot be adequately monetized. A deci-
sion making process that doesn’t provide for the expression of these non-quan-
tifiable benefits is critically flawed.3

CBA  has  been  part  of  the  rule-making  process  since  the  Reagan  Administration.
Prof.  Sally  Katzen  spoke  at  a  September  2006  panel  on  presidential  rule-making
and  stated  that,  although  E.O.  12866  kept  the  CBA  requirements  of  the  earlier
Reagan era executive orders, during her tenure as OIRA Administrator,

we  explicitly  recognized  that  non-quantifiable  costs  and  benefits  are  essential
to consider. That not everything can be counted and it is very important to take

2 See,  for  example,  Lisa  Heinzerling,  Frank  Ackerman  and  Rachel  Massey’s  ‘‘Applying  Cost
Benefit  Analysis  to  Past  Decisions:  Was  Environmental  Protection  Ever  a  Good  Idea?,’’  David
Driesen’s  ‘‘Is  Cost-Benefit  Analysis  Neutral?,’’  and  Richard  Parker’s  ‘‘Is  Government  Regulation
Irrational? A Reply to Morall and Hahn.’’

3 See for example, Heinzerling and Ackerman’s Priceless: On Knowing the Price of Everything

and the Value of Nothing. NY: The New Press, 2004. Chapter 2.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00053 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

48

into  account  those  things  which  can’t  be  counted.  We  also  made  it  clear  that
this economic analysis was not dispositive, but simply informative.4

In  the  hands  of  the  Bush  Administration,  and  particularly  in  those  of  John
Graham,  OIRA  Administrator  from  2001–2006,  CBA  has  risen  to  a  position  of  pri-
macy  in  the  rule-making  process.  In  September  2003,  OIRA  issued  final  guidance
that  instructed  federal  agencies  on  specific  analytical  methods  for  regulatory  deci-
sions. This guidance committed agencies to increased emphasis on cost-effectiveness
analysis  as  well  as  benefit-cost  analysis  and  raised  the  bar  on  new  health,  safety
and environmental protections. Specifically, the guidance

• pushes  for  health  and  safety  benefits  to  be  expressed  in  terms  of  dollars  and
cents,  so  agencies  can  calculate  and  demonstrate  ‘‘net  benefits’’  (benefits
minus costs);
• uses  cost-effectiveness  analysis  which  does  not  monetize  benefits.  Rather,  it
looks at the ratio of costs to units of benefits (i.e., number of lives saved). The
Clinton  guidance  allowed  agencies  to  use  cost-effectiveness  analysis  in  place
of  a  ‘‘net  benefits’’  analysis  if  they  have  difficulty  monetizing.  The  new  guid-
ance requires both types of analyses for all major health and safety rules.
• requires discounting of lives saved in the future. ‘‘Discounting’’—already com-
mon  practice  in  monetizing  benefits—rests  on  the  premise  that  a  life  saved
today  is  worth  more  than  a  life  saved  tomorrow.  The  further  in  the  future
a  life  is  saved  as  a  result  of  regulatory  action  today,  the  more  it  will  be  dis-
counted  from  its  ‘‘present  value,’’  and  the  less  likely  the  action  will  pass  a
cost-benefit test.
• promotes use of ‘‘life years’’ in evaluating fatality benefits. Agencies commonly
base  benefit  estimates  on  the  ‘‘value  of  a  statistical  life’’  (VSL),  drawn  from
the number of lives expected to be saved by regulatory action. On top of VSL
estimates,  OIRA’s  guidance  asks  agencies  to  consider  using  ‘‘value  of  statis-
tical  life  years’’  (VSLY),  which  looks  at  the  number  of  life  years  saved  as  op-
posed  to  the  number  of  lives.  This  would  skew  against  protections  for  the  el-
derly, who have fewer life years remaining.

These  CBA  and  cost-effectiveness  requirements  are  offensive  for  the  devaluation
of  lives,  health  and  safety.  Elderly  and  minority  communities  frequently  suffer  the
consequences of a lifetime’s exposure to industrial contaminants, including heart or
lung failure from smog and soot, and cancer from toxic chemicals. Tens of thousands
die  prematurely  every  year  as  a  result.  They  are  offensive  also  for  their  elevation
of  economic  and  statistical  manipulation  that  results  in  extremely  high  barriers  to
implementing  public  protections  under  the  guise  of  regulatory  relief  for  special  in-
terests.
B. Risk Assessment (RA)

A second regulatory tool that OIRA tried to manipulate was the use of risk assess-
ments.  In  January  2006,  Graham  issued  OMB’s  Proposed  Risk  Assessment  Bulletin
(RAB)  which  contained  a  set  of  guidelines  to  govern  all  risk  assessments  and  in-
cluded  technical  standards  for  all  federal  agencies  to  use  when  conducting  risk  as-
sessments,  as  well  as  other  scientific  documents.  The  OMB  guidelines  would  apply
to risk assessments conducted as part of issuing or revising health, safety and envi-
ronmental  rules,  as  well  as  important  scientific  studies.  OMB  asked  the  National
Research  Council  (NRC)  to  review  the  document  after  its  release.  NRC  suggested
the Bulletin be withdrawn completely.

The  NRC  defined  RA  as  ‘‘the  qualitative  or  quantitative  characterization  of  the
potential  health  effects  of  particular  substances  on  individuals  or  populations.’’
There are components to conducting a public health RA: hazard identification, dose-
response  assessment,  exposure  assessment,  and  risk  characterization.5 Even  with-
out  knowing  the  scientific  definitions  of  these  terms,  it’s  clear  from  the  definition
and its elements that a risk assessment is an evaluative process.

In its review of the RAB, the Council found that OMB’s new definition of risk as-
sessment  was  ‘‘too  broad  and  in  conflict  with  long-established  concepts  and  prac-

4 Panel  4:  A  PRESIDENTIAL  REVIEW  OF  RULE-MAKING:  REAGAN  TO  BUSH  II.  Part  of
a  symposium  on  ‘‘Presidential,  Congressional,  and  Judicial  Control  of  Rule-making,’’  conducted
at the Congressional Research Service on September 11, 2006 as part of the Administrative Law
project  of  the  Subcommittee  on  Commercial  and  Administrative  Law  of  the  House  Judiciary
Committee.

5 National Research Council. 1983. Risk Assessment in the Federal Government: Managing the
Process.  Washington,  DC:  National  Academies  Press.  This  publication  established  the  param-
eters for using RA.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00054 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

49

tices.’’  The  Bulletin  defined  a  risk  assessment  as  a  document  instead  of  a  process
and the goals outlined, when considered together, indicated ‘‘that a risk assessment
should  be  tailored  to  the  specific  need  for  which  it  is  undertaken.’’  The  emphasis,
according to the NRC evaluation, was on efficiency over quality and stated that the
goals outlined did not ‘‘support the primary purpose of the bulletin—to enhance the
technical quality and objectivity of risk assessments.’’

The  report  also  recommended  that  OMB  leave  technical  risk  assessment  guide-
lines  and  standards  to  each  federal  agency  because  one  size  does  not  fit  all  when
it  comes  to  risk  assessments.  The  Council  stressed  concerns  over  ‘‘the  likely  drain
on agency resources, the extended time necessary to complete risk assessments that
are undertaken, and the highly likely disruptive effect on many agencies.’’

As  OMB  has  done  with  other  regulatory  tools,  the  risk  assessment  approach
called for in this release would have created unnecessary delays in the rule-making
process by adding to the already cumbersome process that OMB oversees. The abil-
ity of government agencies to protect the public would be compromised by attempts
to  manipulate  science  and  the  risk  assessment  process.  For  example,  the  proposed
standards  called  for  the  use  of  central  estimates  or  tendencies  instead  of  statistical
ranges.  Using  this  approach  puts  the  most  vulnerable  populations,  who  fall  outside
these ‘‘central estimates,’’ at risk in some analyses.

The rebuke by the NRC is one of the strongest commentaries issued on the trend
over  the  last  six  years  to  centralize  power  over  the  regulatory  process  within  OMB
and  move  it  away  from  agencies  responsible  for  protecting  health,  safety  and  the
environment.  The  Administration  has  consistently  used  regulatory  tools  like  RA  to
manipulate  science  for  its  own  ends,  attempted  to  impose  a  one-size-fits-all  frame-
work  on  the  agencies’  use  of  these  tools,  and  has  shifted  the  criteria  for  defining
when  regulations  are  necessary  away  from  a  health  or  safety  problem  and  toward
market-based  criteria.  The  strongly-worded  NRC  evaluation  should  provide  a  Con-
gress interested in executive oversight with a strong example of the dangers of this
regulatory trend.
C. Peer Review

As happened with the two tools described above, OMB developed a bulletin estab-
lishing government-wide requirements for scientific peer review. The Final Informa-
tion  Quality  Bulletin  for  Peer  Review  was  issued  December  2004  after  OMB  took
comments  from  the  public  regarding  a  proposed  bulletin  that  was  issued  in  April
2004.  OMB  again  attempts  a  one-size-fits-all  approach  that  doesn’t  consider  dif-
ferent agency functions and expertise required to implement legislation. In the final
bulletin,  OMB  asserts  that  its  authority  for  the  peer  review  policies  is  implied  in
the Information Quality Act and OMB’s general authorities. None of the laws or ex-
ecutive  orders  referenced  provide  any  specific  instructions  on  peer  review.  No  new
authority  is  referenced  by  the  agency  and  OMB  did  not  seek  any  clarifying  or  sup-
porting language from Congress.

In  OMB  Watch’s  comments  on  the  proposed  bulletin,  we  argued  that  OMB  had
not  identified  a  peer  review  problem  that  justified  this  government-wide  approach.
OMB implied that a problem had been identified and defined by citing several stud-
ies  and  reports.  However,  none  of  these  documents  actually  claim  that  an  over-
arching  problem  or  failure  of  peer  review  policies  has  occurred  at  federal  agencies.
Nor  do  the  studies  recommend  the  establishment  of  uniform  requirements  for  sci-
entific peer review. Instead, the referenced materials address the importance of peer
review,  the  need  for  changes  at  certain  agencies,  or  types  of  reviews.  Yet,  without
a clear understanding of any problem in peer review standards, OMB finalized these
policies assuming they will do more good than harm.

OMB  granted  itself  an  oversight  role  in  the  peer  review  process.  OMB  has  never
overseen  peer  review  and  holds  very  little  scientific  or  peer  review  expertise—only
a  handful  of  recently-hired  scientists.  This  grant  of  authority  involves  OIRA  per-
sonnel  in  the  technical  and  scientific  discussions  that  often  lead  to  a  pre-rule-mak-
ing  process.  This  part  of  the  regulatory  process  is  already  dominated  by  OIRA’s
gatekeeper  function  by  which  it  develops  acceptable  agency  rule-making  submis-
sions even before the public process.

OMB is a political office working directly for the Administration, not an unbiased
scientific  office.  Yet,  the  agency  places  itself  in  the  role  of  supervisor  for  imple-
menting scientific peer review. OMB Watch recommended oversight authority to an
objective  scientific  body,  such  as  the  National  Academy  of  Sciences  or  an  inter-
agency review panel.

In  the  final  peer  review  bulletin,  OMB  solidified  its  new  oversight  role  for  sci-
entific peer review. OMB has the authority to grant exemptions, approve alternative
peer  review  processes,  and  designate  information  for  stricter  review  requirements.
The final proposal also adds a stipulation that all federal agencies submit an annual

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00055 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

50

report to OMB detailing the use of peer review for the fiscal year. OMB Watch con-
tinues  to  believe  that  the  bulletin  grants  far  too  much  influence  over  the  scientific
peer  review  process  to  the  politically  motivated  offices  of  OMB  and  the  Office  of
Science and Technology Policy. Such power would enable an administration to easily
influence peer reviews and in turn, the rule-makings that follow.

For  the  most  important  peer  reviews,  OMB  created  a  double  standard  in  which
agency  employees,  who  may  peer  review  more  basic  information,  are  essentially
barred  from  serving  as  reviewers.  However,  experts  associated  with  affected  indus-
tries are allowed to serve as peer reviewers with only a requirement that their affili-
ations  be  disclosed.  Highly  influential  scientific  information  has  much  stricter  peer
review  requirements,  and  OMB  explicitly  states  that  government  employees  should
rarely  be  used  as  reviewers.  The  final  proposal  bans  any  experts  from  the  spon-
soring agency from reviewing information, but makes an exception for the ‘‘rare sit-
uation  in  which  a  scientist  from  a  different  agency  of  a  Cabinet-level  department
other than the agency that is disseminating the scientific assessment has expertise,
experience and skills that are essential but cannot be obtained elsewhere.’’ The un-
equal standards for private sector scientists remains, but the final bulletin instructs
agencies  to  ‘‘consider  barring  participation  by  scientists  with  a  conflict  of  interest.’’
The  peer  review  process  outlined  in  the  final  bulletin  creates  delay  by  excessive
bureaucratic information requirements and certifications, and rounds of public com-
ments.  While  we  generally  support  providing  public  access,  the  very  definition  of  a
peer review is to collect assessments from experts. Adding repeated public comment
periods  is  inappropriate  for  peer  reviews  and  can  only  result  in  delaying  important
research.
D. Federal Advisory Committees (FAC)

There  are  many  instances  during  the  Bush  Administration  in  which  candidates
for advisory panels have been passed over, or members replaced, or resigned. While
it is common for new administrations to replace members of these committees, there
is a trend towards making sure that those people who might disagree with the Ad-
ministration’s  opinions  are  not  appointed.  The  scientific  community  has  often  ar-
gued  that  by  appointing  people  from  the  regulated  industries  as  members  of  these
committees,  as  the  Bush  Administration  has  done  consistently,  the  advice  the  com-
mittees  offer  to  an  agency  might  create  real  dangers  to  public  health  and  safety.
In the fall of 2002, a series of reports and articles began to be published charging
the Administration with manipulation of these committees to assist hazardous sub-
stances  manufacturers  especially.6 According  to  DefendingScience.org,  a  website  of
The Project on Scientific Knowledge and Public Policy,

Groups  accused  the  Bush  Administration  of  manipulating  activities  in  two  fed-
eral  committees  advising  the  Centers  for  Disease  Control  and  Prevention’s  Na-
tional Center for Environmental Health (NCEH).

• Several  well-respected  scientists  were  dropped  from  the  Pediatric  Lead
Poisoning  Prevention  Panel.  Nominees  suggested  by  staff  scientists  at
CDC  were  rejected  and  replaced  by  individuals  who  later  reported  that
the  lead  industry  had  contacted  them  initially  to  ask  if  they  would  be
willing to serve on the committee.

• Scientists  employed  by  the  chemical  industry  or  industry  advocacy
groups,  including  the  Heritage  Foundation  and  the  Annapolis  Institute
(established  in  1993  by  the  National  Association  of  Manufacturers  to
challenge  EPA  proposed  regulations)  replaced  15  of  18  renowned  univer-
sity-based scientists on the advisory committee to the Director of NCEH.
We’ve begun to see more resignations by respected scientists as these FACs have
become  more  politicized.  For  example,  last  October,  three  of  the  fifteen  members  of
the EPA’s National Pollution Prevention and Toxics Advisory Committee (NPPTAC)
resigned  because  they  felt  major  problems  with  the  Toxic  Substances  Control  Act
were not being addressed due to industry influence.

The  impacts  of  this  political  approach  to  using  FACs  are  real  dangers  to  public
health,  safety  and  the  environment.  One  example  was  provided  in  the  February  6,
2007  testimony  before  the  Senate  Committee  on  Environment  and  Public  Works  of

6 David  Michaels,  Eula  Bingham,  et  al.  ‘‘Advice  Without  Dissent,’’  Science,  Vol.  298,  25  Octo-
http://www.defendingscience.org/pub-

ber 
lic¥health¥regulations/upload/Advice-Without-Dissent.pdf).

(www.sciencemag.org, 

or 

2002. 

p.703. 

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00056 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

51

Dr. John Balmes, testifying on behalf of the American Lung Association.7 The focus
was on the changes EPA has made to the scientific review process for the National
Ambient Air Quality Standards (NAAQS). EPA’s Clean Air Scientific Advisory Com-
mittee  (CASAC)  participates  in  the  review  process  of  these  standards.  The  review
was  a  multi-step  process  the  end  of  which  was  a  Staff  Paper  reviewed  by  CASAC
and  open  to  public  comment.  According  to  Dr.  Balmes  testimony,  ‘‘  [m]any  regard
the preparation and finalization of the Staff Paper, which is done by EPA’s scientific
staff, as the most crucial step’’ because it is the final analysis of the scientific infor-
mation on which standards are based. It is not a political process.

According to Dr. Balmes testimony:

It  is  the  elimination  of  the  Staff  Paper  that  we  fear  will  lead  to  the  diminish-
ment of science in the standard setting process. The staff paper is to be replaced
with a ‘‘Policy Assessment’’ which according to a memorandum by EPA’s Deputy
Administrator Peacock, ‘‘reflect the Agency’s views, consistent with EPA’s prac-
tice  in  other  rule-makings.’’  However,  the  EPA  does  not  set  standards  exclu-
sively  based  on  the  protection  of  health  using  the  latest  scientific  research  in
any  other  rule-making.  In  sum,  a  unique  standard  demands  a  unique  process,
not  EPA’s  ‘‘usual’’  practice.  We  believe  the  elimination  of  the  Staff  Paper  is
being  done  precisely  because  the  science  underlying  protection  of  public  health
from  air  pollution  is  in  conflict  with  what  policy-makers  in  EPA  want  to  do  in
the implementation of the Clean Air Act. The elimination of the Staff Paper will
make  it  easier  for  policy  staff  to  fuzz  the  lines  in  public  health  protection  and
present  the  basis  for  alternative  standards  and  the  alternatives  themselves  in
a  way  that  favors  the  outcomes  they  are  seeking  rather  than  what  the  science
says  is  needed.  Substituting  an  Advanced  Notice  of  Proposed  Rule-making  for
the  Staff  Paper  will  put  policy  make[r]s  (sic)  at  EPA  and  the  White  House  in
the driver’[s] (sic) seat by enabling them to review and edit before it is reviewed
by CASAC and the public.

The process has been specifically influenced by the American Petroleum Institute
which  suggested  the  Staff  Paper  be  replaced  with  an  Advanced  Notice  of  Proposed
Rule-making, which the EPA has adopted. And the lead industry recommended that
the  Staff  Paper  be  replaced  by  a  new  Policy  Assessment  which  argues  that  lead
should be eliminated as a criteria pollutant.

This  is  one  example  of  the  growing  influence  of  regulated  industries  in  the  rule-
making process. Like the tools discussed above, FACs specifically, and the processes
in which they are used, are being manipulated to achieve results desired by political
considerations, not science, health, safety, or environmental protection.
E. Information Quality Act

The  final  issue  I  would  like  to  address  briefly  is  the  Information  Quality  Act
(IQA),  or  as  it  is  often  called,  the  Data  Quality  Act  (DQA).  This  is  an  issue  in  the
discussion of manipulation of regulatory tools because the guidelines issued by OMB
regarding the use of the DQA has led to delays in the promulgation of public protec-
tions  through  challenges  to  the  science  agencies  rely  on  to  fulfill  their  mandates.
The DQA allows challenges to the information disseminated by agencies that can
dilute,  dismantle  and  remove  essential  pieces  of  the  scientific  information  that  go
into creating a body of scientific knowledge. OMB published a report in 2004 evalu-
ating  the  first  year  of  implementation  of  DQA,  a  report  that  OMB  Watch  criticized
as  ‘‘inaccurate,’’  ‘‘misleading,’’  and  ‘‘flawed.’’  OMB  understated  the  number  of  chal-
lenges, the source of those challenges (mostly industry), and drew conclusions about
the  impact  of  the  DQA  without  the  data  to  support  its  conclusions.  OMB  Watch’s
analysis shows that the Act has had a significant impact on agency actions, yet the
law was added as a last minute rider without Congressional hearings.8

A  report  issued  by  the  Congressional  Research  Service  (CRS)  calls  for  oversight
and investigation of the impacts of DQA, a call OMB Watch argued for in our report
as well. CRS recommends

either  Congress  or  OMB  could  better  define  the  scope  of  the  act  or  the  issues
to be included in any future report. Clarification could also be provided regard-
ing  whether  correction  requests  that  the  agencies  determine  to  involve  issues
outside the scope of the IQA (e.g., a challenge to the minutes of a federal advi-

February 

6, 

2007. 

7 Dr.  John  Balmes  testimony  before  the  U.S.  Senate  Environment  and  Public  Works  Com-
mittee, 
http://epw.senate.gov/public/
index.cfm?FuseAction=Hearings.Hearing&Hearing¥ID=78a52250-802a-23ad-4274-59a54b06a447
8 OMB  Watch.  The  Reality  of  Data  Quality  Act’s  First  Year:  A  Correction  of  OMB’s  Report  to

Available 

Congress. July 2004. Available at http://www.ombwatch.org/info/dataqualityreport.pdf.

at 

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00057 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

52

sory committee meeting) should be included in a report that is supposed to list
correction requests under the act.9

III. Congressional Action

OMB Watch has several concerns about the trends in the regulatory process that
have  occurred  over  the  last  few  decades.  Societal  problems  have  become  more  com-
plex and their solutions are often less obvious and straight forward than, for exam-
ple,  a  command  and  control  approach.  The  role  of  the  federal  government  has  be-
come  more  limited  in  its  perspective  of  what  is  appropriate  for  government  action.
Responsibility  has  increasingly  devolved  to  the  states,  or  been  the  target  of  privat-
ization.  We  believe  that  the  time  has  come  to  change  this  limited  government  per-
spective  to  one  in  which  the  government  plays  a  more  positive  role  in  protecting
health, safety, environmental and civil rights safeguards. A major part of this move-
ment to positive government must be a focus on the regulatory process.

The  Bush  Administration  has  further  reduced  the  Federal  Government’s  general
welfare  protections  by  putting  special  interests’  concerns  above  the  general  public’s
concerns.  The  problems  outlined  in  this  testimony  have  eroded  the  government’s
role  in  public  protections.  They  have  delayed,  diminished  or  destroyed  regulations
that  agencies  are  mandated  to  promulgate.  There  has  been  a  sustained  attack  on
scientific  integrity—on  the  quality  of  scientific  information,  on  the  scientific  exper-
tise  of  agency  professionals,  and  on  the  integrity  of  the  scientific  process.  The  tools
have  been  manipulated  and  the  executive  order  amendments  just  issued,  coupled
with  the  good  guidance  practices  bulletin,  have  further  established  control  of  the
regulatory  process  in  the  executive  branch,  and  OIRA  especially,  at  the  expense  of
both congressional power and agency discretion.

The  real  loser,  however,  is  the  public.  The  regulatory  process  is  highly  partisan
and politicized. In the end, less regulation means less protection. Instead of a regu-
latory  ‘‘cop  on  the  beat,’’  we  have  none.  Instead  of  addressing  regulatory  gaps,  we
operate  based  on  whether  these  gaps  have  political  consequences.  Unfortunately,
now  government  doesn’t  act  until  there  is  national  news  about  people  being  hurt
or,  in  the  case  mine  workers,  dying.  If  you  are  parents,  you  don’t  want  to  gamble
that  the  weekend  barbecue  results  in  your  child  becoming  ill  or  dying  from  E.  coli.
The point is, there are real consequences from these actions and inactions. Our gov-
ernment  should  be  doing  more,  not  less,  to  protect  the  public.  The  amended  E.O.
moves in the wrong direction.

Every year, more than 40,000 people die on our nation’s highways. Food borne ill-
nesses  kill  an  estimated  5,000  and  sicken  76  million.  Nearly  6,000  workers  die  as
a  result  of  injury  on  the  job,  with  an  additional  50,000  to  60,000  killed  by  occupa-
tional disease. And asthma—linked to air pollution—is rising dramatically, afflicting
17 million, including six million children.

There  is  real  danger  to  our  constitutional  system  from  this  arrogation  of  power.
Equally  significant,  in  our  opinion,  is  the  real  danger  presented  to  the  American
public from the delay or refusal to regulate dangerous activities. I want to leave you
with just one example of the danger.

The  Transportation  Recall  Enhancement,  Accountability  and  Documentation
(TREAD) Act, passed by Congress in November 2000, required that ‘‘Not later than
one year after the date of the enactment of this Act, the Secretary of Transportation
shall  complete  a  rule-making  for  a  regulation  to  require  a  warning  system  in  new
motor vehicles to indicate to the operator when a tire is significantly under inflated.
Such  requirement  shall  become  effective  not  later  than  two  years  after  the  date  of
the completion of such rule-making.’’ 10

The  National  Highway  Transportation  Safety  Administration  (NHTSA)  deter-
mined  that  a  direct  tire  pressure  monitoring  system  should  be  installed  in  all  new
vehicles.  OMB  sent  a  return  letter  to  NHTSA,  after  meetings  with  the  auto  indus-
try, deciding this action was an inappropriate one, claiming its cost-benefit calcula-
tions provided a basis for delaying a requirement for direct systems. The final rule,
issued May 2002, would have allowed automakers to install ineffective Tire Pressure
Monitoring Systems (TMPS) and would have left too many drivers unaware of dan-
gerously  under-inflated  tires.  NHTSA  was  sued  because  its  final  rule  would  have
allowed  manufacturers  to  choose  to  install  either  an  effective  (direct)  system  or  an
inferior (indirect) system. In August 2003, the U.S. Court of Appeals for the Second

9 Congressional  Research  Service  The  Information  Quality  Act:  OMB’s  Guidance  and  Initial
Implementation. September 17, 2004. p. CRS–18. Available at http://www.defendingscience.org/
public¥health¥regulations/upload/Congressional-Research-Service-Information-Quality-Act-Re-
port-2004.pdf

10 Public  Law  106–414,  The  Transportation  Recall  Enhancement,  Accountability  and  Docu-

mentation Act, Nov. 2000. Section 13.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00058 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

53

Circuit  ordered  NHTSA  to  rewrite  the  rule  because  NHTSA  acted  in  an  arbitrary
and  capricious  manner  by  writing  a  standard  that  would  allow  installation  of  a
clearly faulty (indirect) system.

In  July  2004,  the  groups  that  had  sued  NHTSA  returned  to  court  because  the
agency  had  not  issued  a  revised  rule.  In  April  2005,  NHTSA  finally  issued  a  rule
requiring automakers to install tire pressure systems in all new passenger cars and
trucks by the 2008 model year, beginning a phase-in with 2006 model year vehicles.
The  new  rule,  however,  still  does  not  meet  the  requirements  set  by  Congress.  Al-
though  better  systems  exist,  the  TPMS  could  allow  tires  to  be  30  percent  below
proper  inflation  before  the  alert  is  provided,  costing  approximately  150  lives  and
countless injuries each year. In June 2005, Public Citizen, the Goodyear Tire & Rub-
ber  Company,  Bridgestone  Firestone  North  American  Tire,  Cooper  Tire  &  Rubber
Co., Pirelli and the Tire Industry Association, filed suit in the U.S. Court of Appeals
for  the  District  of  Columbia,  arguing  that  the  new  rule  is  inadequate  and  should
be  overturned.  Tire  pressure  alert  systems  regulations  that  were  required  by  law
to  be  in  place  by  the  end  of  2003  have,  as  the  tire  manufacturers  legal  action  im-
plies, not been adequately developed.11

So what can Congress do address this process? First, if Congress concurs that the
amendments  to  the  Executive  Order  are  as  bad  as  we  believe  they  are,  it  should
act. Here are three areas to explore.

• Congress should explore the legality of the Executive Order amendments and

their implementation.

• OIRA  will  need  to  provide  guidance  to  agencies  on  implementing  the  market
failure  criteria.  Congress  could  provide  much  needed  oversight  on  this  guid-
ance  to  ensure  OIRA  does  not  create  new  standards  or  irresponsible  require-
ments on agencies.

• Congress  has  the  ability  to  alter  the  implementation  of  these  amendments
through  a  variety  of  vehicles,  including  the  appropriations  process.  Congress
should take a hard look at limiting agencies’ and OIRA’s spending on the spe-
cific elements of the amendments.

Second,  we  believe  it  is  time  for  the  debate  over  regulatory  policy  and  process  to
turn toward the real need to increase public protections not protect special interest
access and influence. Because this regulatory process has real consequences for our
health  and  safety,  Congress  should  explore  legislative  actions  that  put  the  regu-
latory presumption on safety first. Why should products and substances be approved
for  use  before  they  have  been  determined  to  be  safe?  Why  should  the  economics  of
regulation  be  the  overriding,  to  the  point  of  being  nearly  determinative,  consider-
ation  to  the  exclusion  of  protecting  the  vulnerable  populations  like  the  elderly,  the
frail,  children,  and  minorities  exposed  to  flawed  siting  processes?  Government  and
businesses have a responsibility to the public to uphold their parts of the social con-
tract.  Congress  can  lead  the  way  by  providing  its  critical  oversight  responsibilities
and  considering  legislative  proposals  that  renew  the  Federal  Government’s  protec-
tion of the general welfare.

Thank you, Mr. Chairman, for providing me this opportunity to appear before you.

I’m happy to respond to Members’ questions.

11 For another example of the danger to the public from regulatory manipulation, see the testi-
mony of John B. Stephenson, Director of Natural Resources and Environment, GAO, before the
Senate  Committee  on  Environment  and  Public  Works,  February  6,  2007.  Available  at
www.gao.gov/cgi-bin/getrpt?GAO-07-464T. The summary findings read:

Although we have not yet completed our evaluation, our preliminary observations indi-
cate  that  EPA  did  not  adhere  to  its  own  rule-making  guidelines  when  developing  the
proposal  to  change  TRI  reporting  requirements.  We  have  identified  several  significant
differences between the guidelines and the process EPA followed. First, late in the proc-
ess,  senior  EPA  management  directed  the  inclusion  of  a  burden  reduction  option  that
raised the Form R reporting threshold, an option that the TRI workgroup charged with
analyzing  potential  options,  had  dropped  from  consideration  early  in  the  process.  Sec-
ond, EPA reviewed this option on an expedited schedule that appears to have provided
a  limited  amount  of  time  for  conducting  various  impact  analyses.  Last,  the  decision  to
expedite  final  agency  review,  when  EPA’s  internal  and  regional  offices  determine
whether  they  concur  with  the  final  proposal,  appears  to  have  limited  the  amount  of
input they could provide to senior EPA management.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00059 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

Appendix:

54

Undermining Public Protections

PRELIMINARY ANALYSIS OF THE AMENDMENTS TO

EXECUTIVE ORDER 12866 ON REGULATORY PLANNING AND REVIEW

On  January  18,  President  Bush  issued  amendments  to  Executive  Order  (E.O.)
12866,  which  further  centralize  regulatory  power  in  the  Office  of  Management  and
Budget (OMB) and shift it away from the federal agencies given this power by legis-
lative enactments. Among the changes to the E.O.:

• It  shifts  the  criterion  for  promulgating  regulations  from  the  identification  of
a problem like public health or environmental protection to the identification
of  ‘‘. . .the  specific  market  failure  (such  as  externalities,  market  power,  lack
of information). . .that warrant new agency action.’’

• It  requires  guidance  documents  to  go  through  the  same  OMB  review  process

as proposed regulations before agencies can issue them.

• It also requires ‘‘significant’’ guidance documents (those that are estimated to
have  at  least  a  $100  million  effect  on  the  economy,  among  other  criteria)  to
go through the same OMB review process as ‘‘significant’’ regulations.

• It  makes  the  agencies’  Regulatory  Policy  Officer  a  presidential  appointment
and gives that person the approval authority for any commencement or inclu-
sion of any rule-making in the Regulatory Plan unless specifically authorized
by the agency head.

• It  requires  each  agency  to  estimate  the  ‘‘combined  aggregate  costs  and  bene-
fits  of  all  its  regulations  planned  for  that  calendar  year  to  assist  with  the
identification  of  priorities,’’  which  will  be  overseen  by  the  Regulatory  Policy
Officer.

By-Passing Congress With New Policies

Through  amending  the  regulatory  process,  the  President  is  institutionalizing  an
anti-regulatory  approach  by  using  a  market  failure  criterion  in  place  of  actually
identifying  threats  to  public  health  and  safety.  It  diminishes  standards  Congress
may have required agencies to use, such as the best control technology, by elevating
a  new  market  failure  standard  that  Congress  never  required.  This  standard  has
been  advocated  by  Susan  Dudley,  Bush’s  current  nominee  as  administrator  of  the
Office of Information and Regulatory Affairs (OIRA). Dudley’s extreme views on the
use  of  free  market  standards  were  well-documented  during  her  failed  confirmation
last year. Despite the failure to confirm her, the Administration has used the Execu-
tive Order as a backdoor means to implement the Dudley philosophy.

The  market  failure  criterion  is  yet  another  layer  added  to  the  agency  analysis.
The  agency  must  comply  with  the  statutory  criteria  (such  as  best  available  tech-
nology)  as  well  as  an  analysis  demonstrating  market  failures.  If  the  agency  meets
OMB’s standards for assessing ‘‘whether any new regulation is warranted,’’ then the
agency  must  also  comply  with  other  standards  in  the  E.O.,  including  cost-benefit
analysis.

This  new  standard  decidedly  favors  the  regulated  community  and  places  yet  an-

other hurdle for agencies to issue regulations in pursuit of protecting the public.
More White House Control; More Delay

By requiring agency guidance documents to come under OIRA review, and to treat
‘‘significant’’ guidance in the same way as ‘‘significant’’ regulations, the E.O. amend-
ments will lead to further delay in providing information to the public about compli-
ance with regulations, as well as with general guidance on agency policies.

It  may  be  true  that  more  and  more  agencies  are  using  guidance  as  a  means  of
avoiding  the  regulatory  process.  But  that  should  be  a  signal  to  Congress  and  the
public  that  the  rule-making  process  is  seriously  flawed.  Agencies  are  looking  for
faster ways of doing their job and have turned to guidance. The solution is certainly
not  to  require  guidance  to  go  through  the  same  regulatory  process  that  agencies
were trying to avoid in the first place.

In  the  end,  this  will  simply  result  in  more  delay  and  more  White  House  control
over  the  substantive  work  of  the  agencies.  It  will  inevitably  lead  to  a  usurpation
of agencies’ powers.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00060 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

The Foxes Controlling the Hen Houses

55

The  Bush  Administration  has  regularly  appointed  industry  representatives  or  al-
lies to oversee agency regulatory activities. Often this has been dubbed ‘‘foxes in the
hen house.’’ The E.O. amendments add a new dimension by having the foxes control
the hen houses.

The  amendments  require  each  agency  to  have  a  Regulatory  Policy  Office  run  by
a political appointee and that ‘‘no rule-making shall commence nor be included’’ for
consideration  without  the  political  appointee’s  approval.  This  will  further  politicize
the  rule-making  process  and  provide  more  White  House  control  over  the  agency
rule-making process.

A  similar  approach  was  attempted  by  President  Reagan  through  his  E.O.  12498,
the  Regulatory  Planning  Process,  which  was  issued  January  4,  1985.  Under  E.O.
12498,  agencies  were  to  get  approval  from  OMB  prior  to  starting  a  rule-making—
a  pre-rule-making  review.  Many  in  the  business  community  thought  this  would  be
a wonderful approach for choking off agency ideas before they ever really got going.
That  approach,  however,  proved  too  cumbersome  and  difficult  to  administer;  in
short order, it failed.

The new Bush E.O. amendments have the same objective, but put the choke-hold
in the agencies, instead of at OMB. To ensure that the process works, OMB grants
authority to these new political appointees to be the eyes and ears for OMB.
Laying the Groundwork for a Regulatory Budget

The  E.O.  amendments  also  require  regulatory  proposals  that  are  to  be  submitted
to the Regulatory Policy Officer to include ‘‘aggregate costs and benefits’’ during the
calendar  year.  Most  experts  agree  that  aggregating  all  costs  and  benefits  is  like
comparing apples and oranges—and in the end has little value except to create large
numbers intended to scare the public.

Another possible reason to require such information is to begin laying the ground-
work  for  establishing  a  regulatory  budget.  This  concept,  proposed  by  conservatives
since  the  Reagan  Administration,  has  been  criticized  by  Congress  and  never  ap-
proved. Yet the amended E.O. begins to move in this direction.
Pre-Rule-making Review

The  amendments  to  the  E.O.  allow  OIRA  to  play  an  active  role  during  the  pre-
rule-making stage when agencies are formulating annual plans for regulatory activi-
ties.  By  having  OIRA  involved  in  agencies’  planning  process,  OIRA  can  quash  any
contemplated  regulatory  or  guidance  issues  before  they  get  proposed  for  the  Regu-
latory Plan. Under the amended E.O., OMB can now engage the agency, along with
other  government  personnel  (as  provided  for  in  one  amendment),  in  reaching  a
‘‘common understanding’’ on regulatory efforts.
Conclusion

The  revised  Executive  Order  that  results  from  these  amendments  is  a  further
threat  to  public  protections  from  an  administration  committed  to  elevating  special
interests  over  public  interests.  It  codifies  regulatory  delay,  further  removes  agency
discretion  over  legislative  implementation,  and  centralizes  control  over  the  regu-
latory  process  into  a  small  executive  office.  It  substitutes  free  market  criteria  for
the  public  values  of  health,  safety,  and  environmental  protections,  and  substitutes
executive authority for legislative authority.

We  can  only  speculate  as  to  why  the  President  has  issued  these  amendments  at
this  time  in  his  presidency.  With  Congress  now  in  control  of  Democrats,  it  is  un-
likely  that  further  anti-regulatory  efforts  will  be  supported  or  ignored  by  a  compli-
ant Congress. It is a surprising action to take in light of the Dudley nomination now
pending  before  the  Senate.  It  may  be  an  admission  by  the  Administration  that  the
nomination  is  not  likely  to  succeed,  and  that  the  President  has  decided  to  advance
the Dudley philosophy through the back door.

Prepared on January 18, 2007

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00061 Fmt 6633 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

56

BIOGRAPHY FOR RICK MELBERTH

Rick joined OMB Watch in November 2006 as the Director of Federal Regulatory
Policy,  the  program  which  works  to  protect  and  improve  the  government’s  ability
to  develop  and  enforce  safeguards  for  public  health,  safety,  environment,  and  civil
rights.  He  directs  all  activities  related  to  policy  advocacy,  analysis,  research,  moni-
toring,  and  public  education.  Rick  comes  to  OMB  Watch  from  Vermont  Law  School
where  he  was  Director  of  Internal  Planning  and  formerly  the  Associate  Director  of
the  Environmental  Law  Center.  He  helped  design  the  curriculum  and  taught
courses in the Master’s program.

Rick has written several pieces about decision-making in government and environ-
mental issues during his academic career and while working as an independent con-
sultant  and  policy  analyst.  He  started  his  own  used  and  rare  book  business  which
he ran for more than a dozen years. He also worked in the solid waste management
field as the manager of a solid waste division and a program to implement a waste-
to-energy  facility  in  county  government  in  Ohio.  This  led  to  the  opportunity  to  co-
author  a  book  for  local  governmental  officials,  Decision-making  in  Local  Govern-
ment: the Resource Recovery Alternative.

Rick  completed  his  doctorate  in  public  administration  and  public  policy  at  the
University  of  Cincinnati  in  1982.  His  Master  of  Environmental  Science  (M.En)  and
AB in political science are from Miami University.

DISCUSSION
Chairman MILLER. I thank all of you.
There are only two Members here, so the rules do allow waiving
the  five-minute  limits  to  some  extent.  Mr.  Sensenbrenner  has  gra-
ciously offered to help teach me how to be a Chairman.

Mr. SENSENBRENNER. That is called push the button when some-

body starts speaking.

utes.

Chairman MILLER. I am sorry. Okay.
Mr. SENSENBRENNER. I do have questions. It won’t last five min-

Chairman MILLER. Actually, so did I.
Mr. SENSENBRENNER. Okay. You are the Chairman. You go first.

ROLE OF OIRA

Chairman MILLER. All right.
Mr.  Kovacs,  in  Mr.  Vladeck’s  testimony,  his  written  testimony,
he said that the role of OIRA was a one-way ratchet. It always re-
sulted  in  weaker  regulations.  Dr.  Melberth  cited  one  example,  the
gauge  on  tire  pressure,  where  OIRA  had—their  role  had  resulted
in a weaker regulation that was overturned by the courts.

Can  you  give  examples  of  when  agencies  have  sent  proposed
rules  to  OIRA  in  the  last  six  years,  during  the  Bush  Administra-
tion,  where  the  Bush  Administration  has  sent  back  the  rule,  and
said this is not tough enough? We really need to do more to protect
public health, to protect safety, to protect the environment, to pro-
tect privacy rights, or civil rights, or whatever. Can you cite exam-
ples  of  when  OIRA  has  sent  regulations  back  to  the  agency  from
which they came, and said make it stronger?

Mr. KOVACS. I don’t have any list of the rules that they have sent
back  to  the  agencies,  and  I  don’t  even  know  that  one  is  public.  I
do  know  that  the  first  year  and  a  half,  when  John  Graham  was
head  of  OIRA,  he  did  send  a  number  of  rules  back,  and  I  believe
one  of  them  was  the  particulate  matter  rule.  So  the  first  couple  of
years, about 18 months, he did it, and then, for some reason, it all

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00062 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

57

of  a  sudden  stopped.  They  weren’t  sending  as  many  back,  but  it
was a standardized process during that time period.

Chairman  MILLER.  Ms.  Katzen,  are  you  aware  of  circumstances
in  the  last  six  years  that  OIRA  has  sent  regulations  back  and
asked the agency to toughen them up?

Ms. KATZEN. No, I am not. The return letters are public, because
they  are  posted  on  the  website,  and  I  think  OIRA  has,  under  the
Bush Administration, increased the transparency by greater use of
the  website  for  that  purpose.  I  have  read  all  of  the  return  letters,
and  I  have  not  seen  any  requiring,  requesting,  entreating  greater
protection or more stringent, achieving better benefits.

Chairman  MILLER.  Mr.  Vladeck,  you  obviously  want  to  answer.
Mr.  VLADECK.  The  statistics  are  public,  and  in  fact,  Curtis
Copeland  of  the  CRS  has  published  an  article  in  the  33  Fordham
Urban  Law  Journal  which  discusses  all  of  the  statistics  which  are
public  since  1994,  including  those  from  2000  to  2005.  You  will  see
there  are  an  awful  lot  of  return  letters.  There  are  a  lot  of  changes
made.  One  of  the  categories  is  ‘‘consistent  with  change,’’  those  are
changes  pushed  by  OIRA,  and  the  numbers  are  quite  large,  and  I
look  at  the  return  letters,  as  does  Ms.  Katzen,  I  have  never  seen
one  returned  to  beef  up  the  rule,  in  a  way  that  would  protect  the
public health.

TRANSPARENCY PROVISIONS

Chairman  MILLER.  Okay.  Ms.  Katzen,  you  obviously  played  an
important  role  in  the  Clinton  Administration  in  drafting  the  origi-
nal Executive Order 12866, and you spoke a moment ago of trans-
parency  in  the  role  of  OIRA,  and  I  understand  that  transparency
was  part  of  that  Executive  Order.  It  required  communication  be-
tween  the  agencies  and  OIRA  to  be  public,  subject  to  a  FOIA  re-
quest.  It  required,  as  I  understand  it,  any  changes,  the  return  let-
ters,  to  be  public  as  well,  and  communications  between  OIRA  and
outside  agencies,  who  are  urging  a  change  in  the  rules,  whether  it
is  entirely  proper  urging  of  an  industry  to  say  this  is  unworkable,
but  it  made  those  communications  public,  so  that  the  public  could
decide  whether  any  changes  that  OIRA  made  were  appropriate,  or
an  appropriate  response  to  legitimate  concerns  raised  by  those
most  familiar  with  what  the  agencies  would  do,  what  the  regula-
tions would do, or whether it was caving to pressure.

Is that, essentially, are those the——
Ms. KATZEN. There were a number——
Chairman MILLER.—transparency provisions?
Ms.  KATZEN.  Yes.  I  mean,  Mr.  Kovacs  talked  about  going  back
to  Richard  Nixon,  and  I  do  discuss  this  in  my  written  testimony,
President Reagan took a dramatic step forward, and that was high-
ly  controversial,  because  it  was  opaque,  at  best.  It  was  just  not
transparent.

When  we  drafted  12866,  we  were  highly  sensitive  to  that,  and
wanted to make sure that we met that one head-on. In fact, it was
in part because Members of Congress had spoken out so forcefully,
calling  for  openness  and  accountability,  that  we  responded  by  in-
cluding  the  provisions  that  you  mentioned  in  the  Executive  Order.
That  is  the  role  that  I  think  Congress  should  have,  which  is  to
make  sure  that  the  executive  is  aware  that  there  is—are  two

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00063 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

58

branches of government involved, since it is the Congress that dele-
gates to the agencies in the first instance the authority to regulate.
The  other  comment,  if  I  may,  sir,  the  thought  that  we,  that  this
is  simply  a  logical  progression  from  what  the  Clinton  Administra-
tion did cannot be substantiated. I was there for six years. I never
saw  a  guidance  document.  I  never  asked  to  see  a  guidance  docu-
ment.  The  concept  that  this  is  just  business  is  usual,  and  you
know,  President  Clinton  did  it,  he  might  as  well  do  it,  too,  just
couldn’t be further from the truth.

Chairman  MILLER.  Thank  you.  I  have  more  questions,  but  I  will

save them for a later round. Mr. Sensenbrenner.

OUTSIDE COMMENT ON E.O. 12866

Mr. SENSENBRENNER. Thank you very much, Mr. Chairman.
First,  let  me  put  on  the  record  that  the  Executive  Order  that
President  Bush  issued  amending  Executive  Order  12866  was
signed  on  January  18,  2007,  just  28  days  ago.  So,  the  process  that
we  are  talking  about  and  the  issuance  of  the  regulations  are  all
done  pursuant  to  Clinton’s  Executive  Order,  because  I  don’t  think
there  have  been  any  major  regulations  that  have  been  issued  as  a
result of the amendment.

The  amendment  of  the  President’s  most  recent  Executive  Order
talks about process. It doesn’t talk about the bottom line of the reg-
ulation,  and  I  guess  I  would  kind  of  like  to  find  out  why  three  of
the  four  witnesses  did  not  send  any—in  any  comments  relative  to
the amendment when it was under consideration.

Ms. KATZEN. If I may, Executive Orders are not typically put out
for  notice  and  comment.  The  comments  that  were  filed  were  filed
on  the  Good  Guidance  document,  rather  than  on  the  amendment
to the Executive Order.

Mr.  SENSENBRENNER.  I  stand  corrected  on  that,  but  where  the
comments  were  solicited  and  received,  Mr.  Kovacs  had  some  input
on it, but none of the other three of you did, and why is that?

Ms. KATZEN. He represents an entity that is an interested partic-
ipant.  I  am  an  academician,  and  I  write  scholarly  articles,  unless
I am asked to testify in Congress, I——

Mr.  SENSENBRENNER.  Well,  I  think  you  are  really  interested  in

that, given what I have heard you say.

Ms. KATZEN. I am very interested, yes, sir.
Mr.  SENSENBRENNER.  Okay.  But  you  didn’t  comment.  Now,  Mr.

Vladeck.

Mr.  VLADECK.  The  two  organizations  with  which  I  am  affiliated
did  comment,  Public  Citizen  and  OMB  Watch.  I  am  on  the  Board
of  Directors  of  OMB  Watch,  and  I  still  have  a  relationship  with
Public Citizen. They both did comment.

I did not personally comment on the guidance——
Mr. SENSENBRENNER. Dr. Melberth.
Mr. MELBERTH. Mr. Sensenbrenner, we did submit comments on
the  proposed  GGPB  bulletin,  under  Citizens  for  Sensible  Safe-
guards.  It  is  signed  by  members  of  the  coalition  that  we  lead,  and
my  predecessor  as  Director  of  Regulatory  Policy  was  one  of  those
signees.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00064 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

59

COST-BENEFIT ANALYSES

Mr. SENSENBRENNER. Yeah. Now, you know, with respect to mar-
ket  failure,  using  market  forces  the  Regulatory  Reform  Act  that
was  signed  by  President  Clinton,  and  was  a  part  of  the  Contract
With  America,  and  passed  by  Congress  in  1995,  did  require  cost-
benefit analyses to be applied during the regulatory process.

Do  you  think  that  was  a  good  idea?  I  will  start  with  you,  Dr.

Melberth.

Mr. MELBERTH. Yes, sir. I think cost-benefit analysis is an appro-

priate tool to be used, not——

Mr. SENSENBRENNER. Mr. Vladeck.
Mr. MELBERTH.—as a——
Mr. VLADECK. I don’t believe centralized review is a good idea to
begin  with,  and  requiring  all  agencies  to  do  cost-benefit  analysis,
even for significant rules, in my view is a bad idea.

Mr. SENSENBRENNER. Okay. Ms. Katzen.
Ms.  KATZEN.  I  am  a  proponent  of  cost-benefit  analysis  as  an

input to decision-making, not as dispositive of the outcome.

Mr.  SENSENBRENNER.  Now,  do  you  think  that  the  cost-benefit
analyses should be just as transparent as some of the other things
that you have testified on, so that the public and perhaps the Con-
gress can see if there is a proposed regulation that it has about this
much benefit at that much cost?

Ms. KATZEN. Yes, and in fact, during the Clinton Administration,
there were many occasions when the cost-benefit analysis was larg-
er,  more  paper,  more  analysis,  than  actually  the  rule-making,  to
provide the kind of information that people should have.

It is also very important to emphasize that agencies are not free
agents.  They  are  able  to  regulate  only  because  Congress  has  dele-
gated them the power to do so.

Mr. SENSENBRENNER. But the agencies are——
Ms. KATZEN. And we have——
Mr.  SENSENBRENNER.—headed  by  someone  who  is  appointed  by

the President of the United States.

Ms.  KATZEN.  Absolutely.  All  I  am  saying  is  that  we  had  several
instances,  while  I  was  the  Administrator  of  OIRA,  where,  on  the
basis  of  a  cost-benefit  analysis,  we  saw  that  the  costs  were  larger
than the benefits, but that the Congress had given us no discretion,
and that we had to proceed. In at least one instance, we made that
finding  loud  and  clear,  and  sent  a  letter  to  the  Congress  saying
please  amend  the  law,  so  we  don’t  have  to  do  that.  And  Congress
did.

Mr. SENSENBRENNER. It does work.
Ms. KATZEN. Yes, how it should work.
Mr.  SENSENBRENNER.  Yes.  I  yield  back  the  balance  of  my  time.
Chairman MILLER. Thank you, Mr. Sensenbrenner. Mr. Baird.
Mr. BAIRD. I thank the Chairman.
First  of  all,  Dr.  Melberth,  you  were  going  to  continue  your
thought.  I  would  like  to  ask  you  if  you  would  like  to  do  that.  Ear-
lier,  you  were  asked  a  question  by  Mr.  Sensenbrenner,  and  gave  a
partial  answer,  and  were  in  the  middle  of  continuing.  You  care  to
elaborate?

Mr. MELBERTH. Thank you, Mr. Baird.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00065 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

60

I  do  think  cost-benefit  analysis  is  a  good  thing  to  have  as  part
of  the  decision-making  process.  I  have  several  problems  with  cost-
benefit  analysis,  but  however  it  is  used,  it  should  only  be  one  as-
pect  of  that  decision-making  process.  It  should  not  be  dispositive.
It should not be the driving mechanism, in my opinion, in that de-
cision-making process, which does not, if you use cost-benefit anal-
ysis as dispositive, include any of the non-quantifiable aspects that
are so often underestimated in cost-benefit analysis.

Thank you, sir.

MARKET FAILURE PROVISIONS

Mr. BAIRD. I appreciate your expansion on that point.
I  am  a  little  puzzled  by  one  of  the  core  issues  here,  and  it  has
to  do,  this  market—as  a  market  process.  Apparently,  the  issue  is
that  we  don’t  need  regulations  if  the  market  would  already  regu-
late  itself,  and  I  am  just  puzzled,  I  am  completely  puzzled  about
how one operationalizes that. I don’t know that the marketplace in
general,  as  currently  structured,  incentivizes  many  industries  to
engage  in  responsible  behavior,  except  fiduciary  responsibility  to
their stockholders. I am not saying that is a bad thing, but I don’t
think the market intrinsically is designed to protect workers, public
health, environmental issues, so if any of you care to enlighten me
about  what  the  heck  this  means,  and  if  it  is  the  metric  by  which
OMB or other executive branch offices are going to evaluate regula-
tions, I would sure like to operationalize that metric.

Ms. KATZEN. You want me to try this one?
The  concept  is  that  regulations  will  be  necessary  where  there  is
a  failure  of  the  marketplace,  and  the  terms  that  are  often  thrown
around are ‘‘externalities,’’ ‘‘lack of information,’’ ‘‘market power.’’ If
you  are  an  agency,  and  you  can  demonstrate  that  there  are  one  of
these externalities, market power, lack of information, then you are
kind  of  home  free.  The  point  I  think  some  of  us  were  making  is
that  there  are  often  good  reasons  for  regulations  that  do  not  in-
volve  market  failures,  where  the  market  can  be  functioning  abso-
lutely  the  way  a  market  should,  and  I  am  thinking  of  areas  such
as  civil  rights  or  privacy,  where  market  failure  is  irrelevant  to  the
underlying issue, and there is a need for something to be done.

The way the original Executive Order was drafted, it was an in-
struction to the agency to identify the problem that you were trying
to  address,  parenthetically,  was  it  attributable  to  a  market  failure
or  something  else,  close  parentheses,  and  how  you  plan  to  fix  it.
Now,  it  does  tell  us  about  the  market  failure,  and  maybe  it  is  a
failure of a public institution, and then, go on and worry about the
rest of it.

It is a different emphasis on a different syllable. It comes out dif-

ferent, and that is what I am reacting to, I think.

Mr. VLADECK. Well, let me jump in.
The best way to understand the pitfalls of this is just look at the
regulation  of  airbags.  Detroit  waged  what  the  Supreme  Court
called  the  regulatory  equivalent  of  war  to  forestall  regulatory  and
Congressional action requiring the installation of airbags. So, if you
talk about market failure, where exactly is the market failure? Peo-
ple  were  still  buying  cars.  And  even  once  GM,  which  was  the  first
company to introduce airbags, started to introduce them, they have

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00066 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

61

sold them as an add-on, not as part of the car. They were very ex-
pensive.  And  even  today,  when  you  have  certain  kinds  of  airbags,
some  of  the  side  curtain  airbags,  that  are,  you  know,  that  are  not
required  by  federal  law,  the  marketing  of  them  is  done  in,  you
know, for the American companies, they are add-ons, they are very
expensive add-ons. Now, is the market working?

The introduction of airbags in the United States was delayed for
about  15  years  because  of  the  battle  that  the  industry  fought  to
keep airbags off the market, and provided that no one was offering
them,  they  weren’t  suffering  any  economic  consequence.  Now,  if
you  look  at  the  new  Executive  Order,  it  substitutes  the  question
that  was  from  the  Reagan  Executive  Order,  carried  forward  to  the
Clinton  Executive  Order,  which  is  tell  us,  tell  OIRA,  why  it  is  you
want to regulate. That is all you have got to do.

Now,  let  me  just  read  you  what  the  new  Executive  Order  sub-
stitutes in its place. It says: ‘‘Each agency shall identify, in writing,
the  specific  market  failure  that  warrants  the  new  rule.’’  The  word
‘‘shall’’  is  a  word  of  command.  It  is  not  if  you  feel  like  it.  And  so,
what this change to the Executive Order does, is it places the lens
of the agency and OIRA on market failure. Yes, there is an escape
clause.  You  will  hear  a  lot  about  that.  But  it  is  a  substitute  for
market failure analysis, and OIRA, not the agency, ultimately calls
the shots.

Mr. KOVACS. Let me see if I could take a crack at it, because we
have talked about market failure quite a few times, and one of the
advantages  of  not  being  a  law  professor  is  the  only  thing  I  know
is what I read, and what the statement says is: ‘‘Each agency shall
identify, in writing,’’ as the Professor suggests, ‘‘the specific market
failure,’’ but then, it says ‘‘such as externalities, market power, lack
of  information,  or  another  specific  problem  that  it  intends  to  ad-
dress,’’  again,  brackets,  ‘‘including,  where  applicable,  the  failure  of
public  institutions,  that  warrant  new  agency  action,  as  well  as  the
ability to assess the significance of the problem.’’

So,  it  is  not  just  market  failure.  It  is  a  variety  of  failures  that
might  occur.  I  think  it  goes  back  to  the  simple  concept  that  was
raised  35  years  ago,  which  is  tell  us  what  the  problem  is,  and  tell
us  how  you  are  trying  to  address  it.  I  don’t  think  we  can  impute
that  this  is  only  just  market  failure,  when  they  give  all  of  that
other explanatory language.

Mr.  BAIRD.  My  question  is  that  that  sounds  nice,  but  if  someone
actually wishes to use the language as a smokescreen to push a dif-
ferent agenda, that is where the rub is. And if we’re all well-inten-
tioned, sincere, honest, earnest people, with a similar shared value-
set  and  agenda-set,  I  don’t  know  that  there  would  be  a  problem.
My  concern  is  does  the  rewrite,  and  I  think  some  of  the  other
witnesses seem to be hinting at it, saying pretty directly, the prob-
lem is that this new language puts the onus and the decision-mak-
ing  in  a  different  area  than  it  used  to  be,  and  that  that  opens  the
door  for  potential  shenanigans  and  actions  contrary  to  the  public
interest. That is my read of it.

Mr.  KOVACS.  I  guess,  you  know,  there  are  theoretical  ways  to
look  at  the  regulatory  process,  and  we  went  over,  you  know,  what
it  looks  like  from  a  small  business  point  of  view,  but  you  know,  if
it  were  up  to  the  Chamber,  you  know,  we  don’t  just  want  peer  re-

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00067 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

62

view,  we  want  open  peer  review,  so  that  we  can  have  all  the  bril-
liant minds comment. We want complete transparency, because we
think that that is the easiest way to deal with the agencies. Unfor-
tunately,  we  are  in  a  political  situation  that  the  agencies  have  al-
ways opposed that much transparency.

So, I think what you have here is a very practical situation. You
have one President of the United States who is responsible for the
executive branch of government, and he has to have some manage-
ment authority. This President has decided, through the Executive
Order, and through these guidance documents, that this is the kind
of transparency he has.

We  participate  in  that  process.  Are  we  happy  with  it  all  the
time?  No.  But  I  don’t  think  you  can,  as  some  of  the  panelists  sug-
gest,  that  there  is  some  manipulation  here,  or  something  sinister.
The regulatory process is extremely complicated. There are a lot of
laws,  and  a  lot  of  people  trying  to  work  this  process.  All  we  have
ever asked when we go through on these kind of situations is that
we  have  some  mechanism,  if  the  problem  isn’t  addressed  and  as-
sessed, that we can get back into the process. And I think——

MORE ON TRANSPARENCY PROVISIONS

Mr. BAIRD. Mr. Kovacs, I appreciate very much the insight.
If I could ask just one last question. When Vice President Cheney
was  drafting  the  energy  policy,  he  invited  a  number  of  folks,  I
think, from oil and gas, to the White House. Many of us were curi-
ous as to who those folks were. From what you have just said, the
Chamber  of  Commerce  is  very  interested  in  transparency.  Was  it
the  Chamber’s  official  position  back  then,  and  is  it  now,  that  the
Vice President of the United States should share information about
who consulted with him on energy policy?

Mr. KOVACS. Our—well, I don’t know about any particular issue,
but our policy has always been transparency, and I think there are
logs out there, as to who signs it—certainly, when I go over to any
meeting over at the White House, I sign in, give my Social Security
number,  date  of  birth,  and  everything  else,  so  that  information
should be there.

If  it  were  up  to  me  personally,  this  isn’t  the  Chamber,  I  mean,

I would have all schedules of all public officials open to——

Mr.  BAIRD.  Well,  for  the  record,  then,  I  would  just  request  that
you would report back to this committee on—last year, I had a con-
versation  with  your  leadership  of  the  organization,  and  if  that  is
the case, if there is a consistency of value here, that we want open
public  information,  please  send  us  a  letter,  which  we  will  convey
to  the  Vice  President,  asking  him,  on  behalf  of  the  Chamber  of
Commerce,  to  share  the  names  of  the  people  who  helped  draft  his
energy policy.

Mr. KOVACS. I wasn’t addressing it to any particular policy. What
I said, just from my words, is we think that government in general
should be open.

Mr.  BAIRD.  And  I  agree  with  that  entirely.  I  agree  with  that  en-
tirely.  What  I  am  saying  is  it  may  be  a  fairly  selective  belief.  If
that is your belief, I don’t know how many things are more impor-
tant  in  this  country  than  our  energy  policy,  and  if  that  is  your  be-
lief,  share  that  belief  with  us,  and  apply  it  equitably  across,  not

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00068 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

63

just to this particular proposed regulation, but equitably across the
activities  of  the  executive  branch,  and  we  will  convey  that  the
Chamber  of  Commerce  formally  believes  the  Vice  President  of  the
United States, consistent with this policy of openness advocated by
the  Chamber  of  Commerce,  shares  with  the  American  public  the
names of the people who developed this energy policy.

Mr. KOVACS. Just so we are on the same page—I am very willing
to  go  back  and  make  that  request,  just  so  we  are  sure  it  is  going
to be a general statement. How you use it is completely up to you.

Mr. BAIRD. I will look forward to the statement.
Mr. KOVACS. Well, we would hope that you would extend that to
all  of  the  other  agencies,  and  how  all  of  the  other  rules,  like  PM
and ozone and——
Mr. BAIRD. Right.
Mr. KOVACS.—everything else are made.

MORE ON MARKET FAILURE PROVISIONS

Chairman  MILLER.  Mr.  Kovacs,  Mr.  Baird,  I  am  struggling  to
continue  to  chair  this  subcommittee  meeting  without  the  tutelage
of Mr. Sensenbrenner, but we will have time for a second round of
questions,  although  I  understand  the  Judiciary  Committee  has
claimed this room beginning at 2:00.

I  did  have  a  couple  of  questions,  before  turning  to  Mr.  Rohr-
abacher,  kind  of  on  the  doctrine  of  hot  pursuit,  about  the  market
failure issue.

Mr.  Sensenbrenner  said  that  in  1995,  Congress  passed  and  the
President  signed  regulatory  reform  legislation  that  did  place  into
law  cost-benefit  analysis.  Mr.  Vladeck,  you  are  shaking  your  head
no to that, but does market failure appear in statute? Is that a cri-
terion for the approval of regulations, or for a regulatory agency to
act  or  not  to  act,  that  Congress  has  ever  placed  into  federal  law?

Ms. Katzen?
Ms.  KATZEN.  Not  that  I  am  aware  of.  I  think  what  Mr.  Sensen-
brenner  was  referring  to  was  the  Unfunded  Mandates  Act,  which
refers  to  an  analysis  of  the  costs  and  the  benefits,  and  there  is  no
mention,  no  mention  of  market  failure  in  that,  or  in  SBREFA,  the
Small  Business  Regulatory  Flexibility  Act,  which  was  also  passed
at  that  time,  nor  in  the  Congressional  Review  Act,  which  was  an-
other product of that Congress.

So, it is not legislative language, sir.
Chairman MILLER. Okay.
Mr. VLADECK. That is consistent with my understanding, as well.
And the Unfunded Mandates Act is a limited statute. It doesn’t re-
quire cost-benefit analysis across the board.
Chairman MILLER. Mr. Kovacs, do you——
Mr.  KOVACS.  Again,  I  am  not  reading  it  as  just  market—as  that
being the only criteria. I mean, I just don’t think the language gets
you there.

Chairman  MILLER.  Okay.  Mr.  Vladeck,  in  his  written  testimony,
said that the woman appointed or nominated to be chair or to head
the  OIRA,  Susan  Dudley,  who  I  have  never  met,  and  I  have  not
read  her  writings,  but—strongly  believes  that  the  market  seldom
fails,  that  there  is  almost  always  a  market  mechanism  that  cor-
rects any societal ill.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00069 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

64

If we now place into the regulatory framework a criterion, not es-
tablished by Congress, that is going to be administered by someone
who  believes,  apparently,  or  according  to  Mr.  Vladeck,  almost  as
dogma that the market seldom, if ever fails, Mr. Kovacs, is that the
distribution  of  authority  between  the  branches  of  government  you
think the Framers of the Constitution intended?

Mr.  KOVACS.  Well,  first  of  all,  being—or  having  worked  on  the
Hill  for  years,  I  am  a  very  fervent  believer,  personally,  in  the  pre-
rogatives of the Congress as a separate branch of government, and
the  agencies  have  a  Constitutional  obligation  to  implement  the
laws as you pass them.

And granted, within that, there is some discretion, based on a lot
of different factors, whether it be budget or personnel, or how it is,
but I am not, you know, I am not here saying market failure is the
only criteria. There are other criteria here which I would hope that
the agency would recognize.

I  am  taking  a  position  as  I  read  it  that  the  agency  has  to  iden-
tify,  because  of  all  of  these  different  conditions,  what  the  specific
reason  is  that  they  are  going  to  move  forward  with  a  regulation,
not that it can only be market failure, because obviously, there are
reasons  you  would  implement  a  regulation  other  than  market  fail-
ure, civil rights, for example.

Chairman  MILLER.  Okay.  Mr.  Vladeck,  do  you  wish  to  address

that?

Mr.  VLADECK.  Yes.  Let  me  just  use  as  an  example  the  upgraded
airbag  rule,  which  Ms.  Dudley  was  virtually  alone  in  opposing.  As
you  know,  when  Congress  required  the  introduction  of  airbags,  it
did  not  set  performance  standards,  and  as  a  consequence,  the  first
generation of airbags were very inexpensive, and not as effective as
they should have been.

Congress  told  NHTSA  to  go  out,  and  to  improve  the  quality  of
airbags  that  are  available  to  the  American  people.  Ms.  Dudley’s
comments  opposing  the  revisions  to  the  airbag  standard  took  the
position, quite strongly, that market failure had not been shown by
NHTSA,  the  agency,  and  therefore,  the  agency  shouldn’t  proceed.
The  reason  why  I  think  this  is  germane  is  that  phrases  like
‘‘market failure’’ can mean different things to different people, and
if the Administrator of OIRA can block a significant rule, or return
a  significant  rule,  because  she  believes  that  the  agency  has  not
made a case for market failure, it gives OIRA a tool to block impor-
tant developments to protect the public safety and health.

Chairman MILLER. I do want to preserve time for another round

of questions, and that was not one of my rounds, by the way.

Mr. Rohrabacher.

REGULATION AND THE PUBLIC INTEREST

Mr. ROHRABACHER. Thank you very much, Mr. Chairman.
Let us get—this obviously goes to the way we look at things fun-
damentally,  and  not—there  is  a  fundamental  philosophical  issue,
and  whether—how  that  philosophy  relates  to  reality,  and  how  it
impacts  on  people’s  lives,  and  let  me  note  that  people  who  believe
in  the  market  are  not  just  philosophizers,  we  believe  in  the  end,
it means that people’s lives will be better off.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00070 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

65

Some  fundamental  questions,  then,  apply  here.  We  must  note
fundamentally,  that  at  times,  it  is  difficult  to  determine  exactly
what  the  public  interest  is.  This  is  not  where  there  is  an  omnipo-
tent  group  of  people  who  are  commanded  by  God,  who  understand
exactly what the public interest is, whether or not resources should
go,  for  examples,  into  airbags,  or  whether  or  not  resources  should
go  someplace  else.  And  I  think  it  is  somewhat  of  a—to  the  degree
that we are talking about public assets, the air, the water, the soil,
then  we  need  to  sit  down  and  determine  for  the  public  how  those
publicly held assets will be, you know, will be used, and regulation
and  certainly  government  intervention  in  those  areas,  is  justified.
But in terms of how much the public is willing to pay for their safe-
ty  or  something  else  that  they  might  want,  they  might  want  a
higher proportion of this, as compared to what the regulators think
is  best  for  them.  And  that  is  one  issue  that  I  would  like  to  throw
on the table.

Another  thing,  let  me  note  that  my  observation  over  the  years
has  been  that  every  time  that  we  have  people  who  move  forward
in a regulatory process, in the name of protecting the general pub-
lic,  quite  often,  they  are  influenced  by  special  interest  groups,  and
the  more,  the  further  away  from  the  consumer,  and  the  further—
where  they  have  choice  in  the  matter,  or  by  elected  officials,  who
are  by  their  very  nature,  dependent  on  the  voters  or  the  con-
sumers, to approve of the job they have done, once you go to a reg-
ulatory approach, it becomes less responsive to the public need, and
more  responsive  to  people  who  can  work  their  way  into  the  regu-
latory  process,  meaning  people  who  can  hire  the  lobbyists  down
here  who  know  the  system,  and  especially,  the  system  that  hap-
pens in a regulatory process.

So, I just thought I would throw those ideas out. Let me just ask
you,  maybe  if  we  could  have  it  from  both  sides  of  the  spectrum
here, on your analysis of what I just said, or your reaction.

Mr.  MELBERTH.  First  of  all,  the  use  of  willingness  to  pay  as  a

measure of public interest, to determine the relative costs.

Mr.  ROHRABACHER.  Yeah.  A  car,  you  know,  may—people  may
well  be  willing  to  spend  more  money  for  an  airbag  in  a  car,  but
they  may  not.  It  may  deter  people  from  buying  new  cars.  It  may
leave the poor people on the outs, because they don’t have any air-
bags in their cars, and et cetera. So—would—by the way, let us get
into  that.  Would  you  mandate  that  all  cars  be  retrofitted  with  air-
bags? Isn’t that—wouldn’t that be something, if you have the public
interest—and why don’t you do that? You don’t do it because there
is a cost factor. If there is a cost factor with older cars, why is that
cost  factor  not  important  with  newer  cars?  So,  just  a  thought.  Go
right ahead. Be—I am sorry I interrupted you.

Mr.  MELBERTH.  Well,  what  I  understand  by  the  willingness  to
pay  is  the  use  of  that  in  some  kind  of  cost,  economic  assessment.
And  the  problem  with  using  that  kind  of  willingness  to  pay  is  it
puts  people  in  a  hypothetical  situation  of  trying  to  judge  the  risks
that they face.

Mr. ROHRABACHER. Right.
Mr.  MELBERTH.  That  seems  to  be  highly  unrealistic,  and  if  you
put  people  in  a  situation  in  which  they  are  actually  faced  with  a

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00071 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

66

danger,  a  drowning  child,  are  they  going  to  jump  and  save  the
child? Of course they are.

Mr. ROHRABACHER. Right.
Mr. MELBERTH. There are those kinds of situations, and yet, you

know, the willingness to pay doesn’t go anywhere——

Mr. ROHRABACHER. Well, let us go—let us argue a hypothetical—
specifically. I have triplets. My wife had triplets. Everybody knows
that.  And  I  am  a  very  proud  father,  and  I  want  those  kids  safe,
and  I  tell  you,  I  am  willing  to  pay  the  extra  money  for  the  gas  to
have  a  big,  heavy  car,  because  when  my  wife  goes  to  the  market,
I want to make sure if that car is hit, that they are safe. I am will-
ing  to  pay  that  extra.  But  mandating  that  cars  get  much  more
miles  to  the  gallon,  and  are  much  lighter,  because  they  have  to
make it lighter, shouldn’t I, as a consumer, be able to do that, rath-
er than have a regulator make that decision for me?

Ms. KATZEN. If I could come at this from a slightly different way.
Mr. ROHRABACHER. Sure.
Ms.  KATZEN.  I  don’t  have  difficulty  with  the  concepts  that  you
are  putting  on  the  table.  What  I  think  is  important  is  that  when
Congress  legislates,  and  then  when  the  agency  regulates,  it  take
into  account  all  of  the  different  views.  That  is  why  the  process  of
rule-making, under the Administrative Procedure Act, Section 553,
and  in  reality,  is  a  very  open  process.  It  is  a  process  that  features
public  participation,  be  it  by  special  interests  or  by  individuals,
who  can  contribute  their  views,  their  philosophies,  their  ap-
proaches, their data, their analyses, to the issue.

That  is  what  rule-making  is  all  about,  which  is  why  it  takes
months,  sometimes  years,  to  issue  rules.  The  point  I  was  trying  to
make  earlier  is  that  what  I  find  troubling,  deeply  troubling,  is  if
the process is skewed to come out one way or the other. If the proc-
ess is neutral, let us hear your thoughts, let us hear your informa-
tion,  we  will  take  into  account  all  of  these  factors,  and  we  will
reach  a  judgment  and  be  accountable  for  that  judgment,  then,  I
think  it  is  appropriate.  But  if  you  have  got,  as  I  used  the  analogy
earlier,  a  thumb  or  a  fist  on  the  scale,  and  you  say  we  are  going
to come out one way or the other——

Mr. ROHRABACHER. Yeah.
Ms.  KATZEN.—then  you  have  squashed  or  squelched,  or

whatever——

Mr. ROHRABACHER. Well—totally legitimate. Obviously, you have

made a legitimate point there, obviously.

Mr.  VLADECK.  Let  me  try  to  respond  as  well,  because  I  think  I

do disagree with your fundamental premise.

I  think  it  would  be,  at  this  point  in  time,  irresponsible  for  gov-
ernment  to  permit  the  sale  of  motor  vehicles,  cars,  to  transport
somebody else’s triplets without airbags. I think that would be irre-
sponsible, and frankly, you started by saying——

Mr. ROHRABACHER. Would you retrofit it?
Mr. VLADECK. I would——
Mr.  ROHRABACHER.  Would  you  demand  that  all  cars  be  retro-

fitted?

Mr.  VLADECK.  I  wouldn’t,  and  nor  did  Congress  when  it  decreed
that cars have airbags, make that choice. Because ultimately, your
question  was,  you  know,  who  decides  what  is  the  public  interest?

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00072 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

67

You guys do. That is why we pay you the big bucks. And Congress
decided that there should be airbags.

Now, the more difficult questions are what kinds of airbags, and
how much safety to impose, and those are delicate questions of bal-
ancing.  There  are  tradeoffs  there.  If  you  want  a  safer  car,  all  cars
are not created equal. If you want to buy the safest car on the mar-
ket  for  your  triplets,  there  are  better  cars  and  there  are  less  safe
cars.  And  NHTSA  has  not  gotten  a  mandate  from  Congress  to  re-
quire the maximum degree of safety no matter what. Those are the
difficult  tradeoffs  that  you  enlist  expert  agencies  to  help  you,  and
what  I  am  concerned  about  is  that  the  executive  branch  is
handcuffing  those  agencies  in  their  ability  to  do  the  public  busi-
ness.

And let us talk about transparency. One of the odd things about
the  new  Executive  Order  is  the  transparency  and  time  limits  are
not  required  for  guidance  documents.  OIRA  can  sit  on  a  guidance
document  for  five  years,  consistent  with  this  Executive  Order.  It
can  engage  in  all  sorts  of  non-recorded  contacts  with  respect  to
guidance  documents  under  this  Executive  Order.  This  Executive
Order goes back to the early days, where OIRA was allowed to con-
duct a big part of its business in secret, and for someone who cares
about openness, transparency, the way the markets ought to work,
that is inimical to the way government ought to function.

MORE ON TRANSPARENCY PROVISIONS

Chairman  MILLER.  Thank  you.  Thank  you,  Mr.  Rohrabacher.  If
you  would  hang  around  for  a  minute,  you  may  get  another  round
of questions.

But  I  want  to  pursue  the  discussion  that  we  were  just  having
about  transparency,  and  that  I  had  begun  in  my  earlier  round  of
questions.

Mr. Kovacs, you spoke a great deal about transparency, openness
of government, and seemed to take the pro position with respect to
that, the position in favor of that. All the—all that Ms. Katzen de-
scribed about the earlier Executive Order by President Clinton, the
transparency,  the  public  availability  of  documents  by—OIRA  docu-
ments  or  communications  with  the  agency,  their  communications
with  outside  parties  who  are  advocating  for  some  change  in  the
regulations,  any  changes  in  the  regulations,  you  support  all  of
those, all those transparency requirements?

Mr.  KOVACS.  Oh,  certainly.  We  have—well,  I  will  go,  you  know,
one step further. We, actually, were probably the primary advocate
for  the  Information  Quality  Act,  which  is  going  to,  you  know,  turn
everyone sort of bright red here.

But  you  know,  what  that  says  is,  is  that,  what  the  Congress  or-
dered is that the agencies have to use the most accurate, up-to-date
information,  and  that  if  the  information,  if  someone  in  the  public
believes that the information is incorrect, that they can file a peti-
tion  to  correct  the  information.  Again,  you  heard  the  same  argu-
ments.  This  is  trying  to  slow  the  agencies  down,  this  is  trying  to
put everything in secret.

We  have  been  very  clear.  We  don’t  believe  just  in  peer  review.
We  believe  in  open  peer  review.  Just  open  it  up.  Why  should  four
or  five  scientists  have  a  say  over  what  the  issue  is?  So,  when  you

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00073 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

68

come  to  the  openness,  the  only  way  we  are  going  to  get  the  kind
of  information  in,  from  the  public  into  the  agency  is  if  we  know
what  the  agency  is  doing,  and  we  are  able  to  put  it  in,  and  that
is what the guidance documents do.

Chairman MILLER. Okay. Thank you, Mr. Kovacs.
Ms. Katzen, under the new Executive Order, under the old Exec-
utive Order, OIRA was a gatekeeper, and now, the gatekeeper has
a gatekeeper, the public regulatory officers within each agency. All
of the openness requirements with respect to OIRA’s deliberations,
do  those  apply,  under  the  new  Executive  Order,  to  the  conduct  of
the public regulatory officer? What are the requirements for trans-
parency  at  the  agency  level  for  the  gatekeeper’s  gatekeeper,  the
public regulatory officers?

Ms.  KATZEN.  Those  are  not  addressed  in  the  Executive  Order.
Those  would  be  wholly  dependent  upon  the  agency’s  own  internal
rules for ex parte procedures, for disclosure, for rule-making, as the
case may be.

Chairman  MILLER.  Mr.  Vladeck,  rather  than  write  a  note  to  Ms.

Katzen, do you just want to answer yourself?

Mr.  VLADECK.  Well,  I  mean,  it  is  worse  than  that.  I  mean,  not
only  does  the  Executive  Order  not  apply,  but  the  D.C.  Circuit,  in
a case that I helped lose many years ago, it is called Wolfe v. HHS,
held  that  communications  between  officials  at  OMB  and  the  agen-
cies,  like  the  regulatory  officer,  are  presumptively  not  available
under FOIA.

So,  there  is  no—as  far  as  I  can  see,  there  is  no  mechanism  by
which  we  would  be  able  to  see  what  is  going  on  at  that  stage  of
the development process, which is a trouble.

Chairman MILLER. I think every Democratic Member of Congress
not  in  their  first  term  has  in  their  files  letters  from  agencies  ex-
plaining that FOIA does not reach pre-decisional discussions, inter-
nal  agency  documents,  which  presumably,  the  involvement  by  the
NPOs, or——

Ms. KATZEN. RPOs would be.
Chairman  MILLER.  RPOs,  would  fall  within  that  exception  to
FOIA. Mr. Kovacs, do you think the conduct of the regulatory pub-
lic officers, the RPOs, should be as transparent as the conduct, the
involvement of decision-making by OIRA?

Mr. KOVACS. If you are asking me would we support an exempt—
would we support removing that exemption from FOIA, it is likely.
But  we  would  again,  remove  it  for  the  entire  process.  Let  me  just
give  you  really  one  example.  For  years,  one  of  the  biggest  growth
industries  that  is  coming  to  the  United  States  is  nanotechnology.
They  expect  in  ten  years,  for  that  to  be  a  $1  trillion  plus  revenue
stream for the United States, a huge growth industry.

is  putting 

Well,  floating  around  EPA  are  some  pre-decisional  opinions  on
how EPA is going to regulate nanotech. Well, the business commu-
nity 
into
nanotechnology,  and  we  sent  a  FOIA  letter,  I  don’t  know,  six
months,  eight  months  ago,  and  we  can’t  even  get  a  little  postcard
from  them.  So,  it  is  a  frustration  that  we  all  share.  But  if  you  are
going  to  do  it,  rather  than,  you  know,  picking  on  the  Vice  Presi-
dent, or picking on one—open the process——

in  an  enormous  amount  of  money 

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00074 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

69

Chairman  MILLER.  Well,  looking  specifically  at  the  regulatory
public  officers,  who  are  now  going  to  play  an  important  role.  I
mean,  a  great  many  regulations  are  never  going  to  make  it  to
OIRA.  They  will  be  smothered  in  the  crib,  at  the  agency,  by  the
RPO, and all of the requirements for transparency for OIRA appear
not to apply to the RPOs.
Mr. KOVACS. Well——
Chairman  MILLER.  So,  if  the  agency  is  making  the  wrong  deci-
sion  for  the  wrong  reasons,  we  are  not  going  to  know  about  it.  If
OIRA  makes  the  wrong  decisions  for  the  wrong  reasons,  we  are
going to know about it. And now, a great many agents—of the reg-
ulations  that  the  professional  staff,  the  permanent  professional
staff,  the  experts,  the  scientists,  the  researchers  at  regulatory
agencies,  are  never  going  to  make  it  past  the  gatekeeper’s  gate-
keeper, and none of that will be public. Isn’t that right?

Mr.  KOVACS.  I  think  it  would  be  consistent,  to  directly  answer
your question. I think it would be consistent with the policies of the
Chamber that the entire—that that part of the entire agency proc-
ess,  as  to  how  a  rule  is  made,  should  be  made  public.  And  it
wouldn’t  start  just  with  the  rule,  it  would  start  with  the  informa-
tion  that  comes  in,  the  studies  that  they  rely  on,  the  risk  assess-
ments that they rely on. That entire process should be open.

And  the  political  officer,  the  regulatory  officer,  is  only—I  am
sorry—is only the last person in line. And what I would suggest to
you,  that  if  you  are  going  to  do  that,  is  that  you  start  with  what
you  know,  the  EPA  at  Research  Triangle  Park  does,  which  is  let
us look at the risk assessments. What is the basic information, and
what  we  would  say  is  rather  than  just  taking  one  spot  of  the
record,  take  the  entire  record,  because  then,  and  that  is  what  the
Information  Quality  Act  tried  to  do,  it  tried  to  say  rather  than
starting  at  the  end  of  the  rule-making  process,  which  we  are  all
fighting  about  today,  start  at  the  beginning.  So—because  if  the
agency uses the wrong information in the beginning, five years be-
fore  the  rule  starts,  Sally  says  ten,  you  know,  these  processes  can
take ten years. If you use the wrong information in the beginning,
you are going to use the wrong information in the end. So open up
the whole process.

TRANSPARENCY COSTS

Chairman  MILLER.  We  really  are  just  about  out  of  time,  and  I
apologize  to  Mr.  Rohrabacher,  probably  not  be  able  to  get  to  him
for a second round of questions.

Ms.  Katzen,  Mr.  Vladeck,  Dr.  Melberth,  do  you  think  the  same
transparency requirements that apply to OIRA should apply to the
internal  agency  deliberations,  of  the  role  of  the  RPO,  whether
through  changes  to  the  Executive  Order,  or  through  statutory
change?

Ms.  KATZEN.  I  am  not  going  to  answer  your  question  directly,

because——

Chairman MILLER. Okay.
Ms.  KATZEN.—I  spent  enough  years  at  OMB  to  know  that  noth-
ing is cost-free, and one of the points that Mr. Vladeck made, that
I  want  to  underscore,  is  that  the  agencies  have  not  only  been  re-
quired  to  do  more  analysis,  more  everything,  but  they  have  been

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00075 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

70

given  less  funds.  And  when  you  say  shouldn’t  things  be  trans-
parent,  even  that  is  not  cost-free.  Putting  up  a  website  and  main-
taining  it  takes  personnel,  takes  funds,  even  if  you  outsource  it,
you  have  got  to  have  a  contractor,  you  have  got  to  update  it  every
15 days, it takes people, it takes time, it takes talent, and we have
seen  in  the  last—when  I  was  at  OMB,  we  had  surpluses  as  far  as
the eye could see. Now, we don’t, and it is coming out of the agen-
cies’  budgets,  and  I  think  that  is  a  real  concern.  So,  I  can’t  truly
answer your question.

Chairman MILLER. Okay. Mr. Vladeck.
Mr. VLADECK. I would agree. I think that you have to make this

process transparent.

Chairman MILLER. Okay. Dr. Melberth. Melberth.
Mr. MELBERTH. I would also agree. That is something that OMB
Watch has called for in most of these instances. Make this informa-
tion public. It should be available. It should be accessible.

Chairman  MILLER.  Mr.  Rohrabacher,  do  you  want  to  have  one

valedictory question?

Mr.  ROHRABACHER.  Thank  you.  I  am  very  happy  that  when—
what  year  was  that,  when  you  were  saying  we  had  the  surpluses?
I——

Ms. KATZEN. 1999. The year.
Mr. ROHRABACHER. Yeah, I remember that. We Republicans were

in solid control at that time. You know, here in the House.

Ms. KATZEN. Here.
Mr. ROHRABACHER. Yes.
Ms. KATZEN. Not there.
Mr. ROHRABACHER. Right. There you go. Analyzing stuff. Let me
note  that,  years  ago,  it  was  a  consensus  on  global  cooling.  Now,  it
is  a  consensus  on  global  warming.  The  regulators  always—there
are  things  that—trends  that  could  be  true  or  not  true,  that  influ-
ence  these  benevolent  and  not  profit-seeking  regulators,  that  we
want to trust our lives to. One, for example, Mr. Chairman, a deci-
sion that was made years ago by people, I am sure, with very good
hearts,  wanting  to  protect  us  all,  put  severe  restrictions  on  DDT,
and now, we have tens of millions of people in Africa who have lost
their  lives  because  DDT  has  not  eliminated  the  mosquito  popu-
lation, which is plaguing them instead of us. There are unintended
consequences at times, and trendiness, that affects regulators.

I—Mr. Chairman, it doesn’t seem to me that we have a real con-
flict.  If  you  folks  are  advocating  more  scrutiny  and  openness,  and
focusing  on  this  end  of  the  process,  and  you  have  the  Chamber  of
Commerce  just  saying  that  it  should  be  transparent  all  the  way
through,  I  don’t  see  a  big  conflict  here,  and  I  have  learned—I  am
sorry  I  was  late.  I  will  read  your  testimony,  but  I  have  already
learned  quite  a  bit  just  from  what  you  have  said,  and  I  certainly
agree  with  the  idea  of  transparency  and  accountability.  That
doesn’t  seem  to  be  a  big  debate  here,  but  it  seems  a  matter  of
where you are putting your emphasis.

So, thank you very much.
Chairman MILLER. I want to thank everybody. An excellent panel
of witnesses, and I think some of you are now going to appear, this
has been a warm-up for your appearance before the Judiciary Com-

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00076 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

71

mittee, and I look forward, for the Subcommittee on Administrative
Law, that is looking at the same issue.

And  we  had  earlier  tried  to  have  a  joint  hearing,  but  were  not
able to pull off the logistics of that, but again, I appreciate your ap-
pearance,  and  your  very  thoughtful  responses  to  all  of  our  ques-
tions, and with that, our hearing is adjourned.

[Whereupon, at 2:00 p.m., the Subcommittee was adjourned.]

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00077 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00078 Fmt 6633 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

Appendix 1:

ANSWERS TO POST-HEARING QUESTIONS

(73)

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00079 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

74

ANSWERS TO POST-HEARING QUESTIONS

Responses by Sally Katzen, Adjunct Professor and Public Interest/Public Service Fel-

low, University of Michigan Law School

Questions submitted by Chairman Brad Miller
Q1. The testimony Mr. Aitken, Acting Director of OIRA, offered in a House Judiciary
Committee  hearing  repeatedly  asserts  that  the  new  executive  order  amending
E.O.  12866  simply  memorializes  current  practice  and,  in  particular,  practices
that began during your time at OMB. Do you wish to comment on the assertion
that  there  is  no  meaningful  change  in  policy  represented  by  the  provisions  in
E.O. 13422 relating to how regulatory proposals shall be prepared.

A1. If  there  were  no  meaningful  change  in  policy  represented  by  the  provisions  of
Executive Order 13422, then why did the Administration invoke the prestige of the
President and the authority of an executive order to achieve nothing? This President
has not issued many executive orders and it seems to be inconsistent with his man-
agement style to use an executive order for a non-event. Finally, the changes in Ex-
ecutive  Order  13422  do  not  reflect  policies  or  practices  of  the  Clinton  Administra-
tion.  Specifically,  the  Clinton  Administration  did  not  elevate  market  failures  to  a
priority status for justifying rule-making; it did not require aggregation of projected
costs and benefits at the pre-notice stage of rule-making; it did not require that reg-
ulatory policy officers be presidential appointees; it did not encourage the use of for-
mal  rule-making  for  resolution  of  issues;  and  it  did  not  use  OMB  review  for  guid-
ance documents which, by definition, do not have the force and effect of law.
Q2. Do  you  have  any  other  points  you  wish  to  make  for  the  record  regarding  E.O.

13422 and its likely application by the Bush Administration?

A2. Not at this time, thank you.

Questions submitted by Representative F. James Sensenbrenner, Jr.
Q1. Did  President  Clinton’s  E.O.  12866  require  agencies  to  conduct  Cost-Benefit
Analyses  for  proposed  regulations?  If  so,  what  harm  would  come  from  simply
requiring  them  to  report  the  aggregate  of  the  analyses  they  already  conducted?
Is this such a big step?

A1. President  Clinton’s  Executive  Order  required  agencies  to  conduct  cost/benefit
analyses, to the maximum extent feasible, when they were proposing or issuing final
rules.  Executive  Order  13422  requires  agencies  to  aggregate  costs  and  benefits  of
items listed in the Regulatory Agenda, which includes many items at the pre-notice
of  proposed  rule-making  stage,  when  the  agency  has  made  no  decisions  as  to  the
course it is likely to pursue.
Q2. A major criticism of the Market Failure criterion is that some believe it elevates
economic  concerns  above  those  of  public  health  and  safety,  and  that  this  con-
tradicts Congressional guidance. Is this true? If so, why don’t the following sec-
tions give agencies an ‘‘out’’ when they are presented with conflicting values?
Sec.  1,  end  of  last  sentence:  ‘‘unless  a  statute  requires  another  regulatory  ap-
proach.’’
Sec. 1(b), end of last sentence: ‘‘to the extent permitted by law and where applica-
ble.’’

A2. President  Clinton’s  Executive  Order  included  several  references  to  the  superi-
ority of applicable law to provisions of an executive order; those references were not
changed  by  the  provisions  of  Executive  Order  13422,  nor  could  they  be  given  that
wherever there is a conflict, duly enacted law would trump a provision in an execu-
tive  order.  The  agencies  therefore  have  ‘‘an  ‘out’ ’’  where  there  is  a  direct  conflict.
The problem that many foresee, however, is that the amendment elevating economic
concerns  increases  the  burden  on  the  agencies  to  either  demonstrate  that  the  law
reflects congressional intent with respect to the particular issue they are addressing
or  to  justify  its  proposal  on  economic  as  opposed  to  other,  possibly  more  important
or pertinent grounds.
Q3. One  of  the  reasons  agencies  have  increasingly  turned  to  guidance  documents  in
order  to  regulate  industry  is  that  they  do  not  require  public  notice,  public  com-
ment,  or  OMB  notice.  This  has  allowed  for  more  flexible  and  reactive  policies,
but has sacrificed transparency, organization, and accountability. Do you believe

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00080 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

75

the  recent  OMB  bulletin  proposes  a  reasonable  method  of  balancing  these  com-
peting principles?

A3. The  recent  OMB  bulletin  is  a  good  faith  attempt  to  balance  these  and  other
competing principles. The problem, however, is that in some instances and for some
agencies,  the  requirements  of  the  bulletin  will  have  the  effect  of  reducing  (possibly
greatly reducing) the issuance of guidance, which tells both the agency staff and the
regulated  entities  what  is  expected  of  them  under  existing  regulations.  Such  guid-
ance has the salutary effect of providing clarity to regulated entities and protecting
them  from  haphazard  enforcement  of  existing  regulations  by  agency  staff.  In  other
words, there are and will be costs associated with the new bulletin.
Q4. In  reference  to  the  Good  Guidance  Bulletin,  you  state  in  your  testimony  (page
9) that, ‘‘While each step can be justified as helping to produce better regulatory
decisions, the cumulative effect is overwhelming.’’ If you believe that the Bulletin
is  ‘‘justified  as  helping  to  produce  better  regulatory  decisions,’’  are  your  objec-
tions to the Bulletin related to policy or your view that OIRA has an insufficient
budget?

A4. The antecedent for ‘‘each step can be justified as helping to produce better regu-
latory  decisions. . .’’  is  the  various  bulletins,  circulars,  and  guidance  issued  by  the
Bush Administration over the last several years, discussed at pages 6–9 of my writ-
ten testimony. Each step (as in, each bulletin, circular or guidance), standing alone,
can  (as  in,  one  can  reasonably  argue)  be  justified.  ‘‘[T]he  cumulative  effect  is  over-
whelming’’ refers to the agencies, not OIRA, and the fact that agency budgets have
not kept up with the increasing demands made on the agencies by OIRA.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00081 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

76

ANSWERS TO POST-HEARING QUESTIONS

Responses  by  David  C.  Vladeck,  Director,  Institute  for  Public  Representation;  Asso-

ciate Professor of Law, Georgetown University Law Center

Questions submitted by Chairman Brad Miller
Q1. I  am  concerned  about  the  implications  for  the  public’s  right  to  know  embedded
in the changes to the Regulatory Policy Officers. As Presidential appointees with
the  power  to  ‘‘pre-approve’’  even  starting  a  regulatory  or  guidance  initiative,
what  might  this  mean  for  the  ability  of  the  public  and  public  interest  groups
to  know  what  has  happened  on  issues  dispensed  with  by  these  officers?  Might
this  be  an  indirect  way  of  by-passing  some  of  the  much-vaunted  transparency
that has so far marked the OMB E.O. 12866 process?

A1. This  question  was  raised  briefly  during  the  hearing,  and  my  answer  then,  as
it is now, is that the structure of the new Executive Order invites the circumvention
of the transparency provisions of the Executive Order 12866. As the Committee un-
derstands,  Executive  Order  12866,  § 6(b),  requires  OMB  to  place  on  the  record  its
exchanges with an agency during the course of a rule-making proceeding. It also re-
quires  OMB  to  put  on  the  public  record  meetings  between  OMB  and  non-govern-
mental  parties  relating  to  rule-makings.  To  be  sure,  the  openness  requirements  of
the  Executive  Order  apply  only  during  the  rule-making  process,  and  do  not  cover
interactions  between  OMB  and  agencies,  or  OMB  and  outsiders,  prior  to  the  agen-
cy’s  development  of  a  notice  of  proposed  rule-making.  But  once  the  rule-making
process begins, the Executive Order does require a fair degree of transparency.

Executive  Order  13422  undermines  the  openness  guarantee  of  Executive  Order
12866 in two important ways. First, OMB review of guidance documents is not sub-
ject to any of the transparency requirements of section 6 of Executive Order 12866,
which  applies  only  to  ‘‘regulatory  actions’’  for  ‘‘new  and  existing  regulations.’’  The
drafters of Executive Order 13422 understood this limitation, but made no effort to
expand  the  scope  of  section  6  to  cover  OMB  review  of  guidance  documents.  This
omission  was  not  inadvertent.  Instead,  the  omission  was  intended  to  permit  OMB
and  agencies  to  develop  guidance  documents—and  to  integrate  the  input  of  regu-
lated  industry—behind  closed  doors,  with  no  public  record  at  all.  Given  OMB’s  his-
tory of serving as a conduit for industry, which of course led to the Graham memo-
randum  and  the  addition  of  section  6(b)  to  the  Executive  Order,  Congress  ought  to
be wary of OMB’s deliberate effort to exercise control over the issue of guidance doc-
uments insulated from any transparency or openness requirement.

Second, Executive Order 13422 promotes secrecy because it ensures that the pre-
rule-making interchanges between OMB and the Policy Review Officers at the agen-
cies  will  be  off-the-record.  The  law  is  clear  that  dealings  between  OMB  and  agency
officials  that  precede  the  commencement  of  rule-making  are  not  subject  to  manda-
tory  disclosure  under  the  Freedom  of  Information  Act  (‘‘FOIA’’).  Courts  have  ruled
that  these  exchanges  are  ‘‘predecisional’’  and  ‘‘deliberative’’  in  character  and  thus
may be shielded from disclosure under Exemption 5 to FOIA. See Wolfe v. HHS, 839
F.2d 768 (D.C. Cir. 1988) (en banc). As a result, even under Executive Order 12866
pre-rule-making  consultations  between  OMB  and  agencies  were  not  subject  to  dis-
closure.  But  Executive  Order  13422  makes  a  bad  situation  worse.  Under  Executive
Order  12866,  the  Regulatory  Policy  Officers  were  agency  officials  selected  by  the
agency  head,  and  these  Officers  owed  their  loyalty  to  the  agency,  not  the  White
House. Thus, if OMB sought to force an agency to act in a way that was out of step
with  the  desires  of  the  agency  head,  the  agency  had  tools  to  object,  and  to  do  so
on the public record.

Executive Order 13422 reverses that presumption and puts a White House agent
in  charge  of  the  agency’s  regulatory  apparatus,  which  now  extends  not  just  to  the
agency’s regulatory output, but also to non-binding agency guidance. Thus, the abil-
ity  of  the  agency  to  resist  OMB  and  follow  the  course  the  agency  thinks  best  is  di-
minished,  if  not  destroyed.  After  all,  the  White  House  will  now  have  its  own  ap-
pointee  serving  as  the  gatekeeper  of  the  agency’s  machinery.  And,  to  make  matters
worse, all of these exchanges will take place off-the-record.

For  these  reasons,  the  answer  to  Chairman  Miller’s  question—can  OMB  kill  off
a regulatory or guidance initiative an agency wants to take, and do so in a way that
will  escape  public  oversight?—is  plainly  ‘‘yes’’  under  Executive  Order  13422.  And
make  no  mistake,  this  is  not  an  unintentional  consequence  of  inattentive  drafting.
This is precisely the power that OMB has long coveted.
Q2. The  new  E.O.  elevates  market  failure  as  the  preferred  standard  for  an  agency
to meet in explaining the rationale for a regulatory or guidance document. If you

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00082 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

77

have insights into how the President’s proposed director of OIRA, Susan Dudley,
might apply this standard, please share that with the Subcommittee.

A2. There is no need to speculate about how Ms. Dudley would apply the new ‘‘mar-
ket  failure’’  standard  in  the  Executive  Order  were  she  to  serve  as  the  director  or
acting  director  of  OIRA.  Ms.  Dudley  has  an  extensive  track  record  on  this  issue,
which I urge the Subcommittee to review.1 In summary, Ms. Dudley’s writings sug-
gest  that  she  believes  that  markets  almost  never  fail,  and  that  government  inter-
vention is rarely if ever appropriate. Just consider one example. Ms. Dudley was vir-
tually alone in opposing the advanced air bag rule-making just conducted by the Na-
tional Highway Traffic Safety Administration. She did so on the ground that govern-
ment  intervention  was  not  needed,  notwithstanding  the  deaths  of  and  injuries  to
children  and  women  of  short  stature  caused  by  first-generation  air  bags,  because
there  was  no  evidence  of  market  failure.  Ms.  Dudley  was  willing  to  disregard  the
deaths and injuries because she was confident—despite years of contrary evidence—
that, if left alone, the market would provide a range of safety options to consumers
and we ought to trust the market to give consumers adequate protection.2

Ms.  Dudley’s  blind  faith  in  the  markets,  and  her  hostility  to  government  regula-
tion,  would  make  her  an  odd  choice  to  head  OIRA.  If  Ms.  Dudley  saw  no  market
failure  with  regard  to  one-size-fits-all  air  bags,  would  she  have  let  the  Environ-
mental  Protection  Agency  phase  lead  out  of  gasoline,  the  Food  and  Drug  Adminis-
tration require that iron pills, the leading cause of poisonings in the United States,
be  sold  in  child-proof  containers,  or  the  Consumer  Product  Safety  Commission  out-
law the use of flammable material in children’s sleep-wear? The point of regulation
is to prevent market failure, not to pick up the pieces once the damage is done.
Q3. Do  you  have  any  other  points  you  wish  to  make  for  the  record  regarding  E.O.

13422?

A3. I  think  that  my  written  statement  to  the  Subcommittee  covered  the  important
points I want to make about the new Executive Order.

Questions submitted by Representative F. James Sensenbrenner, Jr.
Q1. Did President Clinton’s E.O. 12866 require agencies to conduct cost-benefit anal-
yses for proposed regulations? If so, what harm would come from simply requir-
ing them to report the aggregate of the analyses they already conducted? Is this
really a such a big step?

A1. With all respect, I do think that this is a big step. Let me explain why. To begin
with, the requirement that agencies prepare cost-benefit analyses for proposed regu-
lations was not an invention of President Clinton, but President Reagan, who insti-
tutionalized  this  requirement  in  Executive  Order  12291.  President  Clinton’s  Order
in  fact  modified  that  requirement  in  a  way  that  is  significant  in  answering  your
question; namely, it permitted, almost encouraged, agencies to cite non-quantifiable
costs  and  benefits  of  regulation  in  their  analyses.  As  I  have  previously  discussed,
agencies  generally  can  calculate  the  likely  costs  of  proposed  regulation  in  terms  of
dollars  and  cents.  But  benefits  are  often  far  more  difficult  to  quantify,  and  many
benefits  simply  cannot  be  quantified.  For  instance,  how  does  one  assign  a  dollar
value to each I.Q. point a child might lose as a result of lead exposure; to each day
a  family  will  have  to  endure  a  loved  one  on  kidney  dialysis,  caused  by  the  person’s
exposure to cadmium in the workplace; or damage to a wildlife preserve? Regulation
also avoids unwarranted distributional impacts, protects vulnerable sub-populations
(children,  the  elderly,  the  poor,  for  example),  averts  aesthetic  harms,  and  seeks  to
advance social justice. None of these benefits can be quantified, let alone monetized
in the manner the Executive Order contemplates.

To account for these difficulties, the Clinton Executive Order encourages agencies
to monetize those benefits that it can monetize, but it ‘‘recogniz[ed] that some costs
and  benefits  are  difficult  to  quantify’’  and  therefore  told  agencies  that  they  should
provide  a  ‘‘reasoned  determination  that  the  benefits  of  the  intended  regulation  jus-
tify its costs.’’ Executive Order 121866, § 1(b)(6).

The  problem  with  the  regulatory  accounting  provision  of  Executive  Order  13422,
§ 4(c)(1)(B),  is  that  it  wholly  ignores  this  important  lesson.  By  requiring  that  the
agency  report  its  ‘‘best  estimate  of  the  combined  aggregate  costs  and  benefits  of  all

1 Ms. Dudley’s writings have been extensively critiqued in a report by Public Citizen and OMB
Watch  entitled  The  Cost  is  Too  High:  How  Susan  Dudley  Threatens  Public  Health  Protections
(Sept. 2006) (http://citizen.org/publications/release.cfm?ID=7448&seeID=2565&catlD=126).

2 Susan  E.  Dudley,  Regulatory  Studies  Program  Comments:  Advanced  Air  Bars  7  (Dec.  17,

1998) (http://www.mercatus.org/publications/pubid.1180/pub¥detail.asp).

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00083 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

78

of  its  regulations  planned  for  that  calendar  year,’’  the  new  Executive  Order  puts
aside  all  of  the  non-quantifiable  benefits  that  flow  from  regulation  and  reduces  the
calculus  to  hard,  cold  dollars  and  nothing  more.  And  make  no  mistake,  this  report-
ing requirement will be used by OMB and others to seek limits on agency regulation
on  purely  economic  grounds,  notwithstanding  the  fact  that  regulatory  benefits  are
often not reducible to dollars and cents.
Q2. A major criticism of the market failure criterion is that some believe that it ele-
vates  economic  concerns  above  those  of  public  health  and  safety,  and  that  this
contradicts  Congressional  guidance.  Is  this  true?  If  so,  why  don’t  the  following
sections  give  agencies  an  ‘‘out’’  when  they  are  presented  with  conflicting  values?
Sec.  1,  end  of  last  sentence:  ‘‘unless  a  statute  requires  another  regulatory  ap-
proach.’’
Sec. 1(b), end of the last sentence: ‘‘to the extent permitted by law and where ap-
plicable.’’

A2. The short answer to this question is yes, the market failure criterion in Execu-
tive Order 13422 does indeed ‘‘elevate[] economic concerns above those of safety and
health’’ in a way that undermines Congress’ judgment, and no, the provisions of Sec-
tion  I  of  the  Order,  cited  in  the  question,  do  not  give  agencies  an  ‘‘out.’’  Let  me  ex-
plain the basis for my answer.

To  begin  with,  there  can  be  no  serious  question  that  the  new  Executive  Order
makes ‘‘market failure’’ the pivotal consideration in regulation. Indeed, it is difficult
to see how the drafters of the Order could have been clearer or more emphatic about
this point. As you know, the language in the new Executive Order marks a profound
departure  from  that  in  its  predecessor:  Section  1(b)  of  Executive  Order  12866  re-
quired  the  agency  to  ‘‘identify  the  problem  that  it  intends  to  address. . .as  well  as
the significance of that problem.’’ Executive Order 13422 deletes that language and
says  that  ‘‘[e]ach  agency  shall  identify  in  writing  the  specific  market  failure. . .or
other specific problem that it intends to address. . ..’’ That substitution plainly sig-
nals that, from now on, OMB will expect to see an economic analysis of market fail-
ure  as  a  precondition  to  regulation.  And  the  use  of  the  word  ‘‘shall,’’  the  language
of  command,  only  underscores  the  mandatory  nature  of  the  requirement.  The  only
‘‘out’’  will  be  a  convincing  economic  argument  from  the  agency  that  market  failure
is not at the root of the ‘‘other specific problem’’ the agency intends to address. The
problem here is that this is an ‘‘out’’ in name only, because OMB, and not the agen-
cy,  makes  the  final  decision  as  to  whether  the  agency  has  made  a  sufficient  case
for regulation.

Moreover,  it  is  hard  to  see  how  health  and  safety  agencies  will  be  able  to  point
to ‘‘other specific problem[s]’’ unrelated to market failure when they seek to impose
regulation.  Let’s  not  mince  words:  when  we  speak  of  health  and  safety  regulation,
‘‘market  failure’’  is  a  euphemistic  way  of  saying  that  people  have  been  killed  or  in-
jured because of dangerous products, exposure to toxic chemicals, or some other haz-
ard.  The  point  of  health  and  safety  regulation  is  to  prevent  these  deaths  and  inju-
ries,  not  wait  until  they  occur.  Suppose  an  agency  wants  to  impose  regulation  on
food  producers  to  reduce  the  risk  of  an  emerging  food-borne  illness.  Tens  of  thou-
sands  of  consumers  are  made  ill  by  food-borne  contamination  each  year,  but  it  is
rare that a consumer can link his or her illness to the consumption of a single food
product. Market forces thus place only a weak constraint on market behavior of food
producers.  But  with  regard  to  an  emerging  hazard,  there  is,  by  definition,  no  evi-
dence  of  ‘‘market  failure’’  because  the  needed  evidence  has  not  yet  developed.  How
is  that  agency  going  to  do  business  with  OMB?  The  agency  cannot  pretend  that  it
is  seeking  to  address  some  ‘‘other  specific  problem.’’  Nor  would  OMB  permit  it  to,
do so. The point here, of course, is that a regulatory system that properly functions
seeks to avoid market failure, yet the new Executive Order appears to require agen-
cies to wait until they can prove market failure—by pointing to needless deaths and
injuries—before moving ahead with regulation.

Nor  do  the  fragments  of  two  provisions  of  Section  1  of  Executive  Order  13422
cited in the question give the agencies an ‘‘out,’’ as the question suggests. Both pro-
visions go to the substance of agency regulations, which must be governed by statute
where  there  is  an  inconsistency  between  the  statute  and  the  Executive  Order.  Nei-
ther  provision  addresses  the  justification  an  agency  must  provide  to  OMB  in  order
to proceed with a rule-making, which is the point of the ‘‘market failure’’ super-man-
date imposed by Executive Order 13422. A review of the two provisions cited in the
question drives this point home.

The  question’s  first  reference  is  to  the  last  sentence  of  Section  1(a),  which  is
quoted  only  in  part.  In  full,  the  sentence  reads:  ‘‘Further,  in  choosing  among  alter-
native  regulatory  approaches,  agencies  should  select  those  approaches  that  maxi-

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00084 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

79

mize  net  benefits  (including  potential  economic,  environmental,  public  health  and
safety,  and  other  advantages;  distributional  impacts;  and  equity),  unless  a  statute
requires another approach.’’

Contrary  to  the  implication  in  the  question,  this  provision  has  no  bearing  on  the
justification  the  agency  must  provide  to  OMB  to  receive  OMB  clearance  to  publish
a  proposed  or  final  rule.  The  provision  addresses  an  altogether  different  question:
If  permitted  to  regulate,  what  regulatory  approaches  may  the  agency  pursue?  But
nothing  in  this  language  relieves  an  agency  of  its  obligation  under  the  Executive
Order  to  satisfy  OMB  that  it  may  regulate  in  the  first  instance.  One  illustration
should suffice. The Supreme Court has ruled that in promulgating standards to pro-
tect workers from exposure to toxic substances, the Occupational Safety and Health
Administration  (‘‘OSHA’’)  must  regulate  to  the  limits  of  technological  and  economic
feasibility.  American  Textile  Manufacturers  Assn  v.  Donovan,  452  U.S.  490  (1981).
That  standard  is  arguably  at  odds  with  the  ‘‘net  benefits’’  standard  articulated  in
Section  I  of  the  Executive  Order.  In  such  a  case,  OSHA  would  be  free  to  follow  its
statutory  mandate,  not  that  imposed  by  the  Executive  Order.  But  OSHA  would
nonetheless be bound to justify to OMB its decision to proceed with regulation, and
under  the  new  Executive  Order,  would  not  be  able  to  avoid  defending  its  decision
to  act  on  the  basis  of  market  failure.  There  would  be  no  other  bases  on  which  to
justify regulation, and thus this fragment of Section 1 does not provide agencies an
‘‘out,’’ as the question suggests.

Nor  does  the  language  at  the  end  of  Section  1(b)  provide  agencies  an  out.  That
language  reiterates  the  concern  set  forth  in  the  final  sentence  of  Section  1(b),  by
providing  that:  ‘‘To  ensure  that  the  agencies’  regulatory  programs  are  consistent
with  the  philosophy  set  forth  above,  agencies  should  adhere  to  the  following  prin-
ciples,  to  the  extent  permitted  by  law  and  where  applicable.’’  Once  again,  this  lan-
guage  is  a  directive,  mandated  by  settled  law,  that  an  Executive  Order  cannot
trump  a  statute.  For  that  reason,  the  Executive  Order  does  not  purport  to,  and
could not, direct an agency to ignore statutory directives when issuing a regulation.
But nothing in this language, or any other language in the Executive Order, relieves
the  agency’s  obligation  under  the  Executive  Order  to  explain  to  OMB  on  the  basis
of market failure why the agency is choosing to proceed with regulation.
Q3. One  of  the  reasons  agencies  have  increasingly  turned  to  guidance  documents  in
order  to  regulate  industry  is  that  they  do  not  require  public  notice,  public  com-
ment,  or  OMB  notice.  This  has  allowed  for  more  flexible  and  reactive  policies,
but has sacrificed transparency, organization, and accountability. Do you believe
the  recent  OMB  bulletin  proposes  a  reasonable  method  of  balancing  these  com-
peting principles?

A3. Before  addressing  the  OMB  Bulletin  on  guidance  documents,  it  is  necessary  to
emphasize that I do not agree with several of the explicit premises of the question.
First, I do not know whether it is true, as the question suggests, that ‘‘agencies have
increasingly  turned  to  guidance  documents.’’  Having  practiced  administrative  law
for  thirty  years,  I  think  that  agencies  have  always  used  guidance  documents,  and
have  done  so  precisely  because  they  can  be  issued  quickly  and  flexibly,  as  needs
arise. Second, I do not believe that agencies use guidance documents to avoid trans-
parency  and  accountability.  Unlike  enforcement  policies,  which  are  often  kept  from
public  view,  the  entire  point  of  guidance  documents  is  to  inform  the  public  of  the
agency’s  views,  and  agencies  are  held  accountable  for  the  guidance  they  give.  Woe
to  an  agency  that  brings  an  enforcement  action  and  seeks  to  distance  itself  from
guidance the agency gave; the agency does so only at its peril. Third, I disagree with
the question’s suggestion that agencies have ‘‘turned to guidance documents in order
to regulate industry.’’ Guidance documents do not have the force of law; they do not
‘‘regulate’’ in any meaningful sense of the word.

Having  said  all  of  this,  I  do  believe  that,  at  times,  agencies  issue  guidance  docu-
ments instead of embarking on notice and comment rule-making, not to avoid giving
OMB notice, but because OMB review has made the notice and comment rule-mak-
ing  process  too  time-consuming,  too  cumbersome,  and  too  expensive  to  justify  the
commitment of agency resources to the issuance of a rule. Nothing in the new Exec-
utive Order responds to these concerns.

As  to  OMB’s  recent  bulletin  on  guidance  documents;  I  think  that,  because  it  is
designed  to  carry  forward  the  mandates  of  the  new  Executive  Order,  it  is  deeply
flawed—for the reasons outlined in my testimony. Formalizing and making uniform
the  process  by  which  agencies  give  advice  is  a  tremendous  mistake  and  will  ham-
string  the  ability  of  agencies  to  provide  advice  to  regulated  parties  and  the  public
at large. Because the Executive Order the bulletin seeks to implement is flawed, so
too is the bulletin.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00085 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

80

ANSWERS TO POST-HEARING QUESTIONS

Responses by William L. Kovacs, Vice President, Environment, Technology, and Reg-

ulatory Affairs, U.S. Chamber of Commerce

Questions submitted by Representative F. James Sensenbrenner, Jr.
Q1. Did President Clinton’s E.O. 12866 require agencies to conduct cost-benefit anal-
yses for proposed regulations? If so, what harm would come from simply requir-
ing them to report the aggregate of the analyses they already conducted? Is this
really such a big step?

A1. Yes,  President  Clinton’s  E.O.  12866  already  requires  agencies  to  conduct  cost-
benefit  analyses  for  proposed  regulations  that  will  have  a  significant  impact  on  the
economy.  E.O.  12866  requires  every  federal  agency  to  determine  whether  a  regu-
latory action is ‘‘significant’’ and therefore subject to review by the Office of Manage-
ment  and  Budget  (OMB)  and  the  analytical  requirements  of  the  executive  order.  A
‘‘significant’’ regulatory action is defined as one that is likely to result in an annual
impact on the economy of $100 million or more.

Since  federal  agencies  are  already  required  to  conduct  a  cost-benefit  analysis  for
each proposed significant new regulation, it is not a big step for them to simply add
up  the  aggregate  cost  impact  of  all  new  regulations  for  a  given  year.  As  I  stated
in my original written testimony, rules do not operate in a vacuum. For an accu-
rate  assessment  of  a  rule’s  actual  cost  impact,  it  must  be  considered  in  conjunction
with  other  rules.  In  the  interest  of  transparency  and  full  disclosure,  the  public
should  be  made  aware  of  the  aggregate  costs  associated  with  an  agency’s  annual
rule-makings.
Q2. A  major  criticism  of  the  market  failure  criterion  is  that  some  believe  it  elevates
economic  concerns  above  those  of  public  health  and  safety,  and  that  this  con-
tradicts Congressional guidance. Is this true? If so, why don’t the following sec-
tions give agencies an ‘‘out’’ when they are presented with conflicting values?
a. Section  1,  end  of  last  sentence:  ‘‘unless  a  statute  requires  another  regulatory

approach,’’ or

b. Section  1(b),  end  of  last  sentence:  ‘‘to  the  extent  permitted  by  law  and  where

applicable.’’

A2. Ironically,  the  ‘‘market  failure’’  criterion,  which  has  been  so  derided  by  critics
of  the  new  executive  order,  was  first  detailed  in  the  Clinton  Administration’s  1996
guidelines  for  economic  analysis  under  Executive  Order  12866.1 Those  guidelines
specifically  noted  that  market  failures,  externalities,  natural  monopolies,  market
power,  and  asymmetric  information  are  all  essential  components  of  any  economic
analysis. As a result, it was the Clinton Administration that emphasized the impor-
tance of economic analysis in rule-making.

What  President  Bush’s  executive  order  did  was  actually  broaden  the  scope  of  the
Clinton guidelines to allow for an agency to state additional justifications for a rule-
making. In that way, the market failure criterion would not be elevated above public
health and safety concerns. In 2003, the Bush Administration clearly delineated the
additional  justifications  beyond  market  failure—which  included  the  protection  of
civil  rights,  privacy,  personal  freedom,  and  other  concerns.2 More  importantly—as
Rep.  Sensenbrenner  notes  in  his  question—the  last  phrase  in  Section  1  and  1(b)  of
the  executive  order  clearly  provide  agencies  with  choices  when  they  are  presented
with conflicting values.

It  is  only  logical  that  federal  agencies  should  be  required  to  identify  a  problem
that justifies a regulation before proceeding with a rule-making—whether that prob-
lem  is  a  market  failure  or  something  else.  In  this  way,  we  can  be  assured  that  a
comprehensive  and  thorough  analysis  of  all  potential  impacts  of  a  rule-making  has
been conducted.
Q3. One  of  the  reasons  agencies  have  increasing  turned  to  guidance  documents  in
order  to  regulate  industry  is  that  they  do  not  require  public  notice,  public  com-
ment,  or  OMB  notice.  This  has  allowed  for  more  flexible  and  reactive  policies,
but has sacrificed transparency, organization, and accountability. Do you believe
the  recent  OMB  bulletin  proposes  a  reasonable  method  of  balancing  these  com-
peting principles?

1 OMB,  ‘‘Economic  Analysis  of  Federal  Regulations  Under  Executive  Order  12866’’  (Jan.  11,

1996).

2 See OMB Circular A–4, at p. 4–6.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00086 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

81

A3. Yes.  The  OMB  Bulletin  on  Good  Guidance  Practices  (GGP)  does  not  prohibit
agencies  from  issuing  guidance  documents.  Agencies  can,  and  should,  continue  to
utilize guidance documents to provide the public with information on how to comply
with  a  particular  rule  or  regulation.  Rather,  the  GGP  establishes  uniform  policies
and  procedures  for  the  development,  issuance  and  use  of  significant  guidance  docu-
ments.

The  purpose  of  the  GGP  is  to  ensure  that  guidance  documents  of  Executive
Branch departments and agencies are developed with appropriate review and public
participation.  It  requires  that  guidance  documents  be  accessible  and  transparent  to
the  public,  and  not  improperly  treated  as  legally  binding.  GGP  does  this  by  requir-
ing that each guidance document contain certain standard elements, such as identi-
fying the document as guidance, the name of the issuing office, the activity and per-
sons  to  whom  it  applies,  the  date  of  issuance,  and  the  title  and  docket  number.
Surely  such  requirements,  which  will  vastly  improve  transparency  and  account-
ability in an agency’s regulatory activities, are not overly oppressive.

Perhaps  the  most  important  new  GGP  requirement,  however,  is  that  agencies
avoid  ‘‘mandatory’’  language  in  guidance  documents.  By  law,  guidance  documents
are  advisory  only;  that  is,  they  do  not  have  legally  binding  effect.  Yet  they  have
practical  binding  effect  when  the  agencies  use  them  to  establish  criteria  that  affect
the rights and obligations of private persons. By eliminating mandatory language—
words  such  as  ‘‘must’’  and  ‘‘shall’’—the  growing  problem  of  ‘‘regulation  by  guidance
document’’ will finally be addressed.

The  GGP  also  establishes  public  access  and  feedback  procedure.  Agencies  are  re-
quired  to  maintain  a  current  list  of  significant  guidance  documents  on  their  web
sites  and  to  provide  a  means  for  the  public  to  electronically  submit  comments.  The
Chamber  supports,  and  has  always  supported,  efforts  to  improve  the  operation  of
government by improving the opportunity for the public to participate in the policy-
making  process.  Such  participation  allows  the  public  to  have  a  voice  in  the  making
of  the  laws  that  regulate  them,  and  protects  them  from  arbitrary  decisions  by  fed-
eral agencies.
Q4. Does E.O. 13422 (or the Good Guidance Bulletin for that matter require any new
analysis  to  be  conducted,  or  does  it  simply  require  agencies  to  report  the  work
they  have  already  done?  Do  you  believe  that  reporting  this  work  could  lead  to
‘‘paralysis by analysis?’’

A4. President  Bush’s  E.O.  13422  does  not  require  any  new  analysis  by  an  agency.
What it does require is for an agency to have a reason for creating a new regulation.
It  simply  asks  an  agency  to  state  the  reason  for  the  rule,  and  estimate  how  much
it will cost, particularly in connection with other rules issued that year by the agen-
cy.  Presumably,  these  are  things  the  agency  can  readily  supply,  and  therefore  are
not new and onerous requirements.

Moreover,  the  argument  that  E.O.  13422  (and  GGP)  will  lead  to  ‘‘paralysis  by
analysis’’ is specious. Similar arguments were made regarding the Data Quality Act
(DQA)—namely,  critics  argued  that  it  would  ‘‘shut  down’’  the  regulatory  process  by
forcing  agencies  to  respond  to  public  claims  of  disseminating  faulty  information.  In
reality, very few DQA petitions were filed with federal agencies. For example, in FY
2006,  only  22  DQA  petitions  were  filed  with  government  agencies,  and  only  six  ap-
peals.

Clearly,  the  critics  were  wrong  about  the  DQA,  and  they  are  almost  certainly
wrong  about  E.O.  13422.  The  President’s  actions  will  serve  to  bring  transparency
and  accountability  to  an  opaque  and  complex  process.  This  effort  should  be  lauded.
Q5. OMB  has  stated  that  they  don’t  know  exactly  who  currently  holds  the  position
of  Regulatory  Policy  Officer  at  every  agency.  Do  you  think  the  decision  to  have
those  duties  executed  by  a  Presidential  Appointee  is  a  responsible  way  to  better
organize this process and bring about more transparency and accountability?

A5. The fact that OMB—which is responsible for overseeing the management of the
executive  branch  agencies—cannot  identify  an  agency’s  regulatory  policy  person
speaks volumes regarding the current state of the regulatory process.

By  appointing  a  Regulatory  Policy  Officer,  the  President  effectively  creates  a  sin-
gle point-of-contact for all regulatory issues within an agency. This appointment will
bring  organization,  transparency,  and  accountability  to  policy-making  in  general,
and it will further improve the President’s ability to manage the executive agencies
in  his  Administration.  The  Regulatory  Policy  Officer  also  brings  accountability  to
the agency by ensuring that the President’s executive order is implemented.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00087 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

82

Questions submitted by Representative Brian Baird
Q1. ‘‘From  what  you  have  just  said,  the  Chamber  of  Commerce  is  very  interested  in
transparency.  Was  it  the  Chamber’s  official  position  back  then,  and  is  it  now,
that the Vice President of the United States should share information about who
consulted  with  him  on  energy  policy?  . . .For  the  record,  then,  I  would  just  re-
quest  that  you  would  report  back  to  this  committee  on. . .to  please  send  us  a
letter,  which  we  will  convey  to  the  Vice  President,  asking  him,  on  behalf  of  the
Chamber  of  Commerce,  to  share  the  names  of  the  people  who  helped  draft  his
energy policy.’’—Hearing transcript, page 49–50.

A1. Because Rep. Baird’s question is about transparency in government, let me first
directly  state  the  Chamber’s  current  and  historical  position  on  this  issue,  and  then
I will apply the Chamber policy to Rep. Baird’s question.
(1) Chamber Policy

The  Chamber’s  long  held  position  was  proposed,  voted  on  and  approved  by  our

Board of Directors, and codified into official policy:

A  free  flow  of  information  from  and  concerning  all  branches  of  government  at
all  levels  is  a  right  of  the  public  and  is  essential  to  our  democratic  society. . ..
It  is  the  responsibility  of  government  to  protect  and  preserve  this  constitutional
guarantee by a policy of full disclosure of information. Except for matters clearly
affecting national security or otherwise covered by statute, all business of govern-
ment should be fully disclosed to the public. The burden of proof must rest with
government  in  every  instance  to  justify  withholding  any  information  from  the
public.

Policy Declarations, U.S. Chamber of Commerce

As  our  policy  declaration  makes  clear,  the  Chamber  is  one  of  the  strongest  pro-
ponents  of  an  open  and  accessible  Federal  Government.  This  is  evidenced  not  just
in our policy statements, but also in our public activities. Consider, for example, our
continuing  support  of  the  Administration’s  Electronic  Government,  or  ‘‘E-Gov,’’  Ini-
tiative, which is an effort to make information more accessible to the public through
advanced  technology  and  the  Internet.  Or  consider  the  Chamber’s  unfettered  sup-
port  for  government  ‘‘sunshine’’  laws,  improved  Freedom  of  Information  Act  legisla-
tion, the federal financial grants and contracts online database, Data Access and the
Data Quality Act —all of which promote transparency in government operations.

Similarly,  the  Chamber  has  always  supported  an  open  regulatory  system  that
would  allow  the  public  access  to,  and  a  voice  in,  the  federal  rule-making  process.
That  is  why  the  Chamber  testified  at  the  February  13,  2007,  hearing  in  support  of
Executive  Order  13422,  and  the  Final  Bulletin  on  Agency  Good  Guidance  Prac-
tices—because  these  documents  broaden  public  input  into  and  increase  responsible
management of the current regulatory system.

The purpose of the Subcommittee hearing was ostensibly to discuss the scope and
impact  of  the  Administration’s  Executive  Order  13422,  which  modifies  Executive
Order  12866,  and  specifically  whether  it  constitutes  an  impermissible  expansion  of
executive  authority  over  federal  agencies.  As  stated  in  my  oral  testimony,  E.O.
13422 is not only permissible, but also a necessary tool for the President to manage
his agencies and the regulatory process.

Executive  Order  13422  was  issued  by  President  Bush  for  two  reasons.  First,  it
was intended to prevent federal agencies from circumventing the rule-making proc-
ess by using guidance documents to regulate the public. Guidance documents do not
have to undergo the same rigorous analytical requirements of the rule-making proc-
ess  as  proposed  regulations,  so  agencies  tend  to  couch  regulatory  language  in  guid-
ance  documents  as  a  way  to  compel  public  compliance.  Executive  Order  13422  cor-
rects that abuse by including guidance documents within the scope of the analytical
requirements  of  Executive  Order  12866.  Second,  and  perhaps  more  importantly,  it
is  an  attempt  by  the  President  to  manage  his  executive  agencies.  It  does  this  in
three  ways:  (1)  by  ensuring  agencies  state  why  a  rule  is  needed,  (2)  by  ensuring
agencies give an accurate accounting of costs and benefits of an individual rule and
the aggregate costs and benefits of all rules issued by the agency that year, and (3)
by creating a Regulatory Policy Officer (RPO) within each agency to ensure that the
executive order is implemented by the agency. The RPO is a political appointee, re-
sponsible to the President, who must coordinate with OMB.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00088 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

83

In their testimony before the subcommittee, each of the other three witnesses3 de-
cried  the  creation  of  the  RPO,  claiming  that  it  ‘‘politicized’’  the  regulatory  process
by  allowing  a  political  appointee—who  reports  to  the  President  and  not  Congress—
control over an agency’s regulatory output. Because of this fact, the other witnesses
believed that the activities of the RPO are intended to be opaque and shielded from
public  scrutiny.  In  other  words,  they  feared  that  the  activities  of  the  RPO  will  not
be subject to the same transparency and accountability as, say, an agency adminis-
trator, who is confirmed by, and reports to, Congress.

When asked directly about the accountability and transparency of the RPO by the
Members of the Subcommittee, I stated that, first and foremost, the RPO was most
certainly going to be held accountable—to the Chief Executive. Much like the agency
administrator,  the  RPO  serves  at  the  pleasure  of  the  President  and  is  ultimately
responsible  to  him.  Second,  I  stated  that  the  Chamber  favored  extending  trans-
parency,  not  just  to  regulations,  guidance  documents,  and  the  RPO,  but  also  to  the
entire  regulatory  process.  That  is,  the  Chamber  would  like  to  see  all  the  reports,
studies,  white  papers,  third-party  analyses,  documents,  and  data  that  form  the  un-
derlying  basis  of  an  agency’s  regulatory  decision-making  to  be  made  available  for
public scrutiny and subject to open peer review. No other witness took such a posi-
tion on transparency.

It  is  only  through  an  open  peer  review  of  such  underlying  technical  documents

and analyses that we can ensure that:

• The public remains fully informed of the rules that regulate them;
• Documents  forming  the  basis  of  a  rule  will  be  improved  through  critical  re-

• Final regulations will be narrowly tailored to address a specific harm; and
• The  public  will  have  had  the  opportunity  to  participate  at  every  step  in  the

view;

process.

(2) Application of the Chamber’s Policy to Rep. Baird’s Question

Following  my  statement  of  ‘‘total  transparency,’’  Representative  Baird  suggested
that  the  Chamber’s  support  of  transparency  was  actually  ‘‘selective.’’  That  is,  the
Chamber  claims  to  want  transparency  in  government,  but,  in  fact,  doesn’t  want  it
extended to the activities of the Executive Office. By way of example, Representative
Baird  cited  the  controversy  surrounding  Vice  President  Cheney’s  National  Energy
Policy  Development  Group  (NEPDG),  and  whether  the  identification  of  the  partici-
pants and substance of the preliminary meetings should be made publicly available.
‘‘If  [transparency]  is  what  you  believe,  apply  it  equitably  across  the  Executive
Branch,’’ Representative Baird stated at the hearing.

Transparency is what the Chamber espouses, and favors its application across all
three  branches  of  government.  Yet,  as  even  Representative  Baird  must  agree,  the
doctrine  of  open  government  must  take  a  back  seat  to  national  security  concerns,
the laws enacted by Congress, and the U.S. Constitution. That is why official Cham-
ber  policy  specifically  states  that  we  favor  full  disclosure  of  information  in  all  mat-
ters of government except for matters clearly affecting national security or otherwise
covered  by  statute.  In  other  words,  if  there  are,  for  example,  national  security  rea-
sons  (terrorist  threats),  constitutional  reasons  (separation  of  powers),  or  legal  rea-
sons  (statutes  or  court  decisions)  for  restricting  transparency,  then  these  reasons
must be respected.

In the case of Vice President Cheney’s energy task force, the question of whether
the  identification  of  the  participants  and  substance  of  the  preliminary  meetings
should  be  made  public  is  governed  both  by  separation  of  power  concerns,  and  more
directly,  by  statute—namely  the  Federal  Advisory  Committee  Act  (FACA).4 Under
FACA,  the  work  of  executive  advisory  groups  that  include  non-federal  employees
must  be  publicly  disclosed.  Yet  the  Administration  has  affirmatively  stated  that
NEPDG  was  composed  of  all  federal  employees,  and  therefore  exempt  from  FACA.
If,  in  fact,  any  non-governmental  employees  subsequently  are  determined  to  have
been present at some of the NEPDG meetings, this would not mean that the FACA
exemption  is  lost.  The  non-governmental  employees  would  still  have  to  be  deemed
de  facto  members  of  the  advisory  group  in  order  for  disclosure  to  occur,  as  was  the
case  with  the  health  care  task  force  headed  by  former  First  Lady  Hillary  Rodham

3 Sally  Katzen,  David  C.  Vladeck,  and  Rick  Melberth.  Witnesses’  written  testimony  is  acces-

sible at: http://science.house.gov/publications/hearings¥markups¥detai1s.aspx?NewsID=1269

4 5 U.S.C.S. Appendix Sec. 1, et seq.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00089 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

84

Clinton.5 If  the  courts  ultimately  determine  that  this  was  also  the  case  with  the
NEPDG, then the law would require public disclosure.

The  Chamber’s  policy  will  continue  to  reflect  a  respect  for  the  laws  of  this  na-
tion—as  passed  by  Congress—including  FACA.  If  the  language,  application,  or  im-
pact  of  a  particular  law  is  not  to  the  liking  of  Congress,  then  it  is  certainly  within
the  power  of  Congress  to  change  that  law.  Until  then,  our  policy  will  remain  un-
changed.
Conclusion

I hope this helps to clarify the Chamber’s position on both E.O. 13422, and trans-
parency  in  government.  As  I  have  tried  to  make  clear,  the  Chamber  strongly  sup-
ports the President’s effort to manage the regulatory process, and further advocates
opening the entire regulatory process to public scrutiny—from the underlying docu-
ments  and  discussions  that  form  the  basis  of  regulations,  to  the  final  regulations
themselves. It is only through complete transparency and open peer review that we
can ensure that regulations and guidance documents are sound, balanced, cost-effec-
tive, and ultimately fair.

The Chamber is grateful for the opportunity to present its views about this impor-

tant topic.

5 Association of American Physicians v. Clinton, 302 U.S. App. D.C. 208, 997 F.2d 898 (CADC
1993).  Court  held  that,  although  non-government  employees  had  not  been  officially  named  to
the  committee,  they  had  become  so  involved  in  the  task  force’s  activities  that  they  were  ‘‘func-
tionally indistinguishable’’ from the designated members.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00090 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

85

Responses by Rick Melberth, Director of Regulatory Policy, OMB Watch

ANSWERS TO POST-HEARING QUESTIONS

Questions submitted by Chairman Brad Miller
Q1. I  am  concerned  about  the  implications  for  the  public’s  right  to  know  embedded
in the changes to the Regulatory Policy Officers. As Presidential appointees with
the  power  to  ‘‘pre-approve’’  even  starting  a  regulatory  or  guidance  initiative,
what  might  this  mean  for  the  ability  of  the  public  and  public  interest  groups
to  know  what  has  happened  on  issues  dispensed  with  by  these  officers?  Might
this  be  an  indirect  way  of  by-passing  some  of  the  much-vaunted  transparency
that has so far marked the OMB E.O. 12866 process?

A1. The  public’s  right  to  know  what  happens  to  regulatory  issues  is  already  se-
verely limited in the pre-rule-making process under E.O. 12866. OIRA’s involvement
as  the  gatekeeper  in  the  process  means  that  agencies’  submissions  to  OIRA—the
first public notice of agencies’ proposed actions—are already substantially impacted
by OIRA’s pre-rule-making negotiations as a 2003 GAO report described.1 Proposed
regulations, however, are at least initiated in the agencies with the expertise to rec-
ognize  that  a  problem  may  require  regulatory  action.  The  process  can  begin,  data
may  be  collected,  analyses  conducted,  and  some  determination  may  be  made  of  the
problem to be addressed. Although OIRA’s influence is substantial, the final political
decisions  within  agencies  about  moving  forward  with  regulations  are  made  by  the
agency heads.

The  installation  of  Presidential  appointees  at  the  agency  level  concentrates
OIRA’s authority at the expense of agency personnel. It shifts the decision to initiate
regulations and guidance to someone less familiar with the scope of the problem and
adds political considerations that should only occur at the highest levels of the agen-
cies. These appointees can stop regulations from ever being considered.

We  believe  the  most  damaging  aspect  of  this  political  influence  within  agencies
is that the public will never know what issues were dispensed with inside the agen-
cies.  The  pre-rule-making  stage  becomes  even  more  remote  from  the  public.  While
we  strongly  disagree  with  this  change  in  the  Regulatory  Policy  Officer’s  responsi-
bility,  if  it  is  implemented,  then  the  larger  question  is  the  near  total  lack  of  trans-
parency  and  disclosure  during  the  pre-rule-making  stage.  The  public  can  never
know what alternatives were dismissed or what remedies were forced onto agencies
by political calculations. This process is highly undemocratic and secretive.
Q2. The  new  E.O.  elevates  market  failure  as  the  preferred  standard  for  an  agency
to meet in explaining the rationale for a regulatory or guidance document. If you
have an insight into how the President’s proposed director of OIRA, Susan Dud-
ley, might apply this standard, please share that with the Subcommittee.

A2. In  September  2006,  after  President  Bush  nominated  her  to  be  OIRA  adminis-
trator,  OMB  Watch  and  Public  Citizen  issued  an  analysis  of  Susan  Dudley’s
writings and comments.2 In that report we conclude:

Dudley  believes  that  an  agency  must  do  more  than  prove  that  a  regulation’s
benefits outweigh its costs. Dudley has stated that ‘‘[e]ven policies supported by
the best benefit-cost analysis are not likely to be socially optimal substitutes for
market  forces  unless  they  correct  a  market  failure.’’  With  her  skepticism  about
whether  regulation  can  serve  any  goal  other  than  correcting  a  market  failure
(which, as she has defined it, would be an impossibility), Dudley would bog the
agencies  down  in  endless  analysis,  stalling  regulations  and  leaving  the  public
at risk.

We believe there are three reasons why Dudley would be a threat to public protec-
tions if she were the administrator of OIRA. First, she has an ideological opposition
to  regulations  which  leads  her  to  use  policy  tools  in  biased  ways.  In  her  writings
she  shifts  and  sometimes  uses  contradictory  reasoning  to  conclude  that  regulations
are  not  justified.  From  her  record,  one  can  only  conclude  that  she  would  demand
impossible requirements agencies could not meet.

Second, the elevation of additional economic analyses such as market failure, sen-
ior death discounts, and a free-market-first approach under Dudley’s direction could

1 General Accounting Office, RULE-MAKING: OMB’s Role in Reviews of Agencies’ Draft Rules
and  the  Transparency  of  Those  Reviews,  September  2003.  Available  at  www.gao.gov/cgi-bin/
getrpt?GAO-03-929.

2 The  full  report,  The  Cost  Is  Too  High:  How  Susan  Dudley  Threatens  Public  Protections,  can

be read online or downloaded at http://www.ombwatch.org/regs/2006/dudleyreport.pdf.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00091 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

86

result in substituting these economic considerations for non-economic ones. Even in
policy  areas  where  other  considerations  are  mandated  as  primary  considerations,
such  as  regulations  promulgated  by  OSHA  in  which  costs  are  not  placed  above
worker  safety,  we  believe  Dudley’s  reliance  on  economics  would  be  determinative.
Dudley  also  is  a  strong  advocate  for  regulatory  sunsets  which  would  severely
weaken  public  protections.  She  supports  the  position  that  agencies  should  justify  a
second,  and  third,  and  fourth  time  the  need  for  critical  regulations  as  they  expire
under  sunset  provisions.  Given  how  ossified  the  regulatory  process  already  is,  this
position leads to a de facto roll back of regulations already implemented.

Third, we oppose her nomination because of her very close ties to corporate inter-
ests which have worked strenuously to delay, diminish and defeat health, safety, en-
vironmental  and  civil  rights  protections.  The  regulatory  process  is  already  heavily
tilted toward special interests. We believe Dudley would further tilt the playing field
toward the interests that have supported her work.

In light of this record, we believe Dudley would apply market failure analyses and

other provisions of the amended E.O. to delay if not to stop public protections.
Q3. Do  you  have  any  other  points  you  wish  to  make  for  the  record  regarding  E.O.

13422?

A3. OMB  Watch  has  just  completed  a  final  analysis3 of  the  potential  impacts  of
E.O.  13422  and  OMB’s  Final  Bulletin  for  Agency  Good  Guidance  Practices.  In  its
conclusion, we argue that these regulatory process changes further concentrate con-
trol  in  the  White  House,  especially  in  OIRA,  at  the  expense  of  both  the  separation
of  powers  and  agency  discretion.  OIRA  will  be  able  to  further  delay  the  issuance
of regulations and guidance documents. These delays will have real impacts on peo-
ple’s lives. And submitting guidance documents to OIRA review will hurt regulated
entities which rely on agency guidance to conduct daily activities.

E.O.  13422  and  the  good  guidance  bulletin  move  the  regulatory  process  in  the
wrong  direction  and  this  will  have  real  consequences  for  our  nation’s  public  safe-
guards. Our government should be doing more to protect the public, not less.

Questions submitted by Representative F. James Sensenbrenner, Jr.
Q1. Did President Clinton’s E.O. 12866 require agencies to conduct cost-benefit anal-
yses for proposed regulations? If so, what harm would come from simply requir-
ing them to report the aggregate of the analyses they already conducted? Is this
really such a big step?

A1. E.O. 12866 requires agencies to conduct cost-benefit analyses of proposed regu-
lations.  These  are  individual  analyses  conducted  for  a  very  wide  range  of  types  of
regulations  even  for  those  within  one  specific  agency  like  the  Department  of  Agri-
culture  or  the  Department  of  Labor.  The  harm  that  comes  from  aggregating  costs
and  benefits  from  such  diverse  analyses  is  in  how  those  aggregate  numbers  are
used.

Congress  requires  OMB  to  report  these  aggregated  cost  and  benefit  totals  in  its
annual  Report  to  Congress  on  the  Costs  and  Benefits  of  Federal  Regulations.  The
2007 Draft report just issued March 12th states: ‘‘OMB has chosen a ten-year period
for  aggregation  because  pre-regulation  estimates  prepared  for  rules  adopted  more
than  ten  years  ago  are  of  questionable  relevance  today.’’  But  why  use  ten  years?
Why not five or fifteen? The logic regarding the questionable relevance of pre-regu-
lation  estimates  is  as  valid  for  regulations  conducted  at  any  time.  The  aggregated
numbers have little basis in reality.

U.S.  businesses  excel  at  adapting  to  changing  business  conditions;  they  adapt
technologically,  they  adapt  by  learning  from  experience.  Thus  the  pre-regulation
cost  estimates  provided  by  businesses  for  use  in  cost-benefit  analyses  are  hypo-
thetical,  and  possibly  biased.  A  more  reasonable  approach  would  be  to  perform  ex
post studies of costs and benefits (to the extent that either can be quantified). These
ex post numbers are relatively useless in the aggregate.

The best arguments against aggregating costs and benefits are provided in OMB’s
first annual report in 1997, Report to Congress on the Costs and Benefits of Federal
Regulations.4

3 OMB  Watch,  A  Failure  to  Govern:  Bush’s  Attack  on  the  Regulatory  Process,  March  2007.

Available at http://www.ombwatch.org/regs/PDFs/FailuretoGovern.pdf

4 Office  of  Management  and  Budget,  Report  to  Congress  on  the  Costs  and  Benefits  of  Federal
Regulations.  September  30,  1997.  Available  at  http://www.whitehouse.gov/omb/inforeg/
rcongress.html

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00092 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

87

Third,  it  is  important  to  ask:  What  public  policy  purposes  do  aggregate  esti-
mates serve if the ultimate goal is to develop the information necessary to make
decisions about specific regulatory programs or program elements? And, in par-
ticular:  In  what  ways  can  these  estimates  help  support  the  recommendations
to  reform  the  regulatory  system  required  of  the  Director  by  Section  645  (a)(4)?
Clearly,  knowing  the  costs  and  benefits  of  individual  proposals  for  regulatory
actions  and  their  alternatives,  including  the  alternative  of  no  action,  enables
policy  officials  to  make  decisions  that  improve  society’s  well  being.  But  for  rea-
sons  discussed  below,  knowing  the  total  costs  and  total  benefits  of  all  of  the
many and diverse regulations that the Federal Government has issued provides
little specific guidance for decisions on reforming regulatory programs. [Chapter
II, Overview]

The  report  goes  on  to  argue  that  ‘‘it  is  extremely  difficult,  if  not  impossible,  to
estimate  the  actual  total  costs  and  benefits  of  all  existing  federal  regulations  with
any  degree  of  precision’’  because  of  two  primary  problems.  First,  is  the  problem  of
what baseline to use in order to make these aggregate numbers meaningful. ‘‘Could
a civil society even exist without regulation? In other words, what do we use as the
baseline for world without any regulation?’’

OMB  provides  a  number  of  problems  with  trying  to  identify  a  baseline  for  mean-
ingful  comparison.  Problems  include  the  ex  ante  vs.  ex  post  issue  raised  above,  the
dynamic  quality  of  the  economy,  and  the  dangers  of  attributing  changing  behavior
to  the  presence  of  federal  regulation  as  opposed  to  State  and  local  regulation,  tort
claims,  and/or  public  pressure.  Businesses  simply  cannot  accurately  calculate  the
costs of compliance.

Second,  in  aggregating  costs  and  benefits,  one  is  comparing  apples  to  oranges  to
‘‘kiwis, grapefruit, etc.’’ The cost-benefit analyses ‘‘vary in quality, methodology, and
type  of  regulatory  costs  included.’’  And  not  all  regulations  are  the  same.  Environ-
mental, social (public health, consumer and workplace protections, civil rights), eco-
nomic,  transfer  payments,  and  process  regulations  require  very  different  ap-
proaches.

OMB  Watch  believes  that  aggregating  costs  and  benefit  has  no  useful  purpose  to
policy-makers  because  there  is  no  connection  to  a  problem  government  is  trying  to
solve.  Thus  the  only  uses  can  be  for  creating  a  political  straw  man  or  for  use  in
developing  regulatory  budgets  which  advance  an  already  tenuous  economic  frame-
work  over  the  regulatory  process.  Regulatory  budgets  cap  annual  compliance  costs
of  regulations,  and  as  we’ve  argued  here,  there  is  no  reliable  way  of  knowing  the
extent of these costs. Agencies must submit ‘‘combined aggregate costs and benefits
of  all  its  regulations  planned  for  that  calendar  year  to  assist  with  the  identification
of priorities.’’ [emphasis added] This language from E.O. 13422 provides further evi-
dence that the intent is to use aggregated numbers for policy-making.
Q2. A  major  criticism  of  the  market  failure  criterion  is  that  some  believe  it  elevates
economic  concerns  above  those  of  public  health  and  safety,  and  that  this  con-
tradicts Congressional guidance. Is this true? If so, why don’t the following sec-
tions give agencies an out when they are presented with conflicting values?
Sec.  1,  end  of  last  sentence:  ‘‘unless  a  statute  requires  another  regulatory  ap-
proach.’’
Sec. 1(b), end of sentence: ‘‘to the extent permitted by law and where applicable.’’
A2. We  believe  that  economic  concerns  are  already  elevated  above  public  health,
workplace safety, environmental and civil rights concerns. Under the Bush Adminis-
tration,  these  economic  considerations  have  been  advanced  and  politicized  beyond
the  limits  they  had  in  previous  administrations  as  we  have  documented  for  six
years.  The  language  quoted  above  from  E.O.  12866  might  be  applicable  in  a  regu-
latory implementation scheme in which OIRA acted as a counselor instead of a gate-
keeper.  These  sections  may  provide  a  legal  exit  strategy  when  an  agency  is  chal-
lenged.  The  practical  effect,  however,  is  that  when  one  agency,  OIRA,  has  the  sole
responsibility  for  overseeing  an  agency’s  proposed  rules,  has  control  over  the  agen-
cy’s  budget,  and  has  the  ability  to  keep  an  agency  in  an  endless  loop  of  regulatory
analyses,  OIRA  will  get  nearly  all  of  what  it  wants.  This  situation  is  exasperated
by the lack of transparency in OIRA’s role in the pre-rule-making process.
Q3. One  of  the  reasons  agencies  have  increasingly  turned  to  guidance  documents  in
order  to  regulate  industry  is  that  they  do  not  require  public  notice,  public  com-
ment, or OMB notice. This has allowed for more flexibility and reactive policies,
but has sacrificed transparency, organization, and accountability. Do you believe
the  recent  OMB  bulletin  proposes  a  reasonable  method  of  balancing  these  com-
peting principles?

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00093 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

88

A3. We would add to the list of reasons why agencies have turned to guidance docu-
ments the cumbersome and incredibly slow pace of getting regulations promulgated.
Focusing  on  guidance  documents  ignores  the  real  regulatory  problems  that  exist  in
the  process.  The  process  is  dysfunctional:  it  is  too  centralized,  OIRA  lacks  the  staff
and expertise to judge the adequacy of the non-economic aspects of complex regula-
tions, and it has increasingly imposed a once-size-fits-all approach to the analytical
approaches used in the process.

Far  from  providing  a  reasonable  method  of  balancing  the  principles  cited  above,
submitting  significant  guidance  documents  to  a  review  process  similar  to  that  for
regulations sacrifices all of the principles mentioned. One more aspect of agency ac-
tion  is  subject  to  OIRA’s  black  box  of  regulatory  review  thus  sacrificing  trans-
parency  and  accountability;  adding  more  categories  for  the  small  staff  at  OIRA  to
review  sacrifices  agency  flexibility  and  reactivity  to  anything  more  than  an  indi-
vidual request. That results in providing guidance one transaction at a time.

Instead of implementing good guidance practices, OIRA would have served the ad-
ministration  and  the  public  far  better  if  it  had  attempted  to  fix  the  problems  that
drive agencies to issue guidance in the place of regulation.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00094 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

Appendix 2:

ADDITIONAL MATERIAL FOR THE RECORD

(89)

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00095 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

90

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00096 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

91

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00097 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

92

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00098 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

93

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00099 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

94

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00100 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

95

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00101 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

96

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00102 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

97

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00103 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

98

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00104 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

99

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00105 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

100

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00106 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

101

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00107 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

102

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00108 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

103

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00109 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

104

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00110 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

105

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00111 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

106

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00112 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

107

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00113 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

108

ANALYSIS OF E.O. 12866 WITH EDITS MADE BY E.O. 13422

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00114 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

109

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00115 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

110

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00116 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

111

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00117 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

112

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00118 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

113

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00119 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

114

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00120 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

115

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00121 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

116

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00122 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

117

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00123 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

118

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00124 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

119

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00125 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

120

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00126 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

121

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00127 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

122

While on the Home Front

Missing from the New York Times of January 19—and for that matter the Wash-
ington  Post—was  any  attention  to  an  executive  order  the  President  issued  quietly
on  Thursday,  that  achieves  a  major  increase  in  White  House  control  over  domestic
government. The executive order, issued without explanation or accompanying press
release,  appears  to  be  a  series  of  technical  amendments  to  an  existing  regime  by
which the White House coordinates the activities of federal agencies adopting regu-
lations. Among its measures, the order

• considerably expands the range of activities embraced by the order, from offi-
cial  regulations  having  the  force  to  law  to  less  formal  policy  and  interpreta-
tions;

• requires  agencies  to  place  control  over  these  activities  into  the  hands  of  a
‘‘presidential  appointee’’—that  is,  a  person  whose  appointment  does  not  re-
quire  senatorial  confirmation—unless  a  particular  decision  of  hers  is  specifi-
cally overridden by the agency’s senatorially confirmed head;

• requires  the  agency  to  consider  in  addition  to  its  statutory  responsibilities
issues  Congress  may  not  have  thought  appropriate  factors  for  decision;  and
• gives  the  White  House  considerable  leverage  to  require  the  agency  to  adopt
expensive  and  delaying  procedures  for  considering  proposed  regulations,  that
will greatly enhance the effective power of participants in the process - regu-
lated industries who may have White House friends, in particular.

It  is  perhaps  not  surprising  that,  having  lost  control  of  Congress,  the  President
is doing what he can to increase his control of the executive branch. President Clin-
ton, when he lost the Congress, also worked to achieve by regulation what he could
not expect to do legislatively. Much more law is made today by regulation than leg-
islation, in any event. But yesterday’s steps reflect the view we have seen in connec-
tion with the war in Iraq as well, that the President is a law unto himself, entitled
to act without particular regard to Congress’s wishes.

Senatorial  confirmation  gives  agency  heads  a  relationship  with  Congress  as  well
as  the  White  House.  They  are  the  ones  Congress’s  laws  empower  to  decide  regu-
latory matters. Given the enormous range of governmental responsibilities today, it
is  even  less  thinkable  now  than  it  was  two  centuries  ago  that  these  decisions,  in
their  detail,  are  for  the  President—he  may  consult,  he  may  oversee,  but  the  law
places decisional authority in them. President Andrew Jackson had to fire two Sec-
retaries  of  the  Treasury  before  he  could  find  an  Acting  Secretary  willing  to  move
government  funds  out  the  United  States  Bank;  he  and  they  understood  that  the
decisional authority rested in them—and the Senate promptly refused to confirm the
Acting Secretary’s nomination. Now a presidential ukase places decisional authority
in  the  hands  of  a  person  with  whom  the  Senate  has  no  relationship;  should  the
President  fire  and  wish  to  replace  that  person,  there  will  be  no  such  political  price
to pay.

Congress also sets the factors that an agency is to consider in reaching regulatory
decisions.  It  may  quite  deliberately  exclude  some  possibly  relevant  factors  from
agency  consideration.  A  few  years  ago,  for  example,  the  Supreme  Court  found  that
the  Clean  Air  Act  did  not  authorize  the  Environmental  Protection  Agency  to  con-
sider  costs.  The  new  factors  the  executive  order  makes  potentially  decisive,  in  the
hands of a person answering only to the President, effectively amend the law as the
President—but not the Congress—wishes.

Congress has been chary of requiring the complex procedures the executive order
appears  to  place  in  White  House  control.  Rule-makings  using  them,  in  substantial
control  of  the  participants  as  ordinary  rule-makings  are  not,  can  extend  for  years.
A quarter-century ago, when the DC Circuit had imposed similar requirements judi-
cially,  the  Supreme  Court  said  emphatically  that  any  such  decision  was  for  Con-
gress. Now the President has effectively appropriated that decision for himself—and
his political friends.

We have long been a nation under law. The war emergency has placed that propo-
sition under considerable strain. If the President’s law-transcending claims, however
wrong,  can  be  understood  in  that  context,  they  should  not  be  tolerated  when,  as
now,  they  emerge  in  stealth  documents,  in  the  ordinary  context  of  law-administra-
tion.

Dr. Peter L. Strauss
Betts Professor of Law
Columbia Law School

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00128 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

123

Bush Order Limits Agencies’ ‘Guidance’

BY CINDY SKRZYCKI

TUESDAY, JANUARY 30, 2007; PAGE D01

On Jan. 18, when the headlines in the United States focused on the war in Iraq,
the  new  Democratic  Congress  and  actress  Lindsay  Lohan’s  alcohol  problem,  the
Bush Administration rewrote the book on federal regulation.

President  Bush  issued  an  executive  order  curbing  the  power  of  agencies  to  regu-
late  industry  through  ‘‘guidance’’—informal  advice  that  falls  short  of  official  rules
yet can still cost companies millions of dollars to comply with. The order, which also
calls  on  agencies  to  project  the  cost  of  new  rules,  among  other  demands,  gives  the
White  House  more  power  to  review  how  they  write  standards  to  regulate  corporate
behavior.

The  amendments  are  ‘‘the  most  serious  attempts  by  the  executive  branch  to  con-
trol  the  regulation  mills  of  the  hundreds  of  federal  agencies,’’  said  William  Kovacs,
Vice  President  of  Environment,  Technology  and  Regulatory  Affairs  at  the  U.S.
Chamber of Commerce, the Nation’s largest business lobby.

The  story  behind  those  changes  illustrates  how  important  the  competing  sides
consider rule writing. Even subtle word changes can have significant effects on what
the  chemical,  oil,  home-building,  pharmaceutical  and  other  highly  regulated  indus-
tries must spend.

‘‘It’s another thumb on the scale,’’ said Sally Katzen, who headed the Office of In-
formation and Regulatory Affairs, the top regulatory job, in the White House Office
of Management and Budget during the Clinton Administration. ‘‘There will be more
boxes to check, more I’s to dot, more T’s to cross and more analysis.’’

Federal  agencies  issue  guidance  to  interpret  key  policy  and  technical  questions,
often  at  the  request  of  industry.  The  Labor  Department’s  Occupational  Safety  and
Health  Administration,  for  example,  issued  574  guidance  documents  between  2001
and 2005, many directed at the construction industry.

Though  the  guidance  isn’t  legally  binding,  companies  pay  close  attention  to  it.
More than 30 individuals and groups, including those representing funeral directors
and  ornithologists,  filed  comments  about  ‘‘good  guidance  practices’’  for  a  bulletin
issued with the executive order.

Some,  such  as  the  American  Chemistry  Council  based  in  Arlington,  said  it  was
‘‘frequently  beneficial’’  for  agencies  to  have  the  flexibility  to  issue  guidance  without
a formal rule-writing process. Still, the council and most others who filed comments
backed  the  plan  to  rein  in  the  practice  because  of  concern  that  guidance  at  times
amounted to back-door rule writing.

Guidance  should  be  subject  to  oversight  by  the  OMB  and  public  notice  and  com-

ment, they argued.

General  Electric,  the  world’s  second-largest  company  by  market  value,  said  the
Environmental  Protection  Agency  issued  guidance  on  how  to  clean  up  toxic  chemi-
cals,  which  a  court  ruled  in  2002  was  actually  a  ‘‘legislative  rule.’’  The  Fairfield,
Conn.,  company  recommended  that  agencies  be  required  to  maintain  a  list  of  all
guidance documents on their web sites.

Sanofi-Aventis,  France’s  largest  drug-maker,  said  guidance  documents  ‘‘can  have
significant  impact  on  our  business  as  well  as  on  the  ultimate  lives  of  our  cus-
tomers—patients.’’

The Paris company, whose U.S. headquarters is in Bridgewater, N.J., recapped an
experience  in  which  the  Centers  for  Medicare  and  Medicaid  Services  switched  its
payment policy on four drugs last year, after the final rule had been approved.

Bush’s executive order told agencies they must submit to the White House budget
office  for  review  any  guidance  that  has  an  impact  of  $100  million  or  more  on  the
economy  and  make  such  significant  interpretations  available  to  the  public  for  com-
ment.

Kovacs  said  the  Chamber’s  complaint  about  guidance  ‘‘was  one  of  the  first  issues
we  talked  about’’  with  John  Graham,  the  Administration’s  first  regulatory  czar  at
the OMB.

Another change requires agencies to state in writing ‘‘the specific market failure’’
that  it  intends  to  cure  with  a  new  rule.  Insufficient  competition  can  be  a  sign  of
such a failure, OMB officials said. Or the government may have to order nutritional
labeling because there otherwise would be a lack of information for consumers.

The  market-failure  concept  has  taken  on  new  emphasis  with  the  Bush  Adminis-
tration.  The  President  nominated  Susan  Dudley,  the  former  head  of  the  regulatory
program  at  the  Mercatus  Center,  a  free-market-oriented  research  group  at  George
Mason  University  in  Arlington,  to  replace  Graham  in  the  top  regulatory  job  at  the

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00129 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

124

OMB. Dudley wasn’t confirmed by the Senate in the last Congress and is now a top
aide in the budget office.

Public  Citizen,  a  District  nonprofit  group  that  monitors  regulation,  charged  that
Dudley  will  use  a  market-failure  standard  to  create  economic  barriers  to  protecting
the public.

Under  the  Bush  executive  order,  regulators  also  now  will  have  to  estimate  the
total  costs  and  benefits  of  planned  rules.  And  the  process  will  be  overseen  in  each
agency by a political appointee, another provision that public interest groups oppose.
‘‘There  is  no  question  who  this  panders  to,’’  said  Rena  Steinzor,  a  University  of
Maryland  Law  Professor  who  is  critical  of  administration  regulatory  policy.  ‘‘It’s
something business has wanted.’’

Jeffrey Rosen, OMB’s general counsel, said: ‘‘Simply put: What we are doing here
is  ‘good  government.’  We  are  building  upon  a  process  that  has  been  used  by  presi-
dents of both parties to try to institutionalize best practices.’’

Criticism  of  the  changes  is  ‘‘a  tempest  in  a  teapot,’’  said  Paul  Noe,  an  adviser  to
Graham who is now a Washington lawyer. ‘‘The executive order promotes better-in-
formed and more accountable regulatory decisions.’’

Congress should be paying attention to the President’s action because he is usurp-
ing  the  authority  the  lawmakers  gave  the  agencies  to  regulate,  according  to  Peter
Strauss, a Professor at Columbia University Law School.

‘‘It’s maybe not surprising that having lost control of the Congress, the President

is doing what he can to increase control of the Executive Branch,’’ Strauss said.

Cindy  Skrzycki  is  a  regulatory  columnist  with  Bloomberg  News.  She  can  be

reached at cskrzycki@bloomberg.net.

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00130 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

Bush order on government regulation stirs debate

125

BY TABASSUM ZAKARIA

REUTERS

TUESDAY, JANUARY 30, 2007; 4:28 PM

WASHINGTON  (Reuters)—An  order  signed  by  President  George  W.  Bush  on  the
oversight  of  thousands  of  government  regulations  issued  every  year  was  praised  by
business  as  a  step  toward  controlling  an  unwieldy  process  but  criticized  by  others
as potentially a loser for consumers.

The  White  House  said  the  executive  order  signed  by  Bush  on  January  18  makes
a senior official in each agency accountable for the regulations it issues and provides
greater  openness  by  ensuring  that  ‘‘guidance’’  documents  issued  to  businesses  are
available to the public.

Business groups say the order should help businesses which have to wade through
a myriad of regulations, sometimes conflicting ones from different agencies, by mak-
ing one person in each agency in charge of overseeing the regulations issued.

Consumer  groups  say  the  public  would  lose  out  because  the  order  could  slow  the
process by which regulations in the public interest such as pollution controls would
be  issued,  and  puts  the  process  under  the  control  of  an  official  appointed  by  the
President.

Jeffrey  Rosen,  counsel  at  the  White  House  Office  of  Management  and  Budget,
called the criticism a ‘‘mistaken argument’’ and said the basic regulatory process in
the  order  has  been  in  place  over  both  Democratic  and  Republican  administrations.
‘‘The basic framework is the same,’’ he said of the order which amended an order

issued by President Bill Clinton in 1993.

‘‘This  is  just  another  tool  for  industry  and  their  allies  in  the  Bush  White  House
to  slow  down  and  prevent  agencies  from  getting  things  done  to  protect  the  public,’’
said  Robert  Shull,  deputy  director  for  auto  safety  and  regulatory  policy  at  Public
Citizen.

The  order  requires  agencies  use  a  standard  of  ‘‘market  failure,’’  which  means  de-
termining  whether  private  markets  can  correct  a  social  problem  like  pollution  on
their own, in deciding whether government needs to step in, he said.

Shull said that was too high a bar to meet as the new Democratic-controlled Con-

gress prepares to take on issues like global warming and fuel economy.

Rosen  said  the  new  order  better  defines  the  term  market  failure  from  Clinton’s
order.  On  consumer  advocate  concerns  like  pollution,  ‘‘the  clarification  actually
helps,’’ because it would be a legitimate basis for regulation, he said.

Consumer groups expressed concern about the order’s requirement that the regu-

latory oversight officer at the agencies be appointed by the President.

‘‘This  is  really  just  another  way  of  the  White  House  getting  its  fingers  in  all  of
the  agencies,  manipulating  all  of  their  policies  and  all  of  their  priorities  in  a  way
that Congress never intended,’’ Shull said.

Rosen  said  it  meant  more  accountability.  ‘‘If  you  want  to  know  who’s  responsible
for  regulatory  decisions,  here’s  who  it  is  and  it’s  a  presidential  appointee,  meaning
it’s  somebody  very  senior,’’  he  said.  ‘‘It’s  a  way  of  identifying  some  accountability.’’
The regulatory process puts out about 4,000 regulations every year in addition to
the 192,000 regulations that exist, said Bill Kovacs, Vice President of Regulatory Af-
fairs at the U.S. Chamber of Commerce.

‘‘Imagine  yourself  being  a  small  business  and  trying  to  comply  on  any  given  day
with  labor  standards,  health  standards,  pension  standards,  environmental  stand-
ards,’’  Kovacs  said.  ‘‘So  people  are  trying  to  find  some  way  to  get  control  over  the
process.’’

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00131 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

126

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00132 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

127

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00133 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

128

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00134 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

129

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00135 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

130

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00136 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

131

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00137 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

132

VerDate 11-MAY-2000 09:44 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00138 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105 SCIENCE1 PsN: SCIENCE1

AMENDING  EXECUTIVE  ORDER  12866:  GOOD
GOVERNANCE  OR  REGULATORY  USURPA-
TION?  PART  II

THURSDAY,  APRIL  26,  2007

HOUSE OF REPRESENTATIVES,

SUBCOMMITTEE ON INVESTIGATIONS AND OVERSIGHT,

COMMITTEE ON SCIENCE AND TECHNOLOGY,

Washington, DC.

The  Subcommittee  met,  pursuant  to  call,  at  10:10  a.m.,  in  Room
2318  of  the  Rayburn  House  Office  Building,  Hon.  Brad  Miller
[Chairman of the Subcommittee] presiding.

(133)

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00001 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

134

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00002 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

135

HEARING CHARTER

SUBCOMMITTEE ON INVESTIGATIONS AND OVERSIGHT

COMMITTEE ON SCIENCE AND TECHNOLOGY

U.S. HOUSE OF REPRESENTATIVES

Amending Executive Order 12866:
Good Governance or Regulatory

Usurpation? Part II

THURSDAY, APRIL 26, 2007

10:00 A.M.–1:00 P.M.

2318 RAYBURN HOUSE OFFICE BUILDING

Purpose

On  Tuesday,  February  13,  2007  the  Subcommittee  on  Investigations  and  Over-
sight  of  the  Committee  on  Science  and  Technology  held  a  hearing  to  receive  testi-
mony  regarding  the  President’s  recent  amendment  to  Executive  Order  12866.  That
order  provides  guidance  to  agencies  for  submitting  proposed  regulations  to  the  Of-
fice of Management and Budget (OMB) for pre-approval.

The amendment (Executive Order 13422) expands this process by requiring agen-
cies to submit proposed significant guidance documents for pre-approval. The Order
also  requires  for  the  first  time  that  agencies  identify  in  writing  the  specific  market
failure or problem that warrants the proposed regulation or guidance; that a Presi-
dential appointee in each agency be designated as regulatory policy officer and that
officer must approve each regulatory undertaking by the agency.

The  February  hearing  provided  significant  testimony  highlighting  several  issues.

Three bundles of issues emerged as worthy of further work:

1. How  was  the  Executive  Order  developed  and  what  are  the  consequences  of

changes to the language of E.O. 12866?

2. What does the shift to a ‘‘market failure’’ standard for justifying a regulatory
proposal  mean  and  how  will  the  annual  agency  costs  of  regulations  state-
ments be used?

3. Will the change in the status and authority of the Regulatory Policy Officers
in  the  agencies  have  consequences  for  transparency  in  the  regulatory  proc-
ess?

Witnesses

To  provide  insight  into  these  issues,  the  Subcommittee  has  invited  the  following

witnesses:
Mr.  Steven  Aitken,  General  Counsel  at  OIRA.  Mr.  Aitken  can  address  how  E.O.
13422  was  developed.  He  can  also  offer  up  OIRA’s  take  regarding  how  OIRA  inter-
prets the new E.O. In testimony before the House Judiciary Committee, he indicated
that  the  view  of  OIRA  was  that  most  of  the  changes  were  simply  to  bring  the  lan-
guage of the Executive Order into alignment with practice.

We  will  also  hear  from  Professor  Peter  Strauss  of  Columbia  Law  School  and
Dr.  Gary  Bass  of  OMB  Watch.  They  will  address  some  of  the  institutional  chal-
lenges  OIRA’s  role  pose  to  the  standing  of  Congress  and  the  dangers  that  statute
may  be  trumped  by  non-statutory  Presidential  guidance.  They  will  also  speak  to
problems of transparency that come with a larger role for Regulatory Policy Officers.
Then  Dr.  Robert  Hahn  and  Professor  Richard  Parker  will  also  testify.  Dr.
Hahn is famous for studies, done in residence at the American Enterprise Institute,
regarding  the  costs  of  regulation.  His  degree  is  in  economics  and  he  has  advocated
in  the  past  for  more  reliance  on  cost-benefit  analysis.  Professor  Parker  of  the  Uni-
versity of Connecticut Law School will offer his insights into the problems with cost-
benefit analysis and regulatory budgeting efforts.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00003 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

Key Issues

136

Regulatory  authority  is  the  main  tool  Congress  has  used  to  charge  Executive
agencies  with  responsibilities  to  protect  the  environment,  public  health,  the  safety
of the workplace, the use of public lands and a myriad of other good purposes. Con-
gress  obviously  cannot  pass  a  law,  or  amend  statute,  every  time  a  new  threat  to
air or health arises. Instead, Congress puts into place general purposes, general au-
thority and a set of values that the agency should use in carrying out the law.

When the Office of Information and Regulatory Analysis (OIRA) injects itself into
the  regulatory  process  there  can  be  a  fine  line  between  guaranteeing  that  a  pro-
posed regulation is convincingly demonstrated and efficient in its likely outcome and
substituting the President’s values and preferences for the goals and purposes Con-
gress enacted in statute. This line can be crossed either in the guidance to agencies
from OIRA or by the way OIRA conducts itself.

OIRA has quietly grown into the most powerful regulatory agency in Washington.
The Reagan administration used OIRA to push further and further into the process
of vetting regulations. A string of Executive Orders in the 1980s, many issued dur-
ing  David  Stockman’s  tenure  at  OMB,  forced  agencies  to  let  OIRA  be  a  full  part-
ner—some  thought  dominant  partner—in  moving  regulations  forward.  Several
House  Chairs  fought  a  very  bitter  struggle  to  push  OIRA  back  out  of  the  business
of  interfering  with  the  conduct  of  agencies  as  they  carried  out  the  law.  That  fight
met only mixed success.

As discussed below, E.O. 12866 was a Clinton-era effort to retain Reagan-initiated
White  House  oversight  of  agency  regulatory  processes  that  had  been  the  product  of
Reagan  initiatives,  balanced  against  the  recognition  that  agencies  should  have  pri-
macy in the regulatory process. The thrust of E.O. 12866 was to pare back the array
of  regulatory  actions  that  would  be  swept  up  into  OIRA’s  review  (the  estimate  was
that the annual number of regulations for review declined from 2000 to a mere 500
or so). Clinton’s OIRA, while still assertive, was cognizant that it was ultimately the
agencies  that  were  charged  by  Congress  with  carrying  out  public  purposes  and
OIRA’s assertions of authority had to be tempered by that legal reality.

The Bush Administration has been very aggressive in expanding the role of OIRA.
Independent  agency  action  has,  in  some  cases,  been  by  OIRA,  which  has  acted  as
a  very  stingy  gatekeeper  on  what  proposed  regulations  can  see  the  light  of  day.  In
tone, OIRA has returned to the Reagan-era where OIRA uses its privileged position
as ‘‘the President’s voice’’ in regulatory matters, to push agencies into rethinking ev-
erything they are doing on regulation.

Critics of OIRA’s role since 2001 describe a process whereby the values and judg-
ments of OIRA’s small staff (dominated by economists) trump the judgments of tech-
nical  experts  in  the  agencies  and  supplant  the  values  in  statute  designed  to  guide
agency  regulatory  activities.  The  cumulative  effect  of  OIRA’s  behavior  since  2001
has  been  to  intimidate  agencies  into  running  away  from  pursuing  their  statutory
responsibilities  rather  than  get  caught  up  in  the  political  struggles  associated  with
moving regulation forward. Supporters of this approach are happy to see some office
moving  to  slow  agency  actions  and  argue  that  the  net  result  of  OIRA’s  actions  is
a more defensible regulation at the end of the day.

How does all this matter for science and the agencies under the Science Commit-

tee’s jurisdiction?

Every  year  the  Federal  Government  funds  billions  of  dollars  of  research  at  the
Environmental  Protection  Administration,  the  Department  of  Labor,  the  Depart-
ment of Transportation, the Department of Agriculture, the Department of the Inte-
rior, the Department of Energy and the National Oceanic and Atmospheric Adminis-
tration  that  contribute  directly  or  indirectly  to  regulatory  considerations.  Even  the
National Institutes of Health and the National Science Foundation fund science that
finds  its  way  into  regulatory  proposals.  Experts  at  agencies—often  federal  sci-
entists—charged  with  regulatory  responsibilities  survey  the  relevant  scientific  lit-
erature  to  determine  where  there  may  be  dangers  to  the  public  or  the  public  inter-
est.  In  determining  the  need  for  a  regulation,  the  agency  uses  science  funded  with
public  dollars,  as  well  as  that  from  private  sources,  to  make  reasoned  assessments
of  risks  and  propose  responses.  This  is  all  to  be  done  consistent  with  statutory  re-
sponsibilities as established by Congress.

OIRA  has  been  using  its  circulars  to  force  agencies  to  analyze  and  reanalyze  the
information underlying and supporting proposed regulations. Now, with the amend-
ed Executive Order, OIRA is putting in place an economic criteria—market failure—
for regulation and guidance that may have nothing to do with the values established
in  statute.  This  effort  is  coming  with  no  consultation  or  input  from  Congress.  Fur-
ther,  by  making  the  regulatory  policy  officer  a  more  empowered  gatekeeper,  with
political  allegiance  to  the  President,  it  raises  the  chances  that  the  agencies  them-
selves  will  find  it  hard  during  the  Bush  years  to  get  regulatory  proposals  started

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00004 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

137

or completed simply to submit them to OIRA for review. Congress did not empower
agencies  to  protect  public  health  and  safety  simply  to  then  sit  on  its  hands  to  see
all  Congress  appropriates  for  regulatory-relevant  science  and  the  legal  authority
seated in agencies be trumped through a sweeping Executive Order.
Bush Amendments to E.O. 12866

The Bush Administration has amended this Executive Order two times. The first
amendment  in  2002  simply  removed  the  Vice  President  from  the  process,  replacing
that  office  with  that  of  the  White  House  chief  of  staff.  This  second  occasion  for
amendment has come with limited warning, little discussion and with much broader
implications.  The  attached  CRS  report  goes  into  detailed  discussion  of  the  major
changes,  and  some  of  their  implications.  Below  is  a  summary  of  the  key  observa-
tions.
1. Elevating ‘‘Market Failure’’:

First,  the  amendment  establishes  a  new  standard  that  must  be  met  by  any  pro-
posed  guidance  or  regulation.  Originally,  the  first  principle  guiding  submissions  to
OIRA seeking approval of a proposed regulation was that ‘‘[e]ach agency shall iden-
tify the problem that it intends to address (including, where applicable, the failures
of  private  markets  or  public  institutions  that  warrant  new  agency  action)  as  well
as assess the significance of that problem.’’

Under  the  amended  language,  ‘‘Each  agency  shall  identify  in  writing  the  specific
market  failure  (such  as  externalities,  market  power,  lack  of  information)  or  other
specific problem that it intends to address (including, where applicable, the failures
of public institutions) that warrant new agency action, as well as assess the signifi-
cance  of  the  problem,  to  enable  assessment  of  whether  any  new  regulation  is  war-
ranted.’’

Critics  of  OIRA  allege  that  this  new  standard  of  ‘‘market  failure’’  supplants  the
values  that  exist  in  statute  for  regulatory  action.  They  also  worry  that  OIRA  will
use this standard to summarily dispense with proposals that they deem to be uncon-
vincing  in  their  articulation  of  a  market  failure.  However,  there  is  permissive  lan-
guage allowing for other kinds of analysis. The core question will rest on how OIRA
applies this language in practice.

There  is  a  fundamental  problem  with  ‘‘market  failure’’:  there  is  no  objective  test
for when market failure is present or when an identified ‘‘imperfection’’ in the oper-
ation  of  a  market  is  sufficient  to  justify  regulatory  intervention.  Economists  offer  a
model  of  an  ideal,  perfect  market  (perfect  information,  perfect  competition,  rational
action  by  all  actors,  no  externalities,  no  agency  problems,  predictable  transaction
costs)  and  no  market  in  the  real  world  ever  works  like  these  theoretical  markets.
So  deciding  that  a  particular  ‘‘failing’’  is  worthy  of  intervention  is  really  in  the  eye
of  the  economist.  It  is  a  little  like  the  saying  about  lawyers:  if  you  don’t  like  the
advice  yours  is  giving  you,  get  a  new  one.  The  same  with  economists  and  market
failure.

2. Presidential Appointees as Regulatory Policy Officers

The  amendment  directs  that  each  agency  shall  name  a  regulatory  policy  officer
who  shall  be  a  Presidential  appointee.  While  regulatory  policy  officers  had  been  re-
quired in the Executive Order as originally propounded in 1993, the notion that the
officer must be a Presidential appointee takes the expert staff of agencies out of the
picture.  The  language  of  the  amendment  charges  this  officer  with  being  ‘‘involved
at each stage of the regulatory process to foster the development of effective, innova-
tive, and least burdensome regulations and to further the principles set forth in this
Executive order.’’

This political appointee appears to serve as a kind of gatekeeper’s gatekeeper. The
officer will compose an annual plan and ‘‘no rule-making shall commence nor be in-
cluded  on  the  Plan  without  the  approval  of  the  agency’s  Regulatory  Policy  Office.’’
Previously  such  officers  were  to  be  involved  in  the  rule-making  process  and  now
they have total discretion over the initiation of work that could lead to a regulation.
(CRS  states  that  these  Regulatory  officers  are  largely  drawn  from  political  ap-
pointees  already  so  this  may  not  be  a  notable  change;  however,  the  source  on  that
is  OIRA  and  they  do  not  keep  a  master  list  of  these  officers  so  it  is  hard  to  know
how to evaluate this assertion.)

Chairman Miller has raised questions about the transparency of activities carried
out  by  the  Regulatory  Policy  Officer.  For  example,  will  meetings  between  the  RPO
and  outside  parties  on  matters  that  may  be  considered  for  guidance  or  regulation
be  subject  to  the  same  sorts  of  disclosure  that  OIRA  now  routinely  makes?  Will  a
decision by an RPO to bar an agency from moving forward with a proposed regula-
tion  ever  be  subject  to  public  disclosure?  If  a  proposal  has  been  drafted  and  sent

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00005 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

138

forward  to  the  RPO  who  sends  it  back  with  new  guidance,  will  that  exchange  be
public the way OIRA’s response to proposed regulation would be?

Further,  we  have  found  in  our  own  survey  of  agencies,  that  many  agencies  have
been  relying  or  have  now  named  their  General  Counsel  as  RPO.  Will  the  General
Counsel make a claim of attorney-client privilege in response to FOIA requests (and
even  Congressional  requests)  related  to  any  work  on  a  proposed  regulatory  action?

3. Aggregate Regulatory Costs and Benefits

The original language of 12866 required a ‘‘summary of planned significant regu-
latory action including, to the extent possible, alternatives to be considered and pre-
liminary  estimates  of  anticipated  costs  and  benefits.’’  The  Bush  Administration
amendment  expands  this  requirement  to  direct  that  each  agency  provide  the  ‘‘best
estimate of the combined aggregate costs and benefits of all its regulations planned
for that calendar year to assist with the identification of priorities.’’

Critics allege that this will elevate cost-benefit analysis in the regulatory process.
Cost-benefit analysis is a very controversial analytical tool in guiding regulatory be-
havior. While the call to make sure that the benefits of a regulation exceed its costs
has  a  simple  appeal,  the  reality  is  that  many  of  the  benefits  regulations  are  de-
signed  to  capture  (the  survival  of  a  species,  to  protect  the  lives  and  health  of  citi-
zens,  the  quality  of  the  air  or  water)  are  impossible  to  accurately  value.  However,
the  costs  of  steps  to  implement  a  regulation  are  usually  easy  to  specify  with  preci-
sion.  The  result  is  a  process  that  tends  to  be  very  complete  in  its  enumeration  of
costs  and  incomplete  in  its  ability  to  set  values  on  the  benefits.  Retrospective  stud-
ies  have  found  that  costs  used  in  estimating  the  costs  of  a  regulation  turn  out  to
be  overstated.  And  of  course  because  you  are  using  ‘‘dollars’’  to  estimate  costs,  it
provides the illusion of a precision that does not—perhaps cannot—exist.

Critics  also  view  this  as  a  potential  first  step  towards  a  regulatory  ‘‘budget’’  that
could  be  used  to  stop  future  regulations  based  on  some  ‘‘capping’’  of  that  budget.

4. Review of Significant Guidance Documents

Under the amendment each agency is to provide OIRA with advance notice of all
proposed  significant  guidance  documents.  OIRA  may  then  decide  which  guidance  it
deems to be ‘‘significant’’ from its perspective and ask for the proposed guidance and
a  brief  explanation  of  need.  ‘‘The  OIRA  administrator  shall  notify  the  agency  when
additional  consultation  will  be  required  before  issuance  of  the  significant  guidance
document.’’

There  is  no  time  limit  on  how  long  OIRA  may  take  in  moving  on  these  guidance

proposals.

The impact on agency conduct may be very, very significant and could potentially
sweep up thousands of such proposals each year. Guidance is issued to communicate
to  an  effected  public  how  an  agency  intends  to  interpret  or  enforce  statutory  direc-
tions.  The  business  community  relies  on  guidance  to  ensure  that  conduct  will  com-
ply with agency intentions for application of law.
Conclusion

While  the  language  of  the  Amendment  to  Executive  Order  12866  is  alarming  to
many,  the  fundamental  issue  is  how  does  OIRA  intend  to  implement  it?  The  re-
emergence  of  the  ‘‘gatekeeper’’  approach  to  OIRA  under  President  Bush—an  event
that has not so far received the kind of institutional push-back from Congress which
that  role  drew  in  the  1980s—suggests  that  the  rule  as  amended  will  be  used  very
aggressively  to  stall  agency  action.  But  how  OIRA  intends  to  apply  this  language
in practice is a subject worth some study.

Two other issues loom large from the Committee on Science and Technology’s per-
spective. First, what will these changes imply for the science-based regulatory agen-
cies?  Will  we  increasingly  find  that  the  ‘‘science’’  that  matters  is  no  longer  that  of
climate,  biological  or  medical  researchers,  but  narrow  applications  of  cost-benefit
analysis and market failure theory drawn from economics? Should the Science Com-
mittee, uniquely positioned to examine and evaluate research, undertake a more rig-
orous  review  of  the  validity  and  utility  of  these  economic  approaches  to  regulation?
Second,  what  does  this  new  amendment  imply  for  the  institutional  prerogatives
of  the  legislative  branch?  Agencies  exist  in  statute  and  are  given  mandates  under
the  law.  Should  Congress  passively  accept  an  Executive  Order  that,  just  as  an  ex-
ample, places Presidential appointees in a position where they can arbitrarily block
career  agency  officials  from  carrying  out  the  purposes  of  the  law  Congress  charged
them with?

The growth of power at the Office of Information and Regulatory Affairs has gone
largely  unexamined  in  recent  years.  This  new  Executive  Order  invites  Congress  as
a body, and many, many Committees that are affected, to undertake a vigorous and

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00006 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

139

thorough  review  of  the  changes  in  that  office  since  2001.  One  possible  response  is
to  offer  legislative  language  that  will  enhance  the  transparency  of  the  actions  by
Regulatory Policy Officers; that is an option that Chairman Miller is actively consid-
ering.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00007 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

Appendix:

140

Other Regulatory Tools that OMB has used to Expand its

Powers:

Data Quality: There were two recent acts of legislation that affected OMB’s over-
sight  of  data.  They  are  the  Data  Access  Law  and  the  Data  Quality  Law.  Both  of
these  laws  were  inserted  into  omnibus  appropriations  bills,  and  neither  was  fully
debated in Congress.

The entire Data Access Law consists of the following short passage:

‘‘Office of Management and Budget Salaries and Expenses
. . .Provided  further,  That  the  Director  of  OMB  amends  Section———.36  of
OMB  Circular  A–110  to  require  federal  awarding  agencies  to  ensure  that  all
data produced under an award will be made available to the public through the
procedures established under the Freedom of Information Act: Provided further,
That if the agency obtaining the data does so solely at the request of a private
party, the agency may authorize a reasonable use fee equaling the incremental
cost of obtaining the data. . .’’[11]

The purpose of the law was to increase public access to data conducted with fund-
ing  from  federal  grants.  Another  purpose  of  the  law  was  to  overturn  Forsham  v.
Harris,[12]  which  stood  for  the  principle  that  data  generated  by  a  privately  con-
trolled  organization  which  received  grant  funds  from  a  federal  agency  were  not
‘agency records’ accessible under the Freedom of Information Act.

The Data Quality Act (‘‘DQA’’), was inserted into the FY 2001 Consolidated Appro-
priations  Act.[13]  The  Data  Quality  Act  instructed  OMB  to  establish  guidelines  to
federal  agencies  for  ‘‘ensuring  and  maximizing  the  quality,  objectivity,  utility,  and
integrity  of  information  (including  statistical  information)  disseminated  by  federal
agencies.’’ Through its guidelines,[14] OMB directed agencies to establish ‘‘adminis-
trative mechanisms allowing affected persons to seek and obtain correction of infor-
mation maintained and disseminated by the agency.’’ To date, there appears to have
been  over  100  DQA  petitions  filed  with  numerous  federal  agencies.  OMB  does  not
compile  a  list  of  DQA  petitions,  so  ascertaining  the  exact  number  of  petitions  filed
is cumbersome. OMB Watch (www.ombwatch.org) keeps track of the individual peti-
tions filed at each agency, and maintains a comprehensive list of DQA petitions.

Two major questions concerning the DQA remain unresolved. The first is whether
the  DQA  applies  to  agency  rule-making.  It  is  clear  that  the  DQA  applies  to  agency
action  outside  the  rule-making  process  (for  instance,  agency  dissemination  of  infor-
mation  through  websites).  However,  there  is  no  guidance  in  the  actual  legislation
as to the applicability of the DQA to rule-making. There appears to be a consensus
position  across  the  federal  agencies  that  the  DQA  doesn’t  apply  to  rule-making,  as
the  rule-making  process  already  allows  for  public  comment.  Furthermore,  the  DQA
contains  no  reference  to  the  Administrative  Procedure  Act.  Nevertheless,  industry
petitioners have successfully used the DQA petition process to influence agency rule-
making. One instance involves the chemical atrizine. As a result of a DQA petition,
the EPA included a sentence in a scientific assessment of the risks of atrazine that
stated  hormone  disruption  cannot  be  considered  a  ‘‘legitimate  regulatory  endpoint
at  this  time.’’[15]  Atrazine  is  banned  in  Europe  precisely  because  of  the  evidence
that it is an endocrine disruptor. By attacking the science underlying potential rule-
making, the petitioners were able to avoid agency rule-making altogether.

Another  major  question  concerning  the  DQA  is  whether  DQA  petitions  are  judi-
cially reviewable. Thus far, the major case on the issue held that DQA petitions are
not  judicially  reviewable.[16]  However,  further  challenges  in  different  circuits  are
planned,  and  the  issue  may  not  be  fully  settled.  Judicial  review  of  DQA  petitions
would cause massive delays to the petition process.

DQA Based Regulations: OIRA developed two important new regulations based on
the Data Quality Act: OMB Peer Review Guidelines[17] and OMB Risk Assessment
Bulletin  (Proposed).  OMB’s  Peer  Review  Guidelines  dictate  that  ‘‘important  sci-
entific  information  shall  be  peer  reviewed  by  qualified  specialists  before  it  is  dis-
seminated by the Federal Government.’’ The guidelines apply to all ‘‘scientific infor-
mation  disseminations  that  contain  findings  or  conclusions  that  represent  the  offi-
cial position of one or more agencies of the Federal Government.’’ OMB’s guidelines
establish  minimum  peer  review  standards  for  federal  agencies.  Varying  require-
ments  for  peer  review  are  established  based  on  the  potential  influence  of  the  sci-
entific  information,  with  ‘‘highly  influential  scientific  assessments’’  receiving  the
strictest  peer  review  requirements.  OMB  asserts  its  legal  authority  to  impose  the

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00008 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

141

Peer Review Guidelines flows from the Data Quality Act’s direction to OMB to pro-
vide  guidance  for  federal  agencies  for  ‘‘ensuring  and  maximizing  the  quality,  objec-
tivity, utility and integrity of information’’ which is disseminated.

OIRA  recently  proposed  a  Risk  Assessment  Bulletin.[18]  This  has  not  yet  been
published in its final form. The Risk Assessment Bulletin establishes ‘‘quality stand-
ards for risk assessment disseminated by federal agencies.’’ Much like the Peer Re-
view Bulletin, the Risk Assessment guidelines have varying levels of quality stand-
ards.  There  is  one  set  of  standards  for  general  risk  assessments  and  another  set  of
stricter standards for influential risk assessments. Influential risk assessment is de-
fined  as  ‘‘a  risk  assessment  the  agency  reasonably  can  determine  will  have  or  does
have  a  clear  and  substantial  impact  on  important  public  policies  or  private  sector
decisions.’’  OMB  again  asserts  legal  authority  to  issue  the  bulletin  arises  from  the
Data  Quality  Act.  This  Risk  Assessment  proposal  was  soundly  rejected  by  the  Na-
tional Academy of Sciences in their January review. That step seems to have killed
the proposal.
Analysis

The  effect  of  the  Data  Quality  Act,  Peer  Review  Bulletin  and  Risk  Assessment
Bulletin  is  to  impose  an  additional  layer  of  regulatory  administration  on  agencies
that,  for  the  most  part,  already  have  strong  internal  guidelines  (at  least  for  peer
review and risk assessment). The result of this will likely be greater delay in agency
dissemination  of  information,  and  a  chilling  effect  that  might  discourage  agencies
from  attempting  to  disseminate  information  in  the  first  place.  The  bulletins  also
represent another step in OMB’s continuing effort to insert itself into agency affairs.
In  addition,  the  possibility  remains  that  OMB  will  attempt  to  use  its  authority
under the Data Quality Act to insert itself into the agency rule-making process. This
could  potentially  reek  havoc  on  the  rule-making  process,  and  create  years  of  new
legal  challenges  related  to  the  rule-making  process.  Needless  to  say,  that  would
cause significant slowdown of an already slow rule-making process.
References
[1] 42 Stat. 22, Ch. 18, Sec. 207. OMB currently resides at U.S.C. Title 31, Chapter

5 (31 U.S.C. Sec. 501).
[2] 53 Stat. 1423, Sec. 1.
[3] 84 Stat. 2085, Sec. 102(a), restated 88 Stat. 11, Sec. 1.
[4] 44 U.S.C. Chapter 35, P.L. 96–511, restated P.L. 104–13, 109 Stat. 163.
[5] 44 U.S.C. Sec 3503.
[6] P.L. 104–13, 109 Stat. 163.
[7] P.L. 105–277, 112 Stat 2681.
[8] P.L. 106–554, Sec. 515, 114 Stat. 2763.
[9] 44 U.S.C. Chapter 35, P.L. 96–511, restated P.L. 104–13, 109 Stat. 163.
[10] 44 U.S.C. Chapter 35, P.L. 104–13, 109 Stat. 163.
[11] P.L 105–277, 112 Stat. 2681.
[12] 445 U.S. 169 (1980).
[13] P.L. 106–554, 114 Stat. 2763(A).
[14] 67 FR 8452 (2002).
[15] Data Quality Law is Nemesis of Regulation, Washington Post, August 16, 2004.
[16] Salt Institute v. Michael O. Leavitt, 440 F.3d 156 (2006).
[17] 70 FR 2664 (2005).
[18] Notice  of  proposal  at:  71  FR  2600.  Text  of  the  proposed  bulletin  is  not  pub-

lished in the Federal Register.
[19] P.L. 105–277, 112 Stat. 2681.
[20] P.L. 106–554, Sec. 515, 114 Stat. 2763.
[21] 44 U.S.C. 3502(1).
[22] 67 FR 8460 (2002).

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00009 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

142

Chairman  MILLER.  Good  morning.  This  hearing  will  come  to
order.  Welcome  to  today’s  hearing  entitled  ‘‘Amending  Executive
Order  12866,  Good  Governance  or  Regulatory  Usurpation,  Part  II.’’
I want to welcome everyone to this hearing today on the role of the
Office  of  Information  and  Regulatory  Affairs,  OIRA,  in  overseeing
the development of regulations. The most powerful regulatory office
in Washington is the rarely noticed Office of Information and Regu-
latory Affairs. OIRA was created in the 1980 Paperwork Reduction
Act  with  a  mandate  to  reduce  the  paperwork  requirements  of  the
American  public.  Within  a  few  years  of  its  creation,  the  Reagan
White House had given expansive powers to the office to review all
regulatory  proposals  by  federal  agencies,  and  predictably,  an  office
supposedly  created  to  reduce  paperwork  put  standards  and  proce-
dures  in  place  that  required  agencies  to  generate  mountains  of
paper.  Congress  and  the  White  House  struggled  over  the  proper
role of OIRA all through the 1980s. Various Congressional commit-
tees  believe  that  OIRA  prevented  agencies  from  complying  with
statutory requirements to clean up the environment, to protect the
public and to make workplaces safer.

The  Clinton  Administration’s  Executive  Order  12866  resolved
some of the same aspects of that fight. This subcommittee took tes-
timony from a former director of OIRA, Sally Katzen, in February.
Ms. Katzen was the principal author of Executive Order 12866. She
testified  that  the  Clinton  Administration  order  assured  that  agen-
cies  carried  more  influence  over  the  substance  of  the  regulation
than  did  OIRA.  OIRA  could  ask  hard  questions,  ask  for  more  data
or  more  clarity,  but  in  the  end,  statutory  authority  and  expertise
was with the agency and OIRA must respect that.

Executive  Order  13422  is  a  new  chapter  in  OIRA’s  role  and
opens  again  some  of  the  issues  that  were  resolved  in  the  Clinton
Administration  order.  Under  this  order,  not  just  major  regulations
but  guidance  is  subject  to  review  by  OIRA  and  the  order  creates
a  new  requirement,  and  I  understand,  Mr.  Aitken,  you  will  testify
today it is not really new but it creates a new requirement, market
failure,  for  any  agency  to  promulgate  any  regulation.  Market  fail-
ure does not appear in any statute as a consideration of rule-mak-
ing  and  in  fact  Congress  flatly  rejected  that  argument,  that  the
market  will  work  things  out.  Given  time,  if  we  leave  it  alone,  the
market  will  work  it  out.  Congress  flatly  rejected  that  argument  by
enacting  legislation  that  granted  rule-making  authority.  The  order
also  requires  agencies  to  compose  annual  summaries  of  the  cumu-
lative  costs  of  proposed  regulations,  another  requirement  for  rule-
making that does not appear in statute, and the order creates with-
in  each  agency  a  regulatory  policy  officer  who  can  smother  regu-
latory  efforts  in  the  crib  before  an  agency  can  even  begin  consid-
ering  a  regulatory  action.  The  cumulative  effect  of  all  these
changes  is  to  seize  for  the  President  and  OIRA  power  over  regu-
latory  efforts  consistent  neither  with  statute  nor  the  Constitution.
Professor Strauss has it just right when he warns us that there are
many potential hazards on this path.

I want to hear what process was followed in developing this new
executive  order,  what  deficiencies  in  the  Clinton  Administration
Executive  Order  12866  this  new  order  is  designed  to  address,  and
how  OIRA  intends  to  apply  the  various  new  requirements.  I  want

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00010 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

143

to  also  hear  the  advantages  and  pitfalls  of  using  cost-benefit  anal-
ysis, market failure and even a regulatory budget as a tool for reg-
ulatory policy. The power given to regulatory policy officers is espe-
cially  troubling.  RPOs  are  presidential  appointees  with  political
ties.  OIRA  speaks  for  the  President  and  OIRA  has  set  out  an  eco-
nomic  standard  as  a  guide  to  regulatory  proposals,  a  standard  un-
supported  by  statute.  RPOs  will  address  that  standard  while  also
serving in agencies that have a statutory obligation that is entirely
different from the values and preferences of OIRA, or at least may
be.  Unlike  the  Clinton  Administration,  Executive  Order  13422  re-
quires  no  disclosure.  There  are  no  transparency  requirements  to
explain  the  actions  of  RPOs.  Mr.  Aitken,  in  your  testimony  today,
you  will  sing  the  praises  of  transparency  but  I  think  there  are
questions about how the RPO’s role is consistent with expectations
of transparency in government. Will we ever know in a pre-rule pe-
riod  what  has  happened,  who  has  spoken  with  him,  how  language
has  been  changed  in  an  proposal  or  what  proposed  rules  were
stopped  in  their  tracks  by  an  agency’s  RPO?  What  sort  of  discus-
sions may occur between OIRA and the RPO regarding OIRA’s ex-
pectations, and how would the Congress, much less the public, ever
learn  that  those  exchanges  had  occurred?  Deciding  issues  that  af-
fect the lives of millions of Americans in secret is incompatible with
our democratic traditions.

[The prepared statement of Chairman Miller follows:]

PREPARED STATEMENT OF CHAIRMAN BRAD MILLER

Good  morning,  I  want  to  welcome  everyone  to  Part  II  of  our  hearing  on  role  of
the  Office  of  Information  and  Regulatory  Affairs  in  overseeing  the  development  of
regulations.

The  most  powerful  regulatory  office  in  Washington  is  the  rarely  noticed  Office  of
Information  and  Regulatory  Affairs  (OIRA).  OIRA  was  created  in  the  1980  Paper-
work  Reduction  Act  with  a  mandate  to  reduce  the  paperwork  requirements  on  the
American  public.  Within  a  few  years  of  its  creation,  the  Reagan  White  House  had
given  expansive  powers  to  that  office  to  review  all  regulatory  proposals  by  federal
agencies.  Predictably,  an  office  supposedly  created  to  reduce  paperwork  put  stand-
ards and procedures in place that required agencies to generate mountains of paper.
Congress and the White House struggled over the proper role of OIRA all through
the  1980s.  Various  Congressional  Committees  believed  that  OIRA  prevented  agen-
cies  from  complying  with  statutory  requirements  to  clean  up  the  environment,  pro-
tect the public and make workplaces safer.

The Clinton Administration’s Executive Order 12866 resolved some of the aspects
of  that  fight.  This  Subcommittee  took  testimony  from  a  former  director  of  OIRA,
Sally Katzen, in February. Ms. Katzen was the principle author of E.O. 12866. She
testified  that  the  Clinton  Administration  Order  assured  that  agencies  carried  more
influence  over  the  substance  of  a  regulation  than  did  OIRA.  OIRA  could  ask  hard
questions, ask for more data or more clarity, but in the end statutory authority and
expertise reside in the agencies and OIRA must respect that.

Executive Order 13422 is a new chapter in OIRA’s role. Under this order, not just
major regulations, but guidance is subject to review by OIRA. And the order creates
a new requirement—‘‘market failure’’—for any agency to promulgate any regulation.
‘‘Market  failure’’  does  not  appear  in  any  statute  as  a  consideration  in  rule-making;
in fact, Congress flatly rejected the argument that the market will solve the problem
when Congress enacted the legislation granting rule-making authority.

The Order also requires agencies to compose annual summaries of the cumulative
costs of proposed regulations, another requirement for rule-making that does not ap-
pear in statute. And the Order creates within each agency a ‘‘Regulatory Policy Offi-
cer’’ who can smother regulatory efforts in the crib before an agency can even begin
considering a regulatory action. The cumulative effect of all these changes is to seize
for  the  President  and  OIRA  power  over  regulatory  efforts  consistent  neither  with
statute nor with the Constitution.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00011 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

144

Professor Strauss has it just right when he warns us that there are many poten-

tial hazards on this path.

I want to hear what process was followed in developing this new Executive Order,
what  deficiencies  in  E.O.  12866  is  this  designed  to  redress,  and  how  OIRA  intends
to apply these new requirements.

I want to hear the advantages, and pitfalls, of using cost benefit analysis, market

failure and even a regulatory budget as a tool for regulatory policy.

The  power  give  to  Regulatory  Policy  Officers  is  especially  troubling.  RPOs  are
Presidential appointees with political ties. OIRA speaks for the President and OIRA
has set out an economic standard as a guide to regulatory proposals, a standard un-
supported  by  statute.  RPOs  will  apply  that  standard  while  also  serving  in  agencies
that have statutory obligations that are entirely different from the values and pref-
erences of OIRA?

Unlike  the  Clinton  Administration  order,  Executive  Order  13422  requires  no  dis-
closure  requirements  to  actions  by  RPOs?  Will  we  ever  know,  in  that  pre-rule  pe-
riod,  what  has  happened,  who  has  spoken  with  whom  and  how  language  may  be
changed  in  a  proposal,  or  what  proposed  rules  were  stopped  in  their  tracks  buy  an
agency’s  RPO?  What  sort  of  discussions  may  occur  between  OIRA  and  the  RPO  re-
garding  OIRA’s  expectations  and  how  would  the  Congress,  much  less  the  public,
ever learn that those exchanges had occurred.

Deciding issues that affect the lives of millions of Americans in secret is incompat-

ible with our democratic traditions.

Chairman  MILLER.  With  that,  I  recognize  my  Ranking  Member

today, Mr. Sensenbrenner, for five minutes.

Mr.  ROHRABACHER.  Yes,  sir.  As  you  can  see,  Sensenbrenner  and

Rohrabacher look a little bit alike there.

Chairman MILLER. This fellow here.
Mr.  ROHRABACHER.  Okay.  You  won’t  try  to  pronounce  Rohr-

abacher, and I fully understand that.

Chairman MILLER. The gentleman from California.
Mr.  ROHRABACHER.  Well,  I  would  say  that  it  is  a  pleasure  to  be
with  you  today  but  I  actually  am  taking  the  spot  of  Mr.  Sensen-
brenner,  who  was  called  away  because  he  is  serving  as  Ranking
Member on the new Select Committee on Energy Independence and
Climate Change, so I am taking his spot while he is out doing some
other things that are equally important.

I  would  like  to  welcome  the  witnesses  and  I  understand  that
many of them actually testified before Congress on this topic before
this, some of them having testified before the Judiciary Committee
in  February.  I  am  also  glad  to  see  that  the  Administration  is  here
to  clear  up  any  misconception  either  side  of  the  aisle  may  have
about  some  of  the  proposals  that  have  been  made  by  the  Adminis-
tration.

I  served  on  the  Science  Committee  for  20  years  so  I  am  fully
aware of how science and research influence the regulatory process.
I  have  also  seen  how  several  administrations  have  chosen  to  orga-
nize and oversee the regulatory process. In the past each president
has  set  up  his  own  guidelines  when  taking  office.  With  that  in
mind, I think it is worth nothing that we are here today discussing
this  issue  in  the  seventh  year  of  the  current  Administration.  Up
until  this  point,  the  current  Administration  has  been  operating
under  President  Clinton’s  executive  order.  Furthermore,  the  new
executive  order  that  we  are  looking  at  today  simply  makes  minor
clarifications  and  leaves  the  vast  majority  of  the  Clinton  Adminis-
tration’s executive order in place, asking agencies to report work on
market failure and cost-benefit analysis. Well, they are already re-
quired  to  do  this.  It  doesn’t  seem  like  a  great  leap  in  a  new  direc-
tion  to  me.  Also,  if  we  are  going  to  have  a  regulatory  policy  and

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00012 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

145

if  we  are  going  to  have  officers  of  these  agencies  who  are  making
decisions,  which  is  what  the  previous  executive  orders  have  re-
quired, it might be a good idea to ensure that they are accountable
to  someone.  Ultimately,  all  executive  orders  only  stand  as  long  as
the current president is in office. Thus, the voters will have a way
to  determine  who  they  should  elect  as  president  of  the  United
States and who they will reelect based on the executive orders that
come out of the various candidates. In all likelihood, the next presi-
dent  will  modify  or  even  replace  the  particular  executive  orders
that we are talking about within a very short period of time, within
just a few years, or even a short period of time after the next elec-
tion, so just a very short period of time from now.

Viewing  this  topic  in  this  light,  I  think  that  the  issues  that  we
will  address  here  today  have  less  to  do  with  their  policy  implica-
tions  and  more  to  do  with  who  issued  these  policies.  That  being
said, I will certainly follow how this executive order is implemented
to ensure that public health and safety are observed and that there
continues to be a transparency and accountability in our regulatory
process,  and  again,  let  me  note  this.  When  President  Clinton  be-
came  president,  I  was  fortunate  enough  to  be  serving  in  Congress
at that time, the first thing he did was eliminate every U.S. attor-
ney,  fire  every  U.S.  attorney  without  explanation,  simply  firing
them,  and  there  has  been  a  big  brouhaha  about  President  Bush
getting  rid  of  several  U.S.  attorneys,  but  unfortunately,  Mr.
Gonzales  felt  compelled  to  offer  some  explanation,  which  now  has
put him into hot water. President Clinton chose not to offer any ex-
planations  of  that.  Well,  here  we  are  in  a  similar  situation  where
President Clinton offered executive orders, this is his right to do so,
and  this  President  seven  years  into  his  Administration  now  is  al-
tering  something  that  President  Clinton  did  immediately  upon  en-
tering  his  term  of  office  and  there  is  now  an  attempt  to  call  this
into question, and I would just guess that if it was any other presi-
dent  or  the  past  president  was  doing  this,  this  would  not  be  an
issue  because  the  President  has  a  right  to  issue  executive  orders.
With  that  said,  I  am  looking  forward  to  hearing  from  the  wit-

nesses.

[The statement of Mr. Rohrabacher follows:]

PREPARED STATEMENT OF REPRESENTATIVE DANA ROHRABACHER

Thank  you  Mr.  Chairman.  I  will  be  filling  in  for  Mr.  Sensenbrenner  today,  as  he
was  called  away  to  serve  as  Ranking  Member  on  the  Select  Committee  on  Energy
Independence and Climate Change.

I’d like to welcome our witnesses here today. I understand that, for many of them,
this  is  their  second  appearance  before  Congress  on  this  topic—having  testified  be-
fore the Judiciary Committee in February. I’m also glad to see that the Administra-
tion is here to clear up any misconceptions either side of the aisle may have.

I’ve  served  on  the  Science  Committee  for  almost  20  years,  so  I  am  fully  aware
of how science and research influence the regulatory process. I’ve also seen how sev-
eral Administrations have chosen to organize and oversee the regulatory process. In
the past, each President has set up his own guidelines upon taking office. With that
in  mind,  I  think  it’s  worth  noting  that  we  are  here  today  discussing  this  issue  in
the seventh year of the current Administration. Up until this point, the current Ad-
ministration  had  been  operating  under  President  Clinton’s  Executive  Order.  Fur-
thermore,  the  new  Executive  Order  that  we  are  looking  into  today  simply  makes
minor clarifications and leaves the vast majority of the Clinton Administration’s Ex-
ecutive  Order  in  place.  Asking  Agencies  to  report  work  on  ‘‘market  failure’’  and
‘‘cost-benefit analysis’’ that they are already required to do doesn’t seem like a giant
leap  to  me.  Also,  if  we  are  going  to  have  regulatory  policy  officers  at  agencies  as

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00013 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

146

the  previous  Executive  Order  required,  it  might  be  a  good  idea  to  ensure  that  they
are accountable to someone.

Ultimately all Executive Orders only stand as long as the current President is in
office.  In  all  likelihood,  the  next  President  will  modify,  or  even  replace  this  Execu-
tive  Order  in  a  few  years.  Viewing  this  topic  in  this  light,  I  think  that  the  issues
that  we  will  address  here  today  have  less  to  do  with  their  policy  implications,  and
more  to  do  with  who  issued  them.  That  being  said,  I  will  certainly  follow  how  this
Executive  Order  is  implemented  to  ensure  that  public  health  and  safety  are  pre-
served, and that there continues to be transparency and accountability in our regu-
latory process.

Chairman  MILLER.  Thank  you.  There  are  no  other  Members
here,  but  if  any  other  Members  of  the  Committee  wish  to  present
opening  statements  for  the  record,  we  can  receive  them  in  writing
and include those.

[The prepared statement of Mr. Costello follows:]

PREPARED STATEMENT OF REPRESENTATIVE JERRY F. COSTELLO

Good Morning. Thank you Mr. Chairman for calling a second hearing to examine
the President’s recent amendment to Executive Order 12866, which requires Federal
Government  agencies  to  submit  any  proposed  regulations  to  the  Office  of  Manage-
ment and Budget (OMB) for pre-approval. On Tuesday, February 13, 2007, the Sub-
committee  held  its  first  hearing  on  Executive  Order  12866.  The  February  hearing
provided  significant  testimony  highlighting  several  issues  worthy  of  further  work
and oversight.

Regulatory  authority  is  the  main  tool  Congress  has  used  to  charge  Executive
agencies with responsibilities to protect the environment, public health, safety in of
the workplace, the use of public lands and a number of other good purposes. I have
concerns  that  the  amendment  put  in  place  by  the  Bush  Administration  goes  one
step  further  than  the  current  process  by  requiring  agencies  to  identify  in  writing
the  specific  market  failure  or  problem  that  warrants  the  proposed  regulation  or
guidance.

I  look  forward  to  hearing  the  perspective  of  the  witnesses  on  how  the  Executive
Order developed and what are the consequences of changes to the language to Exec-
utive Order 12866.

I welcome today’s witnesses and look forward to their testimony.
Chairman  MILLER.  Mr.  Aitken,  with  that  bit  of  advice,  support
openness,  transparency  and  accountability  but  don’t  explain  your-
self  or  you  will  get  in  trouble.  We  welcome  your  testimony  today.
Steve  Aitken  is  the  general  counsel  for  the  Office  of  Information
and  Regulatory  Affairs,  OIRA,  the  Office  of  Management  and
Budget,  and  for  the  last  ten  months  Mr.  Aitken  has  served  as  the
acting  administrator  of  OIRA.  Mr.  Aitken,  your  oral  testimony  is
limited  to  five  minutes  but  your  entire  written  testimony  will  be
placed  in  the  record,  and  after  you  have  given  your  testimony,  the
Members  of  the  Committee  will  have  five  minutes  each  to  ask
questions. We do swear our witnesses. Mr. Aitken, do you have any
objection to being sworn in? Okay. You also have a right to be rep-
resented by counsel. Do you have counsel here today?

Mr. AITKEN. No.
Chairman  MILLER.  These  questions  are  designed  to  put  you  at

ease. Please stand and raise your right hand.

[Witness sworn]
Mr. ROHRABACHER. Would we note for the record that the people

on this side of the hearing are never sworn in that way?

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00014 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

147

Panel 1

TESTIMONY  OF  MR.  STEVEN  D.  AITKEN,  GENERAL  COUNSEL
FOR  THE  OFFICE  OF  INFORMATION  AND  REGULATORY  AF-
FAIRS, OFFICE OF MANAGEMENT AND BUDGET
Mr.  AITKEN.  Thank  you,  Mr.  Chairman.  Chairman  Miller,  Rep-
resentative  Rohrabacher  and  distinguished  Members  of  the  Sub-
committee, thank you for giving me the opportunity today to testify
before you on Executive Order 13422.

I  am  Steven  Aitken.  For  a  ten-month  period  starting  in  June  of
last  year  and  ending  at  the  beginning  of  this  month,  I  served  as
Acting  Administrator  of  the  Office  of  Information  and  Regulatory
Affairs.  I  have  worked  at  OMB  for  nearly  18  years.  Except  for  my
service as OIRA’s Acting Administrator, I have served in the Office
of  the  General  Counsel  at  OMB,  first  as  an  Assistant  General
Counsel  and  then  as  a  Deputy  General  Counsel.  I  am  testifying
today  in  my  capacity  as  the  former  Acting  Administrator  of  OIRA.
Earlier  this  year  the  President  issued  Executive  Order  13422,
which  made  several  amendments  to  Executive  Order  12866.  The
most  important  of  these  amendments  relate  not  to  the  regulations
that  federal  agencies  develop  but  rather  to  the  guidance  that  fed-
eral  agencies  develop.  In  addition,  on  that  same  day  the  OMB  di-
rector issued the Bulletin on Agency Good Guidance Practices. This
is  the  final  version  of  the  bulletin  that  OMB  issued  in  proposed
form  for  public  comment  in  November  of  2005.  As  I  note  in  my
written testimony, the draft bulletin received support from a broad
and  diverse  range  of  commenters  and  the  bulletin  reflects  good
guidance  principles  that  are  found  in  the  FDA’s  Good  Guidance
Regulations  and  that  have  been  supported  by  the  Administrative
Conference of the United States and by the American Bar Associa-
tion.

The Bulletin and Executive Order share a good government goal,
to improve the way that the Federal Government does business by
increasing  the  quality,  accountability  and  transparency  of  agency
guidance  documents  including  the  opportunity  for  the  public  to  re-
view  and  comment  on  guidance.  The  good  government  improve-
ments  that  are  made  by  the  bulletin  are  reinforced  by  the  recent
order  which  provides  for  a  relatively  informal  process  whereby
some  but  by  no  means  all  of  the  significant  guidance  documents
that are developed by agencies will be submitted to OMB for inter-
agency  review.  In  addition,  the  recent  order  makes  several  addi-
tional good government improvements. There has been some confu-
sion  in  the  press  and  elsewhere  about  these  changes  and  I  would
like to address those.

First,  concerns  have  been  raised  about  the  order’s  provisions  re-
garding regulatory policy officers. First, these officers are not new.
When President Clinton issued Executive Order 12866, he directed
each  agency  head  to  designate  a  regulatory  policy  officer.  In  addi-
tion, while the recent order specifies that these regulatory policy of-
ficers  will  be  presidential  appointees,  the  case  is  that  for  most  de-
partments and major regulatory agencies, they already were presi-
dential appointees subject to Senate confirmation.

In  addition,  concerns  have  been  expressed  regarding  the  recent
order’s  discussion  of  market  failure.  Before  explaining  what  this

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00015 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

148

amendment  does  do,  I  want  to  explain  first  what  it  does  not  do.
First,  the  concept  of  market  failure  is  not  new  to  Executive  Order
12866.  Instead,  it  has  been  an  integral  part  of  that  order  since
President  Clinton  issued  it  in  1993.  In  the  order,  as  issued  by
President Clinton, the President referred not once but twice to the
‘‘failures  of  private  market’’  as  a  justification  for  regulation.  That
is  the  same  thing  as  a  market  failure.  Second,  the  recent  order
does not make a market failure the only basis on which an agency
can justify regulatory action. Instead, the order expressly allows an
agency to identify as a justification for regulatory action any other
significant  problem  that  the  agency  intends  to  address.  That  is
what  the  recent  order  does  not  do.  What  it  does  do  is  include  in
Executive Order 12866 references to three classic examples of mar-
ket  failure,  namely  externalities,  market  power  and  lack  of  infor-
mation.  These  three  examples  are  not  new  to  the  implementation
of  Executive  Order  12866.  In  fact,  in  1996  then-OIRA  adminis-
trator Sally Katzen issued Best Practice Guidelines to the agencies
that  included  a  separate  discussion  of  market  failure,  and  those
guidelines discussed these three classic examples of market failure.
Some have expressed concern that the recent order could prevent
agencies from issuing regulations to protect public health and safe-
ty  but  this  is  not  correct.  Many  of  the  most  significant  regulations
that  agencies  issue  are  in  fact  in  response  to  market  failures.  For
example,  environmental  pollution  is  the  classic  example  of  an  ex-
ternality market failure. Another type of market failure stems from
a  lack  of  information.  In  response  to  this  kind  of  market  failure,
the  Food  and  Drug  Administration  issued  a  regulation  that  re-
quires  nutritional  labels  on  packaged  foods  to  display  the  amount
of trans fats in them. This rule was not driven by a specific statu-
tory mandate but by the market failure of lack of information.

Finally, I would like to mention that late yesterday the OMB di-
rector  and  the  OIRA  administrator  finalized  a  memorandum  to
agencies  that  provides  them  with  questions  and  answers  to  assist
them  in  the  implementation  of  the  recent  order  and  bulletin.  A
copy  of  the  memorandum  was  forwarded  to  the  Subcommittee  late
yesterday  and  it  is  being  posted  on  OMB’s  web  site  this  morning.
This  concludes  my  opening  statement.  I  would  welcome  any

questions that the Subcommittee has.

[The prepared statement of Mr. Aitken follows:]

PREPARED STATEMENT OF STEVEN D. AITKEN

Chairman Miller, Ranking Member Sensenbrenner, and distinguished Members of
this subcommittee, thank you for inviting me to this hearing and for giving me the
opportunity  to  testify  before  you  today  on  Executive  Order  13422,  in  which  the
President amended Executive Order 12866.

I am Steven D. Aitken. For a ten-month period, starting in June of last year and
continuing  into  the  first  week  of  this  month,  I  served  as  the  Acting  Administrator
of the Office of Information and Regulatory Affairs (OIRA), an office within the Of-
fice of Management and Budget (OMB). I have worked at OMB for nearly 18 years.
Except  for  my  service  as  OIRA’s  Acting  Administrator,  I  have  served  in  the  Office
of General Counsel at OMB, first as an Assistant General Counsel and then as Dep-
uty General Counsel. I am testifying today solely and exclusively in my capacity as
the former Acting Administrator of OIRA.

On  January  18th,  the  President  issued  Executive  Order  13422,  which  made  sev-
eral  amendments  to  Executive  Order  12866  on  ‘‘Regulatory  Planning  and  Review.’’
The most important of these amendments relate, not to the regulations that federal
agencies  develop,  but  rather  to  the  guidance  that  federal  agencies  develop  and  pro-

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00016 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

149

vide  to  the  public.  In  addition,  also  on  January  18th,  the  OMB  Director  issued  the
OMB  Bulletin  for  Agency  Good  Guidance  Practices.  This  is  the  final  version  of  the
bulletin that OMB issued in proposed form for public comment in November 2005.1
The Executive Order and Bulletin share a common goal: namely, the good-govern-
ment  objective  of  improving  the  way  that  the  Federal  Government  does  business—
by  increasing  the  quality,  public  participation,  and  accountability  of  agency  guid-
ance documents and their development and use. Moreover, the Bulletin and the new
Executive  Order  will  operate  in  a  complementary  fashion  to  improve  agency  guid-
ance documents.

For  this  reason,  in  order  to  explain  the  Executive  Order’s  guidance  provision,  it
is first necessary for me to outline briefly the common background for both the Bul-
letin  and  the  Executive  Order  and  then  to  explain,  again  briefly,  how  the  Bulletin
is  designed  to  improve  the  way  that  agency  guidance  documents  are  developed,
issued  and  used.  I  will  then  provide  a  description  and  explanation  of  the  Executive
Order’s guidance provision.

Following that, I will discuss and explain the recent Executive Order’s other non-
guidance provisions. Among the provisions that I will address are the Executive Or-
der’s  provisions  regarding  Regulatory  Policy  Officers,  market  failures,  and  formal
rule-makings. As part of my discussion of these provisions, I will seek to correct the
misunderstandings that have arisen regarding them.
Background  on  the  Good  Guidance  Provisions  of  the  Bulletin  and  Execu-

tive Order2

As  OMB  has  previously  stated,  agency  guidance  documents  can  have  ‘‘enormous
value.’’ 3 As OMB explained in 2002: ‘‘As the scope and complexity of regulation and
the problems it addresses have grown, so too has the need for government agencies
to inform the public and provide direction to their staffs. To meet these challenges,
agencies  have  relied  increasingly  on  issuing  guidance  documents.’’ 4 Guidance  docu-
ments are issued by agencies throughout the Federal Government, and they address
the  wide  range  of  societal  activities  that  are  affected,  in  one  way  or  the  other,  by
the  Federal  Government  and  its  programs.  Thus,  it  is  not  surprising  that,  depend-
ing  on  the  situation,  agency  guidance  can  be  addressed  to  individuals,  businesses
(both small and large), organizations, State, local, and tribal governments, and oth-
ers.

For  instance,  guidance  can  take  the  form  of  an  agency  explaining  to  members  of
the  public  how  they  can  participate  in  a  federal  program.  An  example  of  this  kind
of  guidance  is  the  Medicare  and  You  handbook  that  the  Centers  for  Medicare  and
Medicaid Services (CMS) distribute to Medicare beneficiaries annually.

Guidance  can  also  take  the  form  of  an  agency  providing  advice  and  assistance  to
members  of  the  public  about  recommended  actions  to  ensure  that  they  are  in  com-
pliance with federal laws and regulations. In addition to providing advice and assist-
ance  to  the  regulated  community  on  how  to  comply  with  the  agency’s  regulations,
such  guidance  also  furthers  consistency  and  fairness  in  an  agency’s  enforcement  of
its  regulations.5 Depending  on  the  context,  the  audience  for  this  guidance  can  in-
clude individuals, small entities (such as small businesses and organizations, as well
as local governments), large corporations, and/or State governments.

1 Executive  Order  13422  and  the  Final  Bulletin  are  published  in  the  Federal  Register  at,  re-
spectively, 72 FR 2763 (January 23, 2007), and 72 FR 3432 (January 25, 2007). OMB requested
public  comment  on  the  proposed  bulletin  at  70  FR  71866  (November  30,  2005),  and  extended
the comment period at 70 FR 76333 (December 23, 2005). These documents, along with the pub-
lic comments that OMB received on the proposal and the OMB Director’s memorandum issuing
the  Bulletin  (Memorandum  M–07–07),  are  available  on  OMB’s  website.  The  original  version  of
Executive  Order  12866,  issued  in  1993,  was  published  in  the  Federal  Register  at  58  FR  51735
(October  4,  1993).  Executive  Order  12866  was  previously  amended  once,  in  2002,  by  Executive
Order  13258,  which  was  published  in  the  Federal  Register  at  67  FR  9385  (February  26,  2002).
2 I  discussed  this  background  in  greater  depth  in  my  testimony  of  February  13,  2007,  before
the Subcommittee on Commercial and Administrative Law of the House Committee on the Judi-
ciary. That testimony is available on OMB’s website at http://www.whitehouse.gov/omb/legisla-
tive/testimony/oira/aitken¥02132007.pdf.

3 Office of Management and Budget, Stimulating Smarter Regulation: 2002 Report to Congress

on the Costs and Benefits of Federal Regulations (2002), p. 72.

4 Office of Management and Budget, Draft 2002 Report to Congress on the Costs and Benefits

of Federal Regulations, 67 FR 15014, 15034 (March 28, 2002).

5 ‘‘Guidance  documents,  used  properly,  can  channel  the  discretion  of  agency  employees,  in-
crease efficiency by simplifying and expediting agency enforcement efforts, and enhance fairness
by  providing  the  public  clear  notice  of  the  line  between  permissible  and  impermissible  conduct
while ensuring equal treatment of similarly situated parties.’’ Office of Management and Budget,
Draft  2002  Report  to  Congress  on  the  Costs  and  Benefits  of  Federal  Regulations,  id.,  67  FR  at
15034.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00017 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

150

Examples  of  this  type  of  guidance  are  the  compliance-assistance  guides  that  fed-
eral  agencies  prepare  and  make  available  to  small  businesses.  Congress  has  re-
quired  federal  agencies  to  prepare  and  issue  such  guidance  in  the  Small  Business
Regulatory  Enforcement  Fairness  Act  of  1996.6 In  addition,  Congress  in  the  Small
Business  Paperwork  Relief  Act  of  20027 assigned  to  OMB  the  responsibility,  which
is carried out by OIRA, of publishing annually in the Federal Register a notice that
refers  small  businesses  to  the  Internet  site  where  they  can  locate  the  compliance
assistance resources that federal agencies have prepared for their use.8

In sum, agency guidance documents are intended to—and do—have an impact on
society.  Depending  on  the  situation,  this  impact  can  be  relatively  small  or  can  be
very  substantial.  As  a  result,  while  it  is  the  case  that  guidance  documents  (unlike
regulations) are not legally binding on the public, agency guidance documents never-
theless  can  potentially  have  an  impact  on  society  that  is  of  comparable  magnitude
to the impact that regulations have on society.

In  recognition  of  the  impact  that  its  guidance  has  on  society,  the  Food  and  Drug
Administration  (FDA)  in  February  1997  issued  a  ‘‘Good  Guidance  Practices’’  docu-
ment  to  govern  how  the  FDA  develops,  issues,  and  uses  its  own  guidance  docu-
ments.9 Later that year, and building on this FDA policy, Congress in the Food and
Drug Administration Modernization Act of 199710 directed the FDA to issue a regu-
lation  by  2000  ‘‘specifying  the  policies  and  procedures  of  the  [FDA]  for  the  develop-
ment, issuance, and use of guidance documents.’’ 11 Following this directive, FDA in
early 2000 issued for public comment a proposed rule on Good Guidance Practices.12
After  it  reviewed  and  considered  the  public  comments,  FDA  finalized  the  rule  later
that year.13

The FDA’s Good Guidance Practices regulation is found at 21 C.F.R. § 10.115. Fol-
lowing the congressional direction in the 1997 Act, the FDA regulation provides that
FDA, among other things, shall seek public comment on its guidance documents, ei-
ther before or after their issuance (depending on their level of significance) and con-
sider  the  comments14;  shall  make  its  guidance  documents  easily  available  to  the
public by posting it on the Internet15; ‘‘must not include [in its guidance documents]
mandatory  language  such  as  ‘shall,’  ‘must,’  ‘required,’  or  ‘requirement,’  unless  FDA
is  using  these  words  to  describe  a  statutory  or  regulatory  requirement’’ 16;  ‘‘must
have  written  procedures’’  in  each  FDA  center  and  office  ‘‘for  the  approval  of  guid-
ance  documents,’’  which  procedures  ‘‘must  ensure  that  issuance  of  all  documents  is
approved  by  appropriate  senior  FDA  officials’’ 17;  and  must  provide  members  of  the
public with an opportunity to submit and seek resolution of a complaint ‘‘that some-
one at FDA did not follow the requirements in [the regulation] or. . .treated a guid-
ance document as a binding requirement.’’ 18 These FDA regulations went into effect
in October 2000, and therefore have now been in operation for six years.

In  sum,  as  I  have  just  outlined,  the  Congress  and  the  FDA  both  recognized  that,
because  of  the  impact  that  FDA’s  guidance  can  have  on  society,  it  was  important
that  FDA’s  guidance  be  subject  to  public  comment  (before  or  after  its  issuance);  be
readily available to the public; be developed through agency procedures that ensure
the  review  and  approval  of  appropriate  agency  officials  before  it  is  issued;  be  fol-
lowed  in  practice  by  agency  employees;  and  avoid  the  inclusion  of  language  that
would  suggest  to  the  public  that  the  document  is  mandatory  rather  than  what  it
actually  is—namely,  guidance.  It  should  also  be  noted  that  these  requirements,  in

6 P.L. 104–121, Title II, Subtitle A; 5 U.S.C. § 601 note.
7 P.L. 107–198, Section 2(a); 44 U.S.C. § 3504(c)(6).
8 OIRA  published  the  2006  notice  last  summer,  in  which  OIRA  explained  that  small  busi-
nesses can go to one Internet address (www.business.gov/sbpra) and find the compliance-assist-
ance  resources  that  are  available  from  the  15  Cabinet  Departments  and  25  other  federal  agen-
cies. See 71 FR 39691 (July 13, 2006).

9 62 FR 8961 (February 27, 1997).
10 P.L. 105–115, § 405; 21 U.S.C. § 371(h).
11 Id. § 371(h)(5).
12 65 FR 7321 (February 14, 2000) (proposed rule).
13 65 FR 56468 (September 19, 2000) (final rule).
14 21 C.F.R. § 10.115(g).
15 Id. This direction is consistent with the 2001 recommendation by the American Bar Associa-
tion.  3  American  Bar  Association,  ‘‘Recommendation  on  Federal  Agency  Web  Pages’’  (August
2001)  (agencies  should  maximize  the  availability  and  search  ability  of  existing  law  and  policy
on their websites and include their governing statutes, rules and regulations, and all important
policies,  interpretations,  and  other  like  matters  on  which  members  of  the  public  are  likely  to
request).

16 Id. § 10.115(i)(2).
17 Id. § 10.115(j).
18 Id. § 10.115(o).

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00018 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

151

particular  the  requirements  for  internal-agency  review  and  approval  and  for  public
comment, help to ensure that guidance documents are of high quality.

The FDA Good Guidance Practices regulation also addresses concerns that courts
have raised about the improper development and use of agency guidance documents.
In its 2000 decision in the Appalachian Power case, the United States Court of Ap-
peals for the District of Columbia Circuit discussed these concerns:

‘‘The  phenomenon  we  see  in  this  case  is  familiar.  Congress  passes  a  broadly
worded statute. The agency follows with regulations containing broad language,
open-ended phrases, ambiguous standards and the like. Then as years pass, the
agency issues circulars or guidance or memoranda, explaining, interpreting, de-
fining  and  often  expanding  the  commands  in  regulations.  One  guidance  docu-
ment may yield another and then another and so on. Several words in a regula-
tion  may  spawn  hundreds  of  pages  of  text  as  the  agency  offers  more  and  more
detail  regarding  what  its  regulations  demand  of  regulated  entities.  Law  is
made,  without  notice  and  comment,  without  public  participation,  and  without
publication in the Federal Register or the Code of Federal Regulations.’’

Appalachian  Power  Co.  v.  EPA,  208  F.3d  1015,  1019  (D.C.  Cir.  2000)  (striking
down  emissions  monitoring  guidance  as  legislative  rule  requiring  notice  and  com-
ment).19
OMB’s Issuance of the Proposed and Final Bulletin:

OMB believes that federal agency guidance should be developed, issued and used
through  an  agency’s  adherence  to  procedures  that  ensure  quality,  transparency,
public  participation,  coordination,  and  accountability.  For  this  reason,  OMB  devel-
oped (in consultation with federal agencies) a draft OMB Bulletin that would estab-
lish  as  government-wide  policy  a  set  of  ‘‘best  practices’’  for  achieving  these  goals.
As  I  earlier  noted,  OMB  then  sought  public  comment  on  this  draft  bulletin  by
issuing  it  in  November  2005  as  a  proposal  for  public  comment.20 OMB  received  31
public  comments  on  the  proposal,  and  these  comments  are  available  on  OMB’s
website.  These  comments  were  largely  positive,  and  reflected  the  diverse  nature  of
federal  guidance  documents  and  the  groups  in  American  society  that  are  affected
by  them.  Below  are  examples  of  some  of  the  associations  that  submitted  comments
(as noted below, these listed associations supported OMB’s development of a bulletin
on  Good  Guidance  Practices,  while  also  providing  their  suggestions  for  how  OMB
could improve the bulletin):

— the Association of American Medical Colleges, representing  all  125  ac-
credited  U.S.  medical  schools,  nearly  400  major  teaching  hospitals  and
health  systems,  and  94  academic  and  scientific  societies  (‘‘The  AAMC  com-
mends  the  OMB  for  its  proposal  to  establish  consistent  and  appropriate
standards  for  developing  good  guidance  practices  within  federal  agencies.’’);
— the  National  Association  of  Home  Builders,  representing  more  than
220,000  members  involved  in  home  building,  remodeling.  multifamily  con-
struction,  property  management,  subcontracting,  design,  housing  finance,
building  product  manufacturing  and  other  aspects  of  residential  and  light
commercial  construction  (‘‘The  National  Association  of  Home  Builders
(NAHB)  would  like  to  thank  the  Office  of  Management  and  Budget  (OMB)
for  proposing  a  process  to  bring  transparency  and  consistency  to  Executive
Branch  activities  that  affect  the  public  directly,  but  do  not  qualify  as  rules
under the Administrative Procedure Act (APA).’’);

— the American Society of Safety Engineers, representing 30,000 members
(‘‘ASSE  commends  OMB/OIRA  for  taking  a  proactive  stance  to  ensure  that
agencies  can  readily  provide  interpretation  and  guidance  of  regulations,  but
still do so in a manner that affords due process to the regulated community
and that is in accordance with the requisites of the Administrative Procedure
Act, 5 USC 551 et seq.’’);

— the  National  Funeral  Directors  Association,  representing  more  than
11,000 funeral homes in all 50 states (‘‘NFDA supports the Office of Manage-
ment  and  Budget  (OMB)  proposal  to  establish  standards  to  increase  the

19 See  also  Gen.  Elec.  Co.  v.  EPA,  290  F.3d  377  (D.C.  Cir.  2002)  (striking  down  PCB  risk  as-
sessment  guidance  as  legislative  rule  requiring  notice  and  comment);  Chamber  of  Commerce  v.
Dept. of Labor, 174 F.3d 206 (D.C. Cir. 1999) (striking down OSHA Directive as legislative rule
requiring notice and comment).

20 70 FR 71866 (November 30, 2005).

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00019 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

152

quality and transparency of agency guidance practices and the guidance doc-
uments produced through them.’’);

— the  Association  of  Metropolitan  Planning  Organizations  (‘‘In  general,
AMPO  strongly  supports  the  Proposed  Bulletin’s  intent  and  reliance  on  the
guidance practices adopted by the Food & Drug Administration (‘FDA’) at 21
C.F.R. 5 10.115.’’);

— the Ornithological Council, which consists of eleven leading scientific or-
nithological  societies—the  American  Ornithologists’  Union,  Association  of
Field  Ornithologists,  CIPAMEX,  Cooper  Ornithological  Society,  Neotropical
Ornithological  Society,  Pacific  Seabird  Group,  Raptor  Research  Foundation,
Society  of  Canadian  Ornithologists/La  Socie´te´ des  Ornithologistes  du  Can-
ada, Society for Caribbean Ornithology, Waterbird Society, and Wilson Orni-
thological  Society—that  together  have  a  membership  of  nearly  6,500  orni-
thologists (‘‘we would like to express our gratitude to OIRA for its efforts to
improve agency guidance practices’’);

— the  Aircraft  Owners  and  Pilots  Association,  representing  over  407,000
members  (‘‘AOPA  shares  OMB’s  concern  that  agency  guidance  practices
should be more transparent, consistent and accountable. We also agree with
OMB  that  the  absence  of  procedural  review  mechanisms  undermines  the
lawfulness, quality, fairness and accountability of agency policy-making.’’);

— the  National  Leased  Housing  Association,  which  represents  the  inter-
ests  of  housing  agencies,  developers,  lenders,  housing  managers  and  others
in  providing  federally  assisted  rental  housing,  and  whose  members  are  pri-
marily involved in the Section 8 housing programs and are involved with the
operation  of  rental  housing  for  over  three  million  families  (‘‘we  commend
OMB for its efforts’’);

— the  American  Road  and  Transportation  Builders  Association,  whose
membership  includes  public  agencies  and  private  firms  and  organizations
that own, plan, design, supply and construct transportation projects through-
out  the  country  (‘‘Once  again,  ARTBA  is  extremely  supportive  of  the  GGP
and feels that it represents a significant step forward in the regulatory proc-
ess.  It  will  engender  fairness  and  improved  dialogue  between  agencies  and
those  that  have  a  vital  stake  in  the  guidance  they  issue.  ARTBA  and  our
members  are  eager  to  take  advantage  of  the  new  opportunities  for  involve-
ment  in  the  guidance  process  offered  by  the  GGP  and  help  OMB  make  the
GGP standard agency practice.’’); and

— the Associated Equipment Distributors, representing 1,200 construction
equipment distributors, manufacturers and industry-service firms (‘‘ Our as-
sociation  thanks  the  Office  of  Management  and  Budget  (OMB)  for  recog-
nizing the impact that guidance material issued by federal regulatory agen-
cies  has  on  the  regulated  community.  We  agree  with  the  OMB  that  trans-
parency  in  the  guidance  drafting  process  is  critical,  as  guidance  should  not
be used for rule-making.’’).

As I have indicated, the comment letters from these associations can be found on

OMB’s website, along with the other comment letters on the proposed bulletin.21

On  January  18th  of  this  year,  after  considering  the  public  comments  and  after
further  consultation  with  federal  agencies,  the  OMB  Director  issued  the  Final  Bul-
letin on Agency Good Guidance Practices.22 The final version of the Bulletin is very
similar to the proposal in its overall framework, but—as OMB explained in the pre-
amble  to  the  final  Bulletin—OMB  made  a  number  of  improvements  to  the  Bulletin
in  response  to  comments  that  we  received  from  the  public  and  during  the  inter-
agency review process.

21 OMB  also  received  comments,  some  supporting  and  others  opposing  the  proposed  bulletin,
from  the  following  (in  alphabetical  order):  the  Aeronautical  Repair  Station  Association,  the
American Bar Association, the American Chemistry Council, the American Composites Manufac-
turers  Association,  the  American  Petroleum  Institute,  AMGEN,  C.  Blake  McDowell  (Professor
of  Law),  Citizens  for  Sensible  Safeguards  (OMB  Watch),  Coalition  for  Effective  Environmental
Information,  Consumer  Specialty  Products  Association,  General  Electric  Company,  Keller  and
Heckman LLP, McKenna Long & Aldridge LLP, Mercatus Center, National Mining Association,
Natural  Resources  Defense  Council,  PIMA  County  (AZ)  Wastewater  Management  Department,
Regulatory  Checkbook,  Sanofi-aventis,  Stuart  Shapiro  Ph.D.  (Edward  J.  Bloustein  School  of
Planning and Public Policy, Rutgers University), U.S. Chamber of Commerce.

22 OMB  Memorandum  M–07–07  (January  18,  2007),  which  is  found  on  OMB’s  website.  The

final Bulletin is published in the Federal Register at 72 FR 3432 (January 25, 2007).

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00020 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

153

The following are a few of the noteworthy provisions of the Bulletin, which reflect
the requirements of the FDA’s Good Guidance Practices regulation and are designed
to  improve  the  quality,  transparency,  public  participation,  and  accountability  of
agency guidance documents:

• Each  agency  will  ensure  (as  agencies  should  be  doing  anyway,  as  a  matter
of  good  internal  management)  that  appropriate  officials  within  the  agency
have  reviewed  and  approved  the  agency’s  issuance  of  ‘‘significant’’  guidance
documents;
• Agencies  will  maintain  on  their  websites  current  lists  of  their  ‘‘significant’’
guidance documents that are in effect, so that the public can know what guid-
ance applies to them;
• Agencies will provide the public with access to and the opportunity to provide
feedback on their ‘‘significant’’ guidance documents. Agencies will advertise on
their  websites  a  means  for  the  public  to  submit  comments  electronically  on
these guidance documents; and
• For those guidance documents that are ‘‘economically significant’’ (e.g., a guid-
ance  document  that  ‘‘may  reasonably  be  anticipated  to  lead  to  an  annual  ef-
fect on the economy of $100 million or more’’), agencies will publish drafts of
the  documents  in  the  Federal  Register,  invite  public  comment  on  them,  and
prepare responses to the comments before finalizing the guidance.

In  recognition  of  the  potentially  broad  range  of  guidance  documents  that  are
issued  by  federal  agencies,  the  Bulletin  also  (1)  includes  certain  express  exclusions
from  the  definition  of  ‘‘significant’’  and  ‘‘economically  significant’’  guidance  docu-
ment; (2) authorizes OMB to exempt ‘‘economically significant documents’’ (singly or
by category) from the requirement for prior public comment before issuance; and (3)
includes an express exception from the Bulletin’s requirements for ‘‘emergency situ-
ations  or  when  an  agency  is  obligated  by  law  to  act  more  quickly  than  normal  re-
view procedures allow.’’

In light of concerns that have been raised about the final Bulletin and the Execu-
tive  Order,  this  last  point  bears  emphasis.  The  Bulletin  does  not  stand  in  the  way
of a federal agency responding appropriately to an emergency situation. In addition,
the Bulletin does not override a federal agency’s obligation to comply with applicable
laws.
Executive Order 13422
The Executive Order’s Guidance Provision

In  the  furtherance  of  its  goal  to  improve  the  guidance  documents  that  federal
agencies  develop  and  issue,  the  Bulletin  is  reinforced  by  the  principal  provision  in
Executive Order 13422, which the President issued, also on January 18th. Through
an  amendment  to  Executive  Order  12866,  which  President  Clinton  issued  in  1993,
the recent executive order provides for a relatively informal process whereby federal
agencies  will  submit  to  OMB,  for  interagency  review,  some—but  by  no  means  all—
of the ‘‘significant guidance documents’’ that they develop.

It  is  important  to  underscore  the  point  that  this  amendment  provides  for  an  op-
portunity  for  interagency  review,  and  therefore  that  guidance  documents  are  not
treated  the  same  as  regulations.  When  he  issued  Executive  Order  12866  in  1993,
President  Clinton  directed  agencies  to  submit  the  drafts  of  all  of  their  ‘‘significant’’
regulations  to  OIRA  for  review  (subject  to  certain  limited  exceptions).  By  contrast,
agencies  are  not  required  under  the  recent  amendments  to  submit  all  of  their  ‘‘sig-
nificant’’ guidance documents to OMB for review. Instead, the recent executive order
requires  agencies  to  inform  OMB  of  upcoming  significant  guidance  documents,
which thereby provides an opportunity for interagency review to occur.

In  this  regard,  just  as  the  new  Bulletin  directs  agencies  to  follow  good  guidance
practices  that,  to  a  greater  or  lesser  extent,  are  probably  being  followed  by  many
agencies  for  many  of  their  guidance  documents  (e.g.,  posting  them  on  the  agency’s
website), the recent Executive Order—in recognizing the desirability of ensuring an
opportunity for interagency review—also reflects a practice that already happens in
a number of situations.

In  other  words,  interagency  review  of  important  guidance  documents  is  not  new.
And, one reason why such review is desirable, and already happens, is because the
programs and activities of one federal agency often overlap or have implications for
the  programs  and  activities  of  one  or  more  other  federal  agencies.  For  example,  in
June  of  last  year,  the  Department  of  Health  and  Human  Services  (HHS)  issued  a
State  Medicaid  Director  letter  that  provides  guidance  on  the  implementation  of  the
provision  in  the  Deficit  Reduction  Act  of  2005  that  requires  individuals  claiming
U.S.  citizenship  to  provide—when  initially  applying  for  Medicaid  or  upon  the  first

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00021 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

154

redetermination—satisfactory  documentary  evidence  of  citizenship  or  nationality.
Before  HHS  finalized  and  issued  this  guidance,  OMB  ensured  that  HHS  consulted
first with affected and interested agencies—the Departments of State and Homeland
Security,  and  the  Social  Security  Administration.  This  interagency  consultation,
which  took  place  in  a  two-week  period,  ensured  that  HHS  had  the  benefit  of  the
expertise  and  experience  of  these  other  agencies  and  that  the  HHS  guidance  took
into account their interests and programs.

This interagency coordination, then, had the effect of improving the quality of the
HHS  guidance  in  the  same  way  that  the  quality  of  guidance  can  be  improved
through  public  participation  and  internal-agency  review  and  approval.23 Thus,  by
ensuring that there is an opportunity for interagency review, this amendment made
by Executive Order 13422 serves as a complement to the requirements in the OMB
Bulletin for public participation and internal-agency review and approval.

In  addition,  as  OMB  explained  in  March  2002,  interagency  review  of  a  guidance
document  is  also  justified  because  ‘‘interagency  review  can  ensure  that  agency  ac-
tion  is  consistent  with  Administration  policy  and  is  beneficial  from  a  broader,  soci-
etal  perspective.’’ 24 This  type  of  review  during  the  development  of  agency  guidance
documents  is  entirely  appropriate,  for  the  same  reason  that  the  courts  have  held
that  it  is  appropriate  to  conduct  this  same  type  of  review  during  the  development
of agency regulations. As the United States Court of Appeals for the District of Co-
lumbia Circuit explained in 1981 (in an opinion by Judge Wald):

‘‘The court recognizes the basic need of the President and his White House staff
to  monitor  the  consistency  of  executive  agency  regulations  with  Administration
policy.  He  and  his  White  House  advisers  surely  must  be  briefed  fully  and  fre-
quently about rules in the making, and their contributions to policy-making con-
sidered.  The  executive  power  under  our  Constitution,  after  all,  is  not  shared—
it rests exclusively with the President.

*

*

*

‘‘The authority of the President to control and supervise executive policy-making
is derived from the Constitution; the desirability of such control is demonstrable
from  the  practical  realities  of  administrative  rule-making.  Regulations  such  as
those  involved  here  demand  a  careful  weighing  of  cost,  environmental,  and  en-
ergy  considerations.  They  also  have  broad  implications  for  national  economic
policy.  Our  form  of  government  simply  could  not  function  effectively  or  ration-
ally  if  key  executive  policy-makers  were  isolated  from  each  other  and  from  the
Chief  Executive.  Single  mission  agencies  do  not  always  have  the  answers  to
complex  regulatory  problems.  An  overworked  administrator  exposed  on  a  24-
hour  basis  to  a  dedicated  but  zealous  staff  needs  to  know  the  arguments  and
ideas of policy-makers in other agencies as well as in the White House.’’

Sierra  Club  v.  Costle,  657  F.2d  298,  404,  405–06  (D.C.  Cir.  1981).25 In  that  deci-
sion,  the  D.C.  Circuit  upheld  the  appropriateness  of  discussions  between  the  White
House  and  the  Environmental  Protection  Agency,  regarding  a  draft  Clean  Air  Act
rule.  These  discussions  took  place—and  EPA  issued  the  rule—in  1979,  during  the
Administration of President Carter.

The Executive Order’s Non-Guidance Provisions

In  addition  to  providing  an  opportunity  for  interagency  review  of  draft  guidance
documents,  the  recent  Executive  Order  makes  several  (non-guidance  related)  proc-
ess  improvements.  As  is  the  case  with  the  guidance  amendments  in  the  Executive
Order and the new Bulletin, these process improvements are designed to encourage
good-government practices. Because there has been some confusion in the press and
elsewhere as to the meaning and impact of these changes, let me briefly go through
them.

23 OMB made this same general point in March 2002 when OMB asked the public to identify
examples  of  ‘‘problematic  guidance  documents’’  that  would  be  potential  candidates  for  reform.
Office  of  Management  and  Budget,  Draft  2002  Report  to  Congress  on  the  Costs  and  Benefits
of  Federal  Regulations,  67  FR  15014,  15035  (March  28,  2002)  (‘‘problematic  guidance  might  be
improved by interagency review’’).

24 Office of Management and Budget, Draft 2002 Report to Congress on the Costs and Benefits

of Federal Regulations, id., 67 FR at 15035.

25 See  also  Chevron  v.  NRDC,  467  U.S.  837,  865  (1984)  (‘‘an  agency  to  which  Congress  has
delegated  policy-making  responsibilities  may,  within  the  limits  of  that  delegation,  properly  rely
on the incumbent administration’s views of wise policy to inform its judgments’’).

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00022 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

i. Regulatory Policy Officers

155

Concerns have been raised about the provisions in Executive Order 13422 regard-
ing  Regulatory  Policy  Officers.  The  initial  point  that  should  be  made  is  that  such
officers are not new; when he issued Executive Order 12866 in 1993, President Clin-
ton  directed  each  agency  head  to  designate  a  Regulatory  Policy  Officer  within  the
agency. Nor is it new that, under the recent amendment, Regulatory Policy Officers
will  be  Presidential  appointees.  While  the  original  E.O.  12866  did  not  require  that
agency  heads  choose  a  Presidential  appointee  to  be  the  agency’s  Regulatory  Policy
Officer, the fact is that, in many departments and major agencies, the agency head
did choose a Presidential appointee to serve as the Regulatory Policy Officer.

And,  the  term  ‘‘Presidential  appointee’’  should  not  be  confused  with  ‘‘political  ap-
pointee.’’  Presidential  appointees  are  appointed  by  the  President,  whereas  agency
heads  appoint  ‘‘political  appointees’’  who  are  in  the  non-career  Senior  Executive
Service or are under Schedule C; these agency-head appointees are not Presidential
appointees. Moreover, neither the President nor an agency head can create a Presi-
dentially-appointed  position  in  an  agency.  Rather,  only  Congress  can  do  so.  And,
when  Congress  does  create  a  Presidentially-appointed  position  in  an  agency,  Con-
gress  usually  provides  that  this  appointee  shall  be  subject  to  Senate  confirmation
(a PAS official). Thus, by requiring that agency heads designate a Regulatory Policy
Officer  from  among  the  agency’s  Presidential  appointees,  the  President  is  ensuring
that,  in  most  (if  not  all)  cases,  the  Regulatory  Policy  Officer  will  be  a  PAS  official.
In  addition,  concerns  have  been  raised  that  Executive  Order  13422  may  require
each  agency  to  establish  a  new  ‘‘Regulatory  Policy  Office’’  that  would  be  headed  by
the  agency’s  Regulatory  Policy  Officer.  I  would  like  to  allay  such  concerns  by  ex-
plaining  that  this  reference  to  an  ‘‘Office’’  was  a  typographical  error.  The  reference
should have been to a Regulatory Policy ‘‘Officer’’ rather than ‘‘Office’’; the Executive
Order is being implemented accordingly.

I would also like to make three other points regarding the Regulatory Policy Offi-
cers. First, Executive Order 13422 places no restrictions on an agency head’s discre-
tion in choosing which Presidential appointee within the agency to designate as the
agency’s Regulatory Policy Officer. It is the agency head’s decision to make.

Second,  some  have  raised  a  concern  that  the  deletion  by  Executive  13422  of  the
‘‘report to the agency head’’ phrase (that had been in Executive Order 12866) means
that  the  Regulatory  Policy  Officer  will  no  longer  report  to  the  agency  head.  This  is
not  correct.  The  deletion  of  this  language  does  not  change  the  fact  that  the  Regu-
latory  Policy  Officer  reports  to  the  agency  head.  As  before,  the  agency  head  con-
tinues  to  be  the  official  who  designates  which  official  shall  serve  as  the  agency’s
Regulatory Policy Officer, and that designated official will continue to report to the
agency head in performing this role, just as that official reports to the agency head
in  performing  his  or  her  other  responsibilities.  The  ‘‘report  to  the  agency  head’’
phrase  was  deleted  (as  indicated  above,  without  substantive  impact)  in  the  course
of  amending  the  Executive  Order’s  provision  on  the  Regulatory  Policy  Officer  to  in-
clude  the  requirements  that  the  Regulatory  Policy  Officer  be  a  Presidential  ap-
pointee,  that  the  agencies  need  to  inform  OMB  of  the  designations,  and  that  the
agencies need to provide OMB with annual updates on the designations.

Third, some have suggested that the designation of an agency official as the Regu-
latory  Policy  Officer  means  that  these  officials  (in  the  case  of  PAS  officials)  must
be subject to a new Senate confirmation. My understanding is that an official’s des-
ignation as the Regulatory Policy Officer does not require that the official be subject
to  a  new  Senate  confirmation.  PAS  officials  periodically  are  assigned  additional  re-
sponsibilities (either through statute, executive order, or otherwise), and the assign-
ment of such responsibilities do not require these officials to be confirmed again.

ii. Commencement of a Rule-making

Executive Order 13422 amends Executive Order 12866 to require that an agency’s
commencement  of  a  rule-making  be  either  authorized  by  the  agency  head  or  ap-
proved  by  the  agency’s  Regulatory  Policy  Officer.  As  explained  above,  most  if  not
all  of  the  Regulatory  Policy  Officers  will  be—as  they  generally  have  been  over  the
years—Presidential  appointees  who  are  subject  to  Senate  confirmation.  In  practice,
then,  this  will  mean  that,  in  most  if  not  all  cases,  an  agency’s  commencement  of
a rule-making will be authorized or approved by an agency official who is appointed
by the President and subject to Senate confirmation.

iii. Aggregation of annual costs and benefits in the Regulatory Plan

Section  4  of  President  Clinton’s  Executive  Order  12866  established  a  ‘‘Planning
Mechanism’’ that includes an annual Regulatory Plan that reports the most signifi-
cant  regulatory  actions  anticipated  in  the  coming  year  and  thereafter,  along  with
the  agency’s  estimate  of  each  rule’s  anticipated  benefits  and  costs.  Executive  Order

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00023 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

156

13422  amends  this  section  to  ask  agencies,  in  addition,  to  aggregate  the  estimated
costs  and  benefits  of  the  individual  regulations.  While  the  interested  public  could
always  sum-up  for  themselves  the  cost  and  benefit  estimates  for  each  of  the  indi-
vidual  rules,  this  amendment  enhances  the  transparency  of  the  annual  Regulatory
Plan by requiring the agencies to do the aggregation.

iv. The Encouragement of Agencies to Consider Formal Rule-making

Another  of  the  amendments  in  Executive  Order  13422  encourages  rule-making
agencies  to  consider  using  the  Administrative  Procedure  Act’s  formal—rather  than
informal—rule-making procedures for the agency’s resolution of complex determina-
tions. Agencies already had the option of using the APAs’ formal rule-making proce-
dures,  and  this  amendment  simply  encourages  them  to  consider  the  use  of  a  tool
that has been—and remains—available to them.

v. Market Failure

Executive  Order  13422  amended  Section  1(b)(1)  of  Executive  Order  12866,  which
was—and  remains—the  first  of  that  Order’s  ‘‘Principles  of  Regulation.’’  As  recently
amended, Section 1(b)(1) now states that: ‘‘Each agency shall identify in writing the
specific  market  failure  (such  as  externalities,  market  power,  lack  of  information)  or
other  specific  problem  that  it  intends  to  address  (including,  where  applicable,  the
failures of public institutions) that warrant new agency action, as well as assess the
significance  of  that  problem.’’  Before  explaining  what  this  amendment  does  do,  I
would like to explain first what it does not do.

First,  the  concept  of  market  failure  is  not  new  to  this  amendment,  but  instead
has  been  an  integral  part  of  Executive  Order  12866  since  President  Clinton  issued
it in 1993. Indeed, the overarching ‘‘Statement of Regulatory Philosophy,’’ in Section
1(a)  of  the  original  Executive  Order  12866  (unchanged  by  E.O.  13422),  states  that
‘‘Federal  agencies  should  promulgate  only  such  regulations  as  are  required  by  law,
are necessary to interpret the law, or are made necessary by compelling public need,
such  as  material  failures  of  private  markets  to  protect  or  improve  the  health  and
safety  of  the  public,  the  environment,  or  the  well-being  of  the  American  people’’
(italics added). Furthermore, the first ‘‘Principle of Regulation’’ that was articulated
in  Section  1(b)  of  the  original  Executive  Order  12866  reiterated  the  requirement
that  each  agency  ‘‘identify  the  problem  that  it  intends  to  address  (including,  where
applicable,  the  failures  of  private  markets  or  public  institutions  that  warrant  new
agency action) as well as assess the significance of that problem’’ (italics added).

Second,  the  recent  Executive  Order  does  not  make  the  identification  of  a  market
failure  the  only  basis  on  which  a  federal  agency  can  justify  regulatory  action.  The
revised  section  also  encourages  agencies  to  identify  any  ‘‘other  significant  problem
it  intends  to  address.’’  For  example,  important  social  benefits  are  provided  by  the
federal regulations that govern the delivery of federal assistance to disaster victims,
but  these  regulations  do  not  address  a  market  failure,  per  se.  Moreover,  the  recent
Executive  Order  leaves  untouched  the  provision  in  Executive  Order  12866  that  ex-
pressly  directs  federal  agencies  to  ‘‘promulgate. . .such  regulations  as  are  required
by law, [or] are necessary to interpret the law.’’ In many cases, when a federal agen-
cy  is  issuing  a  regulation,  the  agency  is  doing  so  for  just  those  law-based  reasons,
and  this  will  continue  to  be  the  case;  nothing  in  Executive  Order  13422  changes
this.

Having explained what the revised ‘‘market failure’’ language does not do, I would
like  to  now  explain  what  it  actually  does  do,  which  is  two  relatively  modest  things.
First, Executive Order 13422 states that the agency ‘‘shall identify in writing’’ the
problem—whether it is a market failure ‘‘or other specific problem’’—that the agency
‘‘intends  to  address’’  through  regulatory  action.  Stating  explicitly  that  federal  agen-
cies  shall  identify  ‘‘in  writing’’  the  problem  that  the  agency  is  seeking  to  remedy
through regulatory action does not impose a new requirement on rule-making agen-
cies.  An  agency  should  already  have  been  identifying  in  writing  the  precise  nature
of  the  problem  that  the  agency  is  seeking  to  remedy  through  regulatory  action,  in
order  to  assist  the  agency  in  its  own  analysis  of  whether  regulatory  action  is  war-
ranted  and,  if  so,  which  of  the  available  regulatory  alternatives  would  best  accom-
plish the agency’s intended result.

Thus,  in  order  to  comply  with  the  original  version  of  Section  1(b)(1)  of  Executive
Order  12866,  agencies  as  a  practical  matter  would  have  had  to  make  (or  at  least
should have made) this identification in writing. However, even if an agency did not
do so, the agency should still have identified the problem that it was seeking to rem-
edy  through  regulatory  action  in  the  preamble  to  the  proposed  rule  (to  assist  the
public in understanding the agency’s proposal and in offering their comments on it)
as well in the preamble to the final rule (to persuade the public, Congress, and the
courts  that  the  agency  has  exercised  its  regulatory  authority  in  a  reasonable  and

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00024 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

157

well-considered  manner).  In  sum,  the  requirement  that  agencies  identify  the  need
for  the  regulation  in  writing  is  a  good-government  measure.  It  encourages  greater
transparency in rule-making, by helping the public and others understand the prob-
lem that the regulation is intended to address, enabling more informed comment on
whether  the  proposed  rule  will  likely  meet  its  objectives  and  whether  there  are
other, better alternatives to address the identified problem.

Second, in order to increase the transparency of Executive Order 12866, Executive
Order  13422  incorporates  into  Executive  Order  12866  a  reference  to  three  classic
examples  of  what  constitutes  a  ‘‘market  failure’’—namely,  externalities  (which  jus-
tify,  e.g.,  the  regulation  of  pollution),  market  power  (which  justify,  e.g.,  the  regula-
tion  of  the  rates  charged  by  natural  monopolies,  such  as  local  gas  and  electricity
distribution services), and lack of information (which justify, e.g., the nutritional la-
beling requirements for packaged foods). These three examples of market failure are
not new to the Executive Branch’s implementation of Executive Order 12866. To the
contrary, three years after President Clinton issued Executive Order 12866 in 1993,
these  examples  were  included  in  the  discussion  of  ‘‘market  failure’’  that  was  con-
tained  in  the  1996  ‘‘Economic  Analysis  of  Federal  Regulations  under  Executive
Order No. 12866’’ document that former OIRA Administrator Sally Katzen (working
with former CEA Chairman Joseph Stiglitz) issued to federal agencies for their use
in  meeting  the  analytical  requirements  of  Executive  Order  12866  (as  well  as  those
of the Unfunded Mandates Reform Act and the Regulatory Flexibility Act).26

In its Part I on ‘‘Statement of Need for the Proposed Action,’’ the 1996 ‘‘Economic
Analysis’’  document  had  a  Section  A  on  ‘‘Market  Failure,’’  which  provided  separate
descriptions of ‘‘Externality,’’ ‘‘Natural Monopoly,’’ ‘‘Market Power,’’ and ‘‘Inadequate
or Asymmetric Information.’’ The 1996 ‘‘Economic Analysis’’ document also included
the following introductory discussion:

‘‘I. STATEMENT OF NEED FOR THE PROPOSED ACTION
‘‘In order to establish the need for the proposed action, the analysis should dis-
cuss  whether  the  problem  constitutes  a  significant  market  failure.  If  the  prob-
lem  does  not  constitute  a  market  failure,  the  analysis  should  provide  an  alter-
native  demonstration  of  compelling  public  need,  such  as  improving  govern-
mental  processes  or  addressing  distributional  concerns.  If  the  proposed  action
is a result of a statutory or judicial directive, that should be so stated.
‘‘A. Market Failure
‘‘The  analysis  should  determine  whether  there  exists  a  market  failure  that  is
likely  to  be  significant.  In  particular,  the  analysis  should  distinguish  actual
market failures from potential market failures that can be resolved at relatively
low cost by market participants. Examples of the latter include spillover effects
that affected parties can effectively internalize by negotiation, and problems re-
sulting from information asymmetries that can be effectively resolved by the af-
fected  parties  through  vertical  integration.  Once  a  significant  market  failure
has been identified, the analysis should show how adequately the regulatory al-
ternatives to be considered address the specified market failure.’’

Moreover,  the  three  examples  of  market  failure  that  are  now  referenced  in  the
amended  Executive  Order  12866  (i.e.,  externality,  market  power,  and  lack  of  infor-
mation) were contained in the draft Circular on regulatory cost-benefit analysis that
OMB  issued  for  public  comment  and  peer  review  in  2003,  and  they  are  contained
in the final Circular A–4 that OMB issued later that same year (and which remains
in effect).27

And,  thus,  the  use  of  these  three  market  failure  examples  in  the  implementation
of Executive Order 12866 is not new. Moreover, Executive Order 13422 did not sub-
stantively  change  the  first  ‘‘Principle  of  Regulation’’  in  Executive  Order  12866  or
how  this  Principle  is  implemented  by  the  Executive  Branch.  Instead,  all  that  hap-
pened  as  a  result  of  Executive  Order  13422,  with  respect  to  these  three  examples

26 Memorandum  for  Members  of  the  Regulatory  Working  Group  from  OIRA  Administrator
Katzen,  ‘‘Economic  Analysis  of  Federal  Regulations  under  Executive  Order  12866  (January  11,
1996),  available  on  OMB’s  website  at  http://www.whitehouse.gov/omb/memoranda/
rwgmemo.html. As Administrator Katzen stated in her transmittal memorandum, the ‘‘Economic
Analysis’’  document  ‘‘represents  the  results  of  an  exhaustive  two-year  effort’’  by  an  interagency
working group chaired by Joseph Stiglitz of the Council of Economic Advisers and Steve Kaplan,
the-then General Counsel of the Department of Transportation.

27 Draft  2003  Report  to  Congress  on  the  Costs  and  Benefits  of  Federal  Regulations,  68  FR
5492,  5514–15  (February  3,  2003);  Informing  Regulatory  Decisions:  2003  Report  to  Congress  on
the  Costs  and  Benefits  of  Federal  Regulation  (2003),  at  pages  121–122  (available  on  OMB’s
website).

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00025 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

158

of  market  failure,  is  that  they  are  now  mentioned  in  Executive  Order  12866  itself
(rather  than  only  in  the  implementation  documents).  In  other  words,  the  recent
amendment has simply increased the transparency of Executive Order 12866.

Some  have  expressed  concern  that  this  amendment  to  Executive  Order  12866
could prevent agencies from issuing regulations to protect public health and safety,
but this is not correct. Many of the most significant regulations that agencies issue
are,  in  fact,  driven  by—and  are  in  response  to—market  failures.  As  the  1996  OMB
‘‘Economic  Analysis’’  document  noted,  ‘‘[e]nvironmental  problems  are  a  classic  case
of externality,’’ and this Administration has issued a number of significant environ-
mental  regulations  aimed  at  addressing  environmental  externalities,  including
EPA’s Clean Air Interstate Rule (CAIR) and its Non-road Diesel Engines Rule. Simi-
larly,  regulations  to  protect  homeland  security,  such  as  FDA’s  recent  regulations
under  the  Public  Health  Security  and  Bioterrorism  Preparedness  and  Response  Act,
respond  to  inadequate  private  market  incentives  to  respond  to  potential  terror
threats.

Another type of market failure that is mentioned in the amendment made by Ex-
ecutive  Order  13422  stems  from  lack  of  information.  An  example  of  a  regulation
that is justified by the ‘‘lack of information’’ market failure was the Food and Drug
Administration’s  recent  regulation  that  requires  the  nutritional  labels  on  packaged
foods to display the amount of trans-fats in them. This labeling requirement is esti-
mated  to  have  considerable  public  health  benefits,  by  providing  consumers  impor-
tant  information  with  which  they  can  make  purchasing  decisions.  Moreover,  this
rule  was  the  subject  of  a  ‘‘prompt  letter’’  that  former  OIRA  Administrator  John
Graham sent to HHS in 2001 encouraging the agency to issue a rule to require the
labeling of trans-fats.28

Finally,  in  both  the  CAIR  and  trans-fats  rules,  identification  of  a  market  failure,
rather  than  a  specific  directive  from  statute,  was  the  driving  force  behind  the
issuance of regulations that are expected to have significant public health and qual-
ity of life benefits.

Moreover,  as  noted  above,  nothing  in  this  amendment  to  E.O.  12866  precludes
agencies  from  justifying  regulations  on  grounds  other  than  the  failure  of  private
markets.  Nor  does  it  preclude  agencies  from  justifying  regulations  on  the  ground
that  Congress  has  required  the  agency  to  promulgate  regulations  to  address  a  par-
ticular  situation,  or  on  the  ground  that  the  regulations  are  necessary  to  interpret
the  law,  or  on  the  ground  that  regulations  are  necessary  to  address  a  compelling
public need.

Thank  you  again  for  this  opportunity  to  testify.  I  hope  that  I  have  been  able  to
clarify the purpose of the new Good Guidance Bulletin, and the recent amendments
to Executive Order 12866. As I noted at the beginning of my testimony, the Execu-
tive  Order  and  Bulletin  share  a  common  goal:  namely,  the  good-government  objec-
tive  of  improving  the  way  that  the  Federal  Government  does  business—by  increas-
ing  the  quality,  public  participation,  and  accountability  of  agency  guidance  docu-
ments and their development and use.

I would welcome any questions that the Subcommittee has.

BIOGRAPHY FOR STEVEN D. AITKEN

Steven  D.  Aitken  was  designated  by  the  President  to  begin  service  on  June  3,
2006,  as  the  Acting  Administrator  of  the  Office  of  Information  and  Regulatory  Af-
fairs  (OIRA),  an  office  within  the  Office  of  Management  and  Budget.  He  served  as
OIRA’s  Acting  Administrator  for  the  following  ten  months  (his  service  ceased  in
early  April,  2007,  when  Susan  E.  Dudley  was  sworn  in  as  OIRA’s  Administrator).
Prior to serving as OIRA’s Acting Administrator, Steve was Deputy General Coun-
sel  at  OMB  and,  prior  to  becoming  Deputy,  he  was  an  Assistant  General  Counsel
at  OMB.  In  total,  he  has  served  at  OMB  for  nearly  18  years.  He  has  also  served
in the U.S. Department of Justice as a trial attorney in the Civil and Antitrust Divi-
sions, and he served two judicial clerkships, one in 1986-1987 for Judge (now Chief
Judge) Douglas H. Ginsburg of the U.S. Court of Appeals for the District of Colum-
bia Circuit and the other in 1984–1985 for Justice (later Chief Justice) Christopher
Armstrong of the Massachusetts Appeals Court. He has a Bachelor’s degree in Gov-
ernment from Harvard College and a law degree from Harvard Law School.

Steve lives in Washington, D.C., with his wife and son.

28 Letter from OIRA Administrator Graham to the Department of Health and Human Services

regarding trans fatty acids (September 18, 2001) (available on OMB’s website).

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00026 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

159

DISCUSSION

Chairman  MILLER.  Thank  you,  Mr.  Aitken.  I  want  to  announce
a  policy  this  morning.  In  the  first  couple  of  meetings  of  this  sub-
committee, I have had a hard time overcoming my Southern moth-
er’s teaching that interrupting people was bad manners. I think all
of us struggle as adults to figure out what part of what our mother
taught us we need it ignore as adults. But we do need to keep fair-
ly close to the time allotments. You were fine. You were just a few
seconds over. Mr. Rohrabacher was actually just a few seconds over
in his opening remarks as well. In his opening round, I will ask for
questions  for  seven  minutes,  my  questions  and  your  answers,  Mr.
Rohrabacher for seven minutes. If any other Members appear, they
will  have  turns  to  ask  questions  for  five  minutes.  But  we  do  need
to  keep  fairly  closely  within  that  time  limitation,  and  I  will  bring
the  gavel  down  as  necessary,  hoping  that  in  fact  C–SPAN  is  not
broadcasting this and my mother is not watching it at home.

EXECUTIVE ORDER CONSULTATION PROCESS

Mr. Aitken, in your written testimony you said the OMB believes
that federal agency guidance should be developed, issued and used
through  an  agency’s  adherence  to  procedures  that  ensure  quality,
transparency,  public  participation,  coordination  and  accountability.
All  those  sound  laudable,  I  agree  with  all  of  them,  but  I  am  won-
dering how those standards were applied and actually developed in
this  executive  order  that  we  are  discussing  now.  Were  there  meet-
ings with which agencies about them? When did those occur? Were
there any public comments sought? Was there correspondence with
outside parties? Could you tell me briefly what kind of consultation
occurred in developing this order?

Mr.  AITKEN.  Thank  you  for  the  question.  The  order  was  devel-
oped  in  accordance  with  the  standard  process  that  the  executive
branch  has  for  the  development  of  executive  orders  and  that  proc-
ess  is  set  out  in  an  executive  order  itself.  I  believe  the  number  is
Executive  Order  11030  that  has  been  in  place  for  several  decades.
And  it  provides  for  a  process  whereby  OMB  consults  with  other
agencies  about  a  proposed  executive  order  and  the  executive  order
could be proposed by an agency, another office, by OMB, and those
consultations  then  feed  into  an  internal  deliberative  process  that
results at the end of the day in a proposal being made to the Presi-
dent and it is then the President’s decision on whether to move for-
ward with the proposed order or not. That standard practice, which
was followed here, does not involve putting out a draft of an execu-
tive order for public comment. That is simply not the practice that
has  been  applied  for  decades  in  the  development  of  executive  or-
ders.  In  this  case,  the  agencies  were  consulted  per  the  standard
process and their views were requested and taken into account.

Chairman  MILLER.  You  said  that  there  was  not  a  draft  put  out
for public comment. I assume that you didn’t get it just perfect the
very  first  time,  that  there  were  various  iterations  of  the  executive
order? Am I correct in assuming that?

Mr.  AITKEN.  Yes.  I  can’t  really  get  too  much  into  the  details  of
the  executive  order  process  in  regard  to  the  substance  or  the  dis-
cussions that occurred internally, but yes, as is the case with exec-

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00027 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

160

utive  orders,  and  OMB  does  handle  that  process,  I  am  familiar
with it, executive orders typically go through a number of drafts in
response to comments and further thought.

Chairman  MILLER.  When  you  say  you  can’t  comment,  is  it  be-

cause you are not familiar, you don’t know?

Mr. AITKEN. It is because it is just an internal deliberative proc-
ess and the standard practice is not for the executive branch to re-
veal  the  internal  deliberations  that  resulted  in  an  executive  order.
Chairman  MILLER.  Mr.  Aitken,  we  have  a  point  of  disagreement
about what Congress’s authority is and what the internal delibera-
tive  process  protects  from  disclosure  to  Congress,  and  I  am  afraid
if  you  take  that  view,  we  may  end  up  having  several  hearings
about  this  issue.  Did  you—I  am  sorry.  So  it  is  your  intention  not
to  discuss  further  what  the  procedures  were  in  developing  this
draft, the various drafts, who was consulted, what documents were
generated,  were  there  internal  memoranda,  correspondence,  e-
mails, were there such documents?

Mr. AITKEN. Oh, yes. The standard executive order process in the
OMB’s  general  counsel’s  office  is  a  lead  within  OMB  for  the  inter-
agency  clearance  of  executive  orders,  so  I  am  very  familiar  with
that  process.  It  typically  involves  the  submission  by  an  agency  or
an  executive  branch  office  to  OMB  of  a  proposed  executive  order,
the  circulation  of  that  proposal  to  agencies  and  offices  who  would
be interested in that order for their review and comment——

Chairman MILLER. But you do not intend to testify today to who
made  which  suggestions,  observations,  criticisms,  concerns?  You
view that as not within the information that Congress may seek of
the executive branch?

Mr. AITKEN. We are——
Chairman  MILLER.  That  is  a  bad  course  we  are  on  if  that  is  the

view you take.

Mr. AITKEN. I think what I am offering, again in my capacity as
the  former  acting  administrator  and  as  a  long-time  OMB  career
employee,  is  that  those  deliberations  which  ultimately  lead  to  the
proposals to the President for action are internal deliberative com-
munications.  They  are  privileged.  We  would  not  release  those  for
example in response to a FOIA request or litigation, and my experi-
ence has been that we have not released those deliberations to the
public  or  that  we  have  been  requested  or  provided  those  in  the
past, that is. It is just not my experience.

Chairman  MILLER.  That  has  been  my  experience  too,  but  a  re-
quest from a committee of Congress is not the same as a FOIA re-
quest.  There  are  cases,  as  I  am  sure—I  hope  you  are  aware—
maybe  you  aren’t  aware.  The  courts  have  dealt  with  this  issue.
There is an internal deliberative process. The court says it has very
slight  weight.  If  there  any  need  for  the  information,  the  concern
about  finding  the  truth  overcomes  any  concern  about  protecting
confidentiality, and if there is any suggestion that there was an im-
proper—that  the  executive  agency  action  was  based  upon  any  im-
proper consideration, there is no privilege or immunity at all. This
is not a FOIA request. Now, I am afraid that we are going to have
to have another hearing to discuss these processes, and I certainly
think  that  we  are  going  to  now  request  the  agency  a  great  many
documents.  So  I  would  urge  you  to,  when  you  get  back  to  your  of-

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00028 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

161

to——

fice  this  afternoon,  look  at  the  law  on  internal  deliberations  and
consider  carefully  that  this  is  a  committee  of  Congress  asking,  not
a FOIA request.

Mr. AITKEN. I understand that, and I will do so. I mentioned the
FOIA  in  part  just  because  of  the  Congressional  recognition  in  the
enactment  of  the  FOIA  of  the  importance  of  confidential  delibera-
tions  for  improving  government  decision-making.  Also,  it  is  my  ex-
perience  that  the  executive  branch  over  the  years  through  decades
has  not  received  requests  from  Congress  for  the  internal  delibera-
tions  leading  to  executive  orders,  so  for  me,  this  is  an  unprece-
dented experience and it is just——

Chairman MILLER. Well——
Mr. AITKEN.—being here today, I am not in a position to be able

Chairman  MILLER.  Why  you  did  what  you  did  strikes  me  as

something Congress has every reason in the world to ask.

Mr. AITKEN. Yes, I am happy to answer any questions about the
order  itself,  and  I  think  both  with  respect  to  the  order  and  other
issues, I think it is best or at least I am here to be able to explain
what  these  provisions  mean,  why  they  are  there,  and  I  think  at
least  the  confidential  deliberate  process  tries  to  protect  the  ability
of people to have a dialog, and my sense is that——

Chairman  MILLER.  And  I  know  you  have  a  distinguished  legal
education  and  I  know  that  you  have  studied  the  law  of  privileges
and  you  know  that  there  is  a  tension  between  encouraging  con-
fidentiality,  encouraging  candor,  and  the  need  to  find  the  truth.
There are some privileges that are absolutely respected. Well, actu-
ally there are very few that are absolute. The attorney-client privi-
lege,  for  one,  is  a  very  strong  privilege  but  the  courts  have  struck
a  different  balance  with  respect  to  internal  deliberations  that  the
courts  perhaps  respect  the  confidentiality,  the  candor  of  those  dis-
cussions over a concern based on—or an inquiry based on idle curi-
osity, but if there is a need to know, whatever privilege there may
be gives way. Again, I urge you to look at your law books this after-
noon,  and  I  assure  you,  I  feel  confident  we  will  be  asking  for  fur-
ther documents based upon our conversation just now.

Well,  I  have  many  questions  that  you  may  or  may  not  answer.
Was  anyone  outside  of—I  am  sorry.  I  have  violated  my  own  rule
slightly.

Mr. ROHRABACHER. I think we need to interrogate you into what
mental  processes  you  were  going  through  when  you  violated  that
rule  you  had  set  down.  We  need  to  question  whether  or  not  that
was a planned move or whether this is just something that you just
happened  to  do  because  you  were  being  the  Chairman  and  you
were  asking  some  questions,  but  we  need  to  get  you  under  oath  to
testify to see if you actually were motivated to break that rule that
you just had.

With  that  in  mind,  Mr.  Aitken,  you  have  worked  for  the  Office

of Management and Budget for how many years?

Mr. AITKEN. In May it will be 18 years.
Mr.  ROHRABACHER.  Eighteen  years,  so  you  were  actually  there
and  overseeing  legal  type  of  analysis  of  things  that  were  going  on
even during the Clinton Administration. Is that right?

Mr. AITKEN. That is correct.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00029 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

162

Mr.  ROHRABACHER.  Did  anyone  ever  put  you  under  oath  and
start  inquiring  about  the  internal  deliberations  during  the  Clinton
Administration  when  they  were  trying  to  issue  executive  orders  or
was that normally accepted that basically the President has a right
to  issue  an  executive  order  and  then  has  a  right  to  have  internal
deliberations to what that executive order should say?

Mr.  AITKEN.  My  experience  was  that  OMB  had  not  received  re-
quests, at least to my recollection had not received requests during
the  Clinton  Administration  or  even  during  prior  years  in  this  Ad-
ministration  for  the  internal  deliberations  regarding  an  executive
order.

Mr.  ROHRABACHER.  For  example,  in  the  Clinton  Administration,
you had the wording of the executive order, each agency shall iden-
tify the problem that it intends to address including where applica-
ble  ‘‘the  failures  of  the  private  markets’’  or  public  institutions  that
weren’t  new  agency  action  as  well  as  access  to  the  significance  of
that  problem.  Now,  that  wording  was  changed,  which  seems  to  be
a  big  problem  now.  Instead  of  the  failure  of  private  markets,  it
seems  to  be  that  the  big  problem  is  that  they  changed  that  to  say
each  identify  shall  identify  in  writing,  so  they  are  identifying  this
in writing now, the specific market failures as compared to failures
of  the  private  market,  and  then  we  are  requiring  them  to  do  it  in
writing  rather  than  just  in  an  oral  report.  Now,  I  guess  we  really
need to know whether changing that wording whether or not there
were  memos  going  back  and  forth  and  we  got  to  make  sure  that
you  spent  a  lot  of  time  now  searching  those  records  to  see  about
who wrote that and whether or not that person, you know, may or
may  not  have  had  the  best  interests  of  the  country  at  heart  when
he  wrote  that  as  compared  to  when  the  Clinton  Administration
wrote those words, ‘‘failures of private markets,’’ that nobody ques-
tioned  that.  I  guess  that  is  what  we  are  talking  about  today,  and
your recollection is that nobody bothered to ask anybody about the
wording of ‘‘failures of the private market’’ as compared to ‘‘market
failures’’ when you worked at the OMB under President Clinton. Is
that right?

Mr. AITKEN. That is correct.
Mr.  ROHRABACHER.  No  one  requested  any  information  then.
Would you be surprised if there were directives issued by a political
party  that  every  committee  and  subcommittee  should  find  some-
thing  that  they  can  issue  ominous-sounding  statements  about  and
requesting  voluminous  information  of  the  Administration  trying  to
catch  the  Administration  in  a  mistake  and  then  making  it  into
more  than  a  mistake,  more  than  just  going  over  a  minute,  but  a
calculated  attempt  to  break  the  rules?  Would  you  be  surprised  if
a  group  of  people  who  are  running  for  political  office  might  try  to
use  the  Congress  as  a  forum  to  create  a  false  impression  for  the
voters  in  the  next  election?  You  don’t  have  to  answer  that.  Thank
you very much.

You  know,  I  will  just  have  to  say  that  this,  what  we  are  talking
about  today  and  what  we  are  going  through  today  is  totally  con-
sistent with what, as I say, happens, is happening in other commit-
tees, and President Clinton fires every U.S. attorney, every one im-
mediately without question, and nobody raises an eyebrow because
they know that he has a right to fire those U.S. attorneys, and the

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00030 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

163

President  has  a  right  to  issue  executive  orders.  President  Clinton
issues  an  executive  order,  talks  about  the  failures  of  private  mar-
kets  and  of  course  nobody  raises  the  issue  but  this  President
changes  the  wording  to  say  ‘‘market  failures’’  and  requires  it  in
writing and all of a sudden now we have got all these requests for
documents.

You  know,  when  the  attorney  general  started  answering  ques-
tions  about  what  was  the  President’s  prerogative,  they  found  that
he  didn’t  say  exactly  the  things  that  were  right  in  describing  why
the President made a decision even though everyone acknowledges
the  President  has  every  right  to  make  that  decision  and  now  they
have made that into a big brouhaha. I am not necessarily someone
who likes this attorney general or even likes this President, to tell
you  the  truth,  but  I  can  certainly  believe  that  we  need  to  be  tack-
ling  real  problems  rather  than  political  posturing.  I  would  suggest
that  there  is  a  pattern  here.  The  pattern  isn’t  that  we  have
changed  the  wording  of  ‘‘failures  to  private  markets’’  in  an  execu-
tive order to ‘‘market failure’’ and require it in writing. That is not
the pattern. The pattern is that we are challenging the President’s
authority  hoping  to  find  a  mistake  when  he  answers  that  question
and then making a lot of political hay about it.

I  appreciate  you  being  here.  You  are  not  a  Republican  or  Demo-
crat  appointee.  You  are  actually  a  professional,  having  served  in  a
high  place  in  both  the  Clinton  Administration  and  the  Republican
Administrations, but let me thank you for your professionalism.

And let me note that I am intentionally not going over my time,
and  this  has  been  calculated  now  to  make  sure  that  the  failure  of
the  Chairman  to  go  over  his  time  is  just—is  highlighted,  so  I  will
quit right there, Mr. Chairman.

Chairman  MILLER.  Actually,  Mr.  Rohrabacher,  I  went  over  two
and  a  half  minutes.  If  you  would  like  to  go  on  another  two  and  a
half minutes, you go right ahead.

Mr.  Aitken,  I  assume  that  my  staff  will  punch  me  in  the  ribs
when it comes close to five minutes. I know that you had expressed
some  concern  or  reservation  about  telling  this  committee  some  of
what the OMB considered in issuing this executive order and I had
somehow  confused  transparency  with  candor,  but  can  you  tell  me
at  least  when  the  first  draft  of  this  proposed  regulation  was  cir-
culated and to whom? Who saw it?

Mr.  AITKEN.  The  order  had  been  in  development  for  some  time.
I  don’t  have  a  specific  recollection  of  when  it  was  first  circulated
or  to  which  agency.  That  would  be  typically  done  by  a  career  em-
ployee  within  the  OMB  counsel’s  office  in  consultation  with  others
and so, you know, apart from it being done in the standard process,
I  don’t  have  a  recollection  exactly,  you  know,  what  time  or  exactly
to whom but it was the standard process that was used.

Chairman MILLER. Do you know approximately what month and

Mr.  AITKEN.  Since  I  haven’t  looked  into  that,  I  hesitate  to  say

just because I haven’t looked into that history recently.

Chairman MILLER. Was it circulated to anyone outside of the Ad-

year?

ministration?

Mr. AITKEN. So far as I know, no, it was not.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00031 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

164

Chairman  MILLER.  No  one  outside  of  the  Administration  was
shown, or there was no discussion with anyone outside the Admin-
istration about the proposed executive order?

Mr.  AITKEN.  I  am  not  aware  of  any  such  discussions.  I  can’t  say

that they didn’t occur but I am not aware of them.

Chairman  MILLER.  Who  within  the  Office  of  Management  and
Budget,  or  OMB,  or  any  other  agency  of  the  government  was  in-
volved in developing the draft or changing the draft as drafts went
forward?

Mr.  AITKEN.  In  OMB,  it  would  be—a  variety  of  offices  are  in-
volved  in  executive  orders,  depending  on  the  subject  matter,  be-
cause OMB in the standard process sends a recommendation memo
to  the  President.  It  receives  a  fair  level  of  clearance  through  a
number of offices. And so, again, the standard process was used but
I  don’t  have  a  recollection  of  exactly,  you  know,  who  all  was  con-
sulted  although  as  typically  the  case,  it  was  a  broad  range  of  peo-
ple within OMB.

Chairman  MILLER.  Mr.  Aitken,  my  understanding  is  that  we
didn’t  specify  you  as  a  witness  that  we  wished—nothing  personal,
but we asked OMB and OIRA to produce a witness who could talk
to  us  about  the  process,  how  this  was  done.  It  is  somewhat  sur-
prising, knowing that that is why we asked for a witness to be sent
forth,  that  you  are  so  unfamiliar  with  the  process  and  that  is  ex-
actly what we told you we wanted to hear about.

Mr.  AITKEN.  My  understanding  was  that  when  this  hearing  was
first  raised  as  a  possibility  in  early  March  when  I  was  the  acting
administrator, there was naturally an interest in my testifying, but
when the hearing was then moved to late April and then when Ms.
Dudley  was  sworn  in  as  the  OIRA  administrator,  my  under-
standing  is  that  OMB  did  reach  out  to  the  Subcommittee  staff  to
ask  whether  the  Subcommittee  staff,  or  the  Subcommittee  rather,
wanted  me  to  testify  as  I  was  no  longer  the  acting  administrator.
My  understanding  is  that  the  response  that  we  received  back  is
that  the  Subcommittee  did  want  me  to  testify  even  though  I  was
no longer the acting administrator.

Chairman MILLER. And we understood the reason you were being
offered  was  that  you  were  there  at  the  time,  that  Ms.  Dudley
couldn’t  talk  about  it  because  she  wasn’t  there  at  the  time,  but  I
am not sure there is much further to be gained by this.

Your  statement  in  your  testimony,  OMB  believes  that  federal
agency guidance should be developed, issued and used for an agen-
cy’s  adherence  to  procedures  that  ensure  quality,  transparency,
public  participation,  coordination  and  accountability.  Do  you  be-
lieve that those considerations, those goals should not also apply to
developing an executive order?

Mr. AITKEN. Well——
Chairman MILLER. You can—I will tell you what. Why don’t you

answer that in my next round of questioning?

Mr. Rohrabacher.
Mr.  ROHRABACHER.  Thank  you  very  much.  So  you  were  there
during  the  Clinton  Administration,  did  President  Clinton  discuss
when  he  changed  this  wording  in  his  executive  order  from  failures
of  private  markets  to  whatever  it  was  before  that  to  now  it  has

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00032 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

165

been changed to market failures? Did he ever discuss that with any
other interest groups in this town?

Mr.  AITKEN.  My  understanding  from  the  testimony  that  Ms.
Katzen  provided  in  February,  I  believe,  is  that—and  she  was  the
OIRA administrator at that time, is that she, according to her testi-
mony, did have discussions.

Mr. ROHRABACHER. Oh, she did?
Mr. AITKEN. According to——
Mr.  ROHRABACHER.  So  you  mean  the  President  before  he  issues
an executive order actually talks to people outside the government?
What  kind  of  influence  could  they  possibly  have?  My  gosh,  people
outside  the  government  are  trying  to  maybe  have  an  input  into
what  government  policy  should  be  in  terms  of  executive  orders.
Don’t  you  see  this  as  a  threat  to  democracy  in  this  country?  No,
you  don’t  have  to  answer  that.  Were  there  documents  ever  re-
quested  about  these  discussions  that  President  Clinton  had  with
the outsiders when he changed—when he came up with the phrase
‘‘failures of private markets’’ versus ‘‘market failure’’?

Mr.  AITKEN.  I  am  not  aware  that  there  were  any  such  requests.
Mr. ROHRABACHER. Now, but you don’t know—you said ‘‘I am not
aware,’’  so  we  might  have  to  request  those  documents  as  well,  Mr.
Chairman, of what happened during the Clinton Administration to
see if my gosh, there were some incredible insidious interest groups
at  work  there  too.  Let  us  see.  Now,  let  me  ask  you  this.  You
worked  for  Clinton  and  Republican  Administrations.  It  is  your  un-
derstanding  that  when  you  talk  about  executive  orders,  which  is
what the President is given the right to do under the Constitution,
that  the  process  that  he  develops  that  he  thinks  is  the  best  way
to develop an executive order, that that is pretty well left up to the
President to decide what process he is going to have and what peo-
ple  will  be  in  that  process  as  compared  to  having,  let  us  say,  the
legislative  branch  in  our  Constitution  suggesting  they  have  the
right to establish that process?

Mr. AITKEN. It has been the process that has been established by

Mr.  ROHRABACHER.  Based  on  constitutional  authority  granted  to

the Presidents and——

him. Is that right?

Mr. AITKEN. That is correct.
Mr.  ROHRABACHER.  Does  the  Constitution  permit  the  legislative
branch to determine that for the President about the processes and
have to have approval on that?

Mr.  AITKEN.  I  wouldn’t  want  to  express  an  answer  here  just

because——

Mr.  ROHRABACHER.  Okay.  It  is  just  that  what  we  are  talking
about  here  is  not  the  policy.  I  think  the  founders  of  the  Constitu-
tion wanted us to be talking about policy, not trying to catch some-
body  as  if  they  made  a  mistake  in  the  process  of  how  they  deter-
mined  that  policy,  because  one  is  where  you  destroy  people  and
would stifle debate on policy and the other approach is that you are
discussing  the  issue  at  hand  and  trying  to  dissection  what  is  best
for  the  country,  what  policy  is  best  for  the  country.  I  think  our
founding fathers were very astute when they understood that poli-
tics  might  get  in  the  way  if  we  ended  up  discussing  policy—or  our
process  rather  than  policy,  and  unfortunately  again  I  see  this  dis-

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00033 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

166

turbing ominous trend in this town where people don’t want to dis-
cuss the policy but they want to catch somebody in a mistake while
trying to recall the exact process of how a policy was decided upon
instead  of  just  discussing  whether  that  policy  is  a  good  policy  or
not,  and  if  this  was  just  happening  in  this  subcommittee  I  think
that  we  could  just  sort  of  shrug  our  shoulders  and  say  that  this  is
not—you  know,  this  is  something  that  is  very  legitimate  here,
somebody  really  just  wants  to  go  down  that  road.  But  it  seems  to
be  happing  throughout  the  legislative  branch  now  as  compared  to
what  happened  of  course  during  the  Clinton  years  when  no  one
suggested  the  President  didn’t  have  these  rights  to  make  up  his
own mind in a process that he had established.

So  with  that  said,  I  appreciate  your  testimony,  and  I  appreciate
your  service  to  the  country.  You  are  obviously  someone  who  takes
your  job  very  seriously  and  you  are  the  type  of  person  that  is  not
a partisan. You have worked hard for both Democratic and Repub-
lican  administrations  and  I  am  sorry  that  quite  often  people  like
yourself get caught in the middle of different political power plays.
I appreciate it.

Chairman  MILLER.  Mr.  Rohrabacher,  you  can  take  that  two  and

a half minutes any time that you would like.

We  seem  to  have  stumbled  on  the  only  area  that  was  not  the
subject of Congressional inquiry in the last six years of the Clinton
Administration.  There  were  two  subpoenas  issued  by  the  Govern-
ment  Reform  Committee  a  day  for  every  day  Congress  was  in  ses-
sion  in  the  last  six  years.  There  were  4,000  pages  of  documents
produced  a  day  in  the  last  six  years  for  every  day  that  Congress
was  in  session.  And  Mr.  Aitken,  let  me  make  it  clear  to  you,  and
I  don’t  think  that  you  have  any  doubt  about  this,  consultation  is
a  good  thing.  We  urge  that.  I  hope  you  did  talk  to  people.  I  hoped
you  talked  to  people  within  the  Government.  I  hope  you  talked  to
people  who  deal  with  the  Government.  What  we  want  to  know  is
what  was  said,  that  it  be  open,  that  yes,  there  be  a  debate  and  a
discussion but that it not be in secret. That is why I am asking the
questions. I want to know what the concerns were that this execu-
tive order was designed to address.

Mr. AITKEN. And I can address that.
Chairman MILLER. Well——
Mr. AITKEN. As I indicated in my prepared testimony——
Chairman  MILLER.  Well,  that  is  why  I  asked  the  question,  who
was  involved  with  the  discussion  and  what  they  had  to  say,  and
just  describing  generally  what  were  the  concerns  were  and  the  ob-
jectives  were  does  not  get  us  at  what  the  concerns  were  in  this
order and that is why I am asking the questions.
MARKET FAILURE PROVISIONS

Okay. There are other parts of the order—you testified that mar-
ket failure is not a new consideration, and as I understand market
failure, it is the argument that the market hasn’t failed; if we just
leave  it  alone  it  is  going  to  the  fix  the  problem  without  Congress
doing  anything,  or  a  regulatory  agency  doing  anything.  Is  that  ba-
sically the idea behind market failure?

Mr. AITKEN. As the 1996 Best Practices Guidelines that Adminis-
trator  Katzen  issued  explained  the  rationale  of  market  failure,

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00034 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

167

which is one but not the only rationale for regulatory action, is that
sometimes  the  government  needs  to  step  in  because  private  mar-
kets are not addressing the situation. For example, in the FDA nu-
tritional labeling rule——

Chairman MILLER. So the way I described the concept of market
failure  is  essentially  right?  The  market  hasn’t  failed.  If  we  leave
that market alone, it is going to fix the problem without any inter-
vention  by  government.  That  is  the  idea  behind  market  failure
being a criteria, and has the market failed, is the market not going
to fix this on its own. That is what market failure is, right?

Mr.  AITKEN.  That  is  correct.  If  the  market  is  going  to  address  a

certain situation, then it is not——

Chairman MILLER. Leave it alone?
Mr. AITKEN. Yes.
Chairman  MILLER.  I  was  part  of  the  debate  last  week,  and  I
think we will have this debate replayed again and again on wheth-
er  shareholders  should  have  an  advisory  vote  on  executive  com-
pensation  at  public  corporations  in  America,  and  the  argument  it,
the  argument  against  the  legislation  was,  the  market  will  fix  this.
Now, that seems to me to be a market-failure argument, and every
time that Congress enacts legislation to protect public health, to re-
quire FDA to inspect and assure sanitary conditions and there are
public health consequences of what is being put in the marketplace,
Congress  has  decided  that  the  market  is  not  working  sufficiently
well and we need to do something about it. So it seems that when-
ever we have given an agency rule-making authority, not just rule-
making  authority,  we  have  directed  them  to  make  rules,  to  carry
out a statutory mandate, Congress has already decided the market
is  not  doing  this  well  enough  and  usually  over  the  express  argu-
ment  that  the  market  is  doing  it  well  enough.  Now,  can  you  tell
me, is there a clear, rigorous test that we can look at, that we can
understand for when the administration, the executive branch, the
various  agencies,  the  OIRA  or  the  RPOs  will  apply  to  determine  if
the  market  has  failed  and  the  government  needs  to  intervene
through regulation?

Mr.  AITKEN.  In  terms  of  statutes,  if  Congress  has  directed  an
agency to issue a regulation, then the agency must issue the regu-
lation.  There  is  nothing  in  the  executive  order  either  as  issued  by
President  Clinton  or  the  recent  executive  order  that  overrides  any
statutory  directions  to  agencies.  If  Congress  has  made  a  decision
that  a  regulation  is  necessary,  the  agency  must  issue  the  regula-
tion.  The  issue  of  market  failure  comes  up  in  a  situation  in  which
an  agency  has  discretion;  Congress  has  not  made  a  decision  that
the  agency  has  to  issue  a  regulation.  Instead,  the  agency  has  per-
missive regulatory authority and the question is whether the agen-
cy  decides  in  its  discretion  to  exercise  that  authority,  and  as  re-
flected  in  the  1996  guidelines  that  Administrator  Katzen  issued
and  in  OMB  Circular  A-4,  which  we  went  through  public—and
there  was  some  comment  on,  the  criteria  for  market  failure  as  a
rationale addresses whether there is a problem out there that, one,
if a problem exists, two, is it because the markets have not worked
to address it, and three, is it something that the markets could not
address.  If  that  is  the  case,  then  that  rationale  for  regulatory  ac-
tion  would  argue  for  the  agency  to  act.  However,  there  are  other

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00035 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

168

rationales apart from market failure which the executive order and
the recent amendment recognizes——

Chairman  MILLER.  Mr.  Aitken,  can  you  complete  this  answer  at

the beginning of my next round of questions?

Mr. Rohrabacher.
Mr.  ROHRABACHER.  Well,  I  am  not  a  stickler.  I  will  let  you  sort
of  have  an  extra  couple  of  seconds  there.  That  doesn’t—I  am  not
going to throw the book at you if you break the rules.

Chairman  MILLER.  Mr.  Aitken,  if  you  would  like  to  complete  it

on Mr. Rohrabacher’s time, that would be fine.

Mr.  ROHRABACHER.  That  is  the  type  of  courtesy  that  makes  this
government  work,  unfortunately.  I  hope  everybody  understands
that, the point I just made, that is.

Mr.  AITKEN.  I  was  just  concluding  by  saying  that  the  guidance
that  has  been  out  there  since  as  far  back  as  least  1996,  the  guid-
ance  that  Ms.  Katzen  issued,  describes  the  situations  in  which
market  failure  can  provide  a  justification  for  regulatory  action.
Again,  as  the  original  Executive  Order  12866  provided  and  as  the
amended  one  provides,  market  failure  is  not  the  only  justification
on  which  regulatory  action  can  be  received.  It  can  occur  because
Congress has directed an agency to promulgate a regulation and it
can occur to address other problems that the agency has identified.
That is it.

Mr.  ROHRABACHER.  Thank  you  for  that  answer,  and  let  me  note
that  President  Clinton  issued  the  executive  order  in  question  here
September 30, 1993, which seems to be, if memory serves me, actu-
ally  very  early  into  his  first  term  of  office,  and  this  President  has
permitted  that  executive  order  to  stand  until  very  late  in  his  Ad-
ministration. It seems to me that is perhaps similar to the fact that
when—and when Bill Clinton did change this early on into his Ad-
ministration,  as  I  say,  there  doesn’t  seem  to  have  been  any  of  the
inquiries  made  at  all  into  this,  into  the  process  of  how  he  came  to
the decision to issue his executive order. No documents were man-
dated, no questioning of his motives, only maybe perhaps a discus-
sion  of  the  executive  order  itself.  I  don’t  remember  that  discussion
but it certainly wasn’t accusatory in the discussion. It was probably
a  discussion  of  the  issue  itself.  That  might  be  the  same  as  when
President  Clinton  fired  every  U.S.  attorney  then  in  position  of  au-
thority  when  he  became  President.  Again,  no  one  questioned
whether the President had a right to fire those U.S. attorneys and
to  hire  his  own  people.  That  is—these  are  people  who  serve  at  the
pleasure  of  the  President  as  granted  by  the  Constitution  of  the
United States. No one asked the President, no one came in and put
people  under  oath  and  tried  to  find  out  if  they  can  determine
whether there was any loss of memory in the process, trying to get
people  and  charge  with  them  all  kinds  of  malicious  intent  if  they
didn’t remember exact details in conversations. Thus, and so there
seems  to  be  a  change  of  strategies  here,  that  during  the  Clinton
years  Republicans  were  not  pushing  on  issues  like  that,  and  now
during—when  we  have  a  president  of  the  United  States  who  is  a
Republican and it is getting close to an election year, now we seem
to have a focus on other elements. Rather than policy, we focus on
process  and  trying  to  see  if  people’s  memories  are  exactly  right  to
see if we can catch them in a mistake.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00036 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

169

I  will  tell  you,  it  would  be  hard  for  me,  I  can’t  speak  for  the
Chairman  or  other  Members  of  this  body  but  it  would  be  very  dif-
ficult for me to answer questions about how I came to a determina-
tion  as  to  what  my  position  was  going  to  be  on  specific  issues  of
the  day,  whether  it  was  legislation  or  various  issues.  It  would  be
very  difficult  for  me  to  try  to  search  back  and  found  out  exactly
when  I  decided  on  something,  and  I  think  that  that  really  does
break down the goodwill and camaraderie that we have here in the
Congress  because  people  have  to  assume  that  we  are  going  to  de-
bate  the  issues  and  not  debate  whether  somebody  is  being—what
someone’s  motives  were  and  that  is  one  of  rules  of  thumb  here  in
the  House.  But  I  guess  that  doesn’t  apply  when  we  are  trying  to
talk about the President versus the legislative branch, or the exec-
utive branch versus the legislative branch.

With that, thank you again for your service as being a bipartisan
person  who  worked  in  both  administrations,  Democrat  and  Repub-
lican,  and  tried  your  very  best,  and  certainly  we  are  not  trying  to
catch you on some lack of memory or making a mistake of memory.
Chairman  MILLER.  Mr.  Aitken,  I  had  really  hoped  to  announce
the  new  policy  of  being  stricter  with  the  time  limitations  without
naming  names  on  who  had  abused  my  Southern  manners,  and  I
will stick to that intent despite obvious goading.

Mr.  Aitken,  I  agree  that  if  I  were  asked  I  voted  for  something
three  years  ago,  trying  to  reconstruct  my  thinking  at  the  time
would not be easy and I couldn’t do it on the spot, but on the other
hand,  if  I  had  been  sent  forward  from  a  government  agency  to  an-
swer  specific  questions  as  to  one  at  that  agency  who  would  know
it,  I  would  expect  to  be  prepared.  I  would  expect  to  refresh  my
recollection.  I  would  expect  to  look  at  the  documents.  I  would  not
just show up.

Mr.  AITKEN.  Well,  that  was  not  the  case  in  terms  of  my  coming
here. I did prepare. I prepared as I had prepared for my testimony
in  February  before  the  House  Judiciary  Subcommittee,  which  was
on  the  same  day  in  fact,  just  after  the  hearing  that  this  sub-
committee  held.  I  was  not  aware  in  coming  here  that  I  would  be
asked specific questions about who was consulted or what the time-
table was for the development. I came here prepared and submitted
lengthy,  comprehensive  testimony  regarding  the  issues  in  the  bul-
letin,  regarding  the  reasons  the  bulletin  was  issued,  regarding  the
issues  in  the  executive  orders,  and  consistent  with  my  profes-
sionalism as a career OMB employee, I prepared to the best of my
ability for testifying today.

TRANSPARENCY PROVISIONS

Chairman MILLER. Let us move on to the transparency consider-
ations  again,  and  we  all  seem  to  like  transparency,  at  least  the
word,  and  then  we  have  different  interpretations  what  it  actually
means  or  requires.  The  Clinton  executive  order  that  apparently
somehow escaped being the subject of Congressional subpoena, per-
haps  because  it  was  in  the  first  two  years  of  the  Clinton  Adminis-
tration,  did  put  in  place  transparency  protections.  Isn’t  that  right,
with respect to OIRA’s decisions?

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00037 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

170

Mr.  AITKEN.  The  executive  order  does  include  transparency  pro-
visions.  Many  of  those  transparency  provisions  had  been  in  effect
for a number of years during the prior Administration.

Chairman  MILLER.  And  it  includes  showing  an  original  draft  of
a  proposed  rule  that  had  come  from  the  agency  and  how  it  was
changed. Isn’t that right?

Mr. AITKEN. That is correct, under the disclosure procedures.
Chairman MILLER. And it required showing what outside parties
had  commented  and  what  they  had  to  say,  what  the  correspond-
ence  was  between  OIRA  and  the  outside  parties.  Isn’t  that  right?
Mr.  AITKEN.  Under  the  executive  order,  for  rules  that  under  re-
view  there  are  requirements  which  we  adhere  to  in  OIRA  for  the
notice  of  when  meetings  are  requested  from  outside  parties.  Any-
one  can  request  those  meetings.  They  are  posted  on  the  OMB  web
site.  I  can  say  that  during  my  ten  months,  we  received  a  number
of requests for meetings which so far as I know, we always granted
if we had time and——

Chairman  MILLER.  So  essentially  all  the  questions  that  I  have
asked  you  about  how  this  executive  order  was  decided  upon  are
questions that would be public record, would be public with respect
to  a  rule  that  had  gone  through  OIRA  under  the  Clinton  Adminis-
tration? Isn’t that right?

Mr. AITKEN. I am not sure I understand the question.
Chairman  MILLER.  The  questions  I  have  asked  you  about  who
was  consulted,  what  they  had  to  say,  how  was  the  draft  changed,
those  are  all  questions  that  would  be  public  with  respect  to  a  pro-
posed  regulation  under  the  Clinton  executive  order?  Isn’t  that
right?

Mr.  AITKEN.  The  distinction  is  that  OIRA  doesn’t  review  execu-

tive orders.

Chairman MILLER. I understand that distinction, but the process
I  described,  the  questions  I  have  asked,  those  are  public  based
upon  transparency  concerns  with  respect  to  proposed  rules,  right?
Mr.  AITKEN.  Under  Executive  Order  12866,  President  Clinton
and  this  President  has  continued  disclosure  procedures  about
OIRA’s  reviews  of  regulations.  I  am  not  aware  of  any  president,
and  I  believe  that  the  executive  order—and  the  executive  order
process was established by President Kennedy. I am not aware that
any  president  has  established  a  process  where  the  President  is
going  to  have  his  executive  orders  subject  to  public  comment  or  is
going  to  release  the  drafts  or  is  going  to—I  mean,  you  know,
whether it is President Kennedy, President Johnson——

Chairman  MILLER.  I  understand  the  distinction  you  are  making
between  executive  orders  and  regulations  and  you  are  saying  this
executive order does not apply to regulations. With respect to regu-
lations, with respect to the Bush Administration’s new order, power
is  given  to  regulatory  RPOs  at  each  agency  and  which  regulatory
policy officers, which of these transparency requirements under the
Clinton  executive  order  would  apply  to  decisions  made,  delibera-
tions at the agency level by the RPOs? None of them would, would
they?

Mr.  AITKEN.  The  executive  order  as  it  was  originally  issued  by
President  Clinton  when  he  required  agency  heads  to  appoint  regu-
latory policy officers did not have any disclosure procedures regard-

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00038 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

171

ing  the  regulatory  policy  officers’  activities  and  that  continues
today.  So  since  President  Clinton  issued  the  order  in  1993,  there
have  been  no  disclosure  provisions  regarding  the  regulatory  policy
officer.

Chairman  MILLER.  I  am  out  of  time,  but  you  can  assume  that  I

will ask further questions along these lines.

Mr. Rohrabacher.

CONFIDENTIALITY CONCERNS

Mr. ROHRABACHER. Well, let me note for the record that I am not
opposed to transparency at all. I mean, to the degree that the exec-
utive  order  that  we  are  talking  about  has  in  some  way  decreased
the  transparency,  then  that  is  an  issue  that  we  should  talk  about.
We  shouldn’t  be  talking  about  who  discussed  the  issue  of  trans-
parency  with  the  President.  We  should  discuss  whether  trans-
parency  in  and  of  itself  is  an  issue  that  is  right  or  wrong  and
whether  the  executive  order  went  in  the  right  or  wrong  direction.
That is a totally legitimate area of discussion, and I would support
more  transparency  requirements.  However,  I  may  be  right  or
wrong in that. That is just my inclination. For example, if we have
the  same  transparency  requirements,  if  we  set  the  same  standard
for  Members  of  Congress,  we  would  have  to  say  that  members  of
the executive branch would have a right to query Members of Con-
gress  as  to  who  they  spoke  to,  every  single  person  that  they  spoke
to  about  any  legislation,  specific  pieces  of  legislation  that  would
come  up.  We  are  sitting—we  are  making  policy  too  here,  and  does
the  executive  branch  have  a  right  to  query  us  under  oath  to  find
out  who  we  talked  to  or  do  the  American  people  have  a  right  to
know  exactly  where  we  stand?  I  think  the  American  people  have
a right to know exactly where we stand on an issue, which half the
time  Members  of  Congress,  as  you  know,  try  to  obscure  exactly
what  their  positions  are  to  try  to  make  sure  they  are  not  making
any  enemies,  so  I  would  be  very  supportive,  Mr.  Chairman—if
there is something in this executive order that hurts transparency,
we could work on that and try to pass some legislation that would
insist on transparency. But let us discuss that issue. Let us not dis-
cuss how some decision is come to.

Let  me  get  back  to  that.  Mr.  Aitken,  do  you  think  that  Congres-
sional  demands,  and  this—because  I  may  be  supportive  of  those
Congressional  demands  for  transparency.  Do  you  think  Congres-
sional  demands  for  specific  communications  within  the  executive
branch would curb the discussions and people wouldn’t be quite so
frank in their discussions on an issue if they knew everything was
going to end up being public? Would that be in the end to the det-
riment  of  the  public  more  than  just—would  that  have  a  negative
impact as compared to a positive impact of transparency where we
know all the discussions that were going on?

Mr.  AITKEN.  I  think  I  would  like  to  address  that  in  terms  of  the
confidentiality  of  the  deliberations  and  the  importance  of  pre-
serving  that  confidentiality  is  so  that  people  can  have  frank  and
candid  discussions,  and  Congress  recognized  that  when  in  1966  in
enacting  the  FOIA  statute  it  preserved  the  deliberative  process
privilege.  The  courts  have  upheld  that.  It  is  important  for  people

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00039 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

172

to be able to discuss the issues. If people internally cannot discuss
the issues in a frank manner, decisions are——

Mr.  ROHRABACHER.  I  agree  with  that,  but  I  will  tell  you  on  an-
other  committee—not  another  committee,  actually  this  committee
but  on  another  subcommittee,  we  were  dealing  with  reports  that
were issued by a member of the—someone who worked for the gov-
ernment  issued  a  report  on  a  specific  decision  that  needed  to  be
made and does that person, should we then, when the Administra-
tion  is  trying  to  make  up  its  mind  on  something,  should  we  then
know what was in that report? I happen to believe in transparency
because  I  happen  to  believe—and  I  have  backed  up  the  Democrat
demands  to  see  that  report,  and  I  don’t  think  that  would  in  some
way hinder the debate within the Administration if they knew that
people  when  they  asked  their  opinion  of  various  professionals  like
yourself  what  the  opinion  was  when  it  was  written  down.  Now,
that  is  different  than  talking  about  private  deliberations,  I  think,
but maybe not. Maybe you can clear that up for me.

Mr.  AITKEN.  I  am  not  familiar  with  the  situation  you  just  men-
tioned  in  terms  of  the  report  but  I  can  say  that  having  worked  at
OMB  for  18  years  in  the  counsel’s  office  where  these  issues  come
up quite regularly, that it is important, as it would be with a judge
and a law clerk. I clerked twice. I think judges expect the confiden-
tiality of their——

Mr.  ROHRABACHER.  Especially  for  professionals.  So  if  we  have  a
professional who is over at a department or agency and we ask for
a  report,  you  know,  I  frankly  think  that  should  be  public  record
and  I  would  oppose  the  Administration  keeping  that  secret.  How-
ever,  it  may  make  that  public  employee  less,  let  us  say,  willing  to
be  totally  expressing  his  points  of  view  if  he  knew  it  is  all  going
to be public some day. Is that right?

Mr.  AITKEN.  That  is  the  concern  that  underlies  the  deliberative

process.

Mr. ROHRABACHER. Thank you very much.

REGULATORY POLICY OFFICERS

Chairman MILLER. Mr. Rohrabacher, you just used 20 seconds of

the two and a half minutes that you have got coming.

Mr.  Aitken,  you  said  earlier  that  RPOs  were  not  new  creatures
of  this  executive  order,  that  they  existed  before.  What  additional
authority is given RPOs under this order?

Mr.  AITKEN.  As  I  noted  in  my  prepared  testimony,  the  recent
order  makes  two  relatively  minor  amendments  to  the  provisions.
One  concerns  the  regulatory  plan.  Under  the  original  issuance  of
Executive  Order  12866  by  President  Clinton,  it  was  the  agency
head who had to personally approve the regulatory plan. Under the
revised  order,  it  is  either  the  agency  head  or  the  regulatory  policy
officer  that  would  sign  off  on  the  agency’s  regulatory  plan,  which
is the agency’s once-a-year compendium of the agency’s most impor-
tant  regulatory  initiatives.  Also,  the  executive  order,  the  recent
one,  provides  that  either  the  agency  head  or  the  regulatory  policy
officer  has  to  sign  off  on  a  commencement  by  an  agency  of  a  rule-
making.

Chairman  MILLER.  When  a  professional  employees  of  an  agency
want  to  initiate  rule-making,  the  RPO  can  decide  no,  we  are  not

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00040 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

173

going  to  do  that?  That  is  correct,  right?  That  is  the  power  of  the
RPO now under this order?

Mr.  AITKEN.  The  order  provides  that  in  an  agency,  it  is  ulti-
mately  the  presidential  appointees  who  have  to  decide  what  regu-
latory  activities  the  agency  wants  to  engage  in.  This  is  not  a  new
principle  for  the  executive  branch.  I  know  that  in  the  transition
from the first President Bush to President Clinton, one of the first
things that was done by the incoming OMB director, Leon Panetta,
was  to  issue  a  memo  to  all  agencies  saying  that  there  is  a  new
president and agencies are not to issue new regulations unless they
are  approved  by  the  agency  head,  who  is  appointed  by  the  Presi-
dent,  or  by  somebody  else  who  has  been  appointed  by  the  Presi-
dent.  And  that  is  to  reflect  that,  that  it  matters  who  is  elected
President,  and  in  the  executive  branch,  it  is  not  solely  the  career
employees  who  have  the  authority  to  issue  regulations  or  decide
how governmental power will be organized.

Chairman MILLER. And I don’t think we want to be entirely con-
trolled  by  bureaucrats.  We  do  not  want  government  by  bureaucrat
or  by  platonic  guardians.  We  do  want  the  democratic  processes  to
matter. But what are the transparency requirements, provisions for
RPO  decisions  not  to  initiate  rule-making?  Do  any  of  the  trans-
parency provisions that apply to OIRA apply to the RPO when the
RPO  determines  not  to  initiate  rule-making?  Will  anyone  find  out
that  the  agency  wanted  to  initiate  rule-making  and  the  RPO  said
no?

Mr.  AITKEN.  Just  as  in  the  case  of  the  memorandum  that  Direc-
tor Panetta issued at the very beginning of the Clinton Administra-
tion,  there  is  no  requirement  in  the  executive  order  nor  was  there
any requirement in the original issuance of Executive Order 12866
for there to be disclosure requirements for the regulatory policy of-
ficer  or  even  for  the  agency  head  and  the  agency  head’s  activities
regarding, say, the development of a plan.

Chairman MILLER. We have been joined by Mr. Baird. Mr. Baird,
do  you  have  any  questions?  I  just  gave  back  a  minute  and  a  half.

DIVISION OF POWER IN THE FEDERAL GOVERNMENT

Mr.  BAIRD.  I  am  interested  in  Mr.  Aitken’s  comment  just  a  sec-
ond ago that it matters who is elected president. It surely does, but
the Constitution puts legislative authority in the hands of the Con-
gress,  and  if  Congressional  intent  statute  is  usurped  by  the  execu-
tive,  is  it  your  understanding  that  the  role  of  the  executive  that
they  are  to  execute  faithfully  the  laws  enacted  by  the  Congress  or
that  the  executive  has  the  responsibility  under  the  United  States
Constitution  to  usurp  or  circumvent  those  laws  if  they  so  choose?
Mr. AITKEN. Agencies must faithfully execute the laws that have
been  enacted.  As  a  career  government  attorney,  that  has  been  my
job,  to  ensure  that  agencies  faithfully  implement  the  statutes  that
have  been  enacted,  and  if  Congress  directs  an  agency  to  issue  a
regulation, the agency has to issue that regulation.

Mr.  BAIRD.  And  when  you  say  that  it  matters  who  is  elected

president, what does that mean?

Mr.  AITKEN.  Congress  enacts  statutes  for  very  good  reasons.  It
does not always specify in each last detail exactly what kind of reg-
ulations an agency should issue or has to issue. Therefore, because

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00041 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

174

there are complex issues, because there are policy issues that have
to  be  resolved  and  perhaps  because  there  was  not  enough  con-
sensus  within  Congress  about  which  policies  should  be  pursued,
Congress has provided discretion to agencies in implementing those
statutes, and that policy discretion, as the Supreme Court has rec-
ognized in the Chevron decision, does allow agencies to make policy
judgments  and  those  judgments  appropriately  can  reflect  the  poli-
cies of the President, whoever the President may be.

Mr.  BAIRD.  If  you  are  counseling  somebody,  one  of  these  RPOs,
about  the  process  they  use  to  formulate  their  decision,  is  it  your
counsel that they seek first to understand the executive position on
a  regulatory  matter  or  that  they  seek  first  to  understand  the  Con-
gressional  intent  on  the  regulatory  matter,  and  which  of  those  is
paramount if the two conflict?

Mr. AITKEN. The analysis would begin on any regulatory issue on
how  Congress  has  spoken  on  the  issue.  Every  agency  in  order  to
undertake  a  rule-making  needs  authority,  statutory  authority,  to
carry  out  that  rule-making.  Congress  sometimes  provides  permis-
sive  authority  which  the  agency  can  or  decide  not  to  exercise  or
Congress in other instances mandates that an agency pursue a reg-
ulation and in some cases Congress mandates with great specificity
the  contours  of  that  regulation.  So  the  first  issue  for  an  agency
would be, what has Congress said, has the Congress mandated that
we issue a regulation or given us discretion.

Mr. BAIRD. But isn’t the crux of part of what we are asking about
here is, you just mentioned the first issue for an agency. One of the
concerns is what if the RPO feels more beholden to the administra-
tion  than  to  the  Congressional  intent,  and  if  there  is  no  way  of
tracking how that happens?

Mr.  AITKEN.  The  executive  branch  has  to  comply  faithfully  with

the laws that as passed by Congress.

Mr. BAIRD. How do signing statements fit into this? Does a sign-
ing statement by the executive somehow exculpate them from com-
plying faithfully or unfaithfully, as the case may be, with Congres-
sional  intent?  In  other  words,  so  you  are  saying  on  the  one  hand
that  the  executive  branch  must  comply  with  Congressional  intent
but  this  Administration  has  used  signing  statements  at  unprece-
dented levels. If a signing statement is made by the President, does
the  executive  branch  agency  then  comply  with  the  statement  that
Congress has modified by a signing statement or as intended in the
original text by the Congress?

Mr.  AITKEN.  I  didn’t  come  prepared  to  talk  about  signing  state-
ments  and  the  relationship  of  signing  statement  on  regulatory  ac-
tion.

Mr.  BAIRD.  Okay.  I  can  understand  that.  But  I  will  express  con-
cern  that  I  would  hope  the  agencies  are  complying  with  Congress,
not with the intent as modified by a signing statement.

So  your  testimony  to  us  is  that  you  believe  that  the  statutory
language  as  enacted  by  the  Congress  takes  precedent?  Let  me  say
it  differently.  Let  us  suppose  a  president  were  to  suggest  to  his
people  that  they  just  really  don’t  like  very  much  a  law  passed  by
the  Congress  and  therefore  what  they  would  like  to  see  is  for  an
RPO  to  find  any  way  around  the  law  as  passed  by  the  Congress

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00042 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

175

rather than interpreting the intent of the Congress. Would that be
an  appropriate  use  of  executive  authority  of  an  inappropriate  use?
Mr.  AITKEN.  An  agency  must  comply  with  the  law.  As  the  Su-
preme  Court  discussed  in  the  1984  decision  on  the  Chevron  case,
Congress  sometimes  speaks  very  precisely  on  a  particular  issue.  If
that  is  the  case,  the  agency  must  follow  the  Congressional  direc-
tion. There are other times when Congress has spoken but has pro-
vided  discretion  to  the  agency  on  whether  to  act  or  on  how  to  act.
Mr. BAIRD. Let us suppose we create a continuum and we say on
the  one  end,  Congress  has  spoken  quite  clearly.  Would  it  be  inap-
propriate for the President or one of his designees to say Congress
has spoken clearly but we are still not happy with it, therefore, we
would  like  this  agency  to  find  a  way  to  circumvent  it  and  not  pro-
mulgate a regulation. Would that be inappropriate?

Chairman  MILLER.  I  am  sorry.  If  you  could  make  that  a  short
summary  answer,  we  are  now  out  of  time  and  we  do  need  to  vote
in a moment.

Mr.  AITKEN.  As  the  Supreme  Court  said  in  the  Chevron  case,  if
Congress  has  spoken  on  the  precise  question  at  issue,  the  agency
must follow the Congressional direction.

Mr. BAIRD. And it would therefore be inappropriate? You are not
quite  answering  my  question.  It  would  therefore  be  inappropriate
for  an  executive  officer  to  say  to  an  agency,  do  not  follow  the
Congress’s direction?

Mr.  Chairman,  I  know  we  have  to  vote,  but  if  you  have  more

questions, go ahead. I am sorry.

Chairman  MILLER.  I  don’t,  not  before  voting  anyway.  Do  you

think you could answer that in a sentence?

Mr. BAIRD. Yes or no, would it be inappropriate for the President
or  his  designees  to  tell  an  agency  Congress  had  this  intent,  we
would  like  you  to  try  to  find  a  way  around  that  intent?  Yes  or  no,
would that be inappropriate?

Mr. AITKEN. It would not be appropriate if the Congress has spo-
ken precisely on all the issues. Often it is the case, and it has been
my  experience  over  the  years,  including  during  the  prior  Adminis-
tration,  that  Congress  has  provided  policy  discretion  and  so  one  of
the  issues  that  often  comes  up  is,  is  there  discretion  within  the
statute  that  provides  policy  officials  leeway  to  go  one  approach  or
to  another  approach,  and  that  is  often  a  discussion  that  arises  re-
gardless of who is the President.

Chairman  MILLER.  Mr.  Rohrabacher  needs  to—can  I  come  back
after votes? And I want to offer my condolences and those of all the
Members of the Committee on the loss of your brother. I know you
need to get back to California to that funeral. Do you want to take
some of the time?

Mr. ROHRABACHER. It usually takes us a couple of minutes to get
to the Floor so I will make this a couple minutes worth of questions
so we will have plenty of time to get to the floor.

So what we see here is an ominous trend. I mean, there is a pat-
tern  here.  First  of  all,  President  Clinton  got  rid  of  all  the  U.S.  at-
torneys  immediately  upon  taking  office.  This  president  gets  rid  of
seven  of  them  later  on  but  that  trend—and  then  we  see  here  a
presidential  executive  order  issued  by  President  Clinton  and  no-
body got to ask whether or not he had consulted outside people on

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00043 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

176

this  and  put  them  under  oath  and  actually  required  all  the  docu-
ments and people to have good memories about who they talked to
about  this  executive  order,  and  now  you  have  let  it  slip.  You  were
there. Mr. Panetta issued an edict that the good-hearted public em-
ployees of the various departments and agencies couldn’t issue any
regulations.  These  political  appointees  actually  got  in  place  and
were  able  to  make  the  final  decision.  I  smell  a  real  problem  here.
I  think  that  maybe  we  should  have—there  should  have  been  hear-
ings  under  Mr.  Panetta’s  edict.  Who  did  he  discuss  that  with  that
we  are  cutting  off  the  rights  of  those  good-hearted  honest  public
employees to set regulations down? You know, this is getting a lit-
tle bit absurd and I would suggest that—now, let me ask you. You
have  had  a  lot  of  experience.  You  have  been  around  longer  than
most  people  in  this  system.  Do  presidents  usually  try  when  they
are marking out their policies, is it usually—isn’t one of the consid-
erations maintaining presidential authority and prerogatives?

Mr. AITKEN. That is correct.
Mr. ROHRABACHER. Now, that was President Clinton or President
Bush? I mean, Democrats, Republicans, don’t they all act that way?

Mr. AITKEN. That is correct.
Mr.  ROHRABACHER.  So  when  a  president  is  sort  of  suggesting
that  he  doesn’t  want  to  make  all  private  deliberations  available  to
Congress  but  we  should  discuss  what  the  final  decision  is  rather
than  the  process  he  went  through,  isn’t  that  a  type  of  argument
that Democrat and Republican presidents basically would all agree
upon?

Mr. AITKEN. It has certainly been my experience that those presi-

dents have over the years made that argument.

Mr.  ROHRABACHER.  And  let  me  note  that  you  have  worked  for
Republican  and  Democrat  presidents  both,  and  there  is  no—you
know,  and  you  are  saying  that  with  experience  and  having  been
loyal  to  both  presidents  of  both  parties.  And  so  I  think  that  this
hearing has been good in one respect. We really have had a serious
discussion of some of the fundamental issues in terms of separation
of  powers  of  our  country,  and  I  think  that  that  is  important  as  to
what you would expect employees to do and people to do in various
departments  and  agencies,  how  it  works  out,  and  that  has  been  a
very good discussion. Trying to question the motives of people, how
they have come to their conclusions in that discussion is not appro-
priate.  We  recognize  that  in  the  legislative  branch.  We  have  made
it a rule of thumb that we do not question the motives of someone
who is presenting an argument on the Floor of the House and that
can  actually—you  can  actually  have  your  words  taken  down  if  you
question  the  motives  of  someone.  But  we  want  to  have  an  honest
discussion of the issue at hand. That means you discuss the policy
and  not  the  process  that  someone  has  gone  through  in  order  to
come  to  that  policy  conclusion.  That  type  of  goodwill  I  think  is
something  that  should  be  reflected  in  our  overall  democratic  proc-
ess.  Unfortunately,  when  we  get  into  this  type  of,  why  did  you
come  to  a  decision  and  who  did  you  talk  to,  and  if  you  make  any
mistakes in remembering exactly how many conversations you had,
if  you  forget  one  document,  you  are  going  to  be  prosecuted  for  it.
I  don’t  think  that  leads  to—it  doesn’t  benefit  democracy  and  does

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00044 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

177

not benefit the people, and usually these things start happening as
we are leading up to a major important election.

With  that  said,  I  thank  you  very  much  again  for  your  service
both  to  President  Clinton  and  to  President  Bush  and  for  giving  us
an understanding of how the process works from the inside.

Chairman MILLER. Mr. Aitken, you are dismissed. Thank you for

being here.

I need to go vote. We all need to go vote. I could sprint back and
then  I  would  have  to  sprint  back  again  after  about  15  or  20  min-
utes of being here. Itt will be about an hour and we can go uninter-
rupted.  What  is  the  preference  of  the  next  panel?  Consideration  of
whether  I  should  sprint  or  not  is  not  really  the  issue.  Why  don’t
I  return  in  just  a  few  minutes,  take  some  testimony,  then  I  will
have  to  leave  again.  Thank  you.  The  Committee  stands  in  recess.

[Recess.]
Chairman MILLER. A quick note on the schedule. The full House
is now finishing a vote. After that there will be a motion to recom-
mit,  followed  by  another  15-minute  vote.  So  probably  we  will  be
able  to  go  about  15  or  20  minutes  and  then  I  need  to  run  back
again.  At  that  point  I  will  be  there  for  three  additional  votes  and
it will take me about maybe half an hour, maybe 20 minutes before
I can get back. But it gives us a chance for all of you to begin and
probably complete your initial testimony.

Mr.  Strauss  is  the  Betts  Professor  of  Law  at  Columbia  Law
School. He is a nationally recognized expert in administrative law,
constitutional law, legal method and legislation. He was a member
of  the  faculty  when  I  was  a  student.  It  his  good  fortune  that  I  not
today am not seeking vengeance for having embarrassed me in So-
cratic method as I never took his course as I could not imagine how
I would ever need to know anything about administrative law. But
I will note for Professor Strauss that I will be asking the questions
today. Our next witness is Dr. Robert Hahn, the cofounder and ex-
ecutive  director  of  the  American  Enterprise  Institute’s  Brookings
Joint  Center  for  Regulatory  Studies,  which  must  feel  sometimes
like having Mr. Rohrabacher and I sit beside each other, which ex-
amines  leading-edge  issues  in  law,  economics,  law,  regulation  and
antitrust.  Dr.  Gary  Bass  is  the  founder  and  executive  director  of
OMB Watch and has worked extensively on federal budgetary pro-
gram  management,  regulatory  and  information  policy  issues,  and
finally  Dr.  Richard  Parker,  a  professor  at  the  University  of  Con-
necticut  and  an  expert  on  administrative  law,  environmental  law,
regulatory policy. He chaired the regulatory policy committee of the
administrative  law  section  of  the  ADA  and  has  written  on  the  use
of cost-benefit analysis in OIRA.

As  each  of  you  know,  your  oral  testimony  is  limited  to  five  min-
utes but your entire written testimony will be placed in the record,
and after the entire panel has given their testimony, the Members
of  the  Committee,  which  probably  will  be  me  only,  and  I  will  do  a
series of five-minute blocks of questions. We will five minutes each
to  ask  questions.  So  I  will  put  all  of  you  at  ease  as  I  did  Mr.
Aitken.  I  will  now  ask  you  all  to  stand.  Do  any  of  you  have  any
objection  to  being  sworn  in?  Is  anyone  represented  by  counsel
today?  Okay.  Now  that  you  are  at  ease,  you  may  raise  your  right
hand.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00045 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

178

[Witnesses sworn]
Chairman  MILLER.  Thank  you.  We  will  begin  with  Professor
Strauss. Excuse me. Let me amend that. Dr. Hahn is under a time
restraint.  Dr.  Hahn,  if  you  could  testify  first.  Okay.  Dr.  Hahn  will
go second.

Professor Strauss.

Panel 2

STATEMENT OF MR. PETER L. STRAUSS, BETTS PROFESSOR

OF LAW, COLUMBIA LAW SCHOOL

Mr. STRAUSS. I am sorry that your colleague had to leave because
in  his  opening  statement  he  made  what  seems  to  me  the  central
point,  at  least  from  the  perspective  of  my  testimony,  which  is  that
it  might  be  a  good  idea  to  ensure  that  they,  and  he  was  referring
to  the  regulatory  policy  officers,  are  accountable  to  someone,  and
the  issue  that  I  mean  to  talk  with  you  about  is  to  whom  they  are
accountable and what the Congressional stakes are in that.

The Constitution makes the President the overseer of all the var-
ied  duties  that  you  give  government  agencies  but  equally  clearly,
it seems to me, it permits you to assign those duties to those agen-
cies  and  not  to  the  President,  and  for  those  duties,  he  is  not  the
decider  but  rather  the  overseer  of  decisions  that  others  make.  The
important  point  in  my  judgment  is  to  preserve  this  distinction  be-
tween presidential oversight, which is entirely appropriate and con-
stitutionally  commanded,  and  presidential  decision.  The  assign-
ment  of  decisional  responsibility  to  others  is  a  part  of  those  laws
to  whose  faithful  execution  the  President  must  see,  and  when  he
fails to honor this rather subtle distinction, he fails in his constitu-
tional  responsibility  to  take  care  that  the  laws  be  faithfully  execu-
tive.

The  executive  order  we  are  discussing  amends  the  longstanding
Executive Order 12866 in several ways, and I want to focus on four
language  changes  that  in  my  view  threaten  the  difficult  but  nec-
essary  balance  between  politicians  and  experts,  between  politics
and  law  that  characterizes  agency  rule-making.  These  are  amend-
ments  to  Section  4  and  6  concerning  the  regulatory  plan,  both  of
which diminish the effective control over regulatory decision by the
agency  head  that  you  have  put  in  charge  of  agency  business  and
increase  the  President’s  control  over  regulatory  outcomes,  an  in-
crease  that  in  my  judgment  requires  Congressional  authorization.
You  heard  Professor  Katzen,  the  previous  administrator  of  OIRA,
when she was here at the last hearing, talk to you about the step-
by-step  increase  in  presidential  controls.  Executive  Order  13422  is
another  step  in  that  direction,  and  from  my  perspective,  a  haz-
ardous one.

The first change added these words to Section 4(c)(1) of the exec-
utive  order  applicable  equally  to  executive  and  independent  regu-
latory  commissions:  ‘‘Unless  specifically  authorized  by  the  head  of
the  agency,  no  rule-making  shall  commence  nor  be  included  in  the
plan without the approval of the agency’s regulatory policy officer.’’
This  language  purports  to  confer  legal  authority  on  the  regulatory
policy  officer  to  control  whether  agency  rule-making  occurs  subject

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00046 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

179

only  to  a  specific  countermand  by  the  agency’s  head.  Prior  provi-
sions of the order, President Clinton’s order, merely hinted that de-
nial  of  a  place  on  the  regulatory  plan  would  preclude  rule-making,
and in my efforts to track this issue, I have never heard that it had
happened.  Your  own  provisions  for  the  regulatory  agenda  in
supriva  are  quite  specific  that  presence  on  the  regulatory  agenda
is not a condition of valid rule-making. Where did the President get
the  authority  to  impose  this  condition,  much  less  to  put  it  in  the
hands of a junior officer?

The  second  change  I  invite  you  to  focus  on  subtracted  these
words  from  Section  4(c)(1):  ‘‘The  plan  shall  be  approved  personally
by  the  agency  head.’’  So  the  agency  head  is  no  longer  imagined  as
having  general  personal  responsibility  for  his  agency’s  important
business.  That  is  for  the  regulatory  policy  officer  and  the  agency
head just gets a veto, one whose exercise will doubtless be impeded
by  its  specificity,  visibility  and  vulnerability.  When  the  regulatory
plan  was  first  rationalized,  it  was  rationalized  as  an  aid  and  it
seemed  to  me  an  entirely  appropriate  aid  to  the  political  heads  of
administrative agencies requiring career staff to reveal their prior-
ities  and  plans  for  rule-making  to  agency  leadership  in  the  same
way that the dollar budget process does. So it sensibly injected the
agency’s political leadership into the picture before matters got set
in  bureaucratic  concrete,  but  now  that  has  been  diverted  to  some-
one else.

The third change added this language to Section 6(a)(2): ‘‘Within
60 days of the date of this Executive Order, each agency head shall
designate one of the agency’s Presidential Appointees to be its Reg-
ulatory  Policy  Officer,  advise  OMB  of  such  designation  and  annu-
ally update OMB on the status of this designation.’’ The important
elements to note here are that a presidential appointee is a person
the  President,  not  the  agency  head,  gets  to  hire  and  fire,  and  the
repeated references to OMB make clear who will be overseeing her
performance. You may hear verbal promises that these presidential
appointees will be of the kind that the Senate must confirm but of
course  the  language  doesn’t  say  that,  and  even  if  it  did,  the  fact
would remain that the President, not the agency head, is in charge
of the RPO’s continuing tenure in the office.

The  fourth  change  also  in  6(a)(2)  just  confirms  this  pattern  of
displaced  responsibility  and  division  of  authority.  It  subtracts  the
prior  requirement  of  the  section  that  the  regulatory  policy  officer
shall  report  to  the  agency  head.  Of  course,  the  statute  creating
presidential  appointees  within  an  agency  will  itself  embody  some
kind  of  reporting  relationship  but  I  think  you  can  see  how  neatly
this  change  echoes  the  others  that  I  have  mentioned.  The  order
purports  to  confer  legal  authority  on  the  junior  authority  in  each
agency  whose  identity  must  be  coordinated  with  the  White  House
to  control  the  initiation  of  agency  rule-making,  and  it  seems  to  be
intended  its  continuing  processing  within  the  agency.  Conferring
this  kind  of  legal  authority  is  Congress’s  business,  not  the  Presi-
dent’s,  and  it  is  authority  I  would  urge  you  not  to  grant  because
it  diffuses  political  authority  within  the  agency  that  you  generally
entrust to the agency head. Congress, as well as the President, has
political  relationships  with  the  agency  head.  While  the  President
can  cashier  agency  heads  whose  work  he  doesn’t  like,  that  comes

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00047 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

180

at  a  high  political  cost  including  having  to  get  the  Senate’s  agree-
ment  on  a  successor.  As  a  well-connected  friend  told  me,  I  person-
ally  watched  two  agency  heads  tell  the  President  to  pound  sand.
They wouldn’t do what they were told and the President knew they
had  the  political  capital  to  win.  Junior  officers  appointed  under
close White House supervision, knowing that they can be dismissed
by  the  White  House  at  any  moment,  won’t  have  this  political  cap-
ital. There isn’t as much chance that firing them will have political
costs to the White House. They are not ever going to be telling the
President or OIRA to go pound sand.

[The prepared statement of Mr. Strauss follows:]
PREPARED STATEMENT OF PETER L. STRAUSS

Thank  you  very  much  for  inviting  me  to  testify  before  you  today.  I  am  a  scholar
of administrative law, who has had the privilege of teaching that subject at Colum-
bia  Law  School  for  the  past  36  years  and  who  for  two  years  in  the  1970’s  had  the
honor  of  serving  as  the  first  General  Counsel  of  the  Nuclear  Regulatory  Commis-
sion.  I  was  later  Chair  of  the  ABA’s  Section  of  Administrative  Law  and  Regulatory
Practice,  a  consultant  to  the  ABA’s  Coordinating  Committee  on  Regulatory  Reform,
and  long-time  Chair  of  the  Section’s  Rule-making  Committee.  My  1984  analysis  of
agency  relations  with  the  President  won  the  Section’s  annual  prize  for  scholarship.
I  have  continued  since  then  to  write  about  separation  of  powers  and,  in  particular,
the  President’s  constitutional  relationship  to  the  agencies  on  which  Congress  has
conferred regulatory authority. Attached to this testimony is the current draft of my
most  recent  writing  on  this  subject,  an  essay  to  be  published  this  summer  by  the
George  Washington  Law  Review  entitled  ‘‘Overseer  or  ’The  Decider’—The  President
in  Administrative  Law.’’  Here  is  its  bottom  line:  Our  Constitution  very  clearly
makes  the  President  the  overseer  and  coordinator  of  all  the  varied  duties  the  Con-
gress  creates  for  government  agencies  to  perform.  Yet  our  Constitution’s  text,  with
equal clarity, anticipates that Congress may and will assign duties to executive offi-
cials who are not the President. Respecting those duties, he is not ‘‘the decider,’’ but
the  overseer  of  decisions  by  others.  When  the  President  fails  to  honor  this  admit-
tedly  subtle  distinction,  he  fails  in  his  constitutional  responsibility  to  ‘‘take  Care
that  the  Laws  be  faithfully  executed.’’  The  assignment  of  decisional  responsibility
to  others  is  a  part  of  the  laws  to  whose  faithful  execution  he  must  see.  The  impor-
tant point, in my judgment, is to preserve this distinction between presidential over-
sight—entirely  appropriate  and  constitutionally  commanded—and  presidential  deci-
sion. For any agency’s unique responsibilities, Congress’s delegation makes the pre-
cise  formulation  of  its  priorities  and  plans  the  legal  responsibility  of  the  agency
head.  Honoring  and  protecting  that  responsibility  is  an  important  element  of  the
President’s obligation to assure that the laws are being faithfully executed. And the
recent  Executive  Order  amendments  reflect  a  different  view,  in  effect  making  the
President not just the overseer, but the decider of these matters.

Our subject is Executive Order 13422, 72 Fed. Reg. 2763 (January 23, 2007), that
amends  the  long  standing  Executive  Order  12866,  concerning  regulatory  planning
and review. Others have addressed those elements of the order that reach guidance
documents,  another  of  its  important  elements,  and  that  heighten  the  specificity  of
the  analysis  the  order  requires  agencies  to  perform.  I  will  leave  those  elements
largely to them. Let me say only, as a long-time advocate of the proper use of guid-
ance to help the public deal with agency regulatory standards, that I find the exten-
sion  of  the  order  to  guidance  documents  possibly  troubling  only  in  its  details.  As
a  long-time  supporter,  as  well,  of  the  President’s  constitutional  authority  and  wis-
dom in commanding regulatory analyses in connection with important rule-makings,
I  find  that  heightened  specificity  troubling  only  insofar  as  it  may  be  administered
to  require  agencies  to  decide  matters  on  the  basis  of  factors  Congress  has  not  au-
thorized them to consider.

In these remarks I want to address two other aspects of the order, that I find par-
ticularly troubling. As Professor and former OIRA Administrator Sally Katzen testi-
fied to your committee two months ago, E.O. 13422 marks a distinct increase in the
already  significant  degree  of  presidential  control  over  regulatory  outcomes,  beyond
that  established  by  E.O.  12866,  which  in  turn  exceeded  what  had  been  done  in  its
predecessor  executive  orders.  Each  step  in  a  hazardous  direction  increases  the  haz-
ard. In the aspects that concern me, E.O. 13422 takes a decisive step from President
as overseer to President as decider. The President is not constitutionally entitled to

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00048 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

181

confer  decisional  authority  on  persons  outside  the  White  House,  and  Congress  has
conferred  no  such  authority  on  him  statutorily;  but  that,  too,  is  what  E.O.  13422
purports to do.

The first of the two aspects I wish to address amended the existing provisions re-
specting  the  agency’s  regulatory  plan,  and  its  regulatory  planning  officer,  in  ways
that  at  the  same  time  expand  her  authority,  and  seem  to  disconnect  her  from  the
agency  head.  Thus,  the  executive  order  amended  §4(c)(1)  of  E.O.  12866  by  adding
Unless  specifically  authorized  by  the  head  of  the  agency,  no  rule-making  shall
commence nor be included on the Plan without the approval of the agency’s Reg-
ulatory Policy Officer,

and subtracting a prior requirement that

The Plan shall be approved personally by the agency head

The order also amended §6(a)(2) of E.O. 12866 by adding

Within  60  days  of  the  date  of  this  Executive  order,  each  agency  head  shall  des-
ignate one of the agency’s Presidential Appointees to be its Regulatory Policy Of-
ficer, advise OMB of such designation, and annually update OMB on the status
of this designation

and  by  subtracting  the  previous  requirement  of  the  section  that  the  Regulatory

Policy Officer

shall report to the agency head

The  second  element  I  wish  to  address  added  an  entirely  new  idea  to  §6(a)(1)  of

the Executive Order, requiring that

In consultation with OIRA, each agency may also consider whether to utilize for-
mal  rule-making  procedures  under  5  U.S.C.  556  and  557  for  the  resolution  of
complex determinations.

Both  sets  of  changes,  in  my  judgment,  threaten  to  disturb  the  difficult  but  nec-
essary balance between politicians and experts, between politics and law, that char-
acterizes  agency  rule-making.  The  first  threatens  a  diffusion  of  authority  within
agencies,  and  a  dramatic  increase  in  presidential  control  over  regulatory  outcomes,
to  an  extent  Congress  has  not  authorized  and  in  my  judgment  would  have  to  au-
thorize for this step to be valid. The second threatens redeployment of a discredited,
remarkably expensive rule-making procedure that delivers substantial controls over
the timing and cost of rule-making into the hands of private parties—notably, I fear,
into  the  hands  of  those  whose  dangerous  activities  proposed  regulations  are  in-
tended to limit.
I. Presidential Control of Rule-making Agendas

When  President  Reagan  elaborated  the  idea  of  a  regulatory  agenda  in  Executive
Order 12498,1 Christopher DeMuth, who had responsibilities for these issues in his
administration, characterized it as essentially an aid to the political heads of admin-
istrative agencies—requiring career staff to reveal their priorities and plans for rule-
making to agency leadership, just as the annual dollar budget process does, and con-
sequently  injecting  the  agency’s  political  leadership  into  the  picture  before  matters
got set in bureaucratic concrete. Seen in this way, the measure supported Congress’s
assignments  of  responsibility—it  is,  after  all,  on  the  agency’s  political  leadership
alone  that  Congress’s  statutes  confer  the  power  to  adopt  rules.  To  judge  by  its  own
actions  in  measures  like  the  Regulatory  Flexibility  Act,  Congress  like  the  private
community  was  also  attracted  by  the  transparency  and  added  opportunities  for
broad public participation early notice of rule-making efforts would provide.

President Clinton’s Executive Order 12866 continued and in some ways strength-
ened  this  measure,  requiring  agencies  to  designate  a  regulatory  policy  officer  who
would  coordinate  general  issues  under  the  Executive  Order—in  effect  be  the  agen-
cy’s designated contact person for the OMB Office of Information and Regulatory Af-
fairs (OIRA). While there were hints that this new measure might be used to effect
presidential control over agency policy choices, years of paying fairly close attention
to  this  question  in  my  scholarship  and  professional  associations  have  brought  me
no  indication  that  this  had  happened.  On  specific  issues  of  importance  to  him,  as
Dean Elena Kagan of Harvard has detailed, President Clinton through his domestic
policy  office—not  OIRA—would  issue  directives  to  particular  agencies  on  issues  of
importance to his program. President Bush’s first head of OIRA, John Graham, ini-
tiated  a  practice  of  occasional  ‘‘prompt  letters’’  publicly  directing  agency  attention

1 A predecessor provision may be found in President Carter’s E.O. 12044.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00049 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

182

to matters that he concluded might warrant regulation. But a general centralization
of  actual  control  over  regulatory  agendas,  so  far  as  I  could  tell,  was  never  effected.
Until this order.

President  Bush’s  order  purports  to  confer  authority  on  a  junior  officer  in  each
agency,  whose  identity  must  be  coordinated  with  OIRA,  to  control  the  initiation  of
agency  rule-making  and,  it  seems  to  be  intended,  its  continued  processing  within
the  agency.  It  removes  prior  requirements  that  this  junior  officer  ‘‘shall  report  to
the agency head’’ and that the regulatory plan she is for the first time given explicit
authority to control must be ‘‘approved personally by the agency head.’’ I would have
thought conferring this kind of authority and externally effecting such a striking re-
organization of roles within an agency would be Congress’s business, not something
the President is authorized to do on his own. And if Congress were to ask my judg-
ment  about  these  steps  I  would  call  them  an  unwise  diffusion  of  political  authority
within the agency, that Congress generally entrusts to the agency head. While legis-
lation  may  permit  the  head  to  sub-delegate  some  of  her  authority  to  persons  she
trusts  and  will  take  responsibility  for,  Congress  wisely  has  rarely  if  ever  permitted
sub-delegation of ultimate control over rule-making. It certainly would be unwise to
confer such authority on persons who report to and are controlled by others outside
the  agency.  Congress  as  well  as  the  President  has  political  relationships  with  the
agency  head.  While  the  President  has  a  formal  capacity  to  discipline  agency  heads
whose  work  displeases  him,  that  capacity  is  sharply  limited  by  the  political  costs
of  doing  so—including  the  necessity  of  securing  senatorial  confirmation  of  a  suc-
cessor. As a well-connected friend of mine recently remarked,

I personally have watched two agency heads tell the President to pound sand—
they wouldn’t do what they were told and the President knew they had the po-
litical capital to win.

Junior  officers,  given  their  responsibilities  in  a  process  under  close  White  House
supervision, knowing as ‘‘presidential appointees’’ that they can be dismissed at any
moment,  and  lacking  both  this  political  capital  and  much  prospect  that  their  dis-
missal  would  have,  in  itself,  political  costs  for  the  White  House,  are  not  ever  going
to be telling the President or OIRA to pound sand.

A  number  of  gaps  in  the  order  make  this  problem,  in  my  judgment,  a  lot  worse.
As  remarked,  the  Clinton  executive  order  reinforced  ordinary  agency  hierarchy
by  providing  in  §6(a)(2)  that  the  regulatory  policy  officer  ‘‘shall  report  to  the
agency head.’’ That language has been deleted. Now it is at least ambiguous to
whom  the  RPO  reports.  Since  the  RPO  must  be  a  presidential  appointee—that
is,  subject  to  presidential,  not  agency  head  dismissal—control  over  her  tenure
in this office, and in government service generally, has been moved to the White
House. Anyone aware of the changes—the agency head, for example—will know
that  the  prior  mandatory  relationship  between  RPO  and  agency  head  has  been
eliminated. One need only observe the ongoing drama over the firing of United
States Attorneys to understand the potentials these changes open up.

Second,  in  requiring  that  the  ‘‘policy  officer’’  be  a  ‘‘presidential  appointee,’’  the
amended  order  doesn’t  tell  us  what  kind  of  presidential  appointee—one  who  must
also be confirmed by the Senate? One the President can name without need for con-
firmation? Perhaps a non-career officer in SES, whose appointment occurs only after
White  House  clearance  and  with  a  presidentially-signed  commission?  If  it  is  either
of the latter, then the President has found his way around the constraints the Con-
stitution  insists  upon,  that  people  who  exercise  major  authority  in  government  can
do so only with the Senate’s blessing as well as his. Then it becomes even more ap-
parent that the President has created a divided administration within each agency,
with real power vested in a shadow officer who essentially answers only to him. As
my friend also remarked, this would be ‘‘disastrous.’’

First as a practical matter it takes regulatory power away from the head of the
agency where Congress has vested it. Second, it continues the political accretion
of  power  in  the  bureaucracy  of  the  White  House,  away  from  public  scrutiny.
But, the worst part from my vantage point is that it treats the agency as a con-
quered  province—the  career  staff  is  explicitly  told  it  is  distrusted  and  is  not  to
make  recommendations  to  the  agency  head  but  to  the  White  House’s  political
officers.  That  in  turn  destroys  communication  between  the  staff  and  the  polit-
ical level of the agency. And, the agency is quite ineffective when that happens.
Third, it is unclear to what extent the new controls extend to the independent reg-
ulatory  commissions.  Section  4’s  language,  including  the  requirement  that  ‘‘Unless
specifically  authorized  by  the  head  of  the  agency,  no  rule-making  shall  commence
nor  be  included  on  the  Plan  without  the  approval  of  the  agency’s  Regulatory  Policy

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00050 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

183

Officer,’’  is  explicitly  applicable  to  independent  regulatory  commissions.  Section  6,
that  defines  the  regulatory  policy  officer’s  appointment,  is  not.  As  a  legal  require-
ment of agencies Congress has chosen to constitute as independent regulatory com-
missions, this is truly extraordinary.

The  final  gap  I  want  to  note  for  you,  one  of  signal  importance  in  my  judgment,
concerns  political  access.  Among  the  elements  that  have  made  the  Executive  Order
regime  acceptable  to  Congress,  and  I  might  add  to  much  of  the  academic  commu-
nity,  are  the  commitments  it  contains  to  a  professionalized,  unusually  transparent
and  apolitical  administration.  Oral  contacts  with  outside  interests  are  limited  to
OIRA’s  senate-confirmed  Administrator  or  his  particular  designee;  agencies  attend
any  meetings  with  outsiders;  written  communications  from  outsiders  are  also
logged;  and  all  of  this  information  is  publicly  disclosed.  My  understanding  is  that
Congress has properly insisted on these elements of transparency, as a condition of
its  acceptance  of  this  generally  valuable  regime.  The  OIRA  website,  within  a  gen-
erally  closed  White  House  environment,  has  been  a  remarkable  monument  to  the
worth  of  this  insistence.2 The  professional  qualities,  too,  of  OIRA’s  staff,  and  the
striking  qualities  of  its  leadership  over  time,  have  offered  reassurance.  Notice  that
none of these constraints are made applicable to the Regulatory Policy Officer or his
office. It can be open season there.

So  the  President  has  attempted  to  do  by  executive  order  something  that,  in  my
judgment, can only be done by statute. Moreover, in doing so he threatens excessive
politicization of agency rule-making, the subversion of a public process by back-cor-
ridor  arrangements,  and  compromising  the  lines  of  authority  Congress  has  created.
That  these  officers  will,  in  practice,  be  answerable  chiefly  to  him  is  underscored  by
President Bush’s subtractions from Executive Order 12866, as well as his additions
to it. Their conversations with him, his lieutenants, and any political friends he may
send their way will be invisible to us.

You  will  likely  hear  from  the  other  side  that  the  President  is,  after  all,  our  chief
executive, that our Constitution embodies the judgment that we should have a uni-
tary  executive,  and  so  even  if  the  result  were  to  convert  agency  judgments  about
rule-making into presidential judgments, that would only be accomplishing what the
Constitution  commands.  This  is  the  subject  of  the  writing  I  have  attached  to  this
testimony. In my judgment it is not only an erroneous argument, but one dangerous
to our democracy. The President is commander in chief of the armed forces, but not
of  domestic  government.  In  domestic  government,  the  Constitution  is  explicit  that
Congress  may  create  duties  for  Heads  of  Departments—that  is,  it  is  in  the  heads
of  departments  that  duties  lie,  and  the  President’s  prerogatives  are  only  to  consult
with them about their performance of those duties, and to replace them with senato-
rial  approval  when  their  performance  of  those  duties  of  theirs  persuades  him  that
he  must  do  so.  This  allocation  is  terribly  important  to  our  preservation  of  the  rule
of  law  in  this  country.  The  heads  of  departments  the  President  appoints  and  the
Senate confirms must understand that their responsibility is to decide—after appro-
priate  consultation  to  be  sure—and  not  simply  to  obey.  We  cannot  afford  to  see  all
the  power  of  government  over  the  many  elements  of  the  national  economy  con-
centrated in one office.

Professor  Peter  Shane,  a  highly  respected  scholar  of  the  presidency  and  a  former
lawyer in the Office of Legal Counsel, put the matter this way in a recent discussion
of  President  Bush’s  use  of  signing  statements,  which  I  know  is  not  our  subject
today.

The  Bush  Administration  has  operated  until  recently  in  tandem—can  there
be  a  three-part  tandem?—with  Republican  Congresses  and  a  Supreme  Court
highly deferential to executive power. . .. It has not only insisted, in theory, on
a  robust  constitutional  entitlement  to  operate  free  of  legislative  or  judicial  ac-
countability, but it has largely gotten away with this stance. And that success—

2 This  is  not  the  setting  to  explore  the  accounts  I  am  beginning  to  hear  of  increasing,  and  in
my  judgment,  regrettable,  politicization  and  transparency  violations  in  OIRA  functioning—for
example,  deliberate  holding  back  the  clock  on  formal  submission  of  agency  proposals  to  OIRA,
so  that  negotiations  and  ‘‘adjustments’’  can  be  complete  before  the  transparency  provisions  of
E.O.  12866  kick  in.  See  United  States  General  Accounting  Office,  Report  to  Congressional  Re-
questers,’’  RULE-MAKING,  OMB’s  Role  in  Reviews  of  Agencies’  Draft  Rules  and  the  Trans-
parency  of  Those  Reviews,’’  GAO–03–929,  September  2003,  pp.  47–48.  When  evidence  of  OIRA
changes  has  been  available,  it  has  been  available  to  assist  reviewing  courts  in  determining
whether agencies have themselves reached the decisions statutes commit to their responsibility,
and  done  so  only  on  consideration  of  the  statutorily  relevant  factors.  See  Riverkeeper,  Inc.  v.
EPA,  No.  04–6692–ag(L),  2007  U.S.  App.  LEXIS  1642  (2d  Cir.  Jan,  25,  2007),  where  the  pub-
lished  documents  showed  58  ‘‘major’’  changes  having  been  made  ‘‘at  the  suggestion  or  rec-
ommendation’’  of  OIRA  at  the  proposal  stage,  and  95  ‘‘major’’  changes  made  ‘‘at  the  suggestion
or recommendation’’ of OIRA in the rule as finally promulgated.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00051 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

184

the  Administration’s  unusual  capacity  to  resist  answering  to  Congress  and  the
courts—has  fed,  in  turn,  its  sense  of  principled  entitlement,  its  theory  that  the
Constitution envisions a Presidency answerable, in large measure, to no one.

Critics of the Administration have not infrequently charged that the Adminis-
tration’s  unilateralism  is  antagonistic  to  the  rule  of  law.  After  all,  the  ideal  of
a  ‘‘government  of  laws,  not  of  men’’  seems  conspicuously  at  odds  with  a  Presi-
dent’s  expansive  claims  of  plenary  authority.  But  no  sane  President  claims  to
be above the law and, indeed, President Bush takes pains repeatedly to defend
his  controversial  actions  as  legal,  including  the  widespread  warrantless  elec-
tronic  surveillance  of  Americans,  the  incarceration  of  U.S.  citizens  as  enemy
combatants, and the intense interrogation of detainees in Iraq and Afghanistan.
I  doubt  that  President  Bush  thinks  himself  antagonistic  to  the  rule  of  law;  he
just  has  a  different  idea  of  what  the  rule  of  law  consists  of.  But  what  the  Ad-
ministration  seems  to  believe  in  is  a  version  of  the  ‘‘rule  of  law’’  as  formalism.
It is the rule of law reduced to ‘‘law as rules.’’ Under the Bush Administration’s
conception  of  the  rule  of  law,  Americans  enjoy  a  ‘‘government  of  laws’’  so  long
as executive officials can point to some formal source of legal authority for their
acts,  even  if  no  institution  outside  the  executive  is  entitled  to  test  the  consist-
ency of those acts with the source of legal authority cited. . ..

The  Bush  signing  statements,  like  the  doctrines  they  advocate,  are  a  rebuke
to the idea of the rule of law as norms or process. They are a testament to the
rule of law as law by rules, preferably rules of the President’s own imagination.

This executive order is cut from the same cloth.
What  might  Congress  do  about  this?  This  looks  like  a  simple  affront  to  two  of
Congress’s responsibilities—to confer organization and authority on elements of gov-
ernment  by  enacting  statutes,  and  to  approve  (in  the  Senate)  all  appointments  to
high  office  (thus  creating  one  of  the  Constitution’s  many  checks  on  unilateral  au-
thority  in  any  branch).  Legislative  change  here,  though,  would  likely  encounter  a
presidential  veto.  Can  you  find  a  way  to  avoid  that?  There  remains  the  power  of
the  purse.  While  the  use  of  ‘‘do  not  spend’’  riders  in  appropriations  measures  has
often been criticized, perhaps this is a setting in which such a rider would be appro-
priate,  attached  to  a  budget  the  President  will  find  himself  compelled  to  sign.  Why
should  Congress  tolerate  the  expenditure  of  government  funds  to  pay  the  salary  of
one  whose  powers  it  has  not  authorized,  and  whose  functioning  can  prove  destruc-
tive of the public institutions it has worked to create?
II. Outsider Control of Rule-making

I  can  be  much  briefer  in  addressing  the  provision  of  the  executive  order  that  in-
vites  agencies  to  ‘‘consider  whether  to  utilize  formal  rule-making  procedures  under
5 U.S.C. 556 and 557 for the resolution of complex determinations,’’ ‘‘in consultation
with  OIRA.’’  This  is  permissively  worded,  but  one  must  wonder  how  permissive  its
implementation will be. And what you should note are the differences between ‘‘for-
mal  rule-making  procedures  under  5  U.S.C.  556  and  557’’  and  the  notice-and-com-
ment procedures agencies generally employ. On-the-record rule-making occurs under
the  aegis  of  an  administrative  law  judge,  a  person  trained  in  trials  not  policy-set-
ting;  notice  and  comment  rule-making  is  coordinated  by  the  agency’s  policy  staff.
Even  more  important,  on-the-record  rule-making  confers  on  participants  the  kinds
of rights parties to trials have—rights to put on witnesses, engage in cross-examina-
tion,  and  in  other  ways  slow  rule-making  down  and  add  to  its  internal  costs.  It  is,
simply, the delivery of the henhouse to the foxes.

Experience with on-the-record rule-making led to its virtual abandonment decades
ago,  and  for  good  reason.  Those  familiar  with  the  process  have  recognized  for  40+
years  that  it  is  simply  too  clumsy  to  work  except  in  very  isolated  instances.  In  its
1973 judgment in U.S. v. Florida East Coast Rwy, 410 U.S. 224, the Supreme Court
essentially  ruled  that  agencies  did  not  need  to  use  it  in  the  absence  of  the  clearest
of  statutory  instructions.  Congress  hasn’t  been  giving  those  instructions,  and  agen-
cies haven’t been using that process ever since, and for good reason. Experience has
taught  us  that  the  use  of  formal  rule-making  is  cumbersome  and  out  of  all  propor-
tion  to  its  benefits  because  trial-type  hearings  are  poorly  suited  for  determinations
that  turn  on  policy  judgments,  and  too  subject  to  unwarranted  extension  and  com-
plication  by  the  participant  parties.  Why,  then,  revive  it  now?  Just  to  help  one’s
friends slow things down—to throw a good dose of sand into the gears of rule-mak-
ing?

Thank you for the opportunity to address you today. I would be happy to answer

any questions you might have.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00052 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

185

BIOGRAPHY FOR PETER L. STRAUSS

Peter L. Strauss, the Betts Professor of Law at Columbia Law School, has taught
courses in Administrative Law, Constitutional Law, Legal Methods, and Legislation
since  1971.  A  graduate  of  Harvard  College  and  Yale  Law  School,  he  previously
clerked for the Hon. David L. Bazelon and William J. Brennan, Jr., taught criminal
law  at  the  national  university  of  Ethiopia,  and  spent  three  years  as  an  attorney  in
the  Office  of  the  Solicitor  General,  briefing  and  arguing  cases  before  the  United
States  Supreme  Court.  During  1975–77,  Professor  Strauss  was  on  leave  from  Co-
lumbia  as  the  first  General  Counsel  of  the  United  States  Nuclear  Regulatory  Com-
mission.  His  published  works  include  Administrative  Justice  in  the  United  States
(1989) and 2002 Gellhom’s & Byse’s Administrative Law: Cases and Comments (most
recently,  2003,  with  Rakoff  and  Farina),  Legal  Methods:  Understanding  and  Using
Cases  and  Statutes  (2005),  Legislation:  Understanding  and  Using  Statutes  (2006)
and Administrative Law Stories (Ed., 2006) and numerous law review articles, gen-
erally  focusing  on  issues  of  rule-making,  separation  of  powers,  and  statutory  inter-
pretation. In 1987 the Section of Administrative Law and Regulatory Practice of the
American Bar Association gave Professor Strauss its third annual award for distin-
guished  scholarship  in  administrative  law.  In  1992–93,  he  served  as  Chair  of  the
Section.  He  has  twice  been  Vice  Dean  at  Columbia.  Professor  Strauss  has  visited
at  Harvard  and  NYU,  and  lectured  widely  on  American  administrative  law  abroad,
including programs in Argentina, Belarus, Brazil, China, Germany, Italy, Japan, the
Netherlands,  Mexico,  Turkey  and  Venezuela.  He  is  founding  editor  of  the  Social
Science  Research  Network’s  Administrative  Law  Abstracts,  and  a  member  of  the
board of the Center for Computer Assisted Legal Instruction.

Chairman MILLER. Thank you.
Dr. Hahn.

STATEMENT OF DR. ROBERT W. HAHN, EXECUTIVE DIRECTOR,
AEI–BROOKINGS JOINT CENTER FOR REGULATORY STUDIES
Dr.  HAHN.  Thank  you,  Chairman  Miller.  I  am  going  to  try  to
focus on some of the substantive issues in the executive orders. My
coauthor,  Bob  Litan,  and  I  have  studied  and  written  about  regu-
latory  issues  for,  dare  I  say,  more  than  two  decades  from  an  eco-
nomic  perspective,  and  it  is  from  that  perspective  that  I  approach
the analysis of the President’s new executive order.

Our  bottom  line  is  that  the  new  order  is  not  as  revolutionary  or
far-reaching as the critics make it out to be, and indeed the actual
requirements  or  additional  requirements  of  this  order  are  modest.
I would like to make the following three points.

First,  expanding  the  executive  order  to  consider  guidance  is  a
positive  step.  Second,  the  changes  regarding  regulation  are  not
likely  to  substantially  increase  an  agency’s  analytical  burden.  And
third, the expansion of presidential influence over major regulatory
policies  is  on  balance  a  good  thing  and  will  serve  to  enhance  ac-
countability.

First,  treating  guidance  like  regulation  is  a  good  thing.  The  new
Bush executive order includes regulatory guidance when its impact
is  likely  to  be  significant.  We  don’t  know  the  impact  of  most  guid-
ance, but we do know that regulatory agencies issue a lot of it. For
example,  the  FDA  has  an  online  list  of  over  1,500  guidance  docu-
ments that are currently in use. The new Bush order requires that
each  agency  evaluate  the  need  for  and  consequences  of  guidance,
helping  to  ensure  that  it  is  reasonable.  I  don’t  think  that  is  a  lot
to ask for. Some critics argue that oversight is not needed because
guidance is non-binding. This is simply wrong. Consider a situation
where an agency says that it is acceptable to use blue paint to com-
ply with the regulation, but is silent on whether yellow paint might
be used. I would imagine that you would see a lot more firms com-

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00053 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

186

plying  with  that  regulation  using  blue  paint  rather  than  yellow
paint.  That  to  me  looks  a  lot  like  a  regulation,  and  to  borrow  a
phrase, if it looks like a regulation and quacks like regulation, then
I think it should be treated like a regulation.

Our  second  point  is  that  the  executive  order  changes,  regarding
regulation, are not likely to substantially increase an agency’s ana-
lytical burden. The new E.O. adds some requirements for new regu-
lation.  For  example,  some  critics  have  complained  about  the  re-
quirement  that  an  agency  provide  a  written  rationale  explaining
why it is regulating, but this isn’t really a new thing, as you heard
earlier. The only real difference between the Bush order and Presi-
dent  Clinton’s  order  is  that  the  Bush  order  specifically  requires
that rationale to be in writing. In general, the requirement of a ra-
tionale,  which  was  first  added  by  President  Clinton,  is  important
and should be applicable to all regulation and guidance. If agencies
don’t  have  a  good  economic  rationale  for  regulation,  you  and  the
public  deserve  to  know  that.  Furthermore,  the  Bush  order  stops
short  of  requiring  that  the  agency  specify  a  clear  economic  ration-
ale. It simply needs to specify a rationale, any rationale.

Third, the expansion of presidential influence is likely to promote
greater accountability and better economic policy. I am running out
of time so I will be brief here. The basic idea is one that you men-
tioned  earlier,  that  unelected  government  civil  servants  are  not
necessarily  in  the  best  position  to  be  making  tough  policy  choices.
Indeed,  they  may  suffer  from  a  kind  of  tunnel  vision  as  Justice
Breyer noted in his book, Breaking the Vicious Circle.

If  I  were  to  have  any  complaint  about  the  President’s  executive
order, it is that it does not go far enough. In particular, it excludes
independent agencies like the Federal Trade Commission, the Fed-
eral  Communications  Commission,  and  FERC  from  review.  Pro-
fessor Cass Sunstein and I have argued in a law review paper that
these independent agencies should be subject to regulatory review.
In  addition,  I  would  also  suggest  subjecting  significant  guidance
documents to a broadly based benefit-cost test. This would give reg-
ulators  and  the  public  a  better  understanding  of  the  likely  eco-
nomic impacts of guidance and could also improve guidance.

In  conclusion,  we  think  the  new  executive  order  on  regulation
represents  a  modest  improvement  over  previous  orders.  It  is  also
consistent  with  the  global  trend  towards  featuring  a  more  promi-
nent  role  for  economic  analysis  in  informing  regulatory  decisions.

Thank you, and I would be happy to take your questions.
[The prepared statement of Dr. Hahn follows:]

PREPARED STATEMENT OF ROBERT W. HAHN

Evaluating the New Executive Order on Regulation

ROBERT W. HAHN AND ROBERT E. LITAN1

Executive Summary

In  2007,  President  Bush  amended  President  Clinton’s  executive  order  on  govern-
ment regulation, making changes that could have far-reaching consequences for how

1 Robert  W.  Hahn  and  Robert  E.  Litan  are  the  directors  of  the  AEI-Brookings  Joint  Center
for Regulatory Studies. This testimony builds on our piece in the Economists’ Voice. The authors
would like to thank Caroline Cecot and Molly Wells for excellent research assistance. The views

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00054 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

187

the  government  weighs  the  costs  and  benefits  of  regulatory  activity.  Although  the
new  Bush  executive  order  would  impose  greater  requirements  on  regulatory  agen-
cies than are currently imposed, we think the benefits are likely to exceed the costs.
We  argue  that  the  new–  executive  order  should  have  included  independent  regu-
latory agencies, such as the Federal Communications Commission, in addition to ex-
ecutive regulatory agencies.
I. Introduction

We  are  pleased  to  appear  before  this  subcommittee  to  present  our  views  on  the
recent executive order on regulation. We have studied and written about regulatory
institutions for more than two decades. About a decade ago, we organized a coopera-
tive effort between the American Enterprise Institute and the Brookings Institution
to  study  regulation.  The  result  was  the  AEI–Brookings  Joint  Center  for  Regulatory
Studies.2

A  primary  objective  of  the  center  is  to  hold  lawmakers  and  regulators  more  ac-
countable by providing thoughtful, objective analysis of existing regulatory programs
and  new  regulatory  proposals.  The  Joint  Center  has  been  at  the  forefront  of  out-
lining  principles  for  improving  regulation,  enhancing  economic  welfare,  and  pro-
moting regulatory accountability.3

Our testimony analyzes the new executive order on regulation. In 2007, President
Bush  amended  President  Clinton’s  executive  order  on  government  regulation,  mak-
ing  changes  that  could  have  far-reaching  consequences  for  how  the  government
weighs  the  costs  and  benefits  of  regulatory  activity.4 We  argue  that  the  changes  in
the  order  are  modest  and  that  the  new  order  is  generally  an  improvement.  Specifi-
cally,  we  believe  that  expanding  the  executive  order  to  consider  guidance  is  a  posi-
tive  step;  the  changes  regarding  regulation  are  not  likely  to  substantially  increase
an  agency’s  analytical  burden;  and,  the  expansion  of  presidential  influence  over
major regulatory policies will serve to enhance accountability.5
II. Treating Guidance More Like Regulation

The  new  Bush  order  adds  to  the  old  Clinton  order  in  three  key  ways.  First,  in-
stead  of  focusing  primarily  on  federal  regulations  that  are  likely  to  cost  hundreds
of  billions  annually,  the  Bush  order  also  focuses  on  regulatory  ‘‘guidance’’  when  its
impact  is  likely  to  be  significant.  Guidance  is  similar  to  regulation  because  it  pre-
sents  an  agency’s  interpretation  or  policy  on  a  particular  regulatory  or  technical
issue,  but  it  is  usually  non-binding.6 For  example,  the  Environmental  Protection
Agency  has  issued  guidance  on  the  interpretation  of  waste  management  activities,
and also on some reporting requirements under the Community Right-to-Know Act.7

expressed here represent those of the authors and do not necessarily reflect those of the institu-
tions with which they are affiliated.

the  AEI–Brookings  Joint  Center  can  be 

found  at  http://

2 All  publications  of 

www.aei.brookings.org.

3 See Arrow et al. (1996).
4 See  Exec.  Order  13,422,  72  Fed.  Reg.  2763  (2007)  [hereinafter  Exec.  Order  13,422].  Pre-
viously,  President  Bush  only  made  minor  changes  to  Exec.  Order  12,866,  such  as  transferring
the roles assigned to the Vice President to the OMB Director or Chief of Staff. See Exec. Order
12,866, 58 Fed. Reg. 51,735 (1993) [hereinafter Exec. Order 12,866]; Exec. Order 13,258, 67 Fed.
Reg. 9385 (2002).

5 For  a  more  pessimistic  view  of  Exec.  Order  13,422,  see  Sally  Katzen,  Amending  Executive
Order  12866:  Good  Governance  or  Regulatory  Usurpation?,  Testimony  07–01:  AEI–Brookings
Joint Center for Regulatory Studies (2007) (focusing on the restrictions of agency discretion) and
Peter L. Strauss, Testimony of Peter L. Strauss Concerning President Bush’s Recent Amendments
to Executive Order 12866, Testimony 07–02: AEI–Brookings Joint Center for Regulatory Studies
(2007) (discussing possible separation of powers concerns). See also Robert Pear, Bush Directive
Increases  Sway  on  Regulation,  N.Y.  TIMES,  January  30,  2007;  Cindy  Skrzycki,  Bush  Order
Limits Agencies’ ‘Guidance’, WASH. POST, January 30, 2007, at D01.

6 There are certain kinds of guidance that may be considered binding. See Robert A. Anthony,
Interpretive Rules, Policy Statements, Guidances, Manuals, and the Like: Should Federal Agen-
cies  Use  Them  to  Bind  the  Public?,  41  DUKE  L.  J.  1311,  1311–84  (1992).  OMB  makes  it  clear
that  guidance  cannot  impose  a  legally  binding  requirement.  See  Office  of  Management  and
Budget, Final Bulletin for Agency Good Guidance Practices, Bulletin No. 07–02: Executive Office
of  the  President  (2007)  [hereinafter  OMB,  Guidance].  See  M.  Elizabeth  Magill,  Agency  Choice
of Policy-making Form, 71 U. CHI. L. REV. 1383, 1383–1447 (2004) for a discussion of the kinds
of  regulatory  tools  statutes  and  case  law  make  available  to  agencies,  and  why  agencies  select
certain tools such as adopting a rule, bringing a case to court, or issuing guidance.

7 See Environmental Protection Agency, Interpretations of Waste Management Activities: Recy-
cling,  Combustion  for  Energy  Recovery,  Treatment  for  Destruction,  Waste  Stabilization  and  Re-
lease, Office of Pollution Prevention and Toxics (1999); Environmental Protection Agency, Emer-
gency Planning and Community Right-to-Know Act-Section 313: Guidance for Reporting Releases
and  Other  Waste  Management  Quantities  of  Toxic  Chemicals:  Lead  and  Lead  Compounds.  EPA
Continued

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00055 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

188

No one actually knows the real impact of most guidance, but it could be substan-
tial.  We  do  know  that  regulatory  agencies  issue  significant  amounts  of  guidance.
The U.S. Food and Drug Administration has a list of over 1,500 guidance documents
that  are  currently  in  use.8 Previously,  agencies  could  issue  guidance  documents  in
lieu of regulations in order to circumvent the requirements of regulatory review re-
quired by executive orders used by President Reagan, the first President Bush, and
President Clinton.9

The  new  Bush  order  will  change  the  way  guidance  is  handled  by  requiring  that
each agency evaluate the need for and consequences of the guidance, helping to en-
sure  that  it  is  reasonable.  The  specific  requirements  are  modest,  such  as  making
sure that the guidance is consistent with applicable law, compatible with other reg-
ulations  and  guidance  documents,  and  simple  and  easy  to  understand.  Before
issuing  a  significant  guidance  document,  which  could  have  an  annual  effect  on  the
economy  of  $100  million  or  more,  the  agency  must  notify  OMB’s  regulatory  office
and  submit  the  draft  with  an  explanation  of  why  guidance  is  needed,  but  it  is  not
required to do a full benefit-cost analysis. OMB can then select guidance that could
benefit from regulatory review.

Critics  suggest  that  applying  some  of  the  same  standards  to  federal  guidance  as
now apply to regulation will allow big business to exert more control over the proc-
ess,  either  by  delaying  the  issuance  of  guidance  or  changing  the  guidance  to  meet
its needs. The critics might be right in some instances. In general, however, forcing
guidance to be consistent, compatible, and understandable is appropriate.10

Interestingly,  applying  the  new  standards  to  guidance  could  serve  to  slow  efforts
by  an  administration  interested  in  reducing  burdens  on  business.  If,  for  example  a
regulatory  agency  were  captured  by  business  interests,  but  guidance  had  to  be  ap-
proved  by  OMB,  there  would  at  least  be  some  chance  that  OMB  might  pinpoint
guidance  that  did  not  help  the  general  public,  or  at  least  slow  the  rate  at  which
such guidance is issued.11

Some  critics  also  contend  that  the  new  executive  order  could  impose  undue  ana-
lytical  burdens  on  regulatory  agencies.  For  example,  some  argue  that  oversight  is
not needed because much guidance is non-binding.12

The critics raise an important point, the solution to which is to make sure OMB’s
regulatory office implements its new oversight responsibilities wisely. If guidance is
truly non-binding in an economic sense—say, because it does not affect firm behav-
ior—then there is little reason to spend time analyzing it. However, there are cases
when  guidance  may  be  non-binding  in  a  legal  sense,  but  could  affect  behavior.13
Consider  a  situation  where  an  agency  says  that  it  is  acceptable  to  use  blue  paint
to  comply  with  a  regulation,  but  is  silent  on  whether  using  yellow  paint  is  accept-
able.  This  guidance  could  have  the  effect  of  encouraging  firms  to  use  blue  paint
more  than  they  otherwise  would,  even  though  there  is  not  a  formal  requirement  to
use it.

Still,  we  are  concerned  that  the  process  could  slow  or  stop  the  issuance  of  some
guidance that serves a useful social purpose. One possible example is guidance from
the Food and Drug Administration, which already has good guidance standards and

260–B–01–027: Office of Environmental Information (2001). More Environmental guidance docu-
ments can be found at http://www.epa.gov/epahome/search.html.

8 For  the  list  of  all  Food  and  Drug  Administration  guidance  documents  currently  in  use,  see
Notice,  Annual  Comprehensive  List  of  Guidance  Documents  at  the  Food  and  Drug  Administra-
tion,  70(3)  Fed.  Reg.  824–913  (2005),  available  at  http://www.fda.gov/OHRMS/DOCKETS/
98fr/05-155.htm.

9 See OMB, Guidance, supra note 5 at 3.
10 The  American  Bar  Association,  for  example,  has  issued  statements  calling  for  public  com-
ment  on  significant  ‘‘nonlegislative  rule(s)’’  and  for  availability  of  these  documents  on  agencies’
websites.  See  American  Bar  Association,  Rule-making  Procedures  for  Non-Legislative  Rules,
A.B.A. (1993); American Bar Association, Recommendation on Federal Agency Web Pages, A.B.A.
(2001). The American Bar Association confirms this in a draft letter regarding the amendments
to  Exec.  Order  12,866,  available  at  http://www.abanet.org/adminlaw/midyear/2007/
Tab4Cletter12866.pdf [hereinafter A.B.A., Draft].

11 Those  who  believe  that  the  OMB  review  process  is  captured  by  business  are  unlikely  to  be
persuaded  by  this  argument.  We  believe  OMB  regulatory  review  tends  to  focus  more  on  eco-
nomic  welfare  of  producers  and  consumers.  That  is,  in  part,  because  the  executive  orders  focus
on  economic  efficiency,  which  counts  benefits  and  costs  to  workers,  consumers,  and  owners  of
capital.

12 Non-binding  means  that  firms  and  other  affected  parties  are  not  required  to  do  anything
specific. See OMB, Guidance, supra note 5 at 9 for this concern, raised by several commentators
on the proposed Bulletin.

13 See  OMB,  Guidance,  supra  note  5  at  9–10  (describing  how  guidance  documents  could  have

‘‘coercive effects’’ or lead to a change in behavior).

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00056 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

189

posts  guidance  on  its  web  site.14 It  appears  that  a  significant  amount  of  guidance
issued  by  this  agency  can  reduce  the  overall  regulatory  burden  by  more  clearly  ar-
ticulating  government  policy  toward  getting  approval  of  drugs  or  medical  devices.
Such guidance would likely pass a benefit-cost test if its primary effect is to reduce
regulatory  uncertainty  without  sacrificing  the  social  goal,  which  in  this  case  could
be  assuring  that  a  new  drug  is  reasonably  safe  and  effective.  Determining  the  ap-
propriate  level  of  review  for  the  guidance  review  process  will  entail  tradeoffs  be-
tween limiting guidance that improves economic welfare and discouraging guidance
that reduces economic welfare.

As  OMB  learns  more  about  the  likely  effect  of  different  types  of  guidance,  it
should tailor its analytical reporting requirements accordingly. In addition, it should
take  great  care  in  implementing  a  formal  rule-making  for  particular  guidance  be-
cause  this  process  is  time  consuming  and  relatively  costly.15 Because  OMB’s  regu-
latory  office  has  a  very  small  staff  for  reviewing  regulation  and  guidance,  it  has
some  incentive  not  to  impose  burdensome  reporting  requirements  on  agencies  be-
cause then it would be expected to review these reports.
III. New Requirements for Regulation

The  new  order  also  adds  some  requirements  for  regulation.  One  feature,  high-
lighted in the press, is that the Bush order requires an agency to provide a written
rationale explaining why it is regulating. The only real difference between the Bush
order and the Clinton order is that the Bush order specifically requires that the ra-
tionale  be  in  writing.  A  careful  reading  of  the  Bush  order  suggests  that  a  rationale
for significant guidance should also be provided as a brief explanation for OMB.

This requirement is important, and should be included for all regulation and guid-
ance.  Most  economists  would  agree  that  the  government  should  not  consider  regu-
lating unless there is a clear market failure being addressed, such as pollution, mo-
nopoly,  or  lack  of  good  information.  The  Bush  order  stops  short  of  requiring  that
the  agency  specify  a  market  failure,  per  se.  The  agency  simply  needs  to  provide  a
reason  for  regulating.  Regulatory  agencies  owe  the  citizenry  at  least  that  much  be-
fore they decide to regulate.16

Another  feature  of  the  regulatory  proposal  that  has  been  criticized  in  the  press
is  the  requirement  that  agencies  provide  aggregate  annual  costs  and  benefits  of  all
regulatory  activity  on  the  agency’s  plan.  This  requirement  should  not  add  substan-
tially  to  the  analytical  burden  of  regulatory  agencies  because  they  already  must
present anticipated costs and benefits of individual regulations on the plan.17 There

14 See  Notice,  The  Food  and  Drug  Administration’s  Development,  Issuance,  and  Use  of  Guid-
ance  Documents,  62  Fed.  Reg.  8961  (1997).  The  good  guidance  practices  have  some  of  the  same
features  as  OMB,  Guidance,  supra  note  5,  including  absence  of  mandatory  language,  advance
notice  and  opportunity  for  public  comment  on  some  guidance,  and  posting  of  guidance  on  the
Internet. Guidance from the Food and Drug Administration is available at http://www.fda.gov/
opacom/morechoices/industry/guidedc.htm.  The  Biologics  Consulting  Group  also  maintains  a
database  of  the  Food  and  Drug  Administration’s  guidance  documents,  available  at  http://
www.biologicsconsulting.com/guidancedocuments¥all.htm.

15 The  American  Bar  Association  expressed  concern  about  the  new  provision  to  Exec.  Order
13,422,  supra  note  3,  reminding  agencies  to  consider  using  formal  rule-making  for  complex  de-
terminations.  See  A.B.A.,  Draft,  supra  note  9.  We,  however,  agree  with  the  view  expressed  by
Paul  R.  Noe,  Changes  to  OMB  Regulatory  Review  by  Executive  Order  13422,  Testimony  07–04:
AEI–Brookings  Joint  Center  for  Regulatory  Studies  (2007).  Noe,  supra,  believes  that  because
agencies  always  had  the  option  to  consider  formal  rule-making,  this  provision  is  not  likely  to
change anything.

16 Professor Sally Katzen, supra note 4, former head of regulatory review at OMB, argues, ‘‘By
giving special emphasis to market failures as the source of a problem warranting a new regula-
tion, the Administration is saying that not all problems are equally deserving of attention; those
caused  by  market  failures  are  in  a  favored  class  and  possibly  the  only  class  warranting  new
regulations.’’  See  Katzen,  supra  note  4.  We  think  it  is  good  for  government  generally  to  focus
on  market  failures  because  too  often  government  policies  result  in  serious  economic  inefficien-
cies.  See  CLIFFORD  WINSTON,  GOVERNMENT  FAILURE  VERSUS  MARKET  FAILURE:
MICROECONOMICS  POLICY  RESEARCH  AND  GOVERNMENT  PERFORMANCE  (AEI–
Brookings  Joint  Center  for  Regulatory  Studies  2006).  Katzen  brings  up  the  example  of  civil
rights.  We  think  some  civil  rights  legislation  could  have  been  justified  on  the  basis  of  market
failure arguments. Nonetheless, the Bush EO clearly allows for the agency to provide a rationale
other  than  market  failure.  ‘‘Each  agency  shall  identify  in  writing  the  specific  market  failure
(such  as  externalities,  market  power,  lack  of  information)  or  other  specific  problem  that  it  in-
tends  to  address  (including,  where  applicable,  the  failures  of  public  institutions)  that  warrant
new  agency  action,  as  well  as  assess  the  significance  of  that  problem,  to  enable  assessment  of
whether any new regulation is warranted’’ [emphasis added]. See Exec. Order 13,422, supra note
3.

17 Exec. Order 12,866, supra note 3, already required that the agency report the most signifi-
cant  rules  on  a  ‘‘Regulatory  Plan,’’  along  with  each  rule’s  anticipated  benefits  and  costs.  Exec.
Continued

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00057 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

190

is value in having an estimate of the annual regulatory cost, much in the same way
that  government  provides  an  annual  budget  estimate.  We  would  also  add  that,
where possible, the annual regulatory cost should be compared with the annual reg-
ulatory benefit.
III. Expanding Presidential Influence

The  third  change  in  the  Bush  executive  order  is  to  require  affected  regulatory
agencies  to  designate  a  presidential  appointee  as  the  regulatory  policy  officer.  The
regulatory  policy  office  would  then  need  to  approve  a  specific  regulation  before  it
could  be  included  in  the  agency’s  annual  regulatory  plan  of  the  important  regula-
tions it expects to issue.

This  change  could  be  very  important.  Critics  believe  that  it  would  politicize  the
process by taking away some discretion from civil servants. We agree with the crit-
ics, but think this is ultimately a good thing. The benefits are similar to the benefits
of regulatory oversight in general. First, as Justice Breyer has noted, civil servants
in some regulatory agencies may tend to have tunnel vision, and fail to consider the
broader  impacts  of  their  regulatory  proposals.18 Second,  requiring  that  a  presi-
dential  appointee  in  a  policy  office  approve  regulations  increases  the  chances  that
the regulations will consider costs and benefits because such balancing is more like-
ly to be consistent with the President’s agenda than an agency’s agenda. Third, this
change will hold the President more accountable for regulatory policies that his ad-
ministration selects.19 Of course, the particular person the President appoints could
skew the process away or towards the balancing of costs and benefits, but we think
the  President  should  have  that  choice  because  voters  can  hold  him  accountable  for
his policies.
IV. New Executive Order Should Have Been More Ambitious

If  we  have  any  complaint  about  the  President’s  executive  order,  it  is  that  it  does
not  go  far  enough.  In  particular,  it  excludes  a  whole  group  of  regulatory  agencies
from review—the ‘‘independent’’ regulatory agencies like the Federal Trade Commis-
sion, the Federal Communications Commission, and the Federal Energy Regulatory
Commission—that  play  a  critical  role  in  a  number  of  areas  ranging  from  tele-
communications to energy.

We  would  suggest  bringing  these  independent  agencies  under  the  executive  or-
der’s umbrella.20 This change would hold a wider range of regulators more account-
able  for  the  costs  and  benefits  of  their  policies  and  hopefully  lead  to  more  efficient
policies  across  the  board.  It  is  still  an  open  question  as  to  whether  the  President
has  the  legal  authority  to  make  this  change;  if  the  President  does  not,  then  Con-
gress should give this general authority to the President directly.21

In  addition,  we  would  suggest  subjecting  significant  guidance  documents  to  the
same  requirements  as  significant  regulations—namely  benefit-cost  analysis  and  a
broadly  based  benefit-cost  test.  This  would  give  regulators  and  the  public  a  better
understanding of the likely economic impacts of guidance, and it could also improve
actual guidance.

Although  the  new  Bush  executive  order  would  impose  greater  requirements  on
regulatory  agencies  than  are  currently  imposed,  we  think  the  benefits  are  likely  to
exceed its costs, but a lot will depend on how it is implemented. The new executive
order is also consistent with a global trend toward featuring a more prominent role
for economic analysis in informing regulatory decisions.

BIOGRAPHY FOR ROBERT W. HAHN

Robert Hahn is co-founder and Executive Director of the American Enterprise In-
stitute-Brookings  Joint  Center,  which  examines  cutting-edge  issues  in  law  and  eco-
nomics, regulation and antitrust. Previously, he worked for the Council of Economic

Order 13,422, supra note 3, only asks that agencies sum the estimated benefits and costs of the
regulations, which is a way of enhancing transparency. See Steven D. Aitken, Statement of Ste-
ven D. Aitken, Acting Administrator, Office of Information and Regulatory Affairs, Office of Man-
agement  and  Budget  before  the  Subcommittee  on  Commercial  and  Administrative  Law  of  the
Committee  on  the  Judiciary,  United  States  House  of  Representatives  (2007).  Katzen,  supra  note
4, believes that this estimate will be meaningless and should not be included.

18 See  STEPHEN  BREYER,  BREAKING  THE  VICIOUS  CIRCLE:  TOWARD  EFFECTIVE

RISK REGULATION (Harvard University Press 1993).

19 See Strauss, supra note 4, for objections to this view on the grounds of the need for separa-

tion of powers.

20 See  Robert  W.  Hahn  &  Cass  R.  Sunstein,  A  New  Executive  Order  for  Improving  Federal
Regulation?  Deeper  and  Wider  Cost-Benefit  Analysis,  150  U.  OF  PENN.  L.  REV.  1489  (2002).

21 See Strauss, supra note 4, for an opposing view.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00058 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

191

Advisers,  where  he  helped  design  the  innovative  market-based  approach  for  reduc-
ing  acid  rain.  Dr.  Hahn  also  has  served  on  the  faculties  of  Harvard  University  and
Carnegie Mellon University. He frequently contributes to leading scholarly journals
and general-interest periodicals, including the American Economic Review, Yale Law
Journal, Science, and the New York Times. Dr. Hahn is the author of Reviving Reg-
ulatory  Reform:  A  Global  Perspective  (AEI–Brookings)  and  several  other  books.  He
has  served  as  a  consultant  to  governments  and  business  on  a  variety  of  economic
issues. In addition, Dr. Hahn is co-founder of the Community Preparatory School—
an inner-city middle school in Providence, Rhode Island, that provides opportunities
for disadvantaged youth to achieve their full potential.

Chairman MILLER. Thank you, and I think now I need to go vote.
Dr.  Hahn,  I  understand  you  probably  cannot  be  here  when  I  get
back  but  I  will  be  gone  for  probably  around  20  minutes,  and  I
apologize.  It  is  simply  the  schedule  we  are  on.  There  is  only  so
much  we  can  do  about  it.  But  I  will  be  back  as  quickly  as  I  can.
Thank you, and we will be in recess.

[Recess.]
Chairman  MILLER.  We  will  resume.  Dr.  Gary  Bass  will  testify

next.

Dr. Bass.
STATEMENT OF DR. GARY D. BASS, EXECUTIVE DIRECTOR,

OMB WATCH

Dr.  BASS.  I  appreciate  the  opportunity  to  testify  and  for  your

running back and forth. It is wonderful of you.

Let  me  start  by  just  posing  a  question  for  the  record,  and  that
is,  if  those  people  who  are  so  supportive  of  the  executive  order
changes  say  that  it  is  so  minimal,  then  what  was  the  purpose  of
doing  the  changes  in  the  executive  order?  And  so  I  have  sort  of  a
rhetorical question on that point. If it really was nothing, then why
so late into this Administration was any change made? I also want
to just open by indicating that if Professor Strauss raises constitu-
tional  questions  about  the  executive  order,  you  can  bank  on  it.  I
mean,  that  is  a  critically  important  point,  and  even  if  there  aren’t
constitutional problems, this is bad policy. So let me start with the
whole point that no one has said the objective should be to actually
get rid of this executive order, and whether Congress chooses to di-
rectly approach that or whether it chooses through the power of the
purse to withhold funding for the implementation of components of
it,  that  is  the  strongest  recommendation  that  I  could  possibly
make. Now, within that context, I think that in the immediate side,
transparency and accountability, as you, Mr. Chairman, have men-
tioned, is essential. So let us turn to transparency as a theme.

First  of  all,  let  us  talk  about  transparency  in  the  entire  regu-
latory  process  overall.  At  best,  I  would  describe  it  as  walking  into
a  dark  room  and  the  government  handing  you  a  flashlight  when
you  could  flip  a  switch  and  have  floodlights  instead.  It  is  not  very
transparent,  is  the  point  I  would  make.  And  now  you  add  in  the
enhanced  powers  that  Professor  Strauss  talked  about  of  the  regu-
latory policy officer where there is no transparency, you are totally
in the dark, not even a flashlight. So if Congressman Rohrabacher
and  Mr.  Aitken  believe  in  transparency,  it  seems  to  me  one  place
to  start  is  to  really  provide  some  transparency  for  the  entire  regu-
latory  process.  Now,  I  could  spend  some  moments  about  the  OIRA
power  and  what  has  happened  as  well  as  the  power  that  would
exist  because  of  the  RPO  at  the  agencies,  but  instead  of  spending

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00059 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

my time on that, I want to directly talk about specific recommenda-
tions for transparency.

192

One sentence before that though that I want to mention and that
is, most of the discussion about OIRA’s power has been in the con-
text  of  the  executive  order  itself,  what  they  do  during  the  regu-
latory  review.  That  is  the  formal  review  process.  What  is  striking
is the informal part of it, meaning what I would call pre-rule-mak-
ing. The dialog that occurs between OIRA or the White House and
the  agencies  before  the  formal  process  ever  kicks  in  is  critical  to
any  kind  of  public  accountability,  and  right  now  there  is  no  trans-
parency  on  that  process  at  all,  and  in  fact,  by  the  changes  in  the
executive  order,  we  have  enhanced  more  power  in  that  pre-rule-
making stage and yet no transparency.

So  let  me  turn  to  recommendations.  First,  let  me  do  it  in  two
ways.  One  is  for  the  agency  itself  and  then  turn  to  reviewing  au-
thorities  such  as  OIRA  or  Small  Business  Administration,  and  I
will  only  use  five  under  each  because  I  was  always  told  you  can
count  up  and  then  still  pound  your  hand  and  still  advocate  for  it
all  at  the  same  time.  So  one,  at  the  agency  level,  it  is  essential  to
have  disclosure  of  who  these  new  RPOs  will  be—or  not  new,  the
new  enhanced  power,  but  the  political  appointees  could  be  new—
who  they  are,  what  their  responsibilities  are,  what  the  procedure
would  be  within  the  agency.  For  example,  when  does  a  regulatory
activity  commence,  what  is  the  definition  of  that?  How  do  you
reach  the  person?  All  that  kind  of  information  should  be  publicly
available,  conspicuously  publicly  available  on  the  agency  website.
Second,  since  we  now  have  a  political  appointee  and  it  has  raised
significant  questions,  as  you  heard  from  Professor  Strauss,  what
really  needs  to  be  done  is  to  disclose  all  decisions  by  the  RPO  and
the  justification  for  that  decision.  It  is  not  just  about  what  is  per-
mitted to go forward but also what is stopped, and for that matter,
what is permitted to go forward but altered in its approach. Third,
we  should  have  an  annual  report  to  Congress  summarizing  those
activities.  It  should  also  be  in  the  Unified  Agenda,  which  is  pub-
lished  in  the  Federal  Register,  so  the  public  can  see  what  is  hap-
pening,  but  the  documents  that  are  exchanged  internally  in  the
agency  should  be  sent  to  Congress  in  this  annual  report.  And
fourth  in  my  points  on  the  agency,  and  I  won’t  go  to  five,  all  sub-
stantive  communications,  written  or  oral,  outside  the  government
or  outside  the  agency  including  from  OIRA  should  be  docketed  in
the  agency  rule-making  record.  Moreover,  for  those  activities  that
don’t go forward, a new docket should be created about communica-
tions related to those that don’t go forward.

Let me turn to OIRA and other kinds of reviewing entities. First,
if  a  reviewing  entity  such  as  OIRA  is  now  going  to  play  a  sub-
stantive role in rule-making review, it should be treated under our
Administrative  Procedure  Act  as  involved  in  the  rule-making  and
all  of  the  various  kinds  of  requirements  that  go  with  that  should
be  held  to  OIRA.  If  it  is  really  just  going  to  be  not  the  decider  or
the overseer, as Professor Strauss tried to distinguish, then maybe
it doesn’t apply, but it is clear that they are getting much more en-
gaged  in  the  substance.  Secondly,  all  substantive  communications,
written  or  oral,  particularly  from  outside  of  government,  before
during  and  after  the  OIRA  review,  should  be  docketed  not  only  at

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00060 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

193

OIRA but again back at the agency level. Thirdly, OIRA should es-
tablish  a  government-wide  standard  for  tracking  rule-making  so
that  the  public  can  follow  it  from  the  beginning  all  the  way
through. You can’t today. It is extremely difficult. And then fourth,
the  OIRA  web  site,  which  is  incredibly  important  that  administra-
tors  starting  with  Administrator  Katzen,  moving  to  Administrator
Graham,  have  helped  with  transparency  but  the  web  site  itself
needs  enormous  improvement.  It  should  be  searchable.  Right  now
it is just a long list of things to look at. Finally, the log that is used
at  OIRA  for  meetings  with  external  players  is  at  best  inconsistent
in what you get. Sometimes there is no title even of what the sub-
ject  is.  Almost  never  do  you  get  anything  about  what  the  content
of the meeting was about. You may get a list of participants. In any
case, it needs to be complete, it needs to be consistent and it should
be linked with that web site on what regulatory activities are hap-
pening  so  you  know  what  is  going  on.  I  recognize  that  this  adds
burdens  to  agencies,  but  in  an  environment  like  this  executive
order,  transparency  is  fundamental  and  essential  to  true  account-
ability.

I want to just thank you, Mr. Chairman. This is now your second
hearing.  This  is  wonderful  to  find  oversight,  and  I  hope  the  over-
sight leads to action in terms of legislation. Thank you.

[The prepared statement of Dr. Bass follows:]

Mr. Chairman and Members of the Subcommittee:

PREPARED STATEMENT OF GARY D. BASS

Thank you for the opportunity to testify before you today. I am Gary Bass, Execu-
tive  Director  of  OMB  Watch.  OMB  Watch  is  a  nonprofit,  nonpartisan  research  and
advocacy  center  promoting  an  open,  accountable  government  responsive  to  the
public’s needs. Founded in 1983 to remove the veil of secrecy from the White House
Office of Management and Budget (OMB), OMB Watch has since then expanded its
focus  beyond  monitoring  OMB  itself.  We  currently  address  four  issue  areas:  right
to  know  and  access  to  government  information;  advocacy  rights  of  nonprofits;  effec-
tive  budget  and  tax  policies;  and  the  use  of  regulatory  policy  to  protect  the  public.
OMB Watch does not receive any government funding.

My testimony today focuses on 1) the responsibilities given Regulatory Policy Offi-
cers  (RPOs)  under  Executive  Order  13422,  2)  the  likely  impacts  of  this  regulatory
change,  3)  the  current  rule-making  structure  and  disclosure  requirements,  and  4)
OMB  Watch’s  recommendations  for  improving  transparency  in  the  rule-making
process in light of E.O. 13422.

Before  addressing  these  points,  I  want  to  make  clear  to  the  Subcommittee  that
we strongly oppose E.O. 13422 and urge Congress to find a way to overturn the E.O.
If that is not possible, we urge Congress to use its power of the purse to limit appro-
priations  to  implement  some  or  all  of  the  changes  required  by  the  E.O.  The  E.O.
threatens public protections by further centralizing executive control over the regu-
latory  process,  removing  agency  discretion  over  legislative  implementation,  codifies
regulatory  delay,  and  substitutes  free  market  criteria  for  public  values  of  health,
safety, and environmental protections.
I. President Clinton’s Regulatory Policy Officer and Executive Order 13422
Executive  Order  12866,  Regulatory  Planning  and  Review,  created  the  Regulatory
Policy Officer within each federal agency who reports generally to the agency head.
The E.O. states:

‘‘The Regulatory Policy Officer shall be involved at each stage of the regulatory
process to foster the development of effective, innovative, and least burdensome
regulations and to further the principles set forth in this Executive Order.’’

The  role  of  the  RPO  envisioned  in  the  1993  E.O.  is  to  coordinate  and  carry  out
agency  responsibilities  in  regard  to  regulatory  planning  and  review  of  regulations
by  the  Office  of  Information  and  Regulatory  Affairs  (OIRA).  These  responsibilities
include:  allowing  ‘‘meaningful’’  public  participation  in  the  regulatory  process;  in-

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00061 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

194

forming stakeholders of pertinent regulations; providing OIRA with a list of planned
regulatory  actions;  providing  OIRA  with  cost-benefit  analyses  for  significant  regu-
latory actions; and making available to the public information on proposed and final
regulations.

In  practice,  the  role  of  the  RPO  evolved  differently.  Not  every  agency  maintains
one designated RPO. In the case of the Department of Agriculture (USDA), various
officials  serve  as  de  facto  RPOs.  Familiarity  with  the  issue  is  likely  to  determine
where responsibilities lie on a specific regulation. In the Department of Energy, the
RPO  also  functions  as  an  agency  counselor.  The  RPO  is  not  necessarily  a  political
appointee,  but  the  final  regulatory  decisions  within  an  agency  are  in  the  hands  of
a political appointee, usually the agency head or his or her designee.

Two of President Bush’s amendments to E.O. 12866 impact the RPO. First, agen-
cies  are  now  required  to  designate  a  political  appointee  as  their  RPO,  and  are  to
do so within 60 days of the issuance of the amendments, which should have already
occurred. New text also requires OMB to verify this designation.

Second, in addition to changing the requirements of the designated RPO, the Offi-
cer’s responsibilities are increased. The RPO will now be charged with approving an
agency’s Regulatory Plan, a responsibility previously given to the agency head. The
amendments state that ‘‘no rule-making shall commence nor be included’’ for consid-
eration  in  the  agency’s  regulatory  plan  without  the  political  appointee’s  approval.
The  Regulatory  Plan  includes  the  most  important  regulations  which  an  agency
plans in a given year.
II. The Impact of Executive Order 13422 on RPOs

E.O. 13422, the order that amended E.O. 12866 and was issued January 18, 2007,
will solidify the position of RPO as the preeminent regulatory manager within each
agency. By requiring the Officer to be a political appointee, the amendments suggest
a  further  politicization  of  the  regulatory  process.  OMB  Watch  is  concerned  that  by
installing  a  political  appointee  as  the  RPO  and  increasing  the  responsibilities,  that
appointee  will  significantly  affect  an  agency’s  ability  to  regulate  in  a  fair  and  non-
partisan fashion.

In  some  agencies,  the  amendments  related  to  the  RPO  may  have  little  effect  on
regulatory  development.  In  the  case  of  the  Department  of  Energy,  the  RPO  is  al-
ready  a  political  appointee  albeit  without  the  sole  responsibility  to  initiate  regula-
tions  and  without  final  decision-making  authority  over  regulations  (unless  one  or
both powers have been delegated to the RPO by the agency head). The White House
is  unlikely  to  have  a  greater  or  lesser  impact  on  the  way  in  which  regulations  are
formulated  within  that  agency.  Similarly,  the  process  in  the  Department  of  Labor
is likely to go unchanged.

In  other  agencies,  however,  the  RPO  change  will  likely  centralize  the  regulatory
process  and  create  OIRA-like  structures  within  agencies  even  though  OIRA  has
been  criticized  over  the  years  for  exerting  political  influence.  In  the  case  of  USDA,
this  change,  if  followed,  will  end  the  process  of  dividing  regulatory  authority  based
upon  experience  and  expertise.  Instead,  the  RPO  will  ultimately  be  responsible  for
all  regulatory  decision-making  and  be  involved  in  regulatory  discussions  from  the
beginning  of  agency  considerations.  Furthermore,  installing  a  political  appointee
where one did not previously exist will facilitate White House input into agency reg-
ulatory matters.

A  similar  approach  was  attempted  by  President  Reagan  through  his  E.O.  12498,
the  Regulatory  Planning  Process,  issued  January  4,  1985.  Under  that  order,  agen-
cies  were  to  get  approval  from  OMB  prior  to  starting  a  rule-making—a  pre-rule-
making review. Many in the business community thought this would be an effective
approach  for  choking  off  agency  ideas  in  their  earliest  stage.  That  approach,  how-
ever,  proved  too  cumbersome  and  difficult  to  administer.  E.O.  13422  revises  this
choke-hold  by  placing  that  de  facto  prior  approval  in  the  agencies  themselves,  in-
stead of at OMB.

To ensure that the process works, the E.O. grants authority to these new political
appointees to be the eyes and ears for OMB. And it mounts a challenge to congres-
sional  authority.  When  writing  legislation,  Congress  often  directs  agencies  to  ini-
tiate a rule-making. The presence in the agencies of these appointees by whom rule-
making  must  now  be  initiated  will  create  a  process  that  works  as  if  Congress  had
not  directed  the  agencies  to  act,  or  as  if  that  direction  is  irrelevant  if  the  White
House appointees disagree with it.

Moreover,  a  requirement  that  has  political  appointees  overseeing  all  regulatory
matters raises a public perception concern. When a political appointee instructs sci-
entists  and  agency  experts  to  change  what  they  are  doing,  it  will  raise  questions
about  whether  politics  is  superseding  science.  If  RPOs  are  to  be  operating  in  this

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00062 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

195

way  within  agencies  and  are  to  be  the  points  of  communication  with  OIRA,  then
the need for transparency in the regulatory process has never been greater.
III. Current Rule-making and Disclosure

OMB  Watch  for  years  has  urged  Congress  and  the  Executive  to  require  more
transparency in the regulatory process. This process 1) has become more centralized
in the last three decades and, 2) despite improvements created by OIRA administra-
tors Sally Katzen and John Graham still is not transparent enough. Especially dur-
ing the current Bush Administration, greater access has been provided to those spe-
cial interests who have the time, resources, and political influence to affect the out-
come of the rule-making process. And the influence on agencies of both these special
interests  and  of  OIRA  is  now  more  difficult  to  determine  because  so  much  is  done
outside of the public’s view.

We  are  concerned  about  transparency  in  two  major  directions.  First,  within  the
agency as the RPO takes on the new responsibility of initiating regulations, to what
extent will the RPO allow politics to supersede the need for health, safety, environ-
mental and civil rights protections as determined by agency experts?

Second,  to  what  extent  will  the  RPO  be  a  de  facto  OIRA  official  sitting  in  the
agency  coordinating  and  carrying  out  the  responsibilities  of  the  OIRA  desk  officers
during  the  pre-rule-making  stage?  Having  been  given  the  power  to  initiate  regula-
tions,  we  fear  the  RPO  will  further  decrease  agency  rule-making  discretion  and  in-
crease  the  trend  toward  OIRA  dictating  agency  rule-making.  Transparency  can
prove our fear is groundless.

These  transparency  issues  are  concerns  during  both  of  the  major  time  periods  of
the rule-making process: the pre-rule-making and rule-making (OIRA review/notice-
and-comment) periods.
A. Pre-Rule-making Review

E.O. 12866 allowed OIRA to play an active role during the pre-rule-making stage
when  agencies  are  formulating  annual  plans  for  regulatory  activities.  Even  more
than  the  official  rules,  OIRA  unofficially  encourages  agencies  to  discuss  regulatory
ideas  at  the  earliest  stages.  By  having  OIRA  involved  in  agencies’  planning  proc-
esses,  OIRA  can  quash  or  alter  any  contemplated  regulation  before  it  is  proposed
for  the  Regulatory  Plan.  The  communications  between  OIRA  and  the  agencies  are
not  disclosed,  thus  it  is  difficult  to  measure  the  extent  to  which  OIRA  exerts  influ-
ence over the drafting of the proposed regulation that is finally submitted to OIRA.
A  Government  Accountability  Office  report  concludes  that  OIRA,  by  its  own  admis-
sion  and  by  its  involvement  in  the  pre-rule-making  stage,  has  significant  influence
over the proposed regulations agencies submit for review.1

Knowing  that  OIRA  exerts  this  influence,  it  is  critically  important  to  document
fully  the  pre-rule-making  communications  between  OIRA  and  the  agencies,  or  at
least, the outcome of these communications. Despite OIRA’s involvement in shaping
the content and direction of agency rule-making, it is not covered by the basic statu-
tory  framework  for  the  rule-making  process—the  Administrative  Procedure  Act
(APA).  Because  OIRA  is  not  covered  by  the  APA,  its  activities  are  not  public  and
not accountable.

This has become all the more necessary because of the changed role of OIRA dur-
ing  the  Bush  Administration.  As  former  OIRA  Administrator  Sally  Katzen  testified
earlier  this  year  before  this  subcommittee,  the  intent  of  E.O.  12866  was  to  have
OIRA be a ‘‘counselor’’ to the agencies:

Executive  Order  12866  retained  centralized  review  of  rule-makings,  but  also
reaffirmed the primacy of the agencies to which Congress had delegated the au-
thority to regulate. (Preamble) Among other things, Executive Order 12866 lim-
ited OIRA review to ‘‘significant regulations’’—those with a likely substantial ef-
fect  on  the  economy,  on  the  environment,  on  public  health  or  safety,  etc.  or
those  raising  novel  policy  issues  (Section  6(b)(1) )—leaving  to  the  agencies  the
responsibility for carrying out the principles of the Executive Order on the vast
majority (roughly 85 percent) of their regulations.2

Instead  of  being  a  ‘‘counselor,’’  OIRA  has  become  a  ‘‘gatekeeper’’  over  agencies’
proposed regulations. Before agencies submit proposed regulations to OIRA, the reg-

1 General  Accounting  Office,  OMB’s  Role  in  Reviews  of  Agencies’  Draft  Rules  and  the  Trans-
parency of Those Reviews. September 2003. Available at www.gao.gov/cgi-bin/getrpt? GAO–03–
929. GAO changed its name to Government Accountability Office in 2004.

2 Testimony of Sally Katzen, Adjunct Professor and Public Interest/Public Service Fellow, Uni-
versity  of  Michigan  Law  School  before  the  House  Committee  on  Science  and  Technology,  Sub-
committee  on  Investigation  &  Oversight,  February  13,  2007,  on  ‘‘Amending  Executive  Order
12866: Good Governance or Regulatory Usurpation?’’ p.4.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00063 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

ulatory  outcome  has  already  been  determined.  This  power  is  exerted  in  several
ways:

196

• In 2002, OMB issued its Data Quality Act Guidelines3 which created new cat-
egories of information hierarchy. ‘‘Influential information’’ would now require
a higher level of scrutiny than ‘‘information.’’ OMB required agencies to issue
guidelines,  subject  to  OMB  approval,  establishing  mechanisms  to  allow  enti-
ties to challenge the accuracy of agency information and to report to OMB on
the number and nature of these challenges.

• In  2003,  OMB  issued  its  Proposed  Draft  Peer  Review  Standards  for  Regu-
latory  Science4 which  were  widely  criticized  as  too  restrictive  and  too  favor-
able  to  regulated  industries.  Furthermore,  the  draft  standards  provided  an-
other layer of OMB review of scientific and technical studies used in the pre-
rule-making  process.  The  Final  Bulletin,  issued  December  2003,  was  an  im-
provement over the draft but still left OMB in the position of overseeing peer
reviews, selecting industry representatives for the panels, and requiring pub-
lic comment on peer review conclusions which delays the rule-making process
even further.

• In  2004,  OMB  issued  Circular  A–45 which  describes  in  detail  how  agencies
must  conduct  their  Regulatory  Impact  Analysis  (RIA),  the  basic  cost-benefit
analysis that must be provided for all economically significant proposed regu-
lations.  The  RIA  is  the  primary  mechanism  for  justifying  regulations  and  is
the first point of review by OIRA desk officers.

• In 2006, OMB issued its Proposed Risk Assessment Bulletin6 which, as do all
of the above guidelines, tried to impose a one-size-fits-all standard on the way
agencies  were  to  conduct  risk  analyses.  It,  too,  was  widely  criticized  and  fi-
nally  withdrawn  by  OMB  in  January  2007  after  a  peer  review  by  the  Na-
tional  Research  Council’s  concluded  the  document  was 
‘‘fundamentally
flawed.’’ 7

As  OMB  Watch  described  in  testimony  before  this  subcommittee  in  February,
these  tools  have  been  compromised  by  the  issuance  of  these  guidelines  to  further
bias  the  regulatory  process  and  threaten  public  health,  safety,  and  the  environ-
ment.8
1. Guidance review

In January 2007, OMB issued The Final Bulletin for Agency Good Guidance Prac-
tices9, on the same day as President Bush issued E.O. 13422. The Bulletin requires
internal  review  of  significant  guidance  documents  by  senior  agency  officials  as  well
as  public  notice-and-comment  on  guidance  documents  deemed  ‘‘significant’’  or  ‘‘eco-
nomically significant.’’

The  Bulletin  first  appeared  in  its  proposed  form  late  in  2005.  It  was  announced
in the Federal Register on Nov. 30, 2005, and was open for public comment. In those
comments,  public  interest  groups  (including  OMB  Watch)  criticized  the  Bulletin  for
its  potential  to  allow  OMB  to  interfere  unnecessarily  in  agency  practices.  Industry
organizations  expressed  their  support  for  the  Bulletin,  citing  their  desire  for  OIRA
to review guidance documents in the same way it reviews regulations.

3 Office of Management and Budget, Guidelines for Ensuring and Maximizing the Quality, Ob-
jectivity,  Utility,  and  Integrity  of  Information  Disseminated  by  Federal  Agencies.  February  22,
2002.  Available  at  http://www.defendingscience.org/public¥health¥regulations/upload/Office-
of-Management-and-Budget-Information-Quality-Act-Guidelines-2002.pdf.

4 Office  of  Management  and  Budget.  Final  Information  Quality  Bulletin  for  Peer  Review.  De-
cember  16,  2004.  Available  at  http://www.whitehouse.gov/omb/memoranda/fy2005/m05-
03.pdf.

5 Office  of  Management  and  Budget,  Circular  A–4,  Regulatory  Analysis.  September  17,  2003.

Available at http://www.whitehouse.gov/omb/circulars/a004/a-4.pdf.

6 Office  of  Management  and  Budget,  Proposed  Risk  Assessment  Bulletin.  January  9,  2006.

Available at http://www.ombwatch.org/regs/2006/riskassessmentbulletin-draft.pdf.

7 National  Research  Council,  Scientific  Review  of  the  Proposed  Risk  Assessment  Bulletin  from
the  Office  of  Management  and  Budget.  January  11,  2007.  Available  at  http://www.nap.edu/
catalog.php?record¥id=11811.

8 Testimony  of  Rick  Melberth,  Director  of  Regulatory  Policy  OMB  Watch  before  the  House
Committee  on  Science  and  Technology,  Subcommittee  on  Investigation  &  Oversight,  February
13,  2007,  on  ‘‘Amending  Executive  Order  12866:  Good  Governance  or  Regulatory  Usurpation?’’
Available at http://www.ombwatch.org/regs/PDFs/Melberth¥testimony.pdf.

9 Office  of  Management  and  Budget,  The  Final  Bulletin  for  Agency  Good  Guidance  Practices.
January  18,  2007.  Available  at  http://www.whitehouse.gov/omb/memoranda/fy2007/m07-
07.pdf.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00064 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

197

As OMB Watch reported in our final analysis of the new E.O. and the Good Guid-
ance Practices Bulletin10, the Bulletin defines guidance documents to include ‘‘inter-
pretive  memoranda,  policy  statements,  guidances  (sic),  manuals,  circulars,  memo-
randa, bulletins, advisories, and the like.’’ Federal agencies issue thousands of guid-
ance documents each year relating to hundreds of different types of activities.11

As Section 9 of the amended E.O. also clearly states, the OIRA administrator has
the  power  to  determine  which  guidance  documents  are  significant,  thus  submitting
them to the review process, as well as when ‘‘additional consultation’’ is needed be-
fore a document can be issued. Section I(4) of the Good Guidance Practices Bulletin
provides  that  the  head  of  an  agency,  ‘‘in  consultation  and  concurrence’’  with  the
OIRA  administrator,  may  exempt  categories  of  significant  documents  from  the  Bul-
letin’s requirements.

Section I(5) of the Bulletin adds a further category of guidance document, the eco-

nomically significant guidance document which is:

‘‘a significant guidance document that may reasonably be anticipated to lead to
an  annual  effect  on  the  economy  of  $100  million  or  more  or  adversely  affect  in
a  material  way  the  economy  or  a  sector  of  the  economy,  except  that  economi-
cally significant guidance documents do not include guidance documents on fed-
eral expenditures and receipts.’’

The  definitions  of  both  significant  and  economically  significant  guidance  docu-
ments  include  documents  that  ‘‘may  reasonably  be  anticipated  to  lead  to’’  certain
conditions.  This  language  applies  to  all  four  conditions  in  the  definition  of  signifi-
cant  guidance  document,12 and  the  Bulletin  ‘‘makes  clear  that  the  impacts  of  guid-
ance often will be more indirect and attenuated than binding legislative rules.’’

While the proliferation of agency guidance documents may well deserve attention,
the  solution  is  not  additional  OIRA  review.  If  anything,  the  growth  of  agency  guid-
ance indicates that the existing regulatory process is broken.
2. Guidance and the RPO

This  is  an  area  in  which  the  RPO  may  effect  significant  change  even  in  those
agencies,  like  Labor  and  Energy,  where  the  RPO  has  already  been  a  political  ap-
pointee. Under E.O. 13422, OMB can now engage the agency, along with other gov-
ernment personnel (as provided for in one amendment), in reaching a ‘‘common un-
derstanding’’ on regulatory efforts through the presence of the RPO.

After internal agency approval by the RPO, the agency will send drafts of signifi-
cant  guidance  documents  to  OIRA  for  review.  The  RPO  is  responsible  for  ensuring
that  the  agency  sends  a  draft  of  the  significant  guidance  to  OIRA,  along  with  an
explanation of the need for the guidance and how the guidance document will meet
that  need.  The  fourth  part  of  the  guidance  definition,  raising  ‘‘novel  legal  or  policy
issues arising out of legal mandates, the President’s priorities, or principles set forth
in  this  Executive  order,’’  is  nearly  broad  enough  to  permit  OIRA  to  sweep  into  its
review any guidance it wishes to review. It is likely that the RPOs, in reaching that
‘‘common understanding’’, will be the ones providing that internal approval.

Beyond this grant of authority to review significant guidance, there is little expla-
nation in the Bulletin of OIRA’s role in the review process. Unlike the detailed pro-
cedures  for  OIRA’s  review  of  regulations,  the  procedures  for  OIRA’s  review  of  guid-
ance  is  relatively  vague.  OIRA  will  ‘‘notify  the  agency  when  additional  consultation
is  required  before  the  issuance  of  a  significant  guidance  document.’’  There  are  no
timelines for completing the review, and there is vague language about the adminis-
trator’s ability to exempt guidance for an emergency or ‘‘other appropriate consider-
ation.’’

10 OMB Watch, A Failure to Govern: Bush’s Attack on the Regulatory Process. March 2007, p.

16. Available at http://www.ombwatch.org/article/articleview/3774.

11 Congressional  Research  Service,  Changes  to  the  OMB  Regulatory  Review  Process  by  Execu-
tive  Order  13422,  February  5,  2007.  p.  10.  Available  at  http://www.ombwatch.org/regs/PDFs/
CRS-EO13422.pdf.

12 Section 3(h) of E.O. 13422 defines a significant guidance document as ‘‘a guidance document
disseminated  to  regulated  entities  or  the  general  public  that,  for  purposes  of  this  order,  may
reasonably  be  anticipated  to:  (A)  Lead  to  an  annual  effect  of  $100  million  or  more  or  adversely
affect  in  a  material  way  the  economy,  a  sector  of  the  economy,  productivity,  competition,  jobs,
the  environment,  public  health  or  safety,  or  State,  local,  or  tribal  governments  or  communities;
(B)  Create  a  serious  inconsistency  or  otherwise  interfere  with  an  action  taken  or  planned  by
another  agency;  (C)  Materially  alter  the  budgetary  impact  of  entitlements,  grants,  user  fees,  or
loan programs or the rights or obligations of recipients thereof; or (D) Raise novel legal or policy
issues arising out of legal mandates, the President’s priorities, or the principles set forth in this
Executive order.’’

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00065 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

B. Rule-making Review and Public Comment

198

Currently,  the  public  can  first  learn  about  an  agency’s  intentions  to  regulate
through the semi-annual Unified Agenda which is published in the Federal Register.
It  is  notoriously  inaccurate  in  its  reporting  of  agency  regulatory  work  and  timing
of  an  agency’s  activities.  Nonetheless,  it  is  an  important  document  that  should  be
improved.

In  reality,  the  public  first  learns  of  a  specific  agency  regulatory  activity  from  a
website  operated  by  OIRA  when  OIRA  logs  agency  regulatory  submissions  for  re-
view. The website is meager, however. The public cannot search for a rule; instead,
there is a long list of rules sorted by departments.

E.O. 13422 does not amend the rule-making review procedure significantly; its im-
pact  is  in  the  pre-rule-making  stage.  In  conjunction  with  the  Good  Guidance  Prac-
tices  Bulletin,  however,  it  establishes  OIRA  review  and  notice-and-comment  proce-
dures over agency guidance documents.

By subsuming guidance documents to a review process almost identical to the re-
view  process  OIRA  uses  to  review  and  approve  regulations,  the  extent  of  OIRA’s
reach into agencies’ responsibilities will be at an all-time high, as will the influence
and  access  of  regulated  sectors.  As  a  result,  the  administration  has  unilaterally  re-
defined  the  Administrative  Procedure  Act,  which  specifically  exempts  interpretive
rules  and  policy  statements  from  the  notice-and  comment  process.  All  of  the  docu-
ments  deemed  significant  will  now  come  under  review  by  OIRA’s  staff  of  about  55
people  and  go  through  the  regulatory  notice-and-comment  period—but  only  after
being vetted by the RPO.
1. OIRA Review

OIRA has 90 calendar days to review a proposed regulation after submission, but
this  can  be  extended.  Desk  officers  review  the  RIA  developed  according  to  OMB’s
Circular  A–4.  Review  is  required  only  of  significant  regulations,  but  OIRA  has  the
authority to review those deemed non-significant as well. Although there often is ex-
tensive  communication  between  OIRA  and  the  agency  during  pre-rule-making,
OIRA  has  used  ‘‘return  letters’’  and  ‘‘prompt  letters’’  to  indicate  to  an  agency  areas
in which the proposed regulation has deficiencies, or to urge an agency to take regu-
latory—or deregulatory—action.

According to section 8 of the E.O., during the review period, an agency is not per-
mitted to publish the proposed rule in the Federal Register until the OIRA adminis-
trator  notifies  the  agency  that  OIRA  has  completed  or  waived  its  review  or  the  ap-
plicable  time  limits  for  review  have  expired.  Even  without  a  response  from  OIRA,
the  agency  must  seek  presidential  consideration  through  the  Vice  President  before
publishing the regulatory action.

Section  6  of  E.O.  12866,  Centralized  Review  of  Regulations,  describes  the  disclo-

sure requirements OIRA must follow during and after the review period:

(4) Except as otherwise provided by law or required by a Court, in order to en-
sure greater openness, accessibility, and accountability in the regulatory re-
view  process,  OIRA  shall  be  governed  by  the  following  disclosure  require-
ments:

(A) Only the Administrator of OIRA (or a particular designee) shall receive oral
communications  initiated  by  persons  not  employed  by  the  executive  branch
of  the  Federal  Government  regarding  the  substance  of  a  regulatory  action
under OIRA review;

(B) All  substantive  communications  between  OIRA  personnel  and  persons  not
employed  by  the  executive  branch  of  the  Federal  Government  regarding  a
regulatory  action  under  review  shall  be  governed  by  the  following  guide-
lines:

(i) A representative from the issuing agency shall be invited to any meeting be-

tween OIRA personnel and such person(s);

(ii) OIRA shall forward to the issuing agency, within 10 working days of receipt
of  the  communication(s),  all  written  communications,  regardless  of  format,
between OIRA personnel and any person who is not employed by the execu-
tive branch of the Federal Government, and the dates and names of individ-
uals involved in all substantive oral communications (including meetings to
which  an  agency  representative  was  invited,  but  did  not  attend,  and  tele-
phone  conversations  between  OIRA  personnel  and  any  such  persons);  and
(iii) OIRA  shall  publicly  disclose  relevant  information  about  such  communica-

tion(s), as set forth below in subsection (b)(4)(C) of this section.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00066 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

199

(C) OIRA  shall  maintain  a  publicly  available  log  that  shall  contain,  at  a  min-
imum,  the  following  information  pertinent  to  regulatory  actions  under  re-
view:

(i) The  status  of  all  regulatory  actions,  including  if  (and  if  so,  when  and  by

whom) Presidential consideration was requested;

(ii) A  notation  of  all  written  communications  forwarded  to  an  issuing  agency

under subsection (b)(4)(B)(ii) of this section; and

(iii) The dates and names of individuals involved in all substantive oral commu-
nications,  including  meetings  and  telephone  conversations,  between  OIRA
personnel and any person not employed by the executive branch of the Fed-
eral  Government,  and  the  subject  matter  discussed  during  such  commu-
nications.

(D) After  the  regulatory  action  has  been  published  in  the  Federal  Register  or
otherwise  issued  to  the  public,  or  after  the  agency  has  announced  its  deci-
sion  not  to  publish  or  issue  the  regulatory  action,  OIRA  shall  make  avail-
able  to  the  public  all  documents  exchanged  between  OIRA  and  the  agency
during the review by OIRA under this section.

While  OIRA  publishes  some  of  this  information  on  its  website  or  Reginfo.gov,
much  of  the  information  is  not  available  to  the  public,  but  is  only  available,  if  re-
quested,  in  its  docket  room.  In  October  2001,  OIRA  Administrator  John  Graham
issued  a  memorandum  clarifying  OIRA  procedures  for  disclosure  and  acknowledges
OIRA’s  intent  to  add  more  information  in  compliance  with  the  E-government  plans
of the administration.13

There  are  many  areas,  however,  that  are  not  covered  by  the  disclosure  policies.

For example:

• Rules  not  under  review  are  not  covered  by  its  disclosure  policy:  ‘‘Rules
are not under review prior to the start of informal OIRA review or after OIRA
has  notified  the  agency  that  review  is  concluded;  legislative  discussions  are
not  covered.’’  Thus,  informal  OIRA  pre-rule-making  activities  are  not  public.
• Meetings  with  parties  outside  of  government  about  rules  not  under
review  are  not  covered.  Regarding  meetings  with  outside  parties,  ‘‘any
meeting’’ to discuss the substance of an individual rule is covered, but ‘‘Meet-
ings  to  discuss  rules  not  under  review,  or  meetings  to  discuss  broad  regu-
latory topics (e.g., analytic methodology or legislation)’’ are not covered. More-
over,  even  for  those  meetings  that  are  disclosed,  the  disclosed  information  is
inconsistent.  The  disclosure  sometimes  omits  participants’  affiliations,  or
rules or topics discussed.

• Correspondence  about  rules  not  under  review  are  not  covered.  ‘‘Cor-
respondence  received  while  a  rule  is  not  under  review’’  is  not  covered  by  the
disclosure policy.

• Internal  communications  are  not  disclosed.  ‘‘Outside  parties,’’  for  pur-
poses  of  disclosure,  are  ‘‘persons  not  employed  by  the  executive  branch.’’  So
communications  with  Congress  and  the  public  are  disclosed,  but  not  inter-
and intra-departmental communications.

• Substantive  communications  are  not  defined.  ‘‘Substantive  communica-
tions’’ are not defined while ‘‘non-substantive discussions’’ are defined only by
providing  examples  like  ‘‘status  of  review,  review  procedures.’’  What  kind  of
communications  are  classified  as  substantive,  and  how  does  the  public  know
these policies are being followed?

These kinds of loopholes abound throughout the memo. Limiting disclosure to in-
formation and communications generated during the 90 or so days the rule is under
OIRA review ignores the years involved in developing rules under the current proc-
ess.  There  is  extensive  communication  within  and  among  agencies,  agencies  and
OIRA,  agencies  and  the  regulated  communities,  OIRA  and  the  regulated  commu-
nities, etc. None of these communications are shared publicly as part of OIRA’s dis-
closure  policies.  The  opportunities  for  influence  to  be  exerted  in  multiple  directions
are extensive.

In  addition,  these  disclosure  requirements  are  far  too  limited  in  light  of  publica-
tion of agencies’ regulatory plans in the Unified Agenda. Proposed regulations don’t

13 John D. Graham, OIRA Administrator, Memorandum for OIRA Staff: OIRA Disclosure. Oc-
tober  18,  2001.  Available  at  http://www.whitehouse.gov/omb/inforeg/oira¥disclosure¥memo-
b.html.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00067 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

200

just  appear  one  day  as  submissions  to  OIRA.  Limiting  disclosure  to  the  90  day  pe-
riod  of  OIRA’s  review  is  like  shining  a  flashlight  on  an  item  when  electricity  is
available.
2. Notice-and-Comment Period

The publication of a proposed rule in the Federal Register triggers the public par-
ticipation  phase  of  the  rule-making  process.  The  notice-and-comment  requirements
under  Section  553  of  the  APA  outline  this  public  process  and  have  been  subject  of
criticism and litigation for years.

The  traditional  view  of  section  553  procedure  as  a  process  for  educating  the
agency  has,  however,  been  gradually  replaced,  in  practice  if  not  in  theory,  by
the  belief  that  informal  rule-making  procedure  should  provide  interested  per-
sons an opportunity to ‘challenge the factual assumptions on which [the agency]
is  proceeding  and  to  show  in  what  respect  such  assumptions  are  erroneous.’  In
other words, the public must be informed of the data and assumptions on which
the agency’s proposal is based.14

Anyone  who  has  tried  to  comment  on  or  review  the  comments  of  others  during
this period knows that the information available to the public is far from the stand-
ard  Professor  Lubbers  describes  above.  Information  from  agencies  is  incomplete  or
not available, opportunities to comment on some rules open for comment don’t exist
on  electronic  dockets,  and  the  opportunity  to  see  who  has  commented  and  what
those comments address is too often non-existent.

Furthermore, as this subcommittee well knows, the Bush Administration has dis-
torted science, chilled scientific speech, and manipulated regulatory tools in pursuit
of  ideological  ends.  OMB  Watch  encourages  the  Subcommittee  and  Congress  to  ex-
amine the entire regulatory process for opportunities to increase transparency in the
public process and in the substance of the information available. To that end, OMB
Watch  has  recommendations  for  specific  ways  in  which  regulatory  transparency
could be improved.

I  want  to  again  express  our  opposition  to  E.O.  13422  and  urge  Congress  to  over-
turn the E.O. Short of that option, we urge Congress to use its appropriations pow-
ers to limit the executive’s ability to implement some or all of the E.O.
IV. Recommendations for Improved Transparency

One serious concern with the advent of a politically appointed RPO in each agency
is  that  the  interests  of  the  RPO  may  become  more  closely  aligned  with  those  of
OIRA and the White House than with those of the agency in which the RPO works,
with public sentiment and need, or with scientific consensus on an issue. If the RPO
now has the ability to initiate regulations, then the point at which agency personnel
reach  a  decision  to  recommend  regulatory  action,  and  make  that  recommendation
to the RPO needs to be clearly defined. We recommend the following:
A. Agency Responsibilities

1) That each agency clearly identify the RPO, provide a description of that per-
son’s role in regulatory matters, and how the public can contact that person.
The information should be conspicuously available on agency websites.

2) That each agency be required to disclose with its regulatory plan, those pro-
posed regulatory activities that the RPO has decided the agency will not pur-
sue.  The  plan  and  the  ideas  and  proposed  regulatory  activities  discarded  or
delayed should be published in the Unified Agenda published semi-annually
in the Federal Register along with justification for the delays or decisions not
to undertake the activities.

3) That  the  public  should  have  the  right  to  obtain  from  the  RPO  clarification

of items in the plan in addition to the items rejected or delayed.

4) That each agency provide formal documentation of ideas generated by agen-
cy  personnel  regarding  activities  that  may  lead  to  regulatory  actions.  This
documentation requires:
a) A  clear  definition  of  when  a  regulatory  action  commences.  For  example,
a regulatory action commences at the point at which an agency employee
or  contractor  transmits  a  recommending  document  to  the  RPO  or  starts
a formal communication on the matter.

14 Jeffrey  S.  Lubbers,  A  Guide  to  Federal  Agency  Rule-making.  (Chicago:  ABA  Publishing,

2006.) p. 298–9.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00068 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

201

b) Within  a  very  short  period,  for  example,  30  days,  the  RPO  publishes  a
written  response  to  recommending  actions  with  justification  for  declin-
ing, agreeing, or other actions regarding the recommendation. The public
must be assured that the RPO’s decision to stop a rule from being devel-
oped is not a triumph of politics over responsible government.

c) Placing  all  documents  in  the  agency  rule-making  record  for  activities
that  move  to  the  proposed  rule-making  stage  and  creating  a  new  public
docket, available through the Internet, of all other actions (i.e., those not
pursued).

5) That  agencies  submit  an  annual  report  to  Congress  on  activities  that  have
been  delayed,  withdrawn,  or  rejected  by  the  RPO  and  the  justifications  for
such actions.

6) That  all  intra-agency  communications,  written  and  oral,  between  the  RPO
and the agency personnel responsible for developing the proposed regulation
be documented and included in the agency’s rule-making record.

7) That  all  inter-agency  communications,  written  and  oral,  be  documented  and

included in the agency’s rule-making record.

B. Reviewing Entities Responsibilities

This  section  covers  the  role  of  OIRA  and  other  reviewing  entities  such  as  the

Small Business Administration (SBA).

1) That ‘‘substantive’’ communications be defined and not left to individual dis-

cretion.

2) That  all  substantive  communications,  written  and  oral,  between  the  agency
and the reviewing entities be documented and included in the agency’s rule-
making record.

3) That all substantive communications between parties outside of government,
and  excluding  communications  with  the  President,  and  any  party  involved
in  the  rule-making  process  (agency  or  reviewing  entity)  be  documented  and
included in the agency’s rule-making record. This disclosure covers materials
submitted  by  the  outside  parties,  and  documentation  of  oral  and  written
communications.

4) That OMB establish a government-wide regulatory tracking system. As part
of the implementation of the E-Government Act of 2002, agencies should de-
velop  a  regulatory  tracking  system  by  which  the  public  can  follow  a  regula-
tion through each step of the rule-making. Currently, there is an e-rule-mak-
ing  approach  being  refined  on  Regulations.gov.  Each  agency  should  provide
a clear process by which regulations can be tracked through this system with
appropriate links to the information contained in the rule-making record.

5) That  OIRA’s  website  be  searchable,  with  information  consistent  for  each
record, and with identification numbers that link records clearly to the regu-
latory actions with which they are associated.

6) That meeting logs, made available through OIRA’s website, be complete and
include  the  purpose  of  the  meeting,  generally  what  was  discussed,  the  par-
ticipants  and  their  affiliations,  a  brief  description  of  materials  circulated,
and any conclusions or outcomes that resulted from the meeting.

If  OIRA  and  other  reviewing  entities  like  the  SBA  continue  to  have  significant
impact on the substance of agency rule-making, then the APA informal rule-making
process should apply to these reviewing entities. It is unfair to the agencies who are
sued  as  a  result  of  rule-making  actions  to  bear  the  full  burden  of  litigation  when
they  do  not  have  full  responsibility  for  the  substantive  rule-making  outcome.  If  the
APA needs to be amended to cover these reviewing entities, then we urge Congress
to take appropriate action.

We  realize  the  burden  of  this  transparency  proposal  falls  primarily  on  the  agen-
cies.  But  until  and  unless  the  reviewing  entities  which  influence  the  substantive
outcome  of  regulatory  activities  are  subjected  to  the  same  APA  rules,  the  agencies
must be the repository for the full rule-making record.

Subjecting  agency  guidance  documents  to  the  same  APA-like  review  process  re-
quires  the  same  level  of  transparency,  record  development,  and  information  access
we  are  recommending  for  rule-making.  After  all,  OMB’s  justification  for  subsuming
agency guidance into the review process is that agencies are using guidance to avoid
the  rule-making  process.  Therefore,  the  transparency  principles  should  apply  to  re-
view of guidance documents as well.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00069 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

202

Post  notice-and-comment  communications  may  be  helpful  to  agency  and  the  re-
viewing entities. The decision to limit or accept these communications should be left
to  the  agencies.  But  the  same  principles  apply  if  agencies  decide  to  allow  commu-
nications  at  this  point:  the  communications  and  identification  of  the  parties  should
become part of the record. Similarly, OIRA’s and other entities communications with
parties after the notice-and-comment period should become part of the agency’s rule-
making  record.  These  principles  of  open  and  transparent  decision-making  should
apply to a second notice-and-comment period if deemed necessary.

In  addition  to  helping  to  restore  trust  in  government  by  providing  transparency,
the  ability  to  evaluate  regulatory  outcomes  is  greatly  enhanced  by  having  the  sub-
stantive  basis  of  decisions  available  to  the  public.  Congress,  the  President,  other
government  agencies  responsible  for  providing  information  to  these  branches,  state
decision-makers and policy staffs, researchers, and other segments of the public can
access,  analyze,  and  share  information.  The  technological  advances  that  have  oc-
curred make this transparency far easier than was possible in past decades. As the
Federal  Government  moves  to  increased  transparency  in  its  interaction  with  the
public,  our  political  dialogue  is  enhanced  by  providing  more  information,  and  using
that information to achieve increased government effectiveness and efficiency.

Thank you for the opportunity to testify.

BIOGRAPHY FOR GARY D. BASS

Gary D. Bass is the Founder and Executive Director of OMB Watch. Since found-
ing  the  advocacy  organization  in  1983,  Dr.  Bass  has  testified  before  Congress,  ap-
peared  on  national  television,  addressed  groups  across  the  country,  and  written  ex-
tensively  on  federal  budgetary,  program  management,  regulatory  and  information
policy issues.

Dr.  Bass  is  well  known  for  assisting  nonprofit  organizations  in  better  under-
standing  federal  rules  affecting  their  organizations  and  constituencies  and  was  re-
cently  selected  as  one  of  the  Nonprofit  Times  Power  and  Influence  Top  50.  He  has
led  campaigns  to  preserve  the  advocacy  voice  of  nonprofits,  make  Federal  Govern-
ment a more open and accountable operation, and insure meaningful citizen partici-
pation in government decision-making. He has been an active supporter of right-to-
know  initiatives,  encouraging  the  government  to  make  information  publicly  acces-
sible  in  order  to  empower  its  citizens.  He  has  also  undertaken  initiatives  to  insure
that, as we move into the information age, we do not create a society of information
haves and have-nots.

In  1989,  he  created  RTK  NET  (the  Right-to-Know  Network),  a  free  online  com-
puter  service  to  provide  community  groups  with  access  to  government  data.  More
than  3,000  people  now  use  RTK  NET  to  get  access  to  government  data  about  toxic
chemicals, census, housing demographics, home mortgage activity, and campaign fi-
nances.  He  has  been  a  pioneer  in  identifying  ways  in  which  the  information  super-
highway can be a tool for those working in the public interest sector.

During  1995,  Dr.  Bass  led  OMB  Watch  in  challenging  a  number  of  provisions  in
the  Contract  with  America,  and  successfully  formed  a  number  of  coalitions  that
stopped  proposals  that  would  have  undermined  our  society’s  safety  net.  Working
with  organizations  representing  working  men  and  women,  as  well  as  those  rep-
resenting environmental, educational, civil rights, human needs, religious, consumer
and other public interest concerns, he stopped: a ‘‘no money, no mandates’’ measure
that would have resulted in state and local governments being exempted from com-
plying  with  federal  laws,  such  as  fair  labor  standards,  civil  rights  protections,  and
voter registration laws; a constitutional amendment to balance the U.S. budget that
would  have  seriously  harmed  human  service  delivery  in  this  country;  a  variety  of
regulatory  provisions  that  would  have  undermined  health,  safety,  and  environ-
mental  protections  and  safeguards;  and  an  effort  to  silence  the  advocacy  voice  of
charities across the country.

Over  the  years,  Dr.  Bass  has  stressed  the  importance  of  educating  community
groups about federal issues. He has led many nationwide briefings on issues ranging
from changes in human services programs during the Reagan Administration to bal-
anced  budget  initiatives,  to  issues  pertaining  to  the  advocacy  voice  of  the  nonprofit
sector. He has also employed the use of e-mail to establish two-way communication
with community groups on these issues.

Prior to founding OMB Watch, Dr. Bass was President of the Human Services In-
formation Center, where he wrote two books and numerous articles on human serv-
ices  issues,  and  published  the  Human  Services  INSIDER,  a  bimonthly  newsletter
on  the  politics  of  federal  human  services  program.  He  had  also  served  as:  Director
of  Liaison  for  the  International  Year  of  Disabled  Persons;  consultant  on  several
projects in special education and the mental health of children, youth, most notably,

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00070 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

203

the preparation of the first annual report to Congress on the implementation of the
Education of All Handicapped Children Act (P.L. 94–142); Special Assistant to Wil-
bur  Cohen,  then  Chair  of  the  Michigan  Governor’s  Task  Force  on  the  Investigation
and Prevention of Abuse in Residential Institutions; and in juvenile justice and com-
munity corrections.

Dr. Bass received a combined doctorate in psychology and education from the Uni-
versity of Michigan, along with the University’s highest award for graduate student
teaching and several awards for academic excellence.

Chairman  MILLER.  Thank  you,  Dr.  Bass.  Dr.  Bass,  I  know  that
your red light was on. You said you had five points; you made four
and didn’t make five. Do you wish to make the fifth? All right.

Dr. Richard Parker.

STATEMENT OF MR. RICHARD W. PARKER, PROFESSOR,

UNIVERSITY OF CONNECTICUT LAW SCHOOL

Mr.  PARKER.  Thank  you.  Mr.  Chairman,  I  appreciate  this  oppor-

tunity to review some observations on Executive Order 13422.

Over the past 20 years, I have had a chance to observe the regu-
latory  process  from  a  number  of  different  vantage  points  from  the
private  sector,  from  within  agencies,  both  in  the  Reagan  Adminis-
tration  and  the  Clinton  Administration  and  from  academia.  The
only  perspective  I  haven’t  had  is  your  perspective,  the  perspective
of  the  Oversight  Committee,  but  that  is  obviously  a  very,  very  im-
portant  perspective.  And  I  will  have  to  say  that,  you  know,  when
I  view  this  issue  vicariously  from  your  perspective,  it  seems  to  me
that the entire institution of OIRA review of agency policies is dis-
tinctly problematic and E.O. 13422 should be viewed as a small but
significant step in that already problematic direction.

What  do  I  mean  by  that?  Well,  by  extending  OIRA  oversight  to
guidance  documents,  we  focused  on  transparency.  Not  only  does
E.O. 13422, but all the executive orders, have hugely expanded the
power  of  an  agency  that  has  basically  no  scientific  or  technical  ex-
pertise to shape policies that often have a very important scientific
and  technical  component.  It  extends  the  power  of  an  agency  that
has  a  troubled  history  in  acting  as  a  conduit  and  through  back
channels  for  special  interests,  to  guidance  documents  now  beyond
regulatory documents, and I just wanted to echo what Dr. Bass just
said  about  this  problem  of  informal  reviews.  When  I  was  talking
to old friends from various agencies about what I should say in this
hearing,  just  an  open-ended  question,  what  worries  you  most,  the
first  thing  that  came  out  was  these  informal  reviews  which  basi-
cally are backroom things that they are instructed not to report to
anybody  but  which  turn  out  to  be  very  influential  in  shaping  the
rules from the get-go. So I just want to second Dr. Bass’s comment
on  that  based  upon  what  I  have  been  hearing  from  the  trenches.
The  RPO  issue  I  think  has  been  dealt  with  extensively.  I  won’t

elaborate on that except to say I support it.

The  issue  is  that  basically  where  are  we  going  and  why  are  we
here.  White  House  intervention  in  rule-making  is  not  required  by
the  Constitution  in  the  area  that  we  are  talking  about.  It  is  not
mandated  by  any  statute.  And  the  question  arises,  given  the  costs
to  transparency,  to  expertise  that  we  have  been  talking  about,
what is it that justifies this kind of intervention at all. I would like
to  just  sort  of  think  about  this  from  a  cost-benefit  standpoint.  We
have seen the costs. What are the benefits? And I will have to say

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00071 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

204

that  procedural  steps  are  very  hard  to  quantify.  Their  benefits  are
very  hard  to  quantify,  and  if  my  colleague  were  still  with  me,  I
would point out that there are regulatory critics who basically zero
out  benefits  of  procedures  that  can’t  be  quantified  and  so  by  that
standard,  the  entire  institution  of  OIRA  review  would  have  to  be
assigned  a  zero  benefit  in  a  cost-benefit  analysis.  I  can’t  play  that
game  because  I  favor  the  inclusion  of  qualitative  benefits  and  so  I
have  to  do  a  little  more  work,  but  we  need  to  talk  about  what  is
it  that  OIRA  is  bringing  to  the  process,  and  it  seems  to  me  that
if  you  go  back  through  history,  the  reason  that  OIRA  was  brought
in,  and  the  thing  that  has  been  driving  this  entire  dynamic  from
the  get-go  has  been  a  profound  skepticism  of  the  competence  of
agencies  and  certainly  of  their  evenhandedness.  Going  back  to  the
1980s,  there  was  this  view  that  EPA  is  full  of  environmental
whackos  who  think  the  polar  icecaps  are  melting  or  something.  At
OSHA,  you  know,  just  full  of  these  zealots  who  can’t  stop  pushing
out regulations; we have to rein them in. And if you recall from the
1980s  and  the  1990s,  in  particular  when  these  institutions  were
getting entrenched, there was an endless litany of horror stories of
regulatory abuses, and I will tell you, I was bothered by this litany
and  I  started  investigating  some  of  these  stories  and  I  published
the  results  of  my  investigations  in  two  major  articles,  and  I  can
only summarize, but I can tell you in a nutshell that what I found
is that these stories basically can’t be verified in most cases. Many
are gross exaggerations. Some were just complete fabrications, and
I could give you an example. There are some stories of course that
are  true.  I  mean,  in  any  case  there  are  genuine  problems.  But
there has been no documentation of a pervasive problem of agency
overzealousness  that  would  warrant  this  institution  in  the  first
place.

The  other  great  sort  of  foundation  stone  of  this  regulatory  skep-
ticism  that  gives  us  OIRA  review  has  been  a  series  of  three  really
major  studies  that  looked  broadly  at  regulations  and  all  done  by
regulatory  critics,  all  very  widely  publicized  over  a  period  of  dec-
ades  and  all  coming  to  essentially  the  same  conclusion,  that  while
regulation is overall beneficial, there are many regulations that fail
cost-benefit  analysis.  So  what  I  did  was,  in  these  articles  I  looked
at  the  three  most  influential  studies  and  I  looked  at  the  data  be-
hind them and the methodology behind them, and what I was sur-
prised  to  find  frankly  was  that  they  just  don’t  stand  up.  None  of
these  studies  have  been  peer-reviewed.  Their  samples  are  biased.
They  substitute  educated  guesses  for  the  cost  benefits  of  regula-
tions  and  report  them  as  ex  post  actual  costs  and  benefits.  But
most  of  all,  they  zero  out  whole  categories  of  regulatory  benefit,
and  when  I  actually  looked  at  one  of  the  most  influential  studies
that had been widely quoted to promote this regulatory skepticism,
I found out that 41 of the 136 rules in the database were assigned
a zero benefit, not a zero net benefit but a zero benefit because the
benefits  that  those  regulations  provided  had  not  been  monetized
and  quantified  by  the  agency.  They  were  qualitative  benefits  like
the  benefits  of  freedom,  like  the  benefits  of  enforcement.  The  list
of  zero-benefit  rules  included  rules  to  prevent  major  oil  spills  like
the Exxon Valdez, a rule to protect 3.9 million agricultural workers
from  acute  pesticide  poisoning.  Here  the  rationale  was  that  acute

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00072 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

205

pesticide  poisoning  wasn’t  one  of  the  harms  to  which  we  had  de-
tailed monetary value, so they zeroed it out. All right. So the point
is that these studies are not peer-reviewed studies and I just would
like  to  suggest  before  we  go  further  down  the  road  of  OIRA  inter-
vention  perhaps  OIRA  intervention  itself  ought  to  be  subject  to  a
cost-benefit  analysis.  Perhaps  we  ought  to  look  at  the  empirical
basis underlying the entire project of White House intervention and
expert rule-making.

Let  me  just  close  by  saying  that  I  don’t  want  to  be  interpreted
as  saying  that  there  is  nothing  wrong  with  agency  rule-making,
that there are no bad rules. There are. I suspect though that when
you  look,  you  will  find  agencies  making  errors  both  in  underregu-
lating  and  overregulating.  But  in  any  case,  the  way  to  correct  bad
rule-making  is  public  involvement,  it  is  expert  involvement,  it  is
transparency,  it  is  openness,  and  unfortunately,  this  executive
order is not about public involvement. This executive order is about
building OIRA’s turf and therein lies the problem.

Thank you, Mr. Chairman.
[The prepared statement of Dr. Parker follows:]

PREPARED STATEMENT OF RICHARD W. PARKER

Mr.  Chairman  and  Members  of  this  subcommittee,  I  appreciate  this  opportunity
to  share  with  you  some  observations  on  the  Bush  Administration’s  amendments  to
Executive  Order  12866,  particularly  Executive  Order  13422.  I  have  studied  and
taught  administrative  and  environmental  law—and  regulatory  policy—for  over  a
decade;  published  articles  in  leading  scholarly  journals  on  the  subject  of  OIRA  re-
view and the use of cost-benefit analysis; and benefited from sustained participation
in work of the Administration Law Section of the ABA, where I have co-chaired both
the  Regulatory  Policy  Committee  and  the  Committee  on  e-rule-making.  I  have
served  as  Special  Counsel  to  the  Deputy  Administrator  of  EPA  during  the  Clinton
Administration and as Assistant General Counsel of USTR. And I practiced admin-
istrative  law  in  the  private  sector.  So  I  have  had  a  chance  to  observe  these  issues
from  a  number  of  different  vantage  points.  My  remarks  today  represent,  of  course,
my own view of the matter.

Is  E.O.  13422  good  governance  or  regulatory  usurpation?  The  answer  to  that  all
depends  on  whether  you  buy  the  premises—the  theory  of  government—that  ani-
mates  it  and  that  animated  its  forebears,  the  Reagan/elder  Bush  Executive  Orders
and E.O. 12866 itself. These Executive Orders embody a view of our executive agen-
cies that is deeply skeptical of their competence, and certainly of their even-handed-
ness.  Certain  regulatory  agencies—particularly  those  in  the  field  of  health,  safety
and  environmental  regulation—are  thought  to  be  tunnel-visioned;  obsessively  fo-
cused  on  regulation  regardless  of  cost;  and  unaccountable  to  the  people.  They  need
to be reined in and OIRA is just the agency to come to the rescue. OIRA will impose
a  broad  perspective  which  once  had  been  narrow;  require  cost-benefit  analysis  to
force a more rational and even-handed balancing of costs and benefits in regulation;
and bring political accountability to a process that otherwise would operate without
popular or political check.

If  you  buy  this  vision,  then  E.O.  12866  is  the  order  for  you,  and  if  you  further
buy  that  guidance  documents  are  first  and  foremost  tools  of  choice  for  agencies  in-
tent  on  exploiting  ‘‘loopholes’’  to  avoid  the  rationalizing  benefits  of  OIRA  review  in
the rule-making process then E.O. 13422 is likewise for you.

But  it  is  view  right?  Is  it  based  on  rigorous  empirical  observation  and  sound
science?  Or  is  it  more  like  the  widespread  belief  in  Iraqi  weapons  of  mass  destruc-
tion  circa  2003—immensely  plausible,  boasting  bipartisan  support,  but  somehow  a
bit  lacking  in  the  evidence  department?  I  investigated  these  questions  systemati-
cally  in  two  major  articles,  one  published  in  the  University  of  Chicago  Law  Review
and the second in the Administrative Law Review. They are long articles and I can
only summarize them briefly here; but the main takeaways are clear.

Let’s  begin  by  clearing  away  some  underbrush—an  activity  that  now  has  strong
bipartisan  credentials.  Regulatory  critics  such  as  the  Mr.  Kovacs  who  testified  be-
fore this subcommittee in February not uncommonly point to the size of the Federal
Register  and  the  number  and  cost  of  rules  as  evidence  of  the  ‘‘overwhelming  regu-

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00073 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

206

latory burden’’ our industries face. 73,000 pages of Federal Register! 4000 new regu-
lations each year! $1.13 trillion cost! Horrors!

In  fact,  any  perusal  of  the  any  Federal  Register  quickly  reveals  that  the  Federal
Register  carries  far  more  than  new  rules.  New  rules  comprise  only  a  small  fraction
of its contents. Moreover, even the new rules published in the Federal Register typi-
cally  consist  of  roughly  20  pages  of  preambular  explanation  for  every  page  of  rule.
These 20 preambular pages are actually explanations and defenses of the rule, along
with  detailed  responses  to  comments  from  the  public  that  can  run  to  the  tens  of
thousands. Far from adding to burden, agency explanations lighten the load by eas-
ing  understanding  of  the  basis  and  purpose  of  the  rule  being  proposed  or  promul-
gated. But they do add length to the Federal Register.

As for the rules themselves, length should not be confused with burdensomeness.
Congress  could  reduce  the  environmental  statute  books  (now  two  inches  thick)  to
one  line:  ‘‘Thou  shall  not  pollute.’’  Does  anyone  truly  believe  that  this  would  make
regulation  less  onerous?  Much  of  the  length  and  complexity  of  modern  rule-making
stems from the desire to make it reasonable, not from some tunnel-visioned attempt
to make it harsh.

Admittedly,  four  thousand  rules  per  year  does  seem  like  a  lot,  at  first  blush.  But
a  sophisticated  user  of  numbers  will  ask,  is  this  really  a  large  number—given  our
$12 trillion economy and population of 270 million, not to mention millions of busi-
nesses  spanning  hundreds  or  thousands  of  different  kinds  of  activity?  Remember
also  that  it  takes  a  regulation  to  ease  a  regulation.  It  takes  a  regulation  to  alter
so  much  as  a  comma  in  a  prior  regulation.  Many  regulations  are  minor  and  tech-
nical.  Others  make  changes  in  the  direction  of  providing  greater  clarity  or  greater
leniency. This being so, the mere number of ‘‘regulations’’ in itself tells you nothing
meaningful about regulatory burden.

And what of the alleged $1.13 trillion cost? That figure, if accurate, is a large fig-
ure  even  when  viewed  in  context  of  our  more  than  $10  trillion  economy.  But  that
number  comes  not  from  OMB  but  from  the  Small  Business  Administration  and  I
wonder  whether  it  has  been  rigorously  peer  reviewed.  The  numbers  I  have  seen
commonly  range  from  $200  billion  to  $700  billion,  and  even  those  numbers  are  de-
rived  not  from  actual  measurements  but  from  ex  ante  predictions  of  cost  often  sup-
plied  by  industry.  Moreover,  most  of  these  costs  are  accounted  for  by  a  relative
handful  of  rules  that  also  bring  with  them  enormous  benefits:  like  water  safe  to
drink,  air  safe  to  breathe.  No  credible  study  yet  done—even  by  OMB—has  yet  con-
cluded  that  the  net  benefits  of  rules  as  whole  are  negative.  In  fact,  all  observers
concede that benefits of regulations greatly outweigh their costs overall. So what are
we to make of the allegedly exorbitant aggregate burden of regulation?

Michael  Porter  of  Harvard  Business  School  is  one  of  many  prominent  scholars
who have joined leading businesses like 3–M and Dupont in pointing out that regu-
lations don’t just add costs. Regulations can create lucrative markets, promote tech-
nologies,  build  industries  and  enhance  American  competitiveness  in  producing  the
goods  and  services  of  tomorrow.  Many  companies  discover  important  new  money-
saving efficiencies in the course of auditing their production process to comply with
regulations.  Yet  none  of  these  countervailing  economic  benefits  of  regulation  are
factored  into  (or  subtracted  from)  the  gloom-and-doom  cost  estimates  that  are  rou-
tinely bandied about by leading regulatory critics.

In  short,  the  case  for  more  searching  OIRA  review  cannot  be  made  credibly  by
throwing out Federal Register page counts, or by tossing out aggregate cost statistics
that are exaggerated and then offered in isolation without the context of their bene-
fits. There is a need for sound science in regulatory criticism as well as in regulation
itself.

If  Federal  Register  page  counts,  and  aggregate  cost  quotes  do  not  make  the  case

for the necessity and value of ever-expanding OIRA oversight, what then does?

My  in-depth  research  of  this  very  question  reveals  that  for  decades,  scathing  cri-
tiques of government have been fueled by a stream of horror stories which are typi-
cally  unverified  and  many  (though  not  all)  of  which  turn  out,  on  inspection,  to  be
either  exaggerated,  atypical  or  just  plain  false.  My  University  of  Chicago  article  of-
fers a few anecdotes to illustrate the pitfalls of legislating by anecdote.

Secondly  however,  and  much  more  importantly,  regulatory  skepticism  and  argu-
ments  for  cost-benefit  analysis  and  OIRA  oversight  of  agency  regulations  (and  now
guidance documents) have been fueled by a group of studies called ‘‘regulatory score-
cards,’’  which  examine  a  broad  array  of  major  regulations  to  conclude  that  while
regulation overall may be beneficial in aggregate, the costs of many individual gov-
ernment regulations vastly outweigh their health, safety or environmental benefits.
For  example,  since  at  least  1986,  a  widely-cited  table  by  John  Morrall,  an  OIRA
economist,  has  served  as  Exhibit  A  for  the  proposition  that  federal  agency  regula-
tion—particularly regulation of workplace and environmental toxins—is pervasively

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00074 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

207

over-zealous  and  irrational.  He  reported  that  over  a  third  of  the  44  regulations  in
his  database  cost  more  than  $100  million  per  life  saved,  and  one  infamous  regula-
tion, OSHA’s formaldehyde rule, cost $72 billion per life.

How  can  this  be?  Well,  to  begin  with,  I  and  other  scholars  have  shown  that  he
did  not  draw  on  a  random  sample  of  regulations  in  setting  up  his  database,  but
rather  cherry-picked  the  toxin  regulations  that  he  deemed  most  problematic.  Sec-
ondly, he freely acknowledges that he substituted his own preferred benefit numbers
for agency benefit estimates whenever he found a supporting study (names of which
he  has  yet  to  disclose)  which  he  found  more  credible  than  the  studies  that  agency
scientists  and  science  advisors  had  relied  upon.  For  example,  in  1985  OSHA  esti-
mated  that  its  proposed  formaldehyde  exposure  regulation  would  save  from  six  to
forty-seven lives over forty-five years. Morrall alters that estimate to one life saved
every hundred years.

This  is  a  rather  significant  change.  One  wonders  what  qualifies  Mr.  Morrall,  an
economist,  to  second-guess  panels  of  agency  scientists  on  the  issue  of  the  relative
merits  of  different  risk  estimates.  I  dwell  on  this  because  the  practice  of  altering
or  challenging  agency  science  and  scientific  assessments  is  not  confined  to  Mr.
Morrall,  or  his  table.  It  reflects  long-standing  OIRA  practice  that  persists  to  this
day.  In  fact,  Administrator  Graham  has  tacitly  recognized  the  competence  concern
by hiring one or two toxicologists and other physical scientists to provide a scientific
fig leaf for OIRA second-guessing of agency scientific judgments. But is that the way
science  is  supposed  to  work?  My  understanding  is  that  science  works  not  by  privi-
leging  the  opinions  of  one  or  two  particular  scientists  on  the  basis  of  their  govern-
ment  position—or  their  appeal  to  a  sympathetic  economist—but  by  seeking  a  con-
sensus in the scientific community on how to evaluate the evidence.

Finally, my research shows that Mr. Morrall achieved his shocking figures in part
by  simply  excluding—zeroing  out—benefits  that  did  not  conform  to  his  procrustean
template.  Again,  the  infamous  $72  billion  per  life  formaldehyde  rule  will  illustrate
the  point.  What  Morrall’s  table  conceals,  but  which  the  rule-making  record  reveals,
is  that  OSHA’s  rule  (beyond  preventing  about  one  cancer  fatality  per  year)  which,
in  Morrall’s  hands,  becomes  one-hundredth  of  a  fatality  per  year,  after  adjustment
and  discounting,  was  also  expected  to  yield  a  host  of  unquantified  but  clearly  sub-
stantial benefits of a non-life-saving nature.

Indeed,  the  rule-making  record  makes  clear  that  OSHA’s  formaldehyde  rule  was
never justified as a life-saving rule at all. The non-life-saving benefits and purposes
of  the  rule  are  delineated  at  length  in  the  preamble  to  OSHA’s  proposed  rule:  re-
duced  or  avoided  burning  eyes  or  noses,  sore  or  burning  throats,  asthma  attacks,
chronic bronchitis, allergic reactions, dermatitis and skin sensitization. OSHA notes
that  over  500,000  American  workers  are  regularly  exposed  to  formaldehyde  at  con-
centrations that have been found to cause one or more of these illnesses or discom-
forts.

The  central  policy  questions  for  OSHA  were,  ‘‘Is  avoiding  such  discomforts  and
health  hazards  for  500,000  American  workers  worth  the  expenditure  of  $36  million
a  year  by  a  $30  billion  dollar  group  of  industries?  Will  installing  ventilators  in  the
workplace also reduce employee exposure to other irritating and possibly hazardous
chemical vapors?’’ These questions are quite unlike (and are far more complex than)
the  question  implicitly  posed  by  the  Morrall  table:  how  could  OSHA  be  so  stupid
as to propose a rule that will cost $72 billion for every life saved?

I dwell on this point because, again, the Morrall table is not an isolated case. Un-
fortunately,  it  is  all  too  typical  of  the  approach  that  OIRA  has  taken,  particularly
in this Administration, to regulatory oversight and cost-benefit analysis. Widely ac-
cepted principles of cost-benefit analysis call for the inclusion of non-quantifiable or
non-monetizable  benefits.  In  principle,  non-quantified  benefits  are  recognized  and
respected.  E.O.  12866  calls  for  qualitative  benefits  to  be  included  and  described  in
all regulatory impact assessments. Qualitative benefits are often described, at least
perfunctorily,  in  OMB’s  Reports  to  Congress  on  the  Costs  and  Benefits  of  Regula-
tion.

It  is  the  practice  wherein  the  problems  lie.  In  practice,  agencies  know  that  any
benefits  that  cannot  be  quantified  are  likely  to  be  zeroed  out  in  the  mill  at  OMB.
They  know  that  basing  a  decision  on  un-enumerated  judgment  that  the  costs  of  a
policy or action are ‘‘worth’’ the benefits is perfectly fine for foreign policy, perfectly
fine  for  defense  procurement,  perfectly  fine  for  most  areas  of  government  and  per-
fectly  fine  for  most  decisions  in  daily  life—but  it  means  rough  sledding  for  health,
safety or environmental regulations at OMB.

The  problem  is  that  you  can’t  make  regulatory  policy  by  the  numbers  any  more
than  you  can  draw  or  paint  by  the  numbers.  Many  benefits  are  either  hard  or  im-
possible to quantify and monetize in a scientifically defensible way. How do you put
a  monetary  value,  for  example,  on  a  procedure  that  aids  enforcement,  or  deters

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00075 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

208

wrongdoing,  or  provides  useful  information  to  consumers?  How  do  you  put  a  value
on the benefit on a policy that itself will not solve a problem, but that forms a part
of  a  mosaic  of  responses  and  diplomatic  initiatives  needed  to  address  that  problem
effectively?  How  do  you  put  a  value  on  preserving  the  environment,  when  our  un-
derstanding  of  ecological  risk  and  benefit  is  so  extremely  limited,  and  our  methods
for valuing environmental amenities so crude? In practice, OIRA insists on viewing
regulatory  policy  through  the  prism  of  numbers.  Yet  many  health,  safety  and  envi-
ronmental  regulations  cannot  be  evaluated  sensibly  on  the  basis  of  numbers  alone.
Nowhere  are  the  consequences  of  this  flawed  approach  to  policy  more  apparent
than  in  the  analysis  proffered  by  Robert  Hahn  of  the  AEI–Brookings  Joint  Center
for  Regulatory  Studies,  a  leading  regulatory  critic  and  a  leading  proponent  of  not
only  enacting  E.O.  13422  but  extending  it  further  to  require  cost-benefit  analysis
of agency guidance documents as well as rules.

The  prevailing  approach  to  regulatory  critics  to  regulatory  assessment  is  evident
in  his  much-heralded  and  influential  studies—one  in  1996  and  another  in  2000—
which  purport  to  show,  based  on  a  wide-arranging  analysis  of  over  130  major  rules
spanning  a  ten-year  period,  that  57  percent  of  all  major  environmental  regulations
‘‘fail  a  neutral  economist’s  cost-benefit  tests.’’  This  is  a  powerful  indictment  of
health,  safety  and  environmental  regulation—until  one  learns  that  41  of  the  136
major  regulations  appearing  in  Hahn’s  tabulation  are  assigned  a  zero  benefit.  Not
a zero net benefit, but a zero benefit, meaning the regulations have no use whatso-
ever. The list of zero-benefit rules includes:

— a  rule  to  protect  3.9  million  agricultural  workers  from  exposure  to  harmful

pesticides;

— a rule requiring that owner/operators of tankers develop plans to respond to

large oil spills;

— a rule to require that air polluters hold comprehensive permits which lay out

their pollution control obligations;

— a  rule  requiring  the  public  reporting  of  releases  of  certain  toxic  chemicals

from large manufacturing facilities;

— a Clean Water Act rule aimed at protecting sensitive coastal areas from non-

point-source water pollution;

— three  rules  establishing  national  primary  drinking  water  standards  to  limit

public exposure to toxic pollutants in drinking water; and

— an  FDA  rule  establishing  requirements  for  the  safe  handling  of  seafood  in

commercial processing operations.

Moreover, and this point bears emphasis, even rules that show a positive number
in the benefits column have had whole categories of benefits excluded from the tally.
What is going on? Again, the answer requires careful understanding of what bene-
fits are included and excluded in the underlying cost-benefit tabulation. It turns out
that this study, with a few narrow and limited exceptions, again has assigned a zero
value to any benefit which the government’s regulatory impact assessment does not
quantify  and  monetize.  It  even  zero-values  benefits  that  are  quantified  and  mone-
tized  in  an  agency  RIA,  unless  they  happen  to  fall  into  one  of  his  select  categories
of recognized benefit—even as he insists that he is using the government’s numbers.
Included,  therefore,  are  benefits  of  reducing  physical  accidents,  cancer,  heart  dis-
ease  and  a  range  of  known  ailments  resulting  from  exposure  to  five  named  air  pol-
lutants. Zeroed out, however, are all ecological benefits not monetized by the agency.
Also  zeroed  out  are  all  benefits  of  avoiding  acute  poisoning—hence  the  zero  value
for rules aimed at avoiding acute pesticide poisoning and seafood poisoning. Also ze-
roed  out  are  all  procedural  and  enforcement  benefits  since  they  are  intrinsically
non-monetizable.

In  short,  the  studies  that  purport  to  expose  tunnel  visioned  over-zealousness  in
regulatory agencies—and the need for expanded OIRA review—have failed to make
their case on the facts. Rather than illustrating the benefits of cost-benefit analysis
in  bringing  clarity,  transparency  and  rigor  to  regulatory  analysis  they  expose  the
capacity  of  such  analysis  for  concealing  methodological  icebergs  and  delivering
skewed and misleading results. Far from establishing that OIRA oversight is needed
to  correct  tunnel  vision  in  the  agencies,  they  simply  suggest  a  dangerous  tendency
towards tunnel vision within OIRA itself.

It  is  true,  of  course,  that  cost-benefit  analysis  need  not  be  done  this  way—it  can
be  done  in  a  way  that  does  not  over-ride  inconvenient  truths  delivered  by  science,
that  is  sensitive  to  qualitative  costs  and  benefits,  and  that  is  properly  cognizant  of
relevant  uncertainties.  Cost-benefit  analysis  can  prompt  regulations  as  well  as  em-
barrass  them.  And  OIRA  is  not  always  anti-regulatory.  Indeed,  OIRA,  under  Mr.

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00076 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

209

Graham’s leadership, has prompted a few quite valuable regulations that might not
otherwise have been forthcoming, such as the trans-fat labeling rule.

Overall, however, it must be said that cost-benefit analysis in OIRA’s hands—ap-
plied  within  the  framework  of  E.O.  12866  and  E.O.  13422—is  generally  not  a  par-
ticularly ‘‘fair and balanced’’ test. It is applied, for the most part, only to regulations
and proposals to regulate—not to proposals to de-regulate or failures to regulate. It
privileges quantity over quality, and numbers over judgment. It tends to conceal un-
certainty  behind  the  fac¸ade  of  a  few  summary  statistics.  It  assumes,  without  basis,
that  maximizing  monetary  net  benefits  will  also  maximize  social  welfare—when
economists  themselves  acknowledge  that  this  assumption  only  holds  if  the  losers
from  non-regulation  or  weak  regulation  are  actually  compensated  by  the  winners,
an  event  that  in  the  real  world  very  seldom  happens.  It  takes  as  actual  costs  and
benefits figures that are at best ex ante guesses—adopted in advance of regulation—
as to what those regulatory costs and benefits are likely to be.

Moreover,  we  are  now  in  a  position  to  see  that  the  cumulative  cost-benefit  anal-
ysis  mandated  by  E.O.  13422  is  the  worst  of  the  worst,  methodologically.  For  even
if  you  could  manage  to  preserve  some  nuance—some  attention  to  qualitative  vari-
ables,  dynamic  effects,  asymmetric  uncertainties—in  the  analysis  of  individual
rules,  these  nuances  are  completely  squeezed  out  in  the  ringer  of  cumulative  anal-
ysis.  In  cumulative  cost-benefit  analysis—as  in  regulatory  scorecards—only  sum-
mary statistics survive.

Meanwhile,  applying  OIRA  review  and  cost-benefit  analysis  to  guidance  docu-
ments makes even less sense than applying it to proposed new rules, because guid-
ance documents are very often adopted because the agency’s knowledge of the facts
is  so  limited  that  it  feels  it  is  not  ready  to  propose  a  comprehensive  rule.  The  pur-
pose of guidance is to provide regulated entities some clarity while preserving some
flexibility to change course and make exceptions when the facts of a particular case
reveals  that  the  policy  is  wrong.  By  encumbering  guidance,  E.O.  13422  will  either
deter  it  (thereby  impeding  clarity)  or  else  ossify  it,  thereby  hampering  flexibility.
And  the  uncertainty  that  often  calls  forth  guidance  documents—as  opposed  to
rules—in the first place, does not augur well for the application of cost-benefit ana-
lytical techniques to guidance.

Let me conclude on a more affirmative note by asking what then should be done?
I have challenged the evidence and analysis under-girding studies which purport to
show  that  regulatory  agencies  are  pervasively  irrational  and  biased  in  favor  of  un-
reasonably costly regulation. That said, I certainly do not maintain that agency reg-
ulation  is  pervasively  rational,  on  any  plausible  definition  of  that  term.  I  have  not
proved  that,  and  I  readily  concede  that  I  cannot  prove  it.  The  question,  I  submit,
is an open one.

I  expect  that  what  careful  investigation  would  show  is  that  agencies  vary.  Some
favor  industry,  others  favor  regulatory  beneficiaries.  Moreover,  their  slant  changes
over time, depending on who occupies the White House and the front office and that
agency.  Agency  predilections  may  even  vary  from  office  to  office  and  from  rule  to
rule.  On  balance,  I  expect  the  evidence  will  show  that  under-regulation  is  as  much
a  problem  as  over-regulation—an  insight  that  Mr.  John  Graham  evidently  shares.
But  I  also  conclude  that  quantitative  cost-benefit  analysis  as  currently  practiced  in
OIRA  and  by  its  chief  outside  supporters  is  more  contributor  to  that  problem  than
cure—a stance he most emphatically does not share.

But  all  this  is  speculation.  What  is  needed  both  to  resolve  this  speculation  and
to improve agency regulation, I argue, is not more quantitative cost-benefit analysis
and ever expanding OIRA review of first rules and now guidance. That is the wrong
path  and  the  wrong  direction.  The  right  way  is,  first,  to  undertake  some  strategi-
cally  targeted  retrospective  analyses  of  the  actual  costs  and  benefits  of  actual  rules
to  provide  a  ‘‘ground  truth’’  of  how  accurate,  if  at  all,  ex  ante  analysis  has  been  in
a variety of regulatory situations, and to reveal the kinds of hitherto unanticipated
factors that may arise to defeat ex ante expectations.

Second,  agencies  might  be  asked  to  engage—not  OIRA—but  relevant  experts  and
the public more fully in the development of guidance documents. One might imagine
an abbreviated consultation process commensurate with the magnitude of the guid-
ance  issues  and  their  difficulty  of  resolution  which  agencies  might  be  asked  to  un-
dertake  to  better  guide  their  guidance.  The  advent  of  the  Internet  makes  such  a
process  not  only  conceivable  but  easy  to  imagine  and  design,  and  OIRA  might  well
apply its energies to working with agencies to develop such a process—remembering
also that guidance is intrinsically tentative.

Finally,  agencies  should  think  about  exploring  innovative  ways  to  harness  the
power  of  the  Internet  to  make  rule-making  more  expert,  more  participatory  and
more efficient. The Administrative Law Section of the ABA has undertaken a project
on  e-rule-making,  and  while  none  of  the  views  expressed  here  today  should  be  at-

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00077 Fmt 6601 Sfmt 6621 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

210

tributed  to  the  participants  in  that  project,  I  think  I  can  say  with  conviction  that
all  of  us  in  the  project  would  be  happy  to  work  with  OIRA,  with  public  interest
groups,  regulated  entities  and  not  least  the  members  of  this  committee  and  their
staff  in  a  collaborative  effort  to  achieve  wiser  rules  by  improving  the  rule-making
and guidance development process.

Thank  you  for  the  opportunity  to  address  you  today.  I  would  be  happy  to  try  to

answer any questions you might have.

BIOGRAPHY FOR RICHARD W. PARKER

Professor Parker has studied and taught administrative and environmental law—
and  regulatory  policy—for  over  a  decade;  published  articles  in  leading  scholarly
journals on the subject of OIRA review and the use of cost-benefit analysis; and ben-
efited from sustained participation in work of the Administration Law Section of the
ABA, where he has co-chaired both the Regulatory Policy Committee and the Com-
mittee  on  e-rule-making.  He  also  has  served  as  Special  Counsel  to  the  Deputy  Ad-
ministrator  of  EPA  and  as  Assistant  General  Counsel  of  USTR.  He  holds  a  B.A.
from  Princeton  University,  a  J.D.  from  Yale  Law  School,  and  a  D.Phil.  in  Politics
from Oxford University, which he attended as a Rhodes Scholar.

DISCUSSION

MORE ON REGULATORY POLICY OFFICERS

Chairman  MILLER.  Thank  you.  I  want  to  ask  Professor  Strauss
questions  early  because  I  understand  he  may  need  to  leave  but  I
wanted to ask first a question of Dr. Bass because part of his testi-
mony addressed some issues I have been thinking about myself.

You  discussed  a  reporting  requirement  to  show  what  proposed
rule-making was presented to an RPO and the RPO said no or ad-
justed  what  went  forward,  who  talked,  who  was  involved,  all  the
things that Mr. Rohrabacher seemed to think were suggesting sin-
ister  motives,  but  just  in  the  interests  of  transparency  it  doesn’t
seem  unreasonable  to  know  what  agencies  of  government,  what
they  are  deciding,  why  they  are  deciding  it  and  who  is  involved.
But  you  suggested  it  be  once  a  year.  Why  that  infrequently?  It
seems  like  many  of  these  decisions  if  they  are  to  be  challenged,  a
decision  not  to  go  forward  with  rule-making,  if  that  is  to  be  chal-
lenged,  it  should  be  challenged  much  more  quickly  than  once  a
year. You could easily have an 11-month period. Dr. Bass.

Dr.  BASS.  Well,  I  completely  agree  with  you,  Mr.  Chairman,  and
in  my  haste  to  speedily  move  through  an  oral  statement  I  mushed
together  many  items,  and  that  is  a  technical  term,  mushed.  I  do
think  that  what  needs  to  happen  is,  there  needs  to  be  a  proper
record  established  at  the  agency  so  that  these  RPOs  are  held  ac-
countable,  and  that  would  mean  ongoing  review.  What  I  was  sug-
gesting to help the public is through the twice-a-year Unified Regu-
latory  Agenda  that  is  published  in  the  Federal  Register,  there
should  be  a  section  on  items  that  were  permitted  to  go  forward,
items  that  were  not  permitted  to  go  forward,  and  a  justification
why.  The  annual  report  should  go  to  Congress  and  you  may  seek
to  have  it  even  more  often,  but  that  annual  report  should  also  get
into what changes in those that were going forward, what changes
were proposed in going forward along with the documentation from
the civil service staff that was transmitted to the RPO so that you
have a record of all of that, and let me just say, what we are talk-
ing about, Mr. Chairman, is mini OIRAs. Through this RPO system
and  the  connection  of  the  RPO  to  OIRA  creates  the  equivalent  of

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00078 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

211

an  OIRA  on  steroids,  so  it  is  essential  to  do  what  you  are  saying
and  I  realize  it  is  a  burden  for  the  agencies  and  I  realize  we  are
running up against things but it is essential.

Chairman  MILLER.  Professor  Strauss,  you  raised  great  concerns
about the statutory authority for RPOs to be given the powers that
they are. What remedies do you see that are available to Congress
for RPOs to be acting beyond the powers that Congress thought we
were giving agencies or the executive branch in rule-making? What
can we do about it?

Mr.  STRAUSS.  This  is  a  complex  question  in  the  world  of  politics
as  well  as  law  because  of  course  Congress  doesn’t  act  alone  and
what  you  are  talking  about  is  a  measure  in  which  the  President
has a significant and I would say personal political interest so that
whatever  Congress  might  decide  to  do,  either  has  to  meet  the
President’s  willingness  or  you  have  to  be  able  to  do  it  in  a  fashion
that  he  can’t  resist  over—you  have  to  be  able  to  override  a  presi-
dential  veto  or  perhaps  you  have  to  do  it  in  some  form  where  he
is obliged to accept the whole package, and this bit of remedy goes
with  it.  I  would  suppose  that  if  Congress  were  to  come  to  the  con-
clusion  that  regulatory  policy  officers  had  been  authorized  to  do
things  that  Congress  had  not  authorized  them  to  do  and  Congres-
sional  permission  was  necessary,  one  straightforward  thing  to  do
would  be  to  provide  in  the  annual  budget  no  funds  could  be  ex-
pended for these inappropriate functions. That is a kind of measure
that  is  frequently  found  in  other  contexts  in  appropriations  meas-
ures  that  the  President  signs  on  to.  He  wouldn’t  like  it.  I  don’t
think that is very good legislating in an important way but you are
between a rock and a hard place, it seems to me, and what I imag-
ine might result from this would be some negotiations between the
White  House  and  the  Congress  in  which  one  could  come  to  an  un-
derstanding about how the regulatory policy officers would function
including  provisions  for  transparency.  This  has  been  the  history  of
Executive  Order  12866  and  its  predecessors.  It  has  been  the  reg-
ular  course  of  bargaining  over  time  between  Congress  and  the
White  House.  The  transparency  provisions  currently  in  12866  did
not get there by accident. They were very much the product of Con-
gressional prodding in the period leading up to the adoption of Ex-
ecutive  Order  128666  under  the  Reagan  executive  order  then  ad-
ministered  by  President  Bush.  It  had  got  to  the  point  where  Con-
gress  refused  to  confirm  a  director  of  OIRA  for  a  period  of  years
on  the  understanding  that  we  were  going  to  have  some  bargains
made about the way in which you exercise this authority, and those
bargains were made.

MORE ON SEPARATION OF POWERS AND MARKET FAILURE

PROVISIONS

Chairman MILLER. My time has expired. It is my turn again.
Professor  Strauss,  yes,  I  would  imagine  that  that  would  be  the
subject  of  bargaining  but  I  have  yet  to  see  much  bargaining.  You
saw  some  of  it  in  the  first  panel  when  the  witness  said  that  this
executive  order  was  designed  to  enhance  transparency  and  I  said
how  did  you  decide  that?  He  said  it  is  none  of  your  business.  Cer-
tainly  withholding  funds,  as  you  point  out,  is  not  the  best  way  for
Congress  to  impose  its  will  to  just  prevent  the  President  from  au-

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00079 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

212

thorizing  something  but  politics  as  they  are,  that  is  possible  and
that is certainly one thing that may be possible.

A  question  for  anyone  on  the  panel  who  wishes  to  address  it,  I
raised  questions  in  my  opening  remarks  about  the  criteria  that
were  in  this  executive  order  for  issuing  orders  or  particular  rem-
edies,  particular  regulations,  market  failure  and  then  some  elabo-
ration  of  what  constitutes  market  failure.  Does  that  criterion  ap-
pear in statute, and if it does not, what is the authority of the exec-
utive branch to add that as a criterion in issuing regulations?

Mr. STRAUSS. Well, I am not sure that this will be a wholly satis-
factory  response.  In  part  in  response  to  Congress’s  own  wish  to
have  this  information,  the  President  requires  cost-benefit  analysis
to  be  done  in  accordance  with  the  criteria  that  he  has  in  mind,  I
don’t  myself  find  any  difficulty  with  his  asking  for  agencies  to  do
that analysis. It can be helpful to the President in proposing legis-
lation,  in  pursuing  the  priorities  of  his  Administration.  It  can  be
helpful  to  the  Congress  in  understanding  where  legislation  may  or
may  not  be  needed,  and  at  least  if  honestly  done,  I  really  do  com-
mend  my  colleague  Parker’s  extended  studies  for  their  demonstra-
tion  of  how  poorly  cost-benefit  analysis  is  sometimes  done  in  the
service  ultimately  of  political  ends.  But  if  it  is  well  done,  it  is  an
informative  and  useful  means  of  analysis.  For  me,  the  difficulty
comes,  and  I  think  this  is  instinct  in  your  question,  when  one
moves  from  acquiring  information  from  consulting  with  agencies
that  the  President  is  unquestionably  entitled  to  do,  to  taking  over
decisions, to telling agencies specifically what they are to do. When
you  pass  statutes,  you  give  agencies  responsibilities  and  you  give
agencies  responsibilities  within  specific  parameters.  Not  so  re-
cently,  the  Supreme  Court  made  very  clear,  for  example,  that  for
the  EPA,  costs  are  not  part  of  the  statutory  equation.  It  doesn’t
mean  that  EPA  can’t  develop  for  the  White  House  information
about  costs  and  even  have  discussions  with  the  White  House  in
which the White House’s view about the importance of avoiding ex-
cessively  costly  regulations  may  be  an  element  of  the  discussion,
but  the  responsibility  for  decision  is  placed  in  EPA’s  hands  and
EPA is not entitled when making or explaining its decision to con-
sider  costs.  It  is  quite  straightforward  as  a  matter  of  law.  So  the
issue is not so much not having the analyses made as making clear
where  it  is  that  the  responsibility  for  decision  lies  and  that  deci-
sions have to be taken without regard to these statutorily inappro-
priate factors.

Chairman MILLER. Mr. Parker.
Mr. PARKER. Yeah, and I just would add that I think with regard
to  your  specific  question  about  market  failure,  whether  or  not  this
new  language  is  problematic  I  think  would  depend  a  lot  on  how  it
is  implemented.  For  example,  any  good  lawyer  I  think  who  wants
to  justify  a  regulation  could  within  very  broad  bounds  identify  a
market  failure  that  the  regulation  could  address.  Market  failures
abound around us. It is pretty low-hanging fruit. And there is also
a  savings  clause  in  case  you  can’t  do  it.  But  the  regulation  itself
on its face is not facially problematic. The question is whether this
signals  an  intent  for  OMB  to  come  back  and  start  engaging  in  a
rebuttal process, a dialog and debate about whether there really is
this market failure, how bad is the market failure, would the mar-

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00080 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

213

ket  failure  be  as  bad  as  possible  government  failure,  which  is  a
standard,  you  know,  conservative  anti-regulatory—and  if  that  is
what  this—if  that  is  the  intention  behind  this  language  change,
then  that  is  distinctly  problematic.  The  language  change  itself,  if
market failure is an explanation that needs to be made and can be
made  unilaterally  by  the  agencies  and  is  taken  by  everybody  out-
side,  that  would  cause  no  problem  to  me.  It  is  this  question  about
whether it becomes a debating issue.

Dr. BASS. If I could add just——
Chairman MILLER. Dr. Bass.
Dr.  BASS.—three  more  points  to  the  fine  and  important  com-
ments  from  my  colleagues.  One  is,  I  know  of  nothing  in  cross-
cutting  law  that  requires  a  market  failure  analysis.  There  may  be
specific requirements in individual statutes but there is nothing to
my  knowledge  that  addresses  this,  which  raises  a  question  about
again the separation of powers question that you have been raising
all  day  of  Congressional  authority  versus  executive-branch  author-
ity.  The  second  point  is  that  what  has  not  been  mentioned  about
market-failure criteria today, Mr. Aitken failed to mention that one
of  the  changes  in  the  new  executive  order  is  the  last  line  which  is
an  assessment  of  whether  any  new  regulation  is  warranted.  That
becomes  dangerously  close  to  what  Professor  Strauss  was  talking
about  as  being  determinative,  and  if  this  rises  to  the  level  of  that,
then this is extremely troubling. The third point is confusion. Agen-
cies  have  to  implement  this  in  a  few  months.  What  the  heck  is
market-failure  assessment  supposed  to  involve?  What  we  heard
today is a repeat of three criteria that are simply listed in the new
executive order. That doesn’t help me clarify what it means to hap-
pen. It could be as absurd as the fact that the OIRA administrator,
Susan  Dudley,  drives  a  hybrid.  Is  that  an  indicator  there  is  no
problem with climate change? I mean, I don’t know what a market-
failure  assessment  will  involve  and  the  agencies  are  left  holding
the bag now.

Chairman MILLER. I am not a witness here but I agree with Dr.
Parker’s  assessment  that  there  probably  is  a  role  for  something—
is  the  market  going  to  take  care  of  this,  are  we  fixing  something
that  really  is  not  broken—and  in  deciding  whether  to  issue  new
regulations,  whether  to  address  a  problem  by  regulation.  If  there
is  a  problem  that  is  going  to  work  itself  out  fairly  shortly,  fairly
easily,  there  probably  should  be  some  discretion  but  as  Professor
Parker points out, it is a criterion that lends itself to seeing every-
thing through a dogmatic lens and there is a philosophical point of
view that the market fixes everything, the market never fails, and
that  is  the  point  I  made  in  my  opening  remarks,  or  in  an  earlier
round  of  questioning,  rather.  That  was  the  debate  last  week.  That
will  be  the  debate  again  and  again  on  every  issue  where  Congress
is proposing anything new: is the market going to fix it if Congress
will  leave  it  alone.  And  obviously  when  we  act  in  the  face  of  that,
we  are  rejecting  the  argument  that  the  market  has  not  failed,  the
market will fix it on its own, which does make I think transparency
all  the  more  important.  When  is  that  criterion  being  applied,  how
is  it  being  applied,  so  that  someone  may  challenge  it.  If  someone
wishes to bring a lawsuit to say the agency should have acted and
did  not,  that  they  know  when  it  is  happening,  and  I  think  all  of

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00081 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

214

you  have  made  that  transparency  point  in  your  testimony  and  it
is an issue that I raised in the last hearing on this topic.

MORE ON TRANSPARENCY PROVISIONS

Professor Strauss, Professor Parker, you heard Dr. Bass’s discus-
sion  of  possible  transparency  fixes.  Do  you  all  have  any  thoughts
on how we can address transparency issues?

Professor Strauss.
Mr.  STRAUSS.  I  think  that  it  would  be  useful,  I  am  not  sure  it
would  succeed  for  the  Congress  to  require  OIRA  and  the  agencies
to  follow  what  has  in  fact  been  the  best  practice,  that  I  am  aware
of agencies under the executive order as it now is. The Department
of  Transportation,  as  you  may  know,  has  a  really  quite  terrific
docketing system for all of its rule-makings into which every scrap
of paper that they may get is either scanned, or if it is in electronic
form, dumped, and if one looks at those dockets for the Department
of  Transportation,  one  finds  accounts  of  the  meetings  with  OIRA
that are thorough and extensive, who was there, what did they say,
what did the government officials say. That is done at the Depart-
ment  of  Transportation.  As  it  happens,  they  have  been  running  a
particularly  efficient  and  effective  rule-making  process  that  prob-
ably  not  coincidentally  runs  into  trouble  with  the  courts  a  lot  less
than  the  rule-making  making  processes  in  other  agencies.  That
should  happen  universally.  OIRA  doesn’t  keep  the  Department  of
Transportation  from  making  these  transcripts  available  on  its  web
site.  I  don’t  imagine  that  it  would  be  resisted  as  a  general  matter
but OIRA isn’t enforcing that either.

Chairman MILLER. Professor Parker.
Mr. PARKER. Yes. I would second that, and the suggestion of the
people in the agencies who made the complaint that I reported was
that  an  instruction  be  put  out  that  basically  is  somewhat  like  the
instruction  that  is  there  now  but  extended  into  the  pre-regulatory
initiative  process  and  I  think  that  is  what  DOT  is  already  doing.
So  it  can  be  done.  And  I  would  also  just  offer  a  comment  on  the
anticipated rebuttal, which is that all of this would get into the de-
liberative  process  and  we  can’t  do  that.  It  is  ironic  that  first,  the
Department of Transportation is doing it. Second, I thought it was
interesting  that  the  OMB  in  this  new  executive  order  seems  to  be
favoring  or  encouraging  formal  rule-making,  something  we  haven’t
really  talked  about,  and  actually  exempting  OIRA  review  from
processes to go through formal rule-making. What formal rule-mak-
ing  is,  you  know,  even  though  it  is  too  cumbersome  to  be  really
workable  because  of  its  trial  provisions,  it  does  have  one  provision
involving  ex  parte  contacts,  which  is  a  ban  on  them  once  things
have  initiated,  which  is  directly  relevant  here  and  I  think  it  gives
a  pretty  good  answer  to  arguments  that  oh,  we  must  have  all  of
these  things,  you  know,  in  back  rooms  or  people  won’t  be  able  to
be candid. You know, in that process, things are put on the record
and  we  don’t  consider  that  a  faulty  or  a  hampered  or  an  impaired
decision process because everything has to take place on the record.
So  I  think  that  there  are  answers  to  that  and  I  think  the  solution
that Professor Strauss echoed is a good one.

Dr.  BASS.  Mr.  Chairman,  could  I  just  add  one  more  element  to

this?

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00082 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

215

Chairman MILLER. Dr. Bass.
Dr. BASS. Ultimately, we always have to keep in mind why regu-
lations  are  needed.  We  are  first  and  foremost  about  protecting  the
public and our natural resources, and we tend to get lost in the dis-
cussion  of  the  technicalities  of  the  rule-making  system  and  forget
about  the  end  objective.  In  that  context,  transparency  is  critically
important, and I also think that this committee and other commit-
tees in Congress really need to look at the panoply of analyses im-
posed  on  the  agencies.  This  market-failure  criterion  is  yet  another
one.  Dr.  Melberth  testified  in  your  first  hearing  about  a  range  of
requirements that agencies have, what many call paralysis by anal-
ysis  or  Professor  McGarity  has  called  ossification.  We  have  to  look
at that in the context of our objective to get speedy, responsive reg-
ulation  done.  Ultimately,  what  has  happened  and  is  so  central  to
what  you  are  chairing  here  is  we  find  time  and  again  now  politics
is superseding science, and the only way I know to address that is
to talk about the entire regulatory process as something that needs
to be opened up. That is why the guidance issue that has come up
in this context of the executive order is troubling. If more agencies
are  turning  to  guidance,  it  is  probably  because  the  existing  rule-
making  system  doesn’t  work  that  well  from  their  point  of  view.  It
is then subjected to the same system. We are kind of going around
in circles on this issue.

Mr. STRAUSS. If I could just add one thought to that. The formal
rule-making  provision  is  an  invitation  to  another  form  of  paralysis
by analysis and presumably this is the reason why the OIRA proc-
ess  is  not  regarded  as  being  so  important  there.  What  it  does  is,
it delivers into the hands of those who would wish to obstruct rule-
making  making  the  procedural  tools  with  which  to  do  so  through
cross-examination, through extended processes and the like. This is
why  it  is  not  used  anymore  is  because  it  is  a  terribly  inefficient
means  to  make  rules.  But  I  do  want  to  echo  what  Mr.  Bass  has
said. One job for the Congress, perhaps not your committee but an-
other, clearly is to take the enormous range of provisions that have
been  adopted  by  executive  order  and  by  legislation  requiring  anal-
ysis  of  this  issue  and  that  issue  and  this  other  issue  in  the  course
of  rule-makings  and  to  produce  a  somewhat  more  streamlined
version.  I  don’t  think  that  is  our  work  today  but  it  is  a  matter  of
enormous importance to the success of this mechanism.

Chairman  MILLER.  I  think  that  is  all  the  questions  that  I  have
for  now.  Do  any  of  you  have  any  valedictory  comments,  Professor
Parker, Dr. Bass, Professor Strauss?

Dr. BASS. We appreciate you holding this hearing.
Chairman  MILLER.  Thank  you  very  much  for  being  here.  Our

hearing is adjourned.

[Whereupon, at 1:20 p.m., the Subcommittee was adjourned.]

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00083 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00084 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

Appendix:

ADDITIONAL MATERIAL FOR THE RECORD

(217)

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00085 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

218

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00086 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

219

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00087 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

220

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00088 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

221

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00089 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

222

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00090 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

223

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00091 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

224

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00092 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

225

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00093 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

226

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00094 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

227

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00095 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

228

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00096 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

229

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00097 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

230

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00098 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

231

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00099 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

232

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00100 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

233

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00101 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

234

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00102 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

235

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00103 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

236

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00104 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

237

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00105 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

238

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00106 Fmt 6601 Sfmt 6602 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

239

Æ

VerDate 11-MAY-2000 09:42 Nov 14, 2007 Jkt 033105 PO 00000 Frm 00107 Fmt 6601 Sfmt 6601 C:\WORKD\I&O07\021307\33105A SCIENCE1 PsN: SCIENCE1

